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Abstract 
This inquiry investigated the suitability of the jaw of domestic sheep as an animal model for 
dental implantology research. Initially, parameters for osseous healing of critical size defects 
(CSD) in the sheep mandible were established. Pilot studies were conducted using machined-
surface implants and a surgical protocol established for dental implant placement in ovine 
mandibular sites. Subsequent experiments considered the utility of this animal model for 
examination of techniques designed to enhance osseointegration. Hydroxyapatite-coated 
implants were compared with titanium plasma-sprayed (TPS) implants, either alone or 
combined with autogenous bone grafts or a bone graft/collagen vehicle loaded with 
transforming growth factor-beta (TGF-B). Immunofluorescent bone labelling gave 
information on the mineral apposition rate (MAR). Implant survival and "acceptability" 
(likelihood of clinical success) were major output variables, along with histomorphometric 
analysis of percent bone-implant contact (%BIC) and percent peri-implant bone density 
(%density). Naturally-occurring "broken-mouth" periodontitis in sheep was identified as a 
potential confounder. Subsequent experiments considered implants with different surfaces. 
The model was also extended from a two-stage surgical protocol to include single-stage 
implants. The effect of pre-existing ovine peridontitis was also examined. A systematic 
review and meta-analysis of published animal implant experiments was conducted in order to 
validate the candidate sheep model. 
Major findings were as follows. The size of non-healing sheep mandibular unicortical CSD is 
> 12mm. Attempts to establish a chronic non-healing CSD were unsuccessful. The sheep 
diastema proved unsuitable for implant placement. The model was modified to a post-
extraction protocol. Implant "acceptability" rates after 3 months integration in the sheep 
mandible (defined as implant survival with %BIC >10%) ranged from 50% - 100% for 
different implant surface treatments and placement protocols. Histomorphometric analyses 
revealed that %BIC ranged from 11 ± 17% to 81 ± 29 % for different titanium surfaces and up 
to 85 ± 11 % for hydroxyapatite surfaces. Implants with TGF-B plus autogenous bone grafts 
had %BIC of 36 ± 30% compared with 43 ± 30% for implants with grafts alone. Bone per 
unit area (%density) adjacent to, but outside of the implant threads, ranged from 63 ± 16% to 
86 ± 3% and was markedly lower for titanium plasma-sprayed surfaces and for one-stage 
implants. Within the implant threads, %density varied from 31 ± 33% to 73.4 ± 8.3%, and 
was markedly lower for machined titanium surfaces. Sheep periodontitis had little effect on 
the protocols investigated. The sheep mandibular model was found to be comparable to 
similar models in other species and merits further development. 
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Chapter 1: Introduction and Literature Review. 
1.1. Introduction. 
The overall aim of these experiments was the establishment of a sheep mandibular model for 
dental implantology investigations. Initial work focused on the healing of unicortical critical 
size defects (CSDs) in the lateral surface of the mandible. The results of these studies were 
then used in the development of a model for dental implants. Little or no published works 
exists for either CSDs or dental implants in the sheep mandible. The purpose of this literature 
review is to briefly recapitulate the history of dental implant research, to examine the 
rationale for the use of sheep as an animal model and to scrutinize published evidence from 
animal models for CSDs and for dental implant research. Particular emphasis for the latter is 
placed on modifications to dental implants that may be expected to increase bone-implant 
contact and the techniques that are available for analysing this. This chapter concludes with a 
summary and the formulation of hypotheses. 
1.1.2. History & success of dental implants. 
The original concept of osseointegrated dental endosseous implantation was described for 
titanium solid-screw implants with smooth (machined) surfaces placed using a two-stage 
approach. 1 This was shortly followed by the development of hollow-cylinder implants with a 
titanium-plasma spray (TPS) surface, placed using a single-stage approach.2 Initial treatment 
focused mainly on full-mouth rehabilitation of edentulous subjects.3 During the succeeding 
quarter-century, the clinical applications of dental implant therapy have expanded to include 
partially edentulous subjects, single-tooth implants, single- and two-stage systems, the 
immediate replacement of teeth and the immediate loading of implants. 4-15 Increasingly, 
implants are being placed into less-favourable sites such as those with inadequate bone 
quantity or quality/density, or into high-risk subjects such as smokers, diabetics, elderly 
patients, or patients whose natural dentition is affected by periodontitis. 16-19 
Results for survival and success of a plethora of implants systems have been reported 
including Astra 20 Branemark 21 Endopore 22• 23 Frialit-2 24• 25 ITI 26-28 IMZ 29 3i 30-32 Calcitek ' ' ' , ' ' ' 
HA-coated cylinders and screws,33' 34 ScrewVent,35 Micro Vent and SwedeVent,36 Southern 
Implants37 and SteriOss HA-coated implants.38 The results of long-term trials and meta-
analyses of these trials suggest that most modern implant systems, both one-stage12 and two-
stage, 13 can achieve success rates and/or cumulative survival rates over >5 years of 90 to 
21 
100%. Exceptions to these are results reported for IMZ implants,29 Astra,2° Screw Vent,35 and 
Calcitek HA-coated cylinders,33• 39 
Immediate loading does not appear to adversly affect success rates.40-42• 37 Meta-analyses 
suggest that guided-bone regeneration does not reduce the success rate of implants43 but 
implant success may be reduced for implants with smooth or "as-machined" surfaces placed 
into poor quality bone 31 and bone-grafted maxillae.44 Results appear to be les successful in 
smokers45 ' 46 although this may be more of a problem for smooth-surfaced implants than 
rough.47• 48 Evidence suggests that failure rates may be higher in diabetics49-52 and in patients 
with a past history of periodontitis.53-55 It should be noted however that a recent Cochrane 
Database systematic review and meta-analysis of different implant systems only identified 
nine implant types examined in ten randomised clinical trials (RCTs) as being suitable for 
inclusion.56 The authors concluded that the quality of randomised clinical trials with dental 
implants was generally poor, with insufficient sample size and follow-up periods of short 
duration only.57 A list and synopsis of implant trials and success rates has recently been 
published online.58 
The expansion of the accepted indications for dental implantology has generated an 
astonishing increase in research output. The aims of researchers with respect to dental 
implantology as a treatment protocol may be summarised as follows: to establish the 
biological and biomechanical parameters; to define the risks and contraindications (at levels 
ranging from sub-cellular to population-based research); and to develop strategies for 
modifying the interactions between implant and host. 59• 17• 60-62 Much of this research involves 
clinical investigations carried out in human subjects. The movement towards evidence-based 
medicine (EBM) has generated rules and levels of evidence63-66 which can be used in the 
analysis of such data.57• 56 Data generated by animal models are relegated by these rules to the 
lowermost and least reliable level of evidence. However, medical reviewers have 
"acknowledged that in the absence of definitive human studies, animal studies remain an 
essential research tool" .67 
1.1.3. Meta-analysis of animal research as evidence-based research. 
Recently, Pound et al. (2004) of the "Reviewing Animal Trials Systematically" (RATS) 
Group68 argued that animal research that is not evaluated through systematic reviews is 
wasted research. They listed several methods for evaluating animal research but concluded 
that the best way of producing evidence about the value of animal research is to conduct 
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systematic reviews of animal studies and to compare the results of these with the results of 
the corresponding clinical trials in humans. They then carried out a systematic Medline search 
for published systematic reviews of animal experiments and identified 277 possible papers. 
Twenty-five reports of systematic reviews were identified; 7 had been conducted to find out 
how the animal research had informed the clinical research, 10 were conducted to assess 
evidence for proceeding to clinical trials and 8 reviewed both the animal and human studies in 
a particular field. Only one review in the implant field (peri-implantits including animal 
models) was identified. 69 
The authors concluded that systematic reviews of animal research should be a pre-requisite 
before gaining ethical approval for human clinical trials. They suggested that such reviews 
would be of value in the field of veterinary medicine, and would also ensure that "animal 
experiments do not set out to answer questions that have already been answered". This 
supports the principle of reduction, one of the "three R's" held to be cornerstones of animal 
research. As noted above, databases of systematic reviews of implant trials in humans already 
exist within the Cochrane Database; as yet no attempt has been made to include systemic 
reviews of dental implant trials in animal models. 
Although evidence extrapolated from animal models is generally considered to be of least 
value when an evidence-based approach is used, the expansion of our knowledge with respect 
to dental implantology frequently mandates the use of invasive procedures for analysis. Two 
examples are histological and/or histomorphometric examination of hard-tissue healing in 
bone defects or adjacent to dental implants. For such investigations, initial work may best be 
performed using a well-characterised animal and the results then confirmed by clinical 
examination in human subjects. This work details the development and characterisation of a 
novel animal model for dental implantology, the domestic New Zealand sheep, and examines 
the utility of this model for the two specific examples of invasive investigation discussed 
above. 
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1.2. Rationale for the use of sheep. 
The aim of this work was to develop animal models for studying different aspects of dental 
implantology using the New Zealand domestic sheep (Ovis aries). Sheep have been promoted 
as a useful large animal model for diverse fields of biomedical research because of their 
similarity to humans in size, weight and general physiology as well as their ease of handling 
and their robust recovery from anaesthesia and experimental surgery.70-73 In a chapter entitled 
"How To Choose Animal Models In Orthopaedic Research", An and Friedman (1999) listed 
six considerations, shown in Table 1.1:74 




3) Housing requirements 
4) Ease of handling 
5) Cost 
6) Susceptibility to disease 
1.2.2. Ethical issues. 
Animal experimentation is considered ethically more acceptable to contemporary society 
where a) domestic animals are used rather than companion animals such as dogs and cats, b) 
the studies are directly applicable to human patients rather than primarily of basic scientific 
value, c) the procedures do not cause severe pain or suffering to the animal and d) a limited 
number of animals yields information of scientific merit. 71 • 74 An and Friedman (1999) 
concluded that "for most orthopaedic animal studies, there is no specific reason for dogs to be 
used when goats and sheep are also available" .74 
This work concerns the refinement of animal models using sheep in order to obtain, in the 
first instance, basic scientific information regarding osseous healing in the mandible. 
Information gained from these experiments was then used to develop novel models in order to 
compare the efficacy of various therapies claimed to modify the osseointegration of dental 
implants. In the main the experiments in this work followed the protocols already commonly 
used in humans and fulfilled the criteria for ethical acceptability discussed above. 
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1.2.3. Use of sheep versus other species. 
An and Friedman (1999) surveyed animal models used for scientific articles published in The 
Journal of Orthopaedic Research between 1992-96.74 The most common species were the 
rabbit (26.3%), rat (24.9%), dog (24.6%) and goat (8.2%). Sheep ranked 7th and were the 
animal model of choice for only 1.8% of papers. An and Friedman (1999) noted that 
knowledge regarding the parameters of healing in sheep is increasing with increasing use of 
the species during recent years, although (in common with the more popular goat models), 
basic data is still lacking in some areas. 
According to these authors sheep have a similar cost to dogs in the United States 
(approximately NZ$600 per animal in 1999) and are more difficult to handle, which may 
account for the lower popularity of these species (see: An and Friedman 1999, Table 1, page 
43). However, in New Zealand the cost of sheep is 1110th that of the USA, and neither housing 
nor animal handling are issues. Large numbers of sheep are available and there is a great deal 
of experience in managing this domestic species - in New Zealand, the number of animals 
ranges seasonally from 20 to 80 million, and intensive sheep farming has been a dominant 
part of the economy for over 200 years. 
Others have further documented the worldwide use of sheep for biomedical research. Martini 
et al. (2001) reviewed the use of sheep for orthopaedic research.75 Their survey of the 
literature found that sheep comprised only 2% of orthopaedic animal models during 1970-
2001, with rodents (rats, mice, rabbits and guinea pigs) predominating (76%). The most 
common large mammal used was the dog (9%) which the authors ascribed to the adaptation 
of verterinary research by orthopaedic investigators rather than development of a specific 
model of the human condition. Sheep were more popular for studying fracture repair (12%) 
than bone lengthening (11 %), osteoarthritis (10%) or osteoporosis (9%). 
Martini et al. (2001) noted further that, although some authors have shown similarities in 
structure and mineralisation rate between human, dog and sheep trabecular bone, cortical 
bone in sheep may differ from both; sheep cortical bone healing approximates humans but 
















McMillen (2001) employed a simple Medline search to count the relative number of papers 
published in the biomedical literature during the years 1991-2000 citing the use of either 
human or animal species.76• 77 She suggested that sheep, although relatively little used world-
wide, are proportionately much higher represented in biomedical literature published in 
Australia during the same period. 
This methodology has been repeated below, using the Medline search terms specified by 
McMillen - "sheep or ovine", "human", "rat", "mouse", "goat or caprine", "cow or bovine", 
"monkey or simian" - with the additional term "dog", an important species for dental 
implantology research. The average number of papers per species per year in the period 1991-
2000 are shown in table 1.2 and Figure 1.1 . 
Table 1.2: Mean number of papers published (xl03) per animal species per year for the 
period 1991-2000 
Average papers/year '9 l -'00 % 6f total 
Human 38.3 44.0 
Rat 18 20.7 
Mouse 16.8 19.3 
Cow I bovine 4.4 5.1 
Sheep / ovine 4.3 4.9 
Pig 2.5 2.9 
Dog 1.2 1.4 
Monkey /simian 1.3 1.5 
Goat I caprine 0.3 0.3 
These results differ slightly from McKinley's, however the general trend is similar. In 
Australasia the proportion of publications citing the sheep as an animal model is much higher 
than the rest of the world (15 .6% compared with 5.1 %). The proportion of papers originating 
from Australian institutions that cite the sheep as an animal model over the last decade was 
approximately 14%; the use of sheep ranked 3rd after humans (42%) and rats (21 %). In 
publications by New Zealand institutions, sheep are even more popular, ranking 2nd (26.5%) 
behind humans (35.8%) as the model of choice. 
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As McKinley noted, "not every paper using the word sheep or ovine necessarily uses the 
sheep as an animal model, but may use biochemical reagents of sheep origin". If the search 
terms "blood" and "anti-" are used to identify the use of sheep's blood and sheep 
immunoglobulin, 2 - 4% of the total research output found using "sheep or ovine" might be 
excluded. However, the conclusion remains valid - the use of sheep in biomedical research in 
Australasia is 2-3 times more common than the rest of the world, and the use of sheep 
remains more common globally than for example the use of monkeys or dogs. Sheep are an 
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1.2.4. Criteria for an animal model for dental implant research. 
It is considered desirable that an animal model used for dental implant research should be 
inexpensive, easily obtained and anaesthetised, provide sites with both cortical and cancellous 
bone, and resemble the human mandible with respect to physical dimensions, embryological 
development and physiology.78• 75 
Eitel et al. ( 1981) suggested that extrapolation from sheep to man may not be valid because 
sheep cortical bone contains a higher proportion of primary Haversian lamaellae than human 
bone.79 For this reason they recommended instead the use of the dog model. This hypothesis 
was examined by Lippuner et al (1992) who compared the effect of internal plate-fixation in 
the tibia and femur of four sheep and nine dogs. They found "no appreciable difference in 
subplate cortical vascular damage for comparable plates between the dog and the sheep" and 
concluded that "the animal experiments reported here and previously are comparable and the 
results are applicable to the human situation" .80 Other investigators have also refuted these 
findings (see review by Martini et al. 2001).75 
1.2.5: The sheep as a preclinical surgical model. 
Sheep have been employed as a surgical model for orthopaedic investigations,81-90 for the 
testing of bone graft materials91 -95 and for maxillofacial surgery .70• 96' 97 Examples of osseous 
healing models that use sheep are listed in table 1.3. In these sheep animal models, injuries, 
wounds or metabolic conditions were induced surgically and their healing and/or surgical 
repair studied. However, during the course of the present work, it was observed that the 
exposed portion of the dental implants in some sheep showed evidence of chronic 
inflammation. 
1.2.6. The sheep as a potential model for periodontitis and peri-implantitis. 
In New Zealand, sheep may develop a spontaneous chronic inflammatory periodontal disease 
around their teeth that is similar to the human disease. 127 Moreover, dental implants in human 
beings may be affected by a similar disease, peri-implantitis, which can cause the endosseous 
prosthesis to fail. 128• 61 Since no animal models for spontaneous peri-implantitis currently 
exist, this serendipitous finding was further explored in the current work. An and Friedman 
(1999) commented that "spontaneous diseases in animals during experiments can seriously 
compromise the experimental plan, confuse research data, and raise the cost" .74 However, the 
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existence of a naturally-occurring disease in an animal species that is analogous to a human 
condition may also offer an opportunity for the development of a novel animal model. For 
example, the existence of spontaneous osteoporosis in sheep129 led to the development of 
various ovine models of induced osteoporosis.73' 101 This in turn led to investigations in sheep 
into the interaction between altered bone metabolism and firstly, osseous healing103- 105 and 
secondly, periodontal disease. 102 Recently Fini et al (2002) published a histomorphometric 
analysis of bone-implant contact around threaded titanium alloy impants in an overiectomised 
sheep model. 126 
1.2.7. Selection of methods for analysing dental implant in a sheep model 
In this current work, two kinds of wounds were studied: osseous healing within bone defects, 
and osseous healing adjacent to dental implants. Ideally, in order to gain an accurate picture 
of how these new sheep models compare with other models and with the human situation, 
multiple experiments would be required using the same wound ( eg: a standardised surgical 
defect within bone, or the placement of a standardised titanium implant) performed at 
multiple anatomical and skeletal sites and then comparing the healing of these wounds with 
other different animal species over a standardised time period. Restrictions of time and cost 
did not permit this to be done. One alternative was to analyse the entire published literature 
regarding osseous healing in the defect under consideration. 
Evidence-based medicine emphasises the meta-analysis of results generated by multiple (and 
preferably multi-centre) investigations, as this greatly increases the sample size (N), as well as 
compensating for poorly controlled variables such as natural variations in healing that exist 
between individuals. Most animal trials use relatively small numbers, and there is often very 
poor standardisation of research methodology. Individual direct comparisons between 
different experimental protocols (especially across animal species) generally yield little 
valuable information. A formal meta-analysis of animal models with respect to osseous 
healing puts into perspective the relative rates and percentage of healing for different 
anatomical locations in different species. Coupling the development of a new model to a 
meta-analysis of existing models, clearly defines the merits or otherwise of the novel model. 
30 
1.2.8. Summary of potential areas for study. 
Biomedical and orthopaedic literature supports the potential of the sheep as an appropriate 
animal species for research within the maxillofacial region. Three potential areas of enquiry 
were identified for model development: (1) the healing of critical size defects (CSD) in the 
sheep mandible; (2) the osseointegration of dental implants in the sheep mandible; and (3) 
peri-implant mucosal disease in sheep. This current work details investigations into two 
potential models: sheep mandibular CSD and dental implants in the sheep mandible, and 
includes an preliminary study of peri-implantitis in sheep. The literature regarding each of 
these areas will be discussed under separate subheadings in the remainder of this chapter. 
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Table 1.3: Surgical models of osseous healing in sheep, excluding critical size defect models. 
Moroni et al. 199998 Femora Hip replacement Entire hip successful 
Peltonen et al. 198899 Distal radius Distraction 5 to 18mm 3 -6 weeks 16 weeks for remodelling of 
medullary canal 
Lippuner et al. 199280 Tibia& Cortical plating 9 hours Dog and sheep are comparable 
femur and appropriate models for man. 
Walton 1989 Tibia -patella Suture degradation Intra-articular 1,2,3,4,6 weeks Loading in joint accelerated 
Walton 199181 • 86 sutures suture breakdown. Monofilament 
sutures superior. 
Walton 199990 Tibia ACL' replacement Comparison 0,2,3,6,12,26,& Polyglyconate screw resorbed 
(bone-patellar resorbable 52 weeks after 12 weeks. Titanium screws 
tendon - bone polyglyconate vs not integrated. 
autograft) titanium 5.5 x 
15mm screw 
Laws and Walton Femur/ tibia/ Grade II ligament SS' pins in knee 0,1,3,6 weeks Described healing after injury 
1988.100 patella injury to MCLh and forces applied 
to produce injury 
Newman et al. 1995 Skeleton Osteoporosis Reviews of sheep osteoporosis 
Bellino 200073· 101 model 
Johnson et al. Mandible Osteoporosis Ovariectomy Effect on periodontal condition 
1997.102 and other parameters 
Chavassieux et al. Skeleton Osteoporosis Chemically and surgically 
1991, 1993,2001 103·105 induced osteoporosis in sheep 
De Pablos et al. Femur Segmental defect 4O-5Omm gap O.25mm/day for All gaps healed after 4 months. 
1994106 with distraction 7-10 days; healing Bone repair was more rapid in 6-
osteogenesis @4mo. 12 month old lambs than 6-12 
month old dogs. 
Bolton & Bruchman, Tibia/ femur ACLandMCL GoreTex e-PTFE" 0, 90,218 days Ingrowth of fibrous connective 
1985.107 replacement prosthesis tissue was noted after 105 days. 
Success in this model led directly 
to placement of prosthesis in 
humans. 
Amis et al. 1992108 Tibia/ femur ACL replacement Polyester ligament 6,12,24 months Testing led to clinical use in 
prosthesis humans. 
Edwards et al. 1996109 Patella Meniscus Meniscectomy / 13 to 30 months All joints developed 
replacement autograft I allograft osetoarthritis. 
Karaharju et al. Radius & Distraction 0.5 - 1.0 mm I day 5 - 28 days Similar healing 
199389 mandible osteogenesis. 
McTavish et al. Mandible Distraction 6.0 to 16.5 mm 45 days Permanent, stable bone formation 
2000110 osteogenesis. 
Farhadieh et al. Mandible Distraction 1-4mm/ day 5 weeks Demonstration of growth factors 
2000111 osteogenesis. 24mm total during healing 
Bahr et al 1999.112 Maxilla Distraction Le Fort 1 2,6,12 & 16 Test biodegradable screws 
osteogenesis osteotomy months 
Karaharju-Suvanto et Mandible Distraction 8mm 16 days Similar healing to femoral 
al. 199082 osteogenesis distraction in sheep (note these 
were 13 - 19 week-old lambs) 
Tavakoli et al. Mandible Distraction l.Omm/ day 20 days Demonstration of growth factors 
1999113 osteogenesis during healing 
Karaharju-Suvanto et Mandibular Distraction 0.5 - 1.0mm /day 4-16 days 13.5 - 19 week sheep. Almost 
al. 1992.88 ramus osteogenesis complete healing, 20 weeks after 
distraction. 
Suuronen et Mandibular Osteotomy& Condyle sectioned 6,12,24 weeks Resorbable versus stainless steel 
al.1992114• condyle osteosynthesis screw fixation. Severe changes in 
the head of condyle seen. 
Rachmiel et al Maxilla Distraction Le fort II I year Successfully healed 
1998.115 osteogenesis osteotomy & 
expand to 40mm 
Gagg! et al. 2000. 116 Mandible Distraction 3cmx5mm O.5mm/day for 8 70 - 80% bone appostion after 6 
osteogenesis oseteotomy in days; 1,2,3,6 months. Mean worst ppd' @ I 
Titanium screws diastema, 4.1 x months healing mo"= 3mm, 2mo=2.75, 
11mm Ti' conical 3mo=3.25, 6mo=2.25. Mean 
screw rough- PTVh = +5.75, +3.75, +0.25, -
surfaced implant 1.25. Reconstruction not 
complete at 6 months. NB: 
similar results to dog mandible 
Pl oder et al. 1999. 117 Mandible Distraction Corticotomy in 14 days Note 2.7mm dia Ti screws 
osteogenesis diastema region. lengthening, 6-7 loosened under load. Used 
Titanium screws Implanted motor- weeks follow up. 3.5mm cp; Ti (Leibinger DE) 
driven device inserted bucco-lingually in molar 
1.0mm I day= 7.1 and diastema region. Callus 
to 13.6mm gap healing in gap observed. Early 
loading of 3.5mm Ti screws 
successful? 
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Hipp et al.1990. 118 Femur In vitro and Finite Transcortical defect - Transcortical holes ~0% of 
Edgerton et al. 1990 element models as% of 19.6mm outer bone diameter = risk of 
119 outer (12.8mm pathological fracture. 
inner) diameter of 
bone 
Ylinen et al 1991 95 Mandibular HAi graft & PGAk Subperiosteal 3,6,12,24 weeks 7 dehiscences of suture line on 
diastema mesh tunnel implant side. 35% showed 
bulging of PGA implant. 
Thyne et al. 199297 Mandibular Disc replacement Discectomy 2,4,12,24 weeks Replacement of disc with 
TMJ1 temporalis muscle unsuccessful. 
Bosanquet et al. Mandibular Disc replacement Discectomy 40 weeks Replacement of disc with silastic 
1991 120 TMJ implant unsuccessful. 
Bosanquet et al Mandibular TMJ model TMJ Description 
198770 TMJ 
Suuronen et al. Mandibular Transverse 6,12,24 weeks Resorbable PLLA m plate + 
1992.114 body osteotomy 2.7mm titanium screws.2/3 had 
(diastema) (sectioned) union at 6 weeks, and all at 12 & 
24 weeks with considerable 
callus and mandibular 
thickening. 
Arvier et al. 1989121 Mandible Transmandibular Lower border 4 & 13 weeks Various metals tested for 
implant mandible+ biocompatibility 
transosseous struts 
in diastema 
Miyamoto et al. Mandibular TMJ ankylosis Remove articular 3 months 2 animals lost 4% body weight. 
1999.122 condyle surface condyle All showed loss of jaw 
movement. 
Kluemper et al. Mandible Extraosseous Circum-ramus Not stated 27% had soft tissue 
1995.123 implant extraosseous inflammation, 74% had pus, 27% 
implant for had implant fractures, 505 had 
orthodontic mobility. Both bone resoprtion 
anchorage and apposition were recorded. 
Kallela et al. 1999124 Mandible Resorbable Polylactic acid 3, 6, 12 and 24 No difference stainless steel 
osteosynthesis screws weeks versus PLA0 screws. Both groups 
screws had displacements of the 
osteotomy fragments suggesting 
high loading in the sheep model. 
Hanson et al. 1994125 Mid-face Orbital floor defects Reconstruction 2 weeks, 1, 2, 4, Expanded 
with I-mm thick e- &6months polytetrafluoroethylene found to 
PTFE sheet be an excellent material for 
repair of orbital floor defects in 
this study. 
Fini et al. 2002 126 Tibia Titanium alloy 12 weeks Significant decrease in % bone-
screws, osetoporotic implant contact and % bone area 
sheep in osteopenic cortical bone. 
a.ACL Anterior cruciate ligament h.PTV PerioTest value 
b.MCL Medial cruciate ligament i. cp commercially-pure 
C. SS Stainless steel j.HA hydroxyapatite 
d. e-PTFE expanded polytetrafluoroethylene (Teflon) k.PGA poly-glycolic acid 
e. Ti Titanium l.TMJ temporomandibular joint 
f. ppd Probing pocket depths m.PLLA poly-(L)-lactic acid 









1.3. "Critical size defects" used to verify the suitability of a potential animal 
model for dental implantology. 
The evaluation of new surgical materials and procedures requires an appropriate animal 
model. This allows both a qualitative, histological description of the healed site, and a 
quantitative or histometric analysis of the amount of new tissue produced.78 ' 71 With respect to 
the development of animal implant models, Martini et al. (2001) commented that "strategies 
for selecting an experimental animal model also require clear understanding of spontaneous 
bone defect healing, to correlate experimental data obtained from humans. Interspecies 
differences may be overcome thanks to the knowledge of healing in criticial size defects".75 
Further, Brunski (1999) noted that in the months immediately following implant surgery, 
"bone healing, in gaps between implant and bone, ...... will determine interface structure and 
properties". 130 
Before placing implants into an anatomical site, it is therefore considered desirable to have an 
understanding of the osseous healing potential of the area under consideration. As will be 
discussed later in this review, little is known about the rate and manner of healing in the 
sheep mandibular diastema. However, this knowledge may be gained by creating an intra-
osseous wound large enough to preclude spontaneous osseous healing. 131 ' 132 Bone regenerates 
from the periphery of an intra-osseous wound towards the center. Simultanously, soft tissue 
(eg: connective tissue, muscle, manow) proliferates into the wound. 133 It has been shown that, 
if the wound is larger than a certain size, only the most peripheral part of the defect becomes 
occupied by bone; the central port~on is invaded with soft tissue. 134• 135 This dimension has 
been termed the "critical size" of the osseous defect (CSD).137 Comparison of the relative 
dimensions of such defects, in different animal species and in humans, gives some indication 
of the relative rate of osseous regeneration. Knowldege of this rate would aid in the selection 
of an appropriate healing period, following the placement of dental implants. Development of 
a protocol for surgical access to the mandibular diastema region would also contibute to the 
formulation of a surgical protocol for implant placement in this animal model. 
Factors other than the physical size of the wound are involved, including the animal species, 
the mode of wounding (eg: "acute" surgical wound versus chronic inflammatory destruction), 
the three-dimensional conformation of the wound (eg: segmental, bicortical, unicortical), the 
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anatomical location and functional role of the bone that is wounded, and the age of the 
animal. 136-139 For example, Harris et al. (1968) measured the rate of cortical bone formation in 
different bones (femur, tibia, ulna, radius, humerus and ribs) in three dogs over two separate 
12-week periods using tetracycline bone labelling.140 They found differences in the rate of 
bone formation between different animals, as well between different bones within the same 
animal. Sections from different parts of the same bone healed at differing rates. In addition, 
healing rates differed at various times within the same animal by up to a factor of ten. For this 
reason, knowledge gained from osseous wounds such as segmental defects in limbs, may be 
of limited use when considering a different wound configuration in another anatomical 
location. Dental implant placement commences with the creation of a unicortical osteotomy; 
examination of the response of the sheep mandible to a unicortical osteotomy is a sensible 
first step before proceeding to placement of dental implants (for an fuller explanation of CSD 
configurations, see section 1.3.3 and Figure 1.2). 
Animal species that are lower in the phylogenetic order (eg: rodents) heal much more rapidly 
than mammals, and so on up to the primates and man. Thus, wounds heal more quickly in 
rabbits than in man. A 10mm diameter osseous defect in man, in proportion to the size and 
volume of the wounded bone and the individual organism as a whole, represents a much 
larger defect in the physically smaller rabbit. If an animal model is to generate data regarding 
osseous healing that we can apply to our human patients, the relationship between the animal 
species and humans for both the rate of healing and the size of defects needs to be 
understood. 
1.3.2. Definition of critical size defects. 
The synthesis of all these elements has been termed "the critical size defect" (CSD) and has 
been comprehensively reviewed. 137' 71 ' 74 A CSD has been defined as "the smallest size 
intraosseous wound in a particular bone and species of an animal that will not heal 
spontaneously in the life time of the animal" .137 Hollinger and Kleinschmidt (1990) further 
defined a CSD as "a defect which has less than 10 percent of bony regeneration occur within 
the lifetime of the animal".71 They suggested that the majority of healing should have 
occurred within one year. 
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1.3.3. Previous work on CSDs in sheep. 
Although data has been published about CSDs in the mandibles of other species, and in bones 
other than the mandible in sheep, little is known about osseous healing in the sheep mandible. 
A single, poor-quality publication suggested that 4-5mm-diameter unicortical bur holes in the 
diastema of the sheep mandible fail to heal completely after 4, 8 and 12 months91 but no 
histometric, histological or radiographic data was published to support this. (The same 
group141 also reported the placement of one implant into the sheep mandibular diastema, a site 
they then abandoned without further discussion.) Before investigating the usefulness of the 
sheep mandible for dental implantology, the parameters of osseous healing in the ovine 
mandible need to be established. An appropriate mechanism to achieve this would be 
investigation of the "critical size defect" in the lower jaw of the sheep. 
1.3.4. Review of the literature for CSDs in other animal species. 
To gain some idea as to the possible critical size for defect healing in the sheep mandible, the 
literature regarding critical sizes for maxillofacial skeletal bone in other species was 
examined. Animal species in which researchers have investigated the critical size for osseous 
defects include the rat, 142' 134' 143 the rabbit,78 the dog, 144-146 the sheep147 and primates such as 
baboons148 and monkeys. 149 Various skeletal sites in these species have been investigated. 
Frequently the parietal bones of the calvaria have been used. 150• 78• 146• 142• 151 • 152• 143• 153 The long 
bones of various limbs have also been employed. 133• 154' 155 A common orthopaedic model 
involves the creation of a segmental or discontinuity defect, where a segment of a long bone 
(eg: tibia) is removed. 156 
Another model is the circumscribed, circular defect in bone, created using a trephine bur. In a 
circular defect, bone regenerates from the periphery of the wound towards the centre. 
Simultaneously, soft tissue from the overlying connective tissue flap and from the internal 
marrow proliferates into the wound. 133 In defects of a critical size only the most peripheral 
part of the defect becomes occupied by bone and the central portion is repaired with soft 
tissue.134• 149 The mode of healing in these circumscribed bone defects may differ from 
fractures or segmental defects, in that proliferation of cells from the endosteal callus precedes 
periosteal healing and provides the support without which periosteum fails to bridge the 
defect. 133 
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In the experiments described in the current work, only circumscribed, circular, unicortical 
defects (that is, involving one cortex of bone and not "through-and-through") were 
investigated. The different types of critical size defects are demonstrated diagramatically in 
Figure 1.2. Reports detailing unsuccessful experiments aimed at establishing or testing CSD 
animal models are unfortunately rare, although when published these can be extremely 
informative. Examples include membrane Guided Bone Regeneration (GBR) in a trephinated 
8mm unicortical defect in rabbit tibiae155 and a 10x10x30mm atrophic ridge CSD for 
simultaneous bone grafting and implant placement in the minipig. 157 The authors of these 
reports concluded that the critical size for a non-healing defect was greater than that used in 
the experiments they described. 
1.3.5. Critical size defects around dental implants. 
Examples of peri-implant CSDs (Figure 1.2(d)) have been published in rabbit tibia158 and dog 
mandibular models,159 and reviewed by Botticelli et al (2003a&B).160 161 This latter group 
concluded from earlier studies that the coronal level of bone-to-implant contact was 
influenced by the presence of a gap in the marginal portion of the implant site - a gap of 
>0.5mm (due to bony defects, osteotomy overpreparation or immediate implantation into a 
tooth socket) could be expected to result in bone-to-implant contact being established at a 
more apical level. This group's own experiments in the dog mandible used ITI implants with 
an SLA surface, placed using either a one-stage or two-stage protocol. Results showed that 
marginal circumferential gaps 1-1.25mm wide by 5mm deep filled with new bone in contact 
with the implant surface to the same extent as no-defect control implants, irrespective of 
whether or not the defect was covered with a resorbable membrane. In these experiments, 
modification of the implant surface appeared to alter the dimensions of the peri-implant 
critical size defect in a dog mandibular model. 
1.3.6. Summary of maxillo-facial CSDs in various animal models. 
Maxillofacial CSDs in species other than sheep are summarised in Table 1.4. Various CSD 
models including maxillofacial defects, in sheep and in goats, are listed in Table 1.5. In Table 
1.6, maxillofacial CSDs are compared with published minima and maxima for cranial and 
long-bone segmental defects.71 •74 It can be seen that the critical size of cranial defects 
increases progressively up the phylogenetic order from rats to primates. Moreover, cranial 
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defects in sheep are comparable to both dogs and primates. A similar relationship can be seen 
for tibial segmental (discontinuity) defects. Mandibular defects also show a similar pattern, 
the single exception being the work of Gatti et al. (1990) who reported that 5mm-diameter 
unicortical bur holes in the sheep diastema failed to heal completely after 4, 8 and 12 
months. 91 This is also markedly smaller that the non-healing maxillary defects created in 
sheep by Koole et al. (1991) and is therefore questionable.94 Interpolation from the minimum 
and maximum dimensions of criticial size defects for other species suggests that the sheep 













Figure 1.2. Diagram showing the four main kinds of critical defects. 
This includes (a) the unicortical defect, (b) the bicortical or "through-
-and-through" defect, (c) the segmental defect and (d) the peri-implant 
defect. The pointer demonstrates the site from which bone has been 



















Table 1.4. Examples of critical sized, non-segmental mandibular and maxillary defects by 
animal species and location 
Author Species Site Dimensions 
Dahlin et al. 1988134 rat mandible 5mm bicortical 12 weeks nonhealed controls 
Sandberg et al. angle 
1993162 
Bell & Beirne rat mandible 3mm bi cortical 4 weeks 46 - 50% healing 
1988.163 angle 12 weeks 40 - 57% healing 
Takano-Yamamoto rat premaxilla 2mm bicortical 60 days nonhealed controls 
et al. 1993164 
l):aban & Glowacki rat mandible 4mm bic01tical 16 weeks Unhealed 
1981 165 24 weeks 
Kahan et al. 1979166 
Linde & Hedner rat mandible 5mm bicortical 12 & 24 Minimal healing in controls 
1995 167 angle days 
Hedner & Linde 
1995.168 
Oberg & Kahnberg rabbit mandible 3mm unicortical 6 months incomplete healing in 
1993169 control (2 defects) 
De Vore 1977170 rabbit mandible 5mm unicortical inferior 12 months Healed 
border 
Kahnberg 1979171 rabbit mandible 5mm Square 2 & 3 wall 12 months Incomplete healing 
inferior border 
ltjorting-Hansen & dog mandible 5,6,8mm Unicortical and 16 weeks 5 & 6mm partially healed, 
Andreason 1971 131 bi cortical 8mm non-healing 
Narang et al. 1970172 dog mandible 6x5x rhomboid inferior 4,6,8weeks Defects not completely 
3mm border filled 
Dahlin et al. 1990149 monkey mandible 8 X 1 2± bi cortical 3 months 60% had no healing, 40% 
1mm had healing of lingual plate 
only. 
Dahlin et al. 1990149 monkey maxilla 10mm bi cortical 3 months Incomplete closure of all 
control defects 
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Table 1.5: Critical sized defects in sheep & goats 
Author Site Type Dimensions Duration Result 
Lindholm et skull Uni cortical 18-20mm 6,8,10,12 43 .8 to 69.1 % regeneration 
al, 1986152 circular weeks 
Gatti & Zaffe mandible Uni cortical 4-5mm 8 weeks' No healing in control? 
199193 circular 
Viljanen et al. skull Unicortical 22mm 16 weeks 49.8 ± 6.7% 
1997113 circular 
Viljanen et al. skull Unicortical 22mm 16 weeks 31.32± 17.41% 
• 1996174 circular 
· Marcacci et al tibial Segmental 35mm 20- 270 No control defect 
1999175 diaphysis discontinuity days 
• Petite et al. metatarsal Segmental 6,12,15,& 25mm 16 weeks No bone union in any defect 
2000176 discontinuity 
Anderson et goat ileum Bi cortical 17mm 12 weeks "unfilled defects showed only little 
al. 1999177 circular bone ingrowth" 
Den Boer et tibia Segmental 30mm 12 weeks 2 of 6 control defects showed union. 
al. 1999, discontinuity HA+ rhOPl vs autologous bone 
2003)78, 179 marrow for 2nd experiment. 
Guga1a & tibia Segmental 40mm 12 weeks Regeneration failed with resorbable 
Gogolewski discontinuity PLA membranes (control defects) 
1999180 
Gerhart et al femur Segmental 25mm 12 weeks 100 % failure of union 
1993156 discontinuity 
Jammet et al 1. nasal area Rectangular (1) 2 x 1 x 0.5 cm 3,6,9,12 No controls. No bone growth in 
1994181 & angle of defects grafted (2) 5 x 18mm months mandible - grafts not resorbed. 
t> mandible with coral or 
2.femur & ceramic 
iliac crest 
Koole et al. maxilla Wedge-shaped 25 x 10 x 15mm 26 weeks Mandibular and iliac crest grafts 
199194 alveolar-cleft placed. No bone formation in 
~ defect control at 12 weeks, at 26 weeks BV 
= 37 ± 6 to 39 ± 4.5 %a 
Soderholm et angle of Segmental 50mm gap, ss or 5,9,14 Marked callus formation at 9 & 14 
al. 1991.182 mandible discontinuity tps screws + plate weeks weeks. No gaps were completely 
t> filled. 2.7mm ss screws had 23% 
fixation, 4.5mm hollow titanium tps 
screws had 74%. 
Clemens et al. femoral Implant with gap Spindle-shaped Ti 6&24 Bone contact: lmm=approx 1 % 
1997, 1998183• condyle or ceramic coated weeks (Ti) 27- 34 % (ceramic). 2mm = 1 
184 (goats) Ti with 1mm or % (Ti), 7 -16 % (ceramic). Total 
2mmgap bone area: Imm= 12 - 21.5%; 2mm 
I> = 4 - 6.5 %. 1998 2mm gap, bone 
contact: 2.5% (Ti) 18-21 % 
(ceramic) Bone area 8 - 15% 
,,. Hallfeldt et al. tibia Unicortical 6mm 3&6 Various grafts placed. Using para-
1995185 circular weeks sagital MMA-embedded sections. 
Control @ 6 weeks= 39% "defect 
bridging"(% new bone formation). 
Fluorescence not quantified. 
David et al. femur Segmental defect 20mm gap 9 months Axial intra-medullary grit-blasted or 
1995186 TPS or HA coated Ti rods. HA > 
either Ti for bone-implant contact 
(mechanical and HMA) but showed 
delamination. 45 -55% of rods 
loosened. 
Ehrnberg et femur Segmental 40mm Up to4 unhealed 
al.1993147 months 
Gao et tibia Segmental 20mm 16 weeks Stabilised with various ceramic 
al.1995187 implants. Incomplete healing in all. 
Kirker•Head et femur Segmental 25mm 1 year Plate-stabilised. Non-union in 
al.1995, controls. 
I 998188, 189 
Moxham et tibia Segmental 25mm 12 weeks Non-union in controls 
al.1996190 
Gao et tibia Segmental 16mm 16 weeks Various grafting experiments. No 






Wippermann tibia Segmental 30mm 
et al.1999193 
Blokbuis et tibia Segmental 30mm 
al.2000194 
Schliephake et mandible Segmental 35mm 
al.2001 195 
, Control defects filled with gelatin capsule containing bovine serum albumin 
§ Control defects filled with gelatin capsule containing type IV collagen 
12 weeks Incomplete healing in controls 
12 weeks Incomplete healing in controls 
5 months Autogeneous cultivated 
osteoprogenitor cells in porous CaP 
scaffolds. Bone formation 34.4% vs 
10.4% for ungrafted control group. 




Table 1.6. Comparison of critical size of Calvarial, Maxillofacial and Tibial (segmental) 
defects in different species. 
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4 - 53 
8 X 125 
2 Refers to distance between cut ends of tibia across gap 
3 Questionable results 
4 Rectangular defect 
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Figure 1.3. Graphical representation of Critical Sizes of Defects in mm for 
different anatomical locations in different animal species; (a) minimum and 
(b) maximum dimensions. 
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1.3.7 Summary and Hypothesis with respect to sheep mandibular CSD 
In order to develop an understanding of the healing potential of the proposed mandibular sites 
for dental implants in sheep, it is proposed that an osseous wound healing model be 
investigated in these sites. This will aid in developing surgical and postoperative protocols 
for working in the sheep mandible. The wound model will also permit comparison with other 
animal species with respect to osseous healing rate. The wound model that was selected was 
the unicortical Critical Size Defect (CSD). The critical size at which an osseous defect fails to 
heal spontaneously is an appropriate method for comparing the relative osseous regenerative 
capability of different animal species, provided similar anatomical sites and types of defect 
are chosen eg: unicortical circular defects of the mandible. 
Mandibular sites in dogs and primates are commonly used for dental implantology research 
(see below), and the CSD for these locations and species are well known. Comparison of the 
rate of repair of CSDs in the sheep mandible to that of dogs and primates will allow 
validation of the potential of this animal model before proceeding with the placement of 
dental implants. The sole publication citing the dimensions of CSDs in the sheep mandible91 
appears anomalous with regard to other sites in sheep, and with respect to the same site in 
other animal species; little confidence can be placed in this paper. A hypothesis was therefore 
formulated: 
Hypothesis 1 : 
"The critical size defect of a circular, unicortical defect within the edentulous diastema of the 
sheep mandible lies within the range of 8 to 15mm in diameter". 
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1.3.8. Acute versus chronic wound models in sheep. 
Staff and students at the University of Otago Dental Faculty have been conducting research 
using the sheep as an animal model for more than 35 years. Within the Department of 
Periodontology there have been two foci to this research: periodontally diseased sheep as an 
animal model for periodontal diseases in humans, and periodontally healthy sheep as a 
surgical model to test treatment protocols for periodontal regenerative surgery in humans. 
Naturally occurring "broken-mouth" periodontitis in sheep is considered a suitable animal 
model for human periodontal disease196-199 and initial work within the University of Otago 
focused upon this animal model.200-206 Subsequently, a non-diseased sheep surgical model was 
developed, using the furcation of the second mandibular premolar for periodontal 
regeneration.207-214 In these latter studies, the furcation defect was permitted either to heal 
naturally ( control), or treated using various regenerative procedures. Histomorphometric 
analysis of defects showed that healing within control defects was equal to that within the 
treated sites. 
Species that are lower in the phylogenetic order than primates commonly demonstrate a 
marked potential for post-surgical healing and this holds true for surgically created 
periodontal wounds in the sheep mandible. This spontaneous regenerative potential was 
attributed, in part, to the acute nature of the surgical wound and the lack of chronic 
inflammation.210• 212 Other researchers have also reported differences in healing between 
acute-surgical wounds and chronically-inflamed periodontal defects, in the dog138• 139 and 
monkey215 models, or have commented on the osteogenic potential within their acute surgical 
defects, for example in the pig mandible model.216 Frost (1983) called this accelerated healing 
the "regional acceleratory phenomenon" .217 
To compensate for this accelerated healing in acute surgical defects, the sheep premolar 
model was modified to permit a period of chronic inflammation before treatment.212 No 
significant difference in the quantity of regenerated periodontal ligament and bone was found 
between chronic furcation defects treated with regenerative protocols or treated by surgery 
only. Subsequent experiments using the chronic sheep premolar furcation model213 and the 
acute model214 found that regenerative protocols using, respectively, biological mediators 
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(TGF-B) or grafting materials (Plaster of Paris ± autogenous bone graft) were significantly 
superior to healing within the control defect. However, both authors also commented on the 
"intrinsically greater natural healing capacity" of osseous defects in sheep, and related this to 
the size of the defect and the animal species used. It is also likely that the vascularity of the 
site and the rate of angiogenesis within the experimental wound had a significant influence 
upon the rate and degree of osseous healing.218 
Researchers have used various techniques to convert acute surgical wounds into chronically-
inflamed defects. Animal models that mimic chronic periodontal disease may be created by 
surgically ablating part of the periodontal supporting structures. A device is then placed 
within the surgical wound to prevent spontaneous regeneration. Microbiological colonisation 
of the device also assists in maintaining a chronically inflamed non-healing defect. Examples 
of such devices include copper bands in beagle dogs,219 circumferential silk ligatures in 
squirrel monkeys,220 220 and silk sutures retained by restorative material within the sheep 
premolar defect.212 
The collapse or rapid proliferation of overlying soft tissues may result in similar, chronic 
defects following the wounding of maxillofacial bones. This can be simulated in an animal 
model by removing bone surgically and then physically positioning either soft tissue or a 
device into the wound to prevent healing. In the dog mandibular edentulous-ridge model, the 
teeth are extracted, the alveolar ridge surgically reduced and the overlying soft-tissue flaps 
sutured at an apical position.221 • 222 After two to three months healing, the alveolar ridge in this 
animal model resembles the atrophic mandibular alveolar ridge of human patients and may be 
used to test regenerative protocols.223 More localised chronic defects may be simulated by 
placing an bioine1i device into the wound and then removing it after the bone has healed.224 In 
1961 Melcher and Dreyer demonstrated that solid blocks of polytetrafluoroethylene 
implanted into 2mm diameter circular defects in the rat femur physically obstruct healing of 
the defect.225 The inert and biocompatible nature of this material was demonstrated by the 
lack of a foreign body inflammatory reaction within the healing defect, suggesting that it 
could be used to convert an acute intra-ossoeus wound into a chronic one. 
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1.3.9. Summary and Hypothesis with respect to chronic CSD in sheep. 
Surgically created defects that are prevented from spontaneous regeneration by implanting a 
bioinert device may show a reduced regenerative potential after removal of the device and 
may therefore be more suitable as an animal model for testing regenerative procedures. This 
suggests the following hypothesis: 
Hypothesis 2: 
"Circular, unicortical defects within the edentulous diastema of the sheep mandible that are 
prevented from spontaneous regeneration have a reduced healing potential once the physial 
obstruction is removed". 
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1.4. Guided Bone regeneration. 
Guided Bone Regeneration (GBR) is a surgical technique where a thin sheet-like membrane 
or similar implanted device is used to encourage the regeneration of bone within bony 
defects, by physically excluding soft-tissue and maintaining a protected environment for the 
formation of a stable blood clot. This in tum provides an "osteoconductive" scaffold for the 
inward migration of osteoblastic precursor cells.226' 227 GBR is an extension of the Guided 
Tissue Regeneration (GTR) technique, originally developed for periodontal regeneration,228' 
229 and was developed in order to regenerate bone at intra-oral sites before, during or after the 
placement of dental implants.230-233, 18 Although the clinical outcomes of GTR and GBR are 
becoming more predictable,234-244 further research is still required into the cellular and 
biochemical events which occur during bone regeneration. The efficacy of guided tissue 
regeneration may be analysed by regenerating tissue in periodontal wounds around teeth, or 
in wounds created in bone without involving the periodontium.139 Healing in lesions which 
only involve bone is of interest to periodontists, dental implantologists and maxillofacial 
surgeons, as well as orthopaedic surgeons and neurosurgeons.245 ' 246 The use of tissue 
exclusion and GBR within orthopaedic segmental defects including sheep animal mdels has 
recently been reviewed.247-249 
Experimental lesions that are confined to bone have several advantages over periodontal 
defects: they can be standardised in size and shape more easily than a periodontal defect, they 
generally involve a closed wound rather than one left open to the oral environment via the 
gingival sulcus, and only one of the tissue compartments described by Melcher in 1966 (ie; 
bone) is being regenerated, compared with periodontal defects which require the coordinated 
regeneration of periodontal ligament, cementum and alveolar bone.250 
1.4.2. Membranes used for GBR. 
Gore-Tex Periodontal Membrane® (GTPM) is a semi-permeable Teflon membrane that has 
been referred to as the gold standard for guided tissue regeneration.227 Other non-resorbable 
alternatives to Teflon that have been employed for GTR include Millipore filters, rubber dam, 
synthetic skin substitutes and titanium foil. 251-256 Various resorbable membranes have been 
also been developed, including laminar bone, collagen, and poly-lactic and/or poly-glycolic 
acid_2s1-261, 222,262 
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Another alternative is the use of the high-density Teflon membranes that were originally 
developed for surgical use in non-oral sites and these been investigated for GBR and GTR 
applications.263-267 Gore-Tex® expanded polytetrafluoroethylene soft tissue patch (GTSTP) is 
a high-density Teflon membrane commonly used in general surgery to repair hernia defects, 
for chest wall reconstruction, as a filler for aesthetic facial plastic surgery, and for 
augmentation of the nasal dorsum.268-273 Intra-orally, GTSTP has been used experimentally for 
regeneration of periodontal defects both in a sheep animal model2°7• 274 and in human 
patients.275• 263• 274 Although GTSTP consists of polytetrafluoroethylene it differs structurally 
when compared with the GTPM membranes. Scanning electron microscopy of the surface of 
the GTSTP shows a regular, smooth surface, with short internodal dimensions (40-60µm) 
whereas GTPM has clearly definable nodes spaced at regular intervals of 100-300µm 
(Figures 2.10 -2.12). 
1.4.3. Summary and hypothesis with respect to Guided Bone Regeneration. 
Guided bone regeneration (GBR) is a technique frequently used in conjunction with dental 
implants. The efficacy of GBR may be established using Critical Size Defects in an animal 
model. GoreTex Soft Tissue Patch is an alternative Teflon membrane that has shown promise 
in periodontal regenerative procedures and may be suitable for GBR applications. 
Hypothesis 3: 
" GTSTP membranes placed over a circular, unicortical critical size defect in the sheep 
mandible result in increased bone regeneration". 
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1.5. Dental implants & osseous healing. 
Roberts et al (1988b) published a detailed analysis of the initial healing of dental implants in 
human cortical bone has revealed that during the first month, woven bone callus extends from 
both endosteal and periosteal surfaces.276 Remodelling of the devitalised implant-bone 
interface commences at this time. The turnover rate of adjacent bone (that is, bone near to, but 
not in contact with the implant surface) remains normal. From four to twelve months after 
implant placement, turnover rate in adjacent bone increases in response to the regional 
acceleratory phenomenon,217 the healing callus is resorbed, and remodelling of the interface 
continues. 
Roberts et al. (1988b )276 then defined four types of bone adjacent to endosseous implants: 
woven, lamellar, bundle and composite. Woven or embryonic bone forms at a rate of 30 -
SOµm I day in response to growth, injury or biomechanical adaptation. It has low mineral 
content, randomly oriented fibres, minimal strength and is rapidly replaced by mature 
lamellar bone. Lamellar bone forms at an average rate of 0.6 µm I day and maturation takes 
six to twelve months. Bundle bone is lamellar bone with fibro-osseous attachments eg: 
periodontal ligament, and is not found associated with dental implants. Composite bone forms 
on cortical surfaces during wound healing, growth and biomechanical adaptation. Initially this 
consists of a porous lattice of woven bone that supports blood vessels extending from the 
periosteum or endosteum. In time this bone is replaced by load-bearing lamellar bone through 
a process called "lamellar compaction" .276 This is observed when dental implants are placed 
into sites composed of a core of low-density lamellar trabeculae and/or marrow cavities 
surrounded by a thin shell of cortical lamellar bone. Through lamellar compaction, lamellar 
bone extends in an apical direction down the implant surface into the marrow space, thereby 
increasing the osseous support around the implant. 
A similar process may take place external to the cortical bone, beneath the periosteum, as a 
biomechanical response to loading. The remodelling of compact bone after implant placement 
results in the formation of secondary osteons adjacent to the implant surface. This is known 
as the A-R-(Q)-F cycle (Activation - Resorption-(Quiescence) - Formation), sometimes 
abbreviated to sigma (o). The formation period (F) is the main variable between species. 
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The rate of osseous healing in humans may be compared with other animal species through 
their respective bone remodelling periods or "sigma" .276 The rate of osseous healing in four 
different animal species around 23 dental implants of various types (blade, screw, cylinder, 
and basket) has been examined277 after administering a fluorescent label 2 weeks and 1 week 
before removal of the implant. Plastic-embedded lO0µm-thick specimens were subjected to 
bright field, polarised and fluorescent histomorphometric analysis (HMA) using stereological 
point-hit and linear-intercept methods at 64 to 100 times magnification with a lOxlO ocular 
square. The percentage of fluorochrome-labelled bone with respect to total bone volume was 
determined at or near the implant interface stereologically by counting point-hits on the grid 
in "adjacent" bone (AT) and then counting point-hits on bone formed between the two labels 
(AL)- The inter-label interval (t) was the time elapsed between labelling. Thus, the "sigma" or 
rate of bone turnover(% bone turnover/30-day month) was calculated by a= {(Ad AT)/t} x 
(52 weeks/year). The sigmas for the four species studied are reproduced below, from a table 
in their article. Table 1.7 also shows the a of different animal species as a percentage of the 
rate of osseous healing in humans. 
Table 1. 7: Turnover rate (a) of bone around implants in four different species 
Rabbit 6 weeks 37.5% Roberts et al. (1984 )276 
Dog 12 weeks 75.0% Takahashi et al. (1971)278 
Monkeys 14 weeks (approx.) 87.5% Garetto et al. (1995)277 
Humans 16 weeks 100.0% Frost ( 1969)279 
1.5.2 Dental implants in animals - number of publications. 
The literature published on dental implants continues to expand. A medline search, using the 
search term "dental implants", revealed that the number of publications increased twenty-fold 
in the decade from 1984 to 1994 (from 18 to 371 papers/year); in the decade from 1994 to 
2004, the number doubled (to 794 papers/year), giving a total of nearly 8000 publications 
over the 20 year period. Searching this dataset further with the term "animal" reveals that 
50% of dental implant papers published 20 years ago involved animal experiments; the 
number of dental implant papers involving animals increased five-fold in the following 
decade and more than doubled in the period 1994-2004. During the past decade, animal 
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experiments as a percentage of the total dental implant publications/year has ranged from 12 
to 25%. 
1.5.3. Animal models for dental implantology. 
The most commonly used animal models for dental implant research are the rabbit tibia,280 the 
rabbit distal tibial knee-joint,281-283 the dog mandible,284-286 and the non-human primate 
mandible.287 Dental implants have also been studied in the goat maxilla,288-291 maxillary 
sinus 292' 293 mandibular ramus 294 and edentulous span 295· 296 tibia 297 femur 298· 183· 299-301· 184· 302· 303 
' ' ' ' 
and humerus .304 In the sheep, dental implants have been placed into the mandible121' 305· 141 ' 116· 
306 and mandibular ramus 123 maxillary sinus 307· 308 forehead 309 tibia 310' 311 radius 312 and , ' ' ' 
femur.313-316 
1.5.4. Limbs versus maxillofacial bones for modelling dental implantology. 
Dental implants may be placed into maxillofacial sites in animal models using an extra-oral 
or intra-oral approach. When an intra-oral approach is used, in most cases premolar teeth are 
extracted to create an edentulous ridge that is allowed to heal, generally for three months, 
before implant placement (the exception being immediate placement models, where the 
implants are inserted immediately following tooth extraction). Titanium implants are then 
placed in a second surgical operation. 
Animal models that use the long bones of the limbs (femur, tibia, radius, humerus) have an 
advantage in that only one operation is required - no teeth need be removed prior to implant 
placement. However, the reduction in morbidity and stress on the animal is counterbalanced 
by the questionable relevance of using tibial bone as a substitute for mandibular bone. 133· 78· 310 
Functional loading along the long axis of long bones, compared with cross-axis loading in the 
mandible, may influence patterns of implant osseointegration.317' 318 Differences in bone-
implant contact to unloaded implants placed into different bones within the same animal have 
been demonstrated.319 Differences between tibial and maxillofacial models in sheep have also 
been shown, for example following distraction osteogenesis115' 320· 111 and in the dimensions of 
unicortical critical size defects321-323 • 
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Simultaneous placement of matched dental implants into both the maxillofacial and limb 
bones of a animal model would permit a direct comparison of the healing response in these 
different sites. Direct comparison of mandibular and femoral models has not been undertaken 
in sheep or goats, but has been considered in dogs324 and in rabbits.325 Cook et al. (1992)324 
placed cylindrical hydroxyapatite-coated titanium implants into the mandibles and femora of 
36 dogs for various time periods. These were subjected to push-out mechanical testing to 
determine the mean interface attachment strength. Unfortunately this study was flawed in a 
number of respects; the femoral and mandibular implants differed in length and diameter, 
different drilling protocols were used to place them, and only the femoral implants were 
positioned bicortically. Moreover, the healing periods differed in the mandible (3 weeks and 
15 weeks) and the femora (3,5,6,10 and 32 weeks). Although the authors concluded that there 
were no differences between the two sites, in fact only the comparisons at 3 weeks between 
the two anatomical sites were valid. At this early time point, femoral sites had significantly 
lower attachment strength than mandibular sites for similar implant surfaces. 
Fujimoto et al. (1998)325 compared titanium solid screw implants placed simultaneously into 
the tibiae and mandibles of rabbits. Six rabbits received prednisolone (to induce osteoporosis) 
and six were controls. The 12-week old rabbits had all mandibular incisors extracted and two 
3.7 x 6mm implants placed into the mandible and two into the tibial metaphysis. It is not 
stated in the paper whether these were immediate implants or whether there was a healing 
period before implant placement. Animals were sacrificed after three months. There were 
two primary outcome variables: removal torque (RT) and radiographic microdensitometric 
analysis of the un-operated femur to analyse porosity. There was no histomorphometric 
analyses of bone-to-implant contact. The study focused on comparisons between implants in 
porotic and control bone at the two sites, and did not directly compare the two sites (mandible 
and tibia) with each other. Bone density in the femur and removal torque of the tibial implants 
were significantly lower in osteoporotic rabbits than controls and the two measurements were 
significantly correlated. However, there was no significant difference in RT of mandibular 
implants between osteoporotic and control animals, and femoral density did not correlate with 
RT in the mandible. The authors concluded that steroid administration may have less effect 
on the osseointegration of titanium implants in the mandible compared with limb bones. 
54 
Table 1.8 shows the published RT for the 24 implants in the 12 animals at the two anatomical 
sites. From this it seems that, at least in this animal model and using removal torque as the 
unit of analysis, much higher integration can be achieved in the femur than the mandible, 
despite the deliberate induction of osteoporosis. 
Table 1.8. Removal torque (Newton centimetres, NCm) of implants in rabbits after 12 weeks 
integration in normal and osteoporotic rabbits (Fujimoto et al. 1998)325 
Removal torque control rabbits 
Removal torque osteoporotic rabbits 
35.2 ± 10.2 
29.8 ± 7.4 
62.7 ± 14.9 
45.8 ± 15.2 
Slotte et al. (2003) also considered the differences between rabbit maxilla and tibia. 326 They 
compared tibia and maxilla in the same animals, eight weeks after transcortical osteotomies. 
Histomorphometric analysis of bone density in pairs of tibiae and maxillae from the same 
rabbits revealed changes in bone architecture (increased trabecular bone, decreased cortical 
bone) and significantly increased bone density in the maxilla but little change in tibial bone 
density. The authors concluded that further study is warranted to elucidate whether these 
differences reflect the different embryologic origins or are due to morphologic and functional 
differences between the two sites. They considered this important since "the long bones, 
which are of enchondral origin, are often used in histologic evaluations of dental implants that 
clinically will be placed in bones of membranous origin" .326 
The conclusion that can be drawn from these studies is that maxillofacial sites (maxilla and 
mandible, implanted via an intra-oral approach) may have greater validity than limb bones for 
modelling the healing of dental implants in human patients. This is important, since to date 
the major part of dental implant research has been conducted in the limbs of rabbits. 
1.5.5. Criteria for animal models of dental implantology. 
A list of proposed criteria for an animal model suitable for dental implantology, formulated 
from various sources327' 328' 74 is reproduced in table 1.9. These criteria support the use of the 
sheep as an animal model for dental implantology. 
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Table 1.9: Suggested criteria for selecting an animal model for dental implantology 
Species 
Implant 















Sufficient numbers for statistical power is fiscally achievable 
Animals readily available; model can be duplicated in multiple 
centres. 
Survive anaesthetic, tractable (docile and co-operative) 
Non-companion animals may be preferable 
Size of teeth and jaw comparable to humans 
Relationship between rate of bone healing (o) and human a is 
known. 
May be analysed in presence of systemic diseases and conditions 
that affect humans eg: osteoporosis, diabetes, periodontitis 
Permits standard intra-oral implant protocol 
Permits clinical, radiographic, biomechanical and histological 
measurement of success. 
Predictable implant behaviour in good quality bone. 
Permits testing in poor quality bone 
Healing process similar to humans 
Permits loading of intra-oral implants, comparable to humans 
Effect of intra-oral versus extra-oral microbiological flora? 
Allows creation of peri-implant defects of similar size to humans 
Test commercially-available implants without modifying implant 
size 
Distinguishes in a statistically & clinically meaningful fashion 
between successful and unsuccessful strategies 
Soft tissue healing similar to healing in humans 
Biological width around teeth and implants characterised 
Relationship between periodontal and peri-implant disease is 
known or may be explored 
Microbiological and serological ~0 '·0 ~' 0 • 0 ~~ similar to humans 
May be analysed using commonly accepted methods 
Results in model may be compared across different experimental 
centres and with different species 
May be analysed in unloaded, semi- or early-loaded, fully-loaded 
and overloaded conditions 
Use to analyse different strategies for enhancing integration eg: 
implant surface materials and properties, growth factors, GBR, 
grafting. 
May be analysed using one-stage or two-stage protocols. 
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1.5.6 Methods of analysing dental implant experiments in animal models. 
There is many different methods used to analyse the healing and integration of dental 
implants, both in preclinical animal models and clinically in human subjects. These can be 
divided in a number of ways, as follows. 
1.5.7. Invasive versus non-invasive methods of analysis. 
Dental implant experiments in animal models may be divided into in vivo clinical 
investigations and post-mortem analysis of soft or hard-tissue responses (Figure 1 .4). 
Generally, clinical investigations use the same non-invasive tests that are employed for the 
examination of human patients - verification of implant survival, implant mobility, 
radiography of peri-implant alveolar bone levels, peri-implant bleeding on probing, probing 
depths and attachment levels, peri-implant microbiology and serological responses to this 
flora. The first three of these (survival, mobility, and radiography) form the basis of the 
criteria for implant success in humans proposed by Albrektsson and Zarb (1993).329 
The importance of animal models to clinicians is that the model system can be manipulated to 
produce extreme conditions in which the clinical response is analysed. The two most 
important causes of implant loss -overloading and peri-implant infection ("peri-implantitis") -
have been studied using such animal models.330 331-333 
Animal experimentation also permits the detailed examination of tissues once the implant and 
surrounding bone have been removed (biopsy) or more commonly, after the animal has been 
sacrificed. Soft and hard tissues may be examined separately. Soft-tissues may be subjected to 
histometric examination to determine the dimensions of the peri-implant mucosa! cuff, the so-
called "biological width"334-336 or the proportions of the constituent cellular and non-cellular 
components (including the size and distribution of the inflammatory infiltrate) may be 
analysed using histomorphometric techniques337-339 
The processes of peri-implant osseous healing and the progressive failure of that healing -
described respectively as osseointegration3 and osseodisintegration62 - may also be studied in 
great detail. Again, the model system may be manipulated by changing the quality and/or 
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quantity of bone within the osteotomy site, the length of healing time, the systemic health of 
the animal, or by modifying the implant surface. Analysis of bone-to-implant healing may be 
limited to descriptive histology,304 however such data is not readily quantifiable and therefore 
is difficult to analyse or compare statistically. Linear histometric measurements may be used 
to quantify the height of bone around the implant neck340· 341 · 290· 332· 342 or may be combined 
with fluorescent labelling to reveal the rate of bone healing over time (mineral apposition rate 
or MAR).2n, 313,343,314,344 
1.5.8. Biomechanical versus histomorphometric analysis. 
Statistical comparison of the effects of different variables upon osseointegration requires that 
osseous healing be quantified. This can be done histologically or biomechanically. 
Quantifiable histological measurement involves a process known as histomorphometric 
analysis. The amount of bone in contact with the implant surface and/or the ratio of 
mineralised to non-mineralised tissue within a defined area adjacent to the implant site may 
be measured. Osseointegration may also be quantified biomechanically, by measuring the 
amount of torque required to break the implant-to-bone bond and push-out or uns.crew the 
implant ("removal torque"). 
Generally these two measurements are seen as complementary but mutually exclusive; 
removal of the implant destroys the bone-implant contacts that might be examined 
histologically, and sectioning of the implant for histology makes it impossible to unscrew the 
implant. The different techniques employed for histomorphometric analysis and the relative 
merits of this approach versus biomechanical measurements are examined more fully later in 
this section. Although other methods of analysis exist in addition to histological and 
biomechanical investigation (see Table 1. 10), there is less support within the literature for 
these. 
When implants are placed into non-oral sites such as the tibia or femur, the investigator is 
generally limited to post-mortem examination of the tissues. If the anatomical site selected is 
within the mouth, clinical and post-mortem tissue analyses may be combined; such a 
complementary investigative approach may yield much greater knowledge than either method 


















































































































































































































































































































































































































































































































































Implant Survival and Success 
Digital subtraction radiography 
Linear measurement of radio graphs 
Mobility - Periotest values (PTV) 
Mobility - Resonant Frequency Analysis 
(RFA) 









Histometric Demineralised paraffin-embedded or 
undemineralised resin-embedded sections 
Histomorphometric Microradiographs 
I>- Scanning and backscatter-electron 
micro graphs 
Microtomography 
Confocal and Nomarski microsopy 
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Histomorphometric analysis of resin-embedded undeminseralised sections has been shown to 
have a positive correlation with the mechanical strength of the bone-to-implant interface as 
revealed by removal torque testing.378-381 However, although histomorphometric analysis 
yields a great deal of information regarding the bone-biomaterial interface, the technique also 
has its problems. Retrieval of the implant along with the surrounding bone is invasive and 
destructive. Moreover, sectioning of the implant sacrifices a great deal of material in order to 
produce a limited number of specimens for analysis; thus only a small amount of the total 
bone-implant interface remains for evaluation. Unfortunately, current imaging techniques 
such as computerised tomography lack the resolution to allow 3-dimensional measurement of 
the contact ratio of mineralised bone to the implant whilst in situ within the animal, although 
a microtomographic technique has been proposed for evaluation of retrieved implants.372 
Others of the non-invasive tests listed in Table 1. 10 have been validated against either 
histomorphometric or mechanical analyses, eg: insertion torque versus resonance frequency 
analysis (RFA),364 RFA and insertion torque versus removal torque,365 and Periotest values 
(PTV) versus insertion torque.382 Caulier et al. (1997)290 reported on the relationships between 
histometric analyses and biomechanical testing using the Periotest. Periotest values (PTV) 
were higher for titanium than for HA-coated implants, and showed no correlation with the 
number of threads in contact with bone nor with the height of crestal bone, which was higher 
in both instances around the HA-coated implants. Conventional histomorphometric 
measurements of bone-implant contact or bone density were not recorded or compared with 
PTV in this study. 
1.5.9. Techniques for histomorphometric analysis of dental implants. 
Techniques for the histomorphometric analysis of dental implants have recently been 
comprehensively reviewed383'384 and are summarised in Table 1.11. Both bone-implant contact 
("BIC") and mineralised to non-minealised tisuse within a given area ("density") may be 
measured using either stereological "line intercept" techniques or direct, computer-assisted 
measurement. Both may be expressed as percentages. 
61 
Table 1.11 Techniques of histomorphometric analysis of undecalcified ground sections 
containing dental implants. 
I)irect measurement 
Bone density 
Linear intercept with a Metz grid superimposed within the microscope 
eyepiece 
semi-automated computer-based systems, eg: as a plugin for NIH Image 
manually using a ruler on photographs or projected slides 
semi-automated computer-aided systems (eg: NIH Image or Scion) 
automated 
over the entire implant surface/perimeter 
within the "cortical passage" compared with the marrow space and/or 
cancellous bone 
in the coronal, middle and/or apical 1/3 
for the best three consecutive threads on each side of the implant 
for the best four consecutive threads on each side of the implant 
"within threads" 
within a mirror-outfolded image of these threads 
adjacent to and/or at a stated distance from the implant surface 
using fluorescent markers to determine bone apposition rate 
Computer-assisted histomorphometric analysis (HMA) and stereology as measurement tools 
have been compared. Parafin-embedded histological sections derived from premolar furcation 
defects in sheep were measured by each technique. Stereology consistently identified a higher 
percentage of bone within the area. There was little agreement between the two techniques. 
The authors concluded that the two technques are not interchangeable and cautioned against 
comparing results generated using stereology with those found using computer-assisted 
HMA.385 Conversely, a comparison of computer-assisted planimetry, computer-assisted lineal 
analysis, and point-counting stereology for measurement of ground sections of threaded 
dental implants found significantly greater variance for computer-assisted planimetry in 
estimating bone density.384 Both studies agreed that computer-assisted planimetry (direct 
mesurement of specimens) was more time consuming. 
1.5.10. Further considerations with respect to histomorphometric techniques. 
The method of HMA is only one of the many variables that make it difficult to compare 
different in vivo studies of implant ossoeintegration. Other variables include the animal 
species used and the age of the animal, the location of the implant and anatomy of the 
supporting bone, implant type, material, shape and surface, surgical and retireval techniques 
used, the relative health and functional state of the implant at the time of analysis and the 
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healing interval before analysis.383 Matsuda et al. (1998) commented that "the extent of 
healing as a function of time has not been standardized to a biologic endpoint" .383 
Another consideration is whether the histomorphometric analytic methods discussed in Table 
1.11 are applied to the entire implant perimeter or only to selected portions of the implant. 
Frequently the area of interest reflects the "predominant contribution of cortical bone", 383 also 
described by researchers at Gothenburg University as the "best three consequtive threads"376' 
386 or "the cortical passage".387·38° Care must be exercised in comparing such partial recordings 
with mesurements of the entire implant. The same caveat applies when comparing 
measurement of bone density within the area defined by the implant thread ("within-
thread")388 or defined by an outfolded image of the thread ("mirror-outfold")389 with an area 
defined by a set of measurements in millimetres.312· 298· 390 
HMA of implants placed into rabbit tibiae and sectioned either transversely or along the long-
axis of the bone have shown that the orientation of the section has a statistically significant 
effect on the amount of bone-implant contact and within-thread bone density, with higher 
figures recorded for longitudinal compared with transverse sections.317 In this study, bone 
density was recorded both for the entire implant and for the best three consecutive threads. 
Although partial and complete recordings were not expressly compared in the paper, the 
published results reveal that mean densities for the best-3-threads recordings were markedly 
higher than mean whole implant density recordings (78 - 79% versus 51 - 53%). 
These authors also studied the effect of the thickness of the ground section and found 
statistically significant increases in bone-implant contact and bone density as section 
thickness increased from lOµm to lOOµm. 391 Thus, both section orientation and thickness can 
have a significant effect on the results of histomorphometric analysis. Computer-assisted 
HMA %BIC and %density around submerged implants in dog mandibles after 16 weeks 
healing showed marked differences depending the surface studied (buccal or lingual) and the 
nmeasurement technique (all implant threads versus "best three" consecutive threads) but not 
for the placement protocol (one-stage versus two-stage).392 
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It is thus clear from this overview of the methods used to analyse animal models of dental 
implantology that some care must be exercised when comparing different studies due to the 
lack of standardisation in methods for such studies. 
1.5.11. Animal models for dental implantology. Single-paper review: Rabbit limb model. 
The most widely used animal model for dental implant research is the rabbit limb model. 
Approximately 50% of the published papers included in a systematic review and meta-
analysis for this work (see Chapter 3.11) involved dental implants placed into rabbit limbs. 
This includes the tibial, femoral and femoral condyle (knee-joint) models. These have been 
extensively described by a series of investigators at the Department of Handicap Research of 
the University of Gothenburg282' 283• 366• 376• 380• 828 ' 830• 858 and have been comprehensively 
reviewed in theses published by the University of Gothenburg281 , 496• 864• An example of an 
early paper that employed these models will be discussed in detail. 
Sennerby et al. (1992) 283 used the rabbit tibial and femoral condyle models to compare the 
healing response of titanium screw-shaped implants placed into (respectively) compact and 
cancellous bone. The implants were custom-made, 3.75 mm diameter x 4 mm long, 
machined-surface, threaded titanium screws, manufactured by the dental implant company 
Branemark. A total of 128 implants were placed into both tibial metaphyses and both femoral 
condyles in 18 rabbits. The implants were placed using a standardised, sterile, low-speed 
technique in a submerged configuration and allowed to heal for six weeks, three months or 
six months There were thus six animals and 36 implants for each time period. A group size of 
six is small for valid statistical analysis, which is a common problem with dental implant 
research. 
At the end of each healing period, one tibial and one joint implant per animal was unscrewed 
using a torque gauge. The animals were then killed by anaesthetic overdose, with 
simultaneous cardiac perfusion using glutaraldehyde. The remaining implants were fixed, 
dehydrated, embedded in resin and sectioned into lOµm ground sections, following the 
technique of Donath and Breuner (1982)914. The sections were examined and photographed 
using a microscope connected to a computer. Bone-to-implant contact and thread surface area 
occupied by bone were determined using computer-assisted histomorphometry. In this paper, 
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the bone-implant contact was expressed as a percentage of the entire implant surface length 
ie: for all of the threads within bone. Separation of bone and implant surface by a gap of 
<lOµm was considered a preparation artefact and treated as bone-implant contact. This results 
from the shrinkage of bone around the metallic implant during dehydration and can be 
minimised by using a graded series of alcohol concentrations. Thread area (limited by a line 
drawn to connect the two adjacent thread tips) was expressed as a percentage of this area 
occupied by bone. This protocol conforms to the standards required for histological 
preparation and analysis of dental implants638• 914•915 • Results were published in graphic form, 
however Professor Sennerby has generously made the original figures available on request. 
In addition, the number of osteocytes present in an area measuring 200x265 µm was counted 
in three locations: within the original cortical or subchondral bone and at the tip and base of a 
thread. This was only performed for one thread on each side of the implant. 
The torque required to unscrew the implants increased with increasing healing time. 
Morphologically, the intra-articular implants were described as having cortical bone, cartilage 
and fibrous connective tissue (FCT) in contact with the uppermost threads after 6 weeks, 
whilst the lower threads contained cancellous bone and marrow tissue. At 3 and 6 months, the 
FCT was replaced by bone although cartilage was still present. The cancellous bone was 
described as "becoming condensed with time", which echoes Roberts (1988b)276 description 
of "corticalisation". By contrast, the tibial implants contained only well-organised cortical 
bone in the upper threads with small amounts around the lower threads. 
The histomorphometric analysis showed that bone-to-implant contact increased over time and 
differed significantly between the two groups of implants at all time periods. Bone-to-implant 
contact increased from 18.8 ± 14.6% at 6 weeks to 30.0 ± 6.4% after 3 months and 37.8 ± 
11.4% after 6 months in rabbit tibia; at the same time-periods, bone-implant contact for knee-
joint implants were 38.5 ± 15.0%, 38.4 ± 3.2% and 55.1 ± 9.7% respectively. More bone was 
found occupying the thread areas after 3 months than 6 weeks, but there was no significant 
difference between 3-month and 6-month threads for this parameter. 
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An attempt was made to correlate the bone area within threads of implants examined 
histomorphometrically and the removal torque for implants analysed biomechanically; the 
authors suggested that that the amount of compact bone surrounding the implants was a major 
factor in conferring resistance to unscrewing of the implants. The relationship between 
percent bone-implant contact and removal torque showed the opposite relationship. Higher 
bone-implant contact was found in cancellous bone yet less force was required to remove the 
implants. Analysis of the number of osteocytes in the three areas showed little of interest. 
In this paper, the authors used a non-oral model in rabbits to investigate differences in healing 
in bone of two different types, cortical and cancellous. In the human situation, cortical bone is 
common in mandibular sites, whereas cancellous bone is found in the posterior maxilla. 
These investigators concluded that the amount of bone present within the area of the implant 
threads and the amount of bone-implant contact may be less important than the type of bone, 
and also, that bi-cortical positioning of the implant may be important to provide optimum 
stability. They also noted that the correlation between removal torque and bone-implant 
contact improved when only the bone around threads "situated in the cortical and subchondral 
passage" was considered. In subsequent papers, analysis of bone-implant contact and within-
thread bone area was limited to these areas 366• 376• 380• 523 • 
In this experiment, the biomechanically-tested implants were also examined histologically 
after reverse-torque to loosen the implants. A gap was found between bone and implant 
surface, indicating that failure of osseointegration occurred at the implant-bone interface 
rather than within bone itself. This reinforces that fact that biomechanical testing (using 
reverse-torque) and histomorphometric analysis cannot be performed on the same implant. 
The physical dimensions of this animal species precluded the use of commercially-available 
dental implants - the implants themselves were custom designed. Another limitation of these 
rabbit limb models is that the implants could not be loaded in a fashion clinically relevant to 
intra-oral implants. None-the-less, the rabbit tibial, femoral and knee-joint sites remain 
important animal models for dental implant research. The advantages of the rabbit limb 
models include low cost, ease of handling and rapid healing, permitting the rapid generation 
of preliminary data for implants having novel surface configurations, shapes or materials. 
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1.5.12. Animal models for dental implantology. Single-paper review: Sheep limb model. 
Both the sheep 126' 312-315, 395• 398 and goat limb 291 ' 301 , 303 (radial, tibial and femoral) models have 
also been used extensively for investigation of metallic implants. The goat femoral model is 
particularly relevant to ceramic or hydroxyapatite (HA)-coated implants whilst the sheep limb 
models have been used to investigate machined, roughened and HA-coated implants. Only 
sheep limb models are discussed in this review; goat limb and goat maxillary288 models are 
listed in the appendices. An example of an early paper using the sheep limb model is 
discussed below. 
Lill et al. (1992)312 implanted Branemark and Straumann ITI implants into the radii of 6 
female sheep. Standard, commercially available dental implants were used. The Branemark 
implants had a machined ( comparatively smooth) surface whilst the ITI implants had a 
roughed titanium-plasma sprayed surface. This was the first published comparison between 
these two implant systems, with their distinctly different surfaces. Both the metaphysis and 
diaphysis of the sheep radii were used, which the authors described as consisting of "spongy" 
and "predominantly compact" bone respectively. All implants were placed in a submerged 
configuration. Pairs of animals were killed after one, two or four months healing, apparently 
without perfusion. Resin-embedded ground sections 80-120µm thick were prepared, both 
longitudinal ( down the long axis of the implant) and cross-sectional in orientation. The 
sections were microradiographed and projected at a magnification of 40 times. Fluorescent 
photomicrographs were superimposed over the microradiographs and digitised for 
histomorphometric analysis of bone to implant contact. The intra-cortical and intra-medullary 
sections were considered separately. The authors noted that there was marked variability in 
the amount of bone at each site; they chose to limit their examination to sections with "as 
much spongy bone as possible" but did not say why they did this. 
Results consisted of a description of healing at each time period, and graphical presentation of 
percent bone-implant contact. Correspondence with Professor Plenk retrieved the figure of 
19% for bone-implant contact around the Branemark implant; the figure for the TPS-coated 
implant was unclear. 
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Of particular interest was the description of titanium particles becoming detached from the 
TPS implant surface and incorporated into the healing bone around the implant. In some areas 
macrophages were seen to have phagocytosed the particles. This publication was also one of 
the first to show that dental implants with machined surfaces were surrounded by denser bone 
(described as "strongly-compressed") but had areas around the thread tips that failed to fill 
with bone, which Wiskott and Belser (1999) related to either concentration of forces in this 
region and/or smoothness of the implant surface.318 By contrast, the rough-surfaced implants 
were surrounded by less dense bone but had bone-implant contact distributed evenly over the 
entire implant surface. Lill et al. (1992) related this partly to the poorer fit of the TPS-coated 
self-tapping implant within the osteotomy site, compared with the pre-tapped and machined-
surface Branemark implants. It was felt that the former tended to widen the osteotomy site 
during placement, whilst the latter retained a close fit with the surrounding bone. This pre-
existing bone then provided improved primary stability during the initial healing period. TPS-
coated ITI implants had poor bone-implant contact after 6 weeks healing, but this improved to 
a level similar to the Branemark implants over the course of the investigation. 
The authors also felt that the loss of titanium particles from the TPS surface induced an 
inflammatory reaction, which interfered with osseous healing. It should be noted that 
Branemark have now ceased making machined-surface implants, and that ITI no longer 
manufacture TPS-surface implants. 
This study was important in that it compared the two dental implant systems most commonly 
used in human patients. Unfortunately, the study was mainly descriptive and the presentation 
of quantitave results was so poor that it is unclear what differences existed between the two 
surfaces with respect to percent bone-implant contact. Unlike rabbits, this animal model was 
large enough to accommodate full-sized implants. In common with the rabbit model, the 
extra-oral location of the experimental site meant that the implants could not be loaded. A 
major deficiency of this investigation was the small sample size. Due to the variability in the 
quality of bone found at the medullary and cortical sites, only one implant for each site per 
observation period was studied. Thus, the conclusions that were drawn must be treated with a 
great deal of caution. 
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1.5.13. Animal models for dental implantology. Single-paper review: Dog mandible 
model. 
During the early 197O's, investigators used the edentulous dog mandible to study cemented916 
and blade917 dental implants. Endosseous screw-type titanium dental implants were first 
examined using this animal model by Brunski et al. in 1979;221 the dog mandible since been 
extensively employed by other investigators since_1s9,341,375,390,s30,s32-s34,ss9,s33_336,s60 
Approximately 30% of the papers included in the meta-analysis int his review used the dog 
mandibular model and an example of a recent paper is discussed below. 
Cochran et al. (1998)470 have published a histometric comparison of the original ITI TPS-
surface implants and the new ITI sandblasted, acid-etched (SLA) surface implants, shortly 
before the new implant was released for use in human patients. The authors of the paper 
originated from the two major centres for ITI research, the Universities of Berne 
(Switzerland) and Texas (USA); the study followed up initial work by Buser et al. (1991),410 
who employed femoral and tibial sites in the miniature pig. An older implant configuration, 
the hollow threaded cylinder (rather than the solid threaded screw), was used, although 
Cochran et al. did not give a reason for this. This shape was originally promoted as suitable 
for the posterior mandible in humans; the implants have large holes in the cylinder sides and 
an open base. A central bone core is retained (the final osteotomy is finished using a trephine 
bur) and ingrowing lateral bony spurs connect with this core. It has been suggested that this 
may increase retention of these implants. Saucerisation of the alveolar crest occurs around 
many implants after placement but generally stops during the first year of loading; however, 
if this process extended as far as the lateral holes in cylindrical implants, a rapid and 
irreversible peri-implantitis develops, leading to the loss of the implant and a significant part 
of the supporting bone.61 ' 921 These implants are also a greater risk of fracture through the thin 
walls of the hollow cylinder.922 For this reason, the solid titanium screw is now the main 
configuration promoted by ITI for use in human patients.923 
Six male foxhound dogs had all four mandibular premolars and first molar extracted under 
general anaesthetic; the ridges were allowed to heal for three months. Six implants were 
placed on either side of the jaw. Three test (SLA) and three control (TPS) implants were 
placed alternately, all in a non-submerged one-stage configuration; a total of 69 implants 
were placed. Four of the six dogs received prostheses in order to load the implants after 3 
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months healing. Initially these were gold bridges splinting two implants; in some cases these 
were separated into single implant crowns. 
The two dogs with unloaded implants were killed after 3 months healing; two further pairs of 
dogs were killed after three months and 12 months loading. Resin-embedded specimens were 
sawn to obtain two central, bucco-lingual sections oriented along the long axis of the implant. 
The blocks were then glued together and reoriented to obtain mesio-distal sections (see Figure 
2.38 for a diagram of this technique). Six to eight 80µm-thick sections were stained with 
toluidine blue and basic fushin. Bone-implant contact was measured at 250 times 
magnification using a stereological technique. Line intercepts were counted using a 6 x 6 
grid. Percentage contact was estimated for primary bone contacts (the residual bone left after 
osteotomy preparation, secondary bone contact (new bone ongrowth after implant placement) 
and total bone-implant contact. 
Unlike the TPS implants studied by Lill et al. in 1992, these ITI implants were not self-
tapping and apparently had a close fit within the osteotomy. The quality of images in the 
paper is high and convincing evidence of bone compression, deformation and microfractures 
can be seen. The implant surfaces were in contact with varying proportions of cortical and 
cancellous bone and marrow tissue. Primary bone contact was similar for the two types of 
surface and comprised bone-implant contact of about 20%. At 3 months, total bone-implant 
contact was 72.3±7.2% for SLA and 52.2 ±9.2% for TPS; this difference was statistically 
significant. Three kinds of bone ongrowth were evident. In cortical bone, a gap of up to 
200µm between residual bone and implant was filled with new bone; in cancellous bone, 
trabecular struts extended to envelope the slopes and tips of the implant threads; in marrow, a 
thin, 20-40µm wide layer of bone extended along the surface of the implant and was 
described as being "apparently without any mechanical function". All three responses 
demonstrate the osteo-conductive nature of the roughened surfaces; this phenomenom is 
explained more fully later in this review. All three types of bone response are also presented 
in the results of the current investigation. 
After 3 months additional loading, primary bone comprised less than 9% of the implant 
surface; total bone contact was 68% (SLA) and (78%) TPS and did not differ in a 
statistically-significantly manner. After 12 months loading, SLA surfaces retained a high 
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bone-implant contact (72% ), which was significantly superior to the TPS surfaces (59% ). 
Thus, SLA surfaces appeared to encourage more bone ongrowth during early healing, and 
retained better bone-implant contact long-term. TPS surfaces were again observed to have 
shed particles of titanium into the adjacent marrow tissue, but there was no mention of an 
inflammatory reaction to this. 
This was one of the key papers used, firstly to validate the replacement of an established 
implant surface (TPS) with a novel one (SLA), and secondly, to drive a change in surgical 
protocols to earlier clinical loading of dental implants in human patients. However, there are 
some methodological flaws in this study. The protocol did not permit direct comparison 
between loaded and unloaded implants in the same animal at the same time point. The 
assumption was made that the percent bone-implant contact measured on unloaded implants 
in one group of dogs, would have changed ( either increased or decreased) to same extent 
measured in a different group of animals, after three or 12 months loading. This assumption 
could have been verified by using a split-mouth design, placing both loaded and unloaded 
implants into the same animals and measuring the percent bone-implant contact at all three 
time points (for an example of such a protocol in the dog posterior mandible, see Zubery et al. 
1999918). 
Furthermore, the degree of loading on all implants was assumed to be equivalent; however, 
the authors stated that some implants received superstructures that splinted the implants in 
pairs, whilst others had single crowns and were not splinted. Histological evidence of 
equivalent bone-implant contact around implants loaded with splinted crowns in the posterior 
mandible has been demonstrated,855 as has immediately-loaded non-splinted crowns in the 
anterior maxilla,919 both using a monkey model. However, Misch (2005)920 has suggested that 
the success of implants placed into the posterior jaw of human patients is enhanced when a 
splinted superstructure is used, rather than single crowns. He commented that "natural teeth 
follow a similar biomechanical approach to accommodate the higher bite forces in the 
posterior regions of the mouth ... the roots are splinted together". Histological evidence for 
this hypothesis has yet to emerge. 
The paper of Cochran et al (1998) draws conclusions relevant to clinical implant dentistry, 
based on their statistical analysis of bone-implant contact around 69 implants. However, it is 
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important to note that the mean results for each group of implants is based on a sample size of 
two animals, which is the true unit of analysis.816 Using such a small number of animals is a 
common practice in implant dentistry research, often due to the financial cost of carrying out 
such research. Using a small number of animals may also reduce within-group variability, 
resulting in a smaller standard deviation and increasing the likelihood of finding a statistically 
significant difference between groups. However, it can be argued that the statistical power of 
a study with such small sample sizes is low and the validity of the conclusions questionable. 
1.5.14. Animal models for dental implantology. Single-paper review: Monkey mandible 
model. 
Although non-human primate models are considered highly useful in preclinical research, due 
to the similarities between these species and humans, this animal model constitutes only 10% 
of the papers incorporated in the meta-analysis of dental implant research. Access to a 
primate research facility, financial costs and ethical considerations, appear to be factors 
limiting the use of non-human primate models. An example of an important paper that used 
this model is reviewed below. 
Isidor (1997)330 performed an experiment using Astra titanium solid-screw dental implants 
with roughened surfaces placed into the edentulous dental ridges of four Macaque monkeys. 
Mandibular incisors, premolars and first molars were extracted and 5 implants were placed 
after 8 months healing. Pairs of implants were placed into the posterior mandible and a single 
implant in the anterior region, all using a two-stage (submerged) surgical protocol. Implants 
were exposed after 6 months healing and healing abutments placed except for one posterior 
pair of implants, which received a splinted metal bridge as a superstructure. Another splint 
was cemented to the teeth of the opposing maxillary sextent; both bridges were designed to 
bring the dentition into gross supra-occlusion, so that excessive lateral force was applied to 
the implants. These implants were then mechanically cleaned weekly for 18 months. The 
contra-lateral posterior implants had cotton ligatures tied around them and were not cleaned, 
inorder to promote the development of peri-implantitis. 
After 18 months, the animals were killed with formalin perfusion of the carotid arteries and 
50µm-thick resin-embedded, bucco-lingually-oriented ground sections were prepared through 
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the long axis of the implants. Basic fushin & Light Green-stained sections were digitised at 
100 times magnification and analysed using computer-assisted histomorphometry. Percent 
bone-implant contact for the entire implant surface and for the surface of implant within bone 
(apical to the first bone-implant contact) was measured, as was the density of bone 
(mineralised bone/unit area) lateral to the implant. Density measurements included bone 
within the threads and extended out to lOOOµm from the implant surface. 
The experiment thus consisted of 20 implants; 8 with excessive loading and 12 with ligature-
induced peri-implantitis. Two implants were lost prior to abutment connection. The paper 
does not state whether these were posterior or anterior implants or which experiment group 
they belonged to, but careful reading of the results table suggests that one anterior and one 
posterior implant in the plaque-retaining group failed to achieve initial integration. Two 
overloaded implants were lost during the experiment; four became mobile but were retained; 
two did not become mobile but had a fractured bridge. No plaque-retaining implants became 
mobile or were lost after abutment connection. 
Only 6 overloaded implants were analysed histologically; 10 plaque-retaining implants were 
also analysed. Percent bone-implant contact for overloaded implants (mean for the pair when 
present) was reported to range from 0% to 72.8% however no mean value was reported. 
Analysis of the results (presented in both tabular and graphic form) showed that for the 
overloaded implants, mean bone-implant contact for the total implant surface was 26.4 ± 
32.6% and for surface within bone, 33.4 ± 32.5%. The corresponding figures for the peri-
implantitis group were 47.7 ± 14.0% and 64.3 ± 15.7%. Statistical comparison of the two 
groups was not undertaken due to "the limited number of excessively occlusally loaded 
implants that were available for evaluation". 
Bone density was 55.1 ± 10.2% for overloaded implants and 38.6 ± 10.9% for peri-implantitis 
implants. These figures are not quoted in the paper but come from re-analysis of the tabulated 
data. Similarly, mean bone loss was 5.6 ± 2.8mm compared with 2.4 ± 0.9mm. The author 
commented that there was also a distinctive difference in the response of peri-implant soft-
tissues, with apical downgrowth of epithelium into the peri-implant pockets around implants 
with peri-implantitis. For the overloaded implants, the apical termination of epithelium 
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remained close to the coronal implant margin "rather than covenng the whole non-
osseointegrated implant surface". 
This study was the first to provide convincing histological evidence of complete or partial 
loss of osseointegration around dental implants resulting from excessive occlusal overload. 
Relating these findings to the interpretation of Wolf's law presented by Frost (1994),479 lsidor 
suggested that the strain on the bone surrounding overloaded implants may have exceeded a 
threshold level, below which apposition of bone may have been expected to occur. It was 
also the first to suggest that these two leading causes of implant failure appear to be markedly 
different at a histological level. 
The author was very careful to point out the limitations of this study with respect to numbers 
of implants. Another limitation was the very small number of animals used. However, a split-
mouth design was used, which allowed some comparison between implants in the same 
animal. The importance of this was highlighted by the author's comment that a large range of 
values was found for the different histomorphometric analyses, even between individual 
implants in the same monkey. Examination of the tabulated results however, suggests that 
intra-animal responses for individual implants were more consistent than those found within 
each group, reinforcing the point that the animal is the primary unit of analysis. 
It is unclear why the authors chose to combine mandibular incisor sites with posterior sites. 
Mean results for implants in incisor sites were lower for both percent bone-implant contact 
measurements and for percent density; the differences between premolar and molar sites were 
inconsistent. There was however, a clear difference overall in bone density around overloaded 
compared with peri-implantitis implants, the latter being less dense. Of the four pairs of 
contralateral implants in two monkeys that could be directly compared, the magnitude of the 
differences in density between the left and right side of the animal's jaw ranged from 0.3 to 
18% lower on the peri-implantitis side. The authors did not discuss this, perhaps due to the 
small sample size. 
This paper has been frequently sited as demonstrating clear-cut differences between occlusal 
overload and peri-implantitis. 
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Subsequent authors have reported different results. In a similar monkey model, Miyata et al. 
( 1999, 2000)924' 925 found no histological evidence of failure of osseointegration, provided the 
animals were kept plaque-free and the superstructures had less than 180µm excessive vertical 
dimension. Again, numbers of animals in each experimental group were small (1 to 2 
animals/group) and only 2 implants were placed in each animal; moreover, these were short-
duration studies (4 weeks loading only). Cylindrical, non-threaded implants were used, which 
are known to show more rapid bone loss than threaded screws. Finally, quantitative 
histomorphometric analysis of bone-implant contact was not performed. 
More convincing is the work conducted by Heitz-Mayfield et al. (2004).377 In this well-
designed study, 48 implants were placed into the mandibles of six dogs. A split-mouth design 
was used, comparing unloaded with grossly overloaded, solid-screw ITI implants. A 
secondary aim of the study was to compare implants having either SLA or TPS surfaces. 
Only three implants were lost. Histomorphometric analysis after 8 months loading found no 
statistically-significant differences in clinical, radiographic or histomorphometric parameters; 
bone-implant contact was 73% for the unloaded controls and 74% for the overloaded test 
implants. No differences were found for bone density; nor were differences found between 
the TPS and SLA surfaces. The authors concluded that "excessive occlusal forces may 
present only a very minor, if any, risk for the integrity of osseointegrated implants". 
1.5.15. Other published results for implants in sheep. 
Little use has been made of the sheep as an animal model for dental implantology. The 
literature regarding implants in sheep can be divided into three groups: the use of orthopaedic 
fixation devices (threaded pins and screws) in either the long bones or the jaws, which 
provides indirect evidence for dental implantologists: the implantation of dental titanium 
implants into long bones or other extra-oral sites; and the placement of dental titanium 
implants into intra-oral locations. Only a minority of these studies involved 
histomorphometric analysis of the bone-to-implant contact and the amount of bone/unit area 
(bone density) adjacent to the implants. A synopsis of these investigations is presented in 
Table 1.12. 
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This review focuses mainly upon investigations where the primary outcome variable was 
histomorphometric analysis of the bone-to-implant contact, although orthopaedic 
investigators have employed different measurement techniques such as removal torque393 and 
xray diffraction.394 Examples of orthopaedic devices that yield useful information regarding 
metal-to-bone integration in sheep include threaded external fixation pins and screws. 
Orthopaedic researchers have used tibial and femoral sites in sheep to examine implants and 
fixation pins with various surfaces coatings for various healing periods.395-398 These are not 
covered in detail in this review. 
1.5.16. Dental implants in sheep long bones. 
More relevant to this investigation is the work by dental researchers who have placed dental 
implants in the long-bones of sheep. As review in detail above, Lill et al. (1992) used 
computer-assisted histomorphometry to examine the healing around Branemark machined-
surface and Straumann TPS-coated implants placed into the radii of 6 sheep for one, two and 
four months.312 Percent bone-to-implant contact for the cancellous bone regions and a 
measurement of the amount of bone (in mm2) within a region 1mm lateral to the implant 
surfaces was recorded. 
In a subsequent study, Haider et al. (1993) investigated the effects of heat generated during 
drilling by placing two IMZ TPS-coated titanium cylindrical implants into the compact bone 
(diaphysis) and cancellous bone (metaphysis) of the left tibia of six sheep.310 This experiment 
effectively replicated that of Lill et al. (1992) except that cylinders rather than screws were 
studied. The healing intervals were again one, two and four months. 
Hure et al ( 1996) compared Euroteknika and Branemark implants implanted into the tibial 
diaphyses of two sheep for six months311 and Chappard et al ( 1999) evaluated the same 
implant types after three and six months in the femurs of six sheep.314 
Lucchini et al (1996) compared SERF and Nobelpharma implants placed into femoral sites in 
two sheep for 12 weeks.313 Asikainen et al (1997) placed four custom-made TPS-coated 
hollow-screw titanium implants into the foreheads of five sheep, connected abutments after 
three months and used orthodontic bands to apply lateral forces for a further three months. 
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The thickness of investing bone was described but no histomorphometric measurements were 
presented. 309 
Further evidence has been provided by the placement of dental orthopaedic devices in the 
maxillofacial bones of sheep. Soderholm et al. (1991) sectioned the mandibular angle in 
sheep and placed an osteosynthesis plate retained by stainless steel or titanium screws. The 
percent bone-implant contact around the fxation screws after one to three months healing was 
described. 182 Likewise, Ploder et al. (1999) created critical-sized segmental defects in the 
body and diastema of the sheep mandible wich they stabilised using an osteosynthesis plate 
retained by titanium screws.117 These two papers suggested that titanium screws could be 
placed (albeit to retain a plate during osseous healing) in the mandibular bone of sheep. 
Haas et al (1998) successfully placed 108 Friatec TPS-coated unthreaded cylindrical implants 
into the maxillary bone and sinuses of 27 sheep accompanied by alloplastic or autogenous 
bone grafts, for three, four and six months.307 Gaggl et al (2000a) have investigated a two-part 
commercially-pure titanium threaded implant with a laser-roughened surface used as an 
osteogenic distraction screw in the mandibular diastema of sheep. These authors seem to be 
the first to describe the use in sheep mandibles of an intra-osseous expanding device that 
remains behind after distraction and can be prosthetically restored. This is also the first 
description of a one-stage transgingival implant in sheep mandibles. 116 
1.5.17. Implants in the sheep mandible. 
The literature regarding the use of the sheep mandible as a test-bed for dental implants is 
extremely small. Arvier et al. (1989) described the use of the sheep mandibular diastema site 
as an animal model for the placement of screws and cylinders manufactured out of various 
alloys and linked to a submandibular casting designed for use in individuals with highly 
atrophied jaws.121 Histomorphometric analysis was not performed in this study. Wie et al. 
(1995) coated small titanium conical cylinders with hydroxyapatite and compared these with 
uncoated, sandblasted implants inserted via an extra-oral approach into the lower margin of 
the mandibles of two sheep for two months.305 Rodrigues Y Baena et al. (1998) placed one 
titanium dental implant into the mandibular diastema of a sheep for 74 days. Analysis was 
limted to a brief comment that integration failed and the site was not further investigated.141 
Frisken et al. (2002) placed single Branemark Mark II machined-surface implants, 10mm x 
3.75mm diameter, into the edentulous mandibular diastema in each of 12 adult sheep for one, 
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four or eight to 12 weeks. Animals were sacrificed and various organs assayed for whole 
body distribution of titanium. Clinical or histological data on the effectiveness of 
osseointegration in this site was not reported, however implant failure was identified in two 
animals, one at four weeks and the other at 12 weeks post-operatively, giving a presumable 
success rate of 83% (based on successful "animals" rather than successful "implants").306 
1.5.18. Summary- animal models for dental implantology. 
The use of sheep animal models for testing dental implants is summarised in table 1.11. The 
sheep tibia is well characterised as a model for both dental implants and orthopaedic screws. 
Two publications describe the use of the sheep mandible via an intra-oral approach for the 
testing of maxillofacial orthopaedic devices. One publication describes a novel dentofacial 
implant system utilising various non-titanium metallic alloys placed into sheep mandibles. 
Two publications refer to conventional dental implants placed in the sheep mandibular 
diastema. Detailed characterisation of the sheep mandible as an animal model system for 
conventional dental implants, using quantitative histological analysis, does not appear to have 
been undertaken. 
Hypothesis 4: "The sheep mandible is a suitable site for the testing of dental implants". 
78 
Table 1.12: Dental implants using the sheep as an animal model. 
Arvier et aI. 121 1989 Extraction Alloy screws & cylinders 6, 12, 13 weeks Descriptive histology 
mandible & 
diastema 
Wilke et al. 393 1990 Tibiae Tia screws, 6 surfaces - polished, 2,9,12,18,24,52 Removal torque 
titanium plasma sprayed, or variety weeks 
of grit-blasting & acid etching 
Soderholm et 1991 Angle of Stainless steel or Ti screws in 5,9,12 weeks % Fixation of screws 
al.1s2 Mandible osteosynthesis plateb described 
Lill et al. 1992 Radii Branemark machined-surface & ITI 4 weeks Histomorphometric 
TPS0 implants analysis 
Haider et al.310 1993 Tibial diaphysis TPS titanium dental implants 4,8,16 weeks Histomorphometric 
and metaphysis analysis 
Wie et al. 305 1995 Inferior border Unthreaded conical titanium 60 days Histomorphometric 
mandibular cylinders analysis 
ramus 
Hure et al.311 1996 Sheep femur Titanium dental implants 6 months Histomorphometric 
analysis 
Lucchini et 1996 Femur Titanium dental implants 12 weeks Histomorphometric 
al.313 analysis 
Asikainen et 1997 Forehead Titanium TPS hollow-screw dental 6 months Descriptive histology 
al.309 implants 
Rodrigues Y 1998 Mandibular One titanium dental implant 74 days Brief description -
Baena et al. 141 diastema integration failed 
Haas et aL307 1998 Maxillary sinus Titanium TPS dental implants. 12, 16, 26 weeks Histomorphometric 
analysis 
Rodrigues Y 1998 Proximal tibia & Ti dental implants, grafts & 24 &45 days Descriptive histology 
Baena et al. 141 distal femur membranes. 
Rocca et al. 398 1998 Femur & tibia TPS-coated threaded implant 2, 4, 12 weeks Histomorphometric 
analysis 
Savarino et 1998 Tibia Titanium implant 2,4,12,36 weeks X-ray diffraction 
al.394 analysis 
Ploder et al.117 1999 Body& Titanium screws in osteosynthesis 6 -7 weeks Descriptive histology 
diastema of plate 
mandible 
Chappard et 1999 Femur Titanium dental implants 12 & 24 weeks Histomorphometric 
al.314 analysis 
Grizon et al. 2002 Femur Titanium dental implants 3,6,12,18 Histomorphometric 
400 months analysis 
Gaggl et al. 116 2000 Mandibular Laser-etched Ti distraction screwd 6 months Histomorphometric 
diastema analysis 
a titanium 
b orthopaedic device 
c titanium plasma-sprayed 
d two-part dental implant used as orthopaedic device 
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1.6. Enhancing osseointegration - investigations using animal models. 
As noted above, animal models are useful in dental implant research, in that they permit 
detailed analysis of the response of a biological system, especially when the critical 
determinants of successful implant osseointegration are varied. A successful model would 
allow consideration of a range of variables. Ideally, results should separate the successful 
strategies or the important variables from other factors in a statistically significant and 
clinically relevant fashion. The remainder of this literature review considers some of the 
variables affecting the success of dental implant treatment, that might be considered using a 
sheep mandibular model for dental implantology. 
1.6.2. Overview of strategies to increase or enhance bone-to-implant contact. 
Brunski et al. (2000) reviewed ways by which selection and modification of the implant 
biomaterial affect the bone-implant interface.404 Potential approaches were divided into three: 
physiochemical, morphologic and biochemical methods. Physiochemical methods included 
modifications to implant surface energy or charge282• 405• 406 and the addition of calcium 
phosphate or hydroxyapatite coatings.407-409 Morphological methods primarily focused upon 
the surface texture of the implant410-412 although implant shape and geometry were considered 
important.413 Biochemical modification encompassed the use of cell adhesion molecules such 
as laminin, fibronectin or collagen,414• 415 osteotropic biomolecules such as the growth factors 
transforming growth factor-B (TGFB) and bone morphogenetic protein (BMP), and the 
combination of the two into appropriate delivery systems for coating dental implant 
surfaces.416-419 Other variables which may be modified in order to increase bone-to-implant 
contact include (1) bone overheating during surgery ,420• 310• 421 • 368• 422• 423 (2) operator surgical 
experience,424• 425• 348• 426 (3) implant surface area for attachment (wide implants, long 
implants),427-430 (4) implant mobility (bicortical stabilisation),431 • 432 (5) bone density of the 
implant site (osteotome compaction)433-436 and (6) height and width of the site (bone grafting 
or guided bone regeneration). 437• 232• 438' 439 
According to Albrektsson et al. (1981 ), six factors are considered the major variables that 
influence the fixation of endosseous implants within bone.327 In Table 1.11, these factors are 
summarised and examples for each are suggested. These factors were derived from 
observations in human subjects. The same criteria apply to animal models, although 
additional factors (species, intra-oral versus non-oral site) need to be considered, whilst some 
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factors (such as smoking) may be less important (although the effect of nicotine adminstration 
has been studied using the rabbit tibia model).440 
Table 1.13. Six variables influencing implant fixation (adapted from Albrektsson et al. 
1981), with examples.327 
Micro:,copic design elements 
Status of the host tissue 
Surgical technique 
Loading conditions · 
1 Titanium-plasma sprayed surface 
2 Sandblasted, large grit, acid etched surface 
* Indicates variables considered in this thesis 
Titanium-vanadium-aluminium alloy 
Ceramic/Hydroxyapatite* 
Hollow vs solid screw 
Threaded vs non-threaded cylinder 
One-piece vs two-piece system* 
Rough vs smooth (machined or "as-turned") surface* 
TPS 1 vs SLA2 or similar* 
Bone quantity and quality 
Age and gender 
Smoking, osteoporosis, medications, systemic diseases 
Peri-implant infection during early or late healing 
Pre-existing periodontitis* 
Operator experience 
Quality of drills / Overheating 
Length of integration period 
One-stage vs two-stage surgical protocol* 
Unloaded* 
Immediate- or early-loading* 
Overloading 
Non-axial loading 
1.6.3. The clinical rationale for bone generating strategies around dental implants. 
Patients often express a desire for early restoration and loading of their implants, especially 
when the maxillary anterior aesthetic zone is involved.441 This creates a dilemma for the 
clinician if the quantity and/or quality of bone within the proposed implant site is not ideal.442' 
443 It would be clinically advantageous in such cases to have a treatment strategy that 
increases both the quantity of osseointegration (the amount of bone in intimate contact with 
the implant surface) and the quality of osseointegration (bone density ie: proportion of 
mineralised to non-mineralised tissue within the implant threads). Ideally this strategy should 
modify the early phases of osseous healing and accelerate the rate of integration, thereby 
permitting early loading of the prosthesis.41 • 444 
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1.6.4. Dental implants with machined ("as-turned") surfaces. 
The original implant protocol described by Branemark and co-workers in 1969 consisted of 
titanium solid-screw implants with smooth (machine-turned) surfaces, placed into patients 
using a two-stage surgical procedure. 1 Initially this treatment focused on the rehabilitation of 
fully edentulous subjects.3 The technique has since been extended to include partly-dentate 
subjects, single-tooth implants, single- and two-piece systems, immediate replacement of 
teeth and immediate loading of implants.4-11 ' 13-15• 42 Moreover, implants may now be placed 
into less-favourable sites despite inadequate bone quantity or quality.227• 16-19 
1.6.5. Effect of bone quality. 
Although the mean long-term success rates for machined-surface implants of the Branemark 
system is approximately 92.3%, failures (both short- and long-term) increase when fixtures 
are installed into sites of poor volume and/or quality, particularly in the edentulous maxilla.348 
Lekholm and Zarb (1985) divided the quality of bone at intended implant sites into four 
categories: type I (homogenous cortical bone), type II (thick cortical bone with a marrow 
cavity), type III (thin cortical bone with dense trabecular bone of good quality) and type IV, 
where II a thin layer of cortical bone surrounds a core of low density trabecular bone 11 •445 A 
similar classification system has been proposed by Misch (1999).446 These classification 
systems are shown diagramatically in Figure 1.5. 
Atrophic changes in the edentulous human jaw are highly variable but may include cortical 
porosity, thinner cortices, and loss of trabecular bone, leading to a classification as type IV 
bone.447-450 Dental implants placed in edentulous human jaws with type IV bone are less 
successful than in bone types I - 111.451 -454 Success rates range from 55% for the posterior 
maxilla and mandible combined454 to 73 - 81 % for the posterior mandible only.451-453 Jaffin 
and Berman (1991) concluded that type IV bone is "the single greatest determinant in 
predicting fixture failure" .453 
Histomorphometric analysis has demonstrated that mobile implants placed in type IV bone 
have poorer bone-implant contact and a poorer prognosis.455 However, one systematic review 
and meta-analysis ranked "implant loss in type IV bone" as only the 7th most common 
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implant complication, with an incidence of 16%.456 Some have reported that type IV bone 
causes higher rates of loss in non-HA coated implants compared with HA-coated implants457• 
443 or for oxidised surfaces compared with machined surfaces458 whilst other reported no 
increase in failure rates even for machined-surface implants.459 
1.6.6. Dental implants with roughened surfaces. 
Seven years after the first Branemark publications, Schroeder et al (1976) described an 
alternative protocol for osseointegrated implants.2 An important feature of these Straumann 
implants was the roughened titanium-plasma-sprayed surface.460 The cumulative 7-year 
survival rate of these implants in a recent multi-centre clinical trial was 92.2%461 and a review 
of short and long-term trials using this system quotes values of 93.3 - 100%.460 
Subsequent experimentation has revealed further techniques for altering implant surface 
topography with similar, advantageous effects to that of TPS surfaces upon osseous healing. 
Grit-blasting with 25 - 250µm alumina particles has been shown to enhance 
osseointegration380• 462-465• 389 as does chemical etching with combined hydrochloric/sulphuric 
acid.466• 367• 467• 468 Radiographic and histologic studies have established that the combination of 
grit-blasting and acid-etching promotes "greater osseous contact at earlier time points 
compared to TPS-coated implants" .469• 470 More recently, oxidisation of the titanium dioxide 
surface has been promoted.412• 471 • 472• 458 Surface roughening is now a well-established method 
for increasing early bone-to-implant contact,473 and has been described as a major paradigm 
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Four typical bone qualities described by Lekholm and Zarb 
Bone Quality 
Bone Quality is Usually Categorized as Follows: 
Type/ 
Almost the entire jaw is comprised of homogeneous 
compact bone. 
Type/I 
A th.id:. b yer of compx:t bone surrounds a core of dense 
t rabecul::ir bone . 
Type/II 
A thin b yer of cortical bone surrounds :i core of dense 
tr:ibecuk1r bone of fuvomhl e !ltrength. 
Type IV 
A very thin layer of <.-ortical bone surrounds ::a <.-ore of low-
density trobecub r bone. 
From: Lekholm U and Zarb GA. Patient 
selection. In: Tissue Integrated Pros-
-theses: Osseoinfegration in Clinical 
Dentistry. P-T Branemark, GA Zarb and 
T Albrektsson (editors). Chicago: 
Quintessence, 1985, p199-209 . 
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Four human jaw sections stained with the von Kossa technique and 
related to the t:.ekholm and Zarb bone quallty classifications.· 
Specimens 1 and 2 come from the anterior mandible, speciment 3 
from the anterior maxilla and specimen 4, posterior maxilla. 
From: Watzek G and Ulm C. Compromised 
alveolar bone quality in edentulous jaws. 
In: Aging, Osteoporosis and Dental Implants. 
G Zarb, U Lekholm, T Albrektsson and H Tenen-
-baum (editors). Chicago:Quintessence, 2002, 
p67-84. 
From: Nobel Biocare catalogues, accessed on line 
October 2004. URL:http://www.nobelbiocare.com/-
-global/en/Products/ProductCatalog/download_catalogs.htm 






Dense cortical bone 
Thick dense to porous cortical bone on crest and 
coarse trabecular bone wi thin 
Thin porous cortical bone on crest and fine 
trabecular bone within 
D4 Fine rtabecular bone 
D5 Immature, nonmineralized bone 
Arranged by Misch in order of density: 
1. Dense cortical 
2. Porous cortical 
3. Coarse trabecular 




Macroscopic description of four Misch bone densi ties. 
From: Misch C.E. Contemporary Implant Dentistry 2nd Ed, St Louis : Mosby, 
1999, p 113. 
Figure 1.5. Various diagrams showing classifications of bone density types.444•445•474•475 
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1.6.7. Effect of implant surface upon bone - stress shielding. 
Roughened-surface implants appear to be superior at maintaining the density of the 
surrounding bone. When smooth-surfaced bone plates are used to stabilise fractures in long 
bones, surface contact between plates and bone results in reduced bone density (bone 
porosis), by one month after surgery. Bone loss in the vicinity of these orthopaedic implants 
has hitherto been explained as being induced by mechanical unloading of the bone (stress 
protection or stress shielding). 
Experiments in sheep, dogs, and rabbits combining intra-vital staining of blood circulation 
and fluorescent labelling of bone remodelling have suggested that early bone porosis in the 
vicinity of implants is the result of internal remodelling of cortical bone induced by necrosis 
rather than by unloading.476 The evidence given for this was: (1) bone porosis is a temporary, 
intermediate stage in internal bone remodelling; (2) the pattern of the remodelling zone is 
closely related to that of the disturbed circulation, and not to that of unloading; (3) plastic 
plates may produce more porosis than steel plates; and (4) improved blood circulation using 
modified plates resulted in reduced porosis. 
This process has been further characterised as a positive feedback loop via A-R-F 
remodelling, with continued loading of a damaged and porous area of bone resulting in 
increased resorption and increased damage;404 this review paper then listed a number of 
clinical and animal studies using dental implants that provide support for this hypothesis. Of 
particular note were the seminal monkey studies of Isidor (1996 & 1997)477 ' 330 that 
demonstrated two distinctive mechanisms leading to implant failure. Plaque-induced peri-
implant inflammation resulted in destruction of coronal bone and intra-bony pockets 
analogous to periodontitis, without an increase in mobility. Occlusal overload caused loss of 
osseointegration over the entire implant surface as a result of "fatigue micro-fractures in the 
bone exceeding the repair potential"; these implants became mobile and were exfoliated. 
Wiskott and Belser ( 1999) reviewed the concept of stress shielding by dental implants with 
smooth surfaces.318 They noted that the mechanisms responsible for lack of osseointegration 
include "increased pressure on the osseous bed during implant placement, establishment of a 
physiological "biologic width", stress shielding and lack of adequate biomechanical coupling 
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between the load-bearing implant surface and the surrounding bone". This paper developed a 
hypothesis to explain why II available clinical evidence indicates that crestal bone resorption 
around dental implants tends to be arrested by threads or a porous surface texture 11 • One 
mechanism for this suggested by the authors was rough implant surfaces encourage cells 
alignment and adherence. However, they noted that this does not explain why macroscopic 
features such as threads also arrest alveolar crest resorption. 
Wiskott and Belser (1999) went on to develop a hypothesis based on stress linkage between 
the implant and bone. The unit responsible for this is the Basic Multicellular Unit (BMU) 
consisting of a functional grouping of osteoblasts, osteoclasts, precursor and supporting cells 
and capillaries478 which carries out the normal osseous cycles of resorption and apposition. 
From this concept, Frost (1994)479 defined a rho fraction (p) to represent the balance between 
bone anabolism and catabolism. The p fraction is "a function of the strain levels that act on 
the bone"318 and may be divided into five overlapping domains: 
1) disuse (negative p and disuse atrophy eg: post-extraction ridge resorption); 
2) normal load (p fraction= 0, normal homeostasis) 
3) mild overload (strains of 2000 - 4000 µ£ , some microcracks in bone, positive 
p fraction = bone mass increases) 
4) pathological overload (strains > 4000 µ£ , bone "creep" and fatigue, negative 
p fraction = bone mass decreases) 
5) fracture (stretching of bone >2% or 25,000 µ£, although this varies according to 
anatomical site). 
The time relationship of force to strain is also important ie: the peak magnitude and frequency 
of strains. It seems that up to a certain point, yet to be defined, minute shear forces and 
micromotion at the implant/bone interfaces result in increased bone mass; beyond this point, 
bone loss occurs. 
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Results supporting this hypothesis have been reported in for slightly and excessively mobile 
dental implants in an animal model480 The mechanosensor responsible for converting strain 
into cellular growth has not been clearly identified, although hypotheses include both growth 
factors and extracellular fluid shear stress. The transfer of stress from the implant (under 
different loads) to bone is also critical. Two opposing mechanisms have been proposed for the 
process of "bone saucerisation II seen once dental implants are loaded: local overload and 
microfractures at the alveolar crest481 or insufficient load and disuse atrophy.482 The latter may 
be due to "stress shielding" which results from the difference between the modulus of 
elasticity of bone and of the implant. During loading bone flexes more than the implant, thus 
unloading areas in contact with the implant, resulting in atrophy or osteoporosis. 
Wiskott and Belser (1999) expressed scepticism about the applicability of this orthopaedic 
concept (where the majority of loading on the implant is axial and unidirectional) to the 
mandible, where the implant is exposed to multidirectional non-axial loading.318 The authors 
concluded that "the implant's neck should subject the majority of the circumferential bone to 
adequate strain levels and thus preclude resorption". With respect to type IV bone, they 
suggested that it is not the porous nature of the bone which causes an increase in implant loss 
but rather the inability of the implant to transfer adequate strain to the bone ( due to the 
paucity of trabecular struts directly contacting the implant surface). They noted that according 
to Frost's mechanostat principle,483 type IV bone would be expected to respond to load by 
forming more bone in contact with the implant surface and thus "densify the initially loose 
osseous structure" .318 
This process, which Roberts (1988b) refers to as "corticalisation" ,276 results from successful 
coupling of stress (on the implant) to strain (on the bone). This coupling concept is the 
opposite of "stress shielding", an uncoupling phenomenon. Wiskott and Belser (1999) 
proposed that roughened implant surfaces increase force coupling, not due to mechanical 
interlock so much as due to their in-egular shape. This creates II a heterogeneous field of force 
vectors inside the sun-ounding bone II which then triggers "specific lineages of bone cells to 
start bone production" .318 These authors concluded that smooth surfaces fail to provide 
adequate stress transfer to bone which results in reduced bone-to-implant contact, whereas 
threaded, plasma-coated or sandblasted implants generate a heterogeneous stress field around 
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the implant during functional loading, thereby maintaining or potentially increasing the 
amount of direct bone-implant contact. 
1.6.8. Proposed mechanisms by which roughened implant surfaces affect bone. 
Although it is known that changes in the surface chemistry, energy, roughness and micro-
topography of an implant surface affect the osseointegration of implants, exactly how and 
why this occurs is only now becoming clear. Schwartz et al. (1997, 1999)484' 485 have shown in 
vitro that changes in surface roughness (ranging from polished surfaces, to SLA and TPS 
surfaces) modify the differentiation of precursor cells into osteoblasts and affect osteoblast 
proliferation and matrix production as well as local concentrations of cytokinse and growth 
factors. Production of the growth factors (GFs) PGE2 and TGFB are increased with increasing 
surface roughness. These GFs appear to have complementary roles in the critical pathways 
for the stimulatory effect of surface roughness.486•487 
The clinical application of this knowledge lies in two approaches, which are not seen as 
mutually exclusive: (1) optimise the roughened surfaces of implants and/or (2) increase the 
concentration of critical biological factors around the implant during healing. 
1.6.9. Comparing implants with different surfaces - meta-analyses of clinical studies. 
The clinical effectiveness of implant surface with respect to successful osseointegration has 
been assessed by Cochran (1999)488 in a meta-analysis (details of the process of systematic 
search and meta-analysis, are given later in this review). In this study, the formal search 
protocol was deliberately inclusive rather than exclusive. This attracted quite marked 
criticism, as did the sub-categorisation into machined-surface, rough-surfaced or 
hydroxyapatite-coated implants.489-491 Statistical analysis was performed using the Peto 
method (reviewed in section 4.3.3). Despite these criticisms, the results make interesting 
reading. 
When compared by jaw, the odds ratio of success for HA-coated implants was higher than 
either smooth or rough surfaces when placed into the maxilla. In the mandible, smooth 
surfaces were significantly more likely to succeed than either HA-coated or rough surfaces, 
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which were indistinguishable. For three other sub-groups included in the meta-analysis 
(edentulous, partially edentulous and overdenture patients) rough surfaces had significantly 
higher success rates than smooth. For single tooth implants, rough surfaces had a better 
success rate on average than smooth, but this was not statisotically significant. Clear evidence 
of an advantage using rough surfaced implants was not found in this study; overall odds ratios 
for all implants in all locations showed that smooth surfaces were superior to rough. 
However, the author chose to interpret these results as clinical proof of the advantage of 
rough-surfaced implants. 
1.6.10. Comparisons of implants with different surfaces - in vitro studies. 
Comparison of the effect of titanium implants with machined (smooth, Astra), hydroxyapatite 
plasma-sprayed (HA, IMZ), titanium-plasma-sprayed (TPS, ITI or IMZ) and titanium dioxide 
grit-blasted (Ti02-blasted, Astra) surfaces at cellular level has been performed using in vitro 
cultivation with neonatal rat osteoblasts.492 Osetoblast migration, spreading, proliferation and 
differentiation was analysed for up to 4 weeks by scanning electron microscopy. Attachment 
and spreading was identified after 20 minutes exposure to suspended cells. Attachment was 
classified into four stage:- (1) rounded cells, (2) focal cytoplasmic extensions or 
lammellipodia, (3) circumferential spreading, and (4) fully spread and flattened polygonal 
cells. 
Proliferation and differentiation was studied on additional implants cultivated in nylon mesh 
pockets with bone fragments and incubated with cell culture media. Pockets were dried and 
SEMs of implant surface prepared after 1, 2 or 4 weeks. TPS surfaces appeared to favour cell 
spreading, with Ti02-blasted surfaces the least conducive to spreading. HA surfaces were 
heterogeneous:- cells in smoother areas resembled TPS-surfaces, whereas cells in rough areas 
with incompletely melted hydroxyapatite resembled those on Ti02-blasted surfaces. Mature 
cells (stage 4) were in intimate contact with smooth surfaces, less so on TPS-surfaces, 
variably so on HA surfaces, and had little intimate contact with Ti02-blasted surfaces. Only 
TPS and HA surfaces were compared long-term; TPS-surfaces developed multilayer sheets of 
cells after 4 weeks, whereas cells on HA surfaces remained sparse. This work provides 
further evidence that the differences in mode of interaction between bone to titanium 
compared with bone to hydroxyapatite. 
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1.6.11. The effect of micro-motion. 
A prominent researcher in both orthopaedic and dental implantology recently summarised 
current thinking on the bone-prosthesis interface.493 Plenk (1998) stressed the importance of 
primary fixation to eliminate micromovement, the risk of thermal and compression i:µjury to 
the prepared osseous bed, and the inhibitory effect of titanium particle loss from "plasma-
sprayed or blasted microrough surfaces. Although implantation into tibial or maxillary 
spongiosa carries the risk of instability due to limited primary bone contacts, trabecular 
(lamellar) bone also exceeds compact bone in the rate of new bone apposition. An unloaded 
healing period was originally considered necessary for osseointegration, however Plenk noted 
that orthopaedic and dental research into early loading suggest that "relative micromotion" 
may stimulate bone apposition on the implant surface. He also quoted work suggesting that 
degradation products from calcium phosphate coatings may impair mineralisation in the 
surrounding bone; this has been reported elsewhere,494 as has loss of titanium particles from 
TPS-surface implants.312 
1.6.12. Comparisons of implants with different surfaces - effect of surface topography. 
In their review of the effect of implant surfaces, designs and topographies, Sykaras et al 
(2000)495 categorised implants according to their chemical composition into metals such as 
titanium, ceramics such hydroxyapatite and polymers. They then further divided each implant 
type by what the authors labelled "biodynamic activity" into biotolerant, bioinert and 
bioactive materials. Biodynamic activity was defined as the type of biologic response the 
materials elicit when implanted and the long-term interaction that develops with the host 
tissue. One aspect that determines this biodynamic behaviour is the surface topography of the 
implant. 
The authors noted that simply dividing surfaces into "smooth" and "rough" is inaccurate, and 
instead recommended the use of descriptive parameters such as average surface roughness 
(Ra) as described by Wennerberg in her thesis.496 Ra is the arithmetic average of the absolute 
deviation from the mean line over a sampling length, given in micrometers. 
Similar comments were made by another reviewer497 who criticised the practice of 
categorising implant surfaces by the manufacturing process rather than by the characteristics 
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of the surface produced and made the point that "distinct manufacturing methods may 
converge on a similar surface topography that imparts common biologic and mechanical 
attributes to the implant". When the surface topography of four etched implant systems were 
examined using a contact profilometer, marked differences were observed between them. 
Three systems presented a combination of macro- and microroughness, and one presented a 
combination of machined surface and microroughness. Significant differences were found for 
surfaces prepared in an apparently similar fashion, and also between different batches from 
the same manufacturer.498 
1.6.13. Comparisons of implants with different surfaces - reviews of biomechanical and 
histomorphometric studies. 
Roughened surfaces include surfaces eroded and pitted by acid etching, sandblasting, or 
sandblasting and then etching, as well as titanium plasma-sprayed surfaces and surfaces 
produced by sintering titanium spheres.497•495 Sykaras et al. (2000)495 tabulated results for both 
biomechanical and histomorphometric analysis of implants in various species including man. 
Results were expressed as N or MPa required push, pull or rotate the implant out of bone, or 
% bone-to-implant contact; no attempt was made to meta-analyse results by species, surface 
or implant type. The authors also presented a four x three matrix of implant parameters that 
affect histological and biomechanical data, summarised in Figure 1.6. 
Implant Implant Implant Implant 
length diameter design material 
Surface Animal Implantation Implantation 
topography model time site 
B iomechanical Functional 
Analysed 
Orientation 




Figure 1.6. Factors that affect biomechanical and/or histomorphometric analysis of implants 
(from Sykaras et al. 2000).495 
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Cooper (2000)497 also tabulated results from selected animal and human experiments with 
implants having different surface treatments; these were listed showing results in terms of 
rank order for each experiment (eg: HA> TPS) for separate tables listing either percent bone-
implant contact or biomechanical testing (pull-out or removal torque value) but again 
conducted no meta-analysis. The same group published a separate review of the process of 
oseeointegration as revealed by in-vivo studies383 where results were tabulated by skeletal 
site, species, duration, materials (titanium, HA etc.) and type of analysis (LM, SEM, 
biomechanical etc.). This study employed a systematic search strategy but no other criteria for 
inclusion/exclusion; the numerical results of the individual studies were neither tabulated nor 
exposed to meta-analysis. 
1.6.14. Advantages of implants with roughened surfaces. 
Cooper (2000)497 went on to discuss five supposed advantages of roughened versus machined 
implant surfaces: (1) increased surface area of the implant adjacent to bone, (2) improved cell 
attachment to the implant surface, (3) increased bone present at the implant surface, (4) 
increased biomechanical interaction of the implant with bone, and (5) possibly increased 
inflammation of the peri-implant mucosa around transmucosal rough surfaces. Their 
conclusions are summarised Table 1.12. 
Table 1.14: Advantages of roughened implant surfaces (from Cooper 2000).497 
Increased bone at bone-implant interface? Yes - why is not fully understood 
Rough surfaces are osteoconductive? HA surfaces are - other rough implant surfaces may 
Osteogenesis increased at implant surfaces? 
Osteoinduction increased by titanium implants? 
Biomechanical interaction with bone enhanced? 
Peri-implant mucosal inflammation promoted? 
Risk from delamination of surface coatings? 
be. 
In vitro and in vivo evidence supports this. "More bone 
is formed and maintained at rougher surface 
implants". 497 
No evidence that titanium can induce osteoblast 
differentiation by multi-potential stromal cells. Surface 
topography may influence the response to topically-
applied GFs such as BMPs. 
Yes. "Although the relative merits of different 
biomechanical tests of implants in bone ...... remain 
controversial, the majority of the tests indicated that 
increased surface roughness enhances the 
biomechanical interlocking of the implant with 
bone"497 
To date, no evidence from prospective of retrospective 
studies supports this. 
Particulate debris is recognised as a risk for failure of 
orthopaedic implants but remains to be confirmed for 
dental implants. 
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1.6.15. Comparisons of implants with different surfaces - other studies. 
Measurements of bone-implant contact and descriptive histology of double-acid ectched 
(Osseotite) and machined-surface implants in a dog model of type IV bone show clear 
evidence of both osteoconduction and of improved bone-implant contact in apical areas 
(within the loose trabecular bone of the mandibular marrow cavity).499 Histomorphometric 
comparison of blasted and machined-surface implants in type IV bone of the posterior maxilla 
in human patients showed a similar picture,500 with narrow bony trabeculae conducted to and 
along the blasted implant surfaces, a response described by Roberts as "corticalisation".276 It 
should be noted that Szmukler-Moncler et al. (2004) distinguish between the processes of 
contact osteogenesis, trabeculisation and rapid bone ingrowth to the surface of roughened 
implant on the one hand, and distance osteogenesis and slower bone corticalisation as is seen 
around machined-surface implants; they relate these differences in osseous healing response 
to the micromechanical anchorage and concomitant strain reduction and distribution achieved 
by roughened implant surfaces.501 • 498 
Others have reviewed the effect of roughened implant surfaces. Hansson (2000) defined a 
mathematical model for implant surface roughness which they claimed related well to 
interfacial strength. Other parameters commonly used to define surface roughness, in 
particular values generated using confocal scanning microscopy and surface profilometry (for 
reviews see: Johansson, 1991 502 and Wennerberg, 1998496) were of limited value as predictors 
of interfacial shear strength when compared to their own model.503 
1.6.16. Comparisons of implants with different surfaces - finite element modelling. 
Simmons et al. (200la&b)504• 413 developed a finite element model that related the surface 
geometry of the implant to local tissue strain and subsequent de novo bone induction. Two 
prior experiments were analysed, both involving cylindrical press-fit implants with porous-
surfaced or plasma-sprayed surfaces. When loaded perpendicular to the implant interfac~, 
porous surface implants had a large region with low distortional and volumetric strains, 
whereas plasma-sprayed implants gave little local strain-protection to the healing tissue. The 
strain-protected region within the pores of the sintered porous surface layer was also the 
region where these implants had markedly more mineralization than plasma-sprayed 
implants. 
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The finite element predictions suggested that appositional bone growth occurred when the 
magnitudes of the strain components at the tissue-host bone interface were <8%. Localized de 
nova bone formation occurred when the distortional tissue strains were <3%. Based on these 
threshold tissue strains, the authors proposed a mechanoregulatory model relating local tissue 
strains to peri-implant bone formation, dependent on implant surface geometry. The authors 
concluded that low distortional and volumetric strains favour osteogenesis, and that this 
model supports the hypothesis that porous-surfaced geometry provides a local mechanical 
environment that encourages rapid bone apposition. 
1.6.17. Comparisons of implants with different surfaces - photolithography. 
Hallgren et al. (2001) analysed the effect of surface topography on the integration of an 
implant in bone by using a photolithography technique to produce a specific surface pattern 
on the screw flanks of 60 Branemark implants.411 Surface topography was qualitatively 
assessed by scanning electron microscopy (SEM) and a confocal laser scanning profilometer. 
Quantitative analysis with the confocal laser profilometer derived parameters for surface 
roughness and surface roughness together with waviness. The patterned and control (turned) 
implants were inserted in femoral and tibial sites in 10 NZ White rabbits with a healing 
period of 3 months. Bone fixation was evaluated with resonance frequency analysis (RF A), 
peak removal torque analysis (RTQ), and by histomorphometry; the latter carried out on 
ground sections of implants that had dual surfaces (both patterned and machined). No 
statistically significant differences were found for bone-to-implant contact, between the 
patterned and control implants. 
1.6.18. Summary - different implant surfaces with respect to a sheep mandibular model. 
Titanium implant surfaces may be roughened by various additive or subtractive processes. 
Evidence suggests that such roughening may increase fixation of the implant within bone, 
leading to an enhanced success rate even in poor quality bone. This may be measured in an 
animal model either by biomechanical or histomorphometric means. An animal model that 
exhibits poor-quality bone and clearly distinguishes between different implant surfaces would 
be useful. 
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1.7. Hydroxyapatite as a surface material for dental implants. 
Proponents of HA-coated implants consider that "due to more bone-to-implant contact, 
greater shear and anti-torque strength, the HA-coated dental implant may be used in any area 
in the oral cavity but is indicated: (1) in Type IV bone, (2) in fresh extraction sites, (3) in 
grafted maxillary and/or nasal sinuses, or (4) when shorter implants ...... are used".457 
1.7.2. Hydroxyapatite as a surface material - in vitro studies. 
Keller (1998) performed in vitro SEM comparisons of osteoblast attachment to titanium alloy 
(Ti-6Al-4V) and commercially-pure titanium (cpTi) surfaces having either a machined or 
roughened finish or a hydroxyapatite coating. Percent osteoblast attachment after one hour 
was higher on hydroxyapatite surfaces and sandblasted rough surfaces.505 This study 
concluded that the initial interactions of the host tissues with the implant surface are the key 
to long-term acceptance, that both uncoated Titanium implants and similar implants with 
calcium phosphate or hydroxyapatite-like coatings, are capable of supporting initial cellular 
attachment, and that they probably occur by different and incompletely understood 
mechanisms. 
1. 7 .3. Hydroxyapatite as a surface material - clinical studies. 
The clinical predictability of hydroxyapatite-coated (HA-coated) endosseous implants has 
been reviewed.506 Disadvantages of HA may include (1) enhanced microbial adhesion (2) 
susceptibility to peri-implant osseous breakdown and (3) dissolution or delamination of the 
surface coating. The authors concluded from their review that (1) there is a great deal of 
variability in the chemical nature of HA-coatings used on implants, (2) in vivo evidence does 
not show increased microbial colonisation of HA-coatings, (3) oral hygiene of HA surfaces 
that do become exposed may be more difficult, (4) there is little evidence that commercially-
available plasma-sprayed, crystalline HA coatings are prone to dissolution and (4) long-term 
multi-centre trials do not support previous anecdotal evidence of coating delamination507-5o9 
On the other hand, these authors also noted the abundant published evidence that HA coatings 
promote greater bone-implant contact at an early time point compared with titanium surfaces. 
A careful analysis of the clinical research led them to state that "HA-coated implants are as 
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predictable clinically as titanium implants in short-term periods". This was not meant to 
imply that HA-coated implants are not successful long-term but rather that the evidence for 
this (comparable to that available for titanium surfaces) has yet to be published. In particular, 
they suggested that HA-coated implants may be valuable treatment modalities when placing 
implants in type IV, low density, cancellous bone. 
Other studies have shown different results. An eight-year clinical retrospective study of 889 
TPS versus 313 HA-coated press-fit cylindrical implants in 479 patients revealed no 
significant differences in simple percent survival rates.510 However, cumulative survival rates 
(life table analysis) up to 98 years showed significantly better results for TPS systems 
(92.7%) compared with HA-coated systems (77.8%). TPS-coated cylinders had most losses 
within two years of placement after which survival levels tapered off; HA-coated cylinders 
showed good early survival but increasing loss with time. 
A ten-year study of a small number of implants in the posterior mandible showed similar 
survival figures. 511 Life-table cumulative survival figures for 443 HA-coated cylindrical 
implants decreased as one moved posteriorly from first mandibular premolar to second molar 
region (from 85.8% to 71.8%). Combined survival rates were 79.3 ± 2.5%. Combined 
cumulative success rate (surviving implants with~ 2.5mm bone loss) was only 64.6 ± 2.8%. 
The authors attributed the increased loss of implants in the posterior mandible to a 
combination of poor bone quality and quantity. Signs indicating both occlusal overload and 
peri-implantitis were recorded. 
Saadoun and Le Gall (1996) published eight-year survival figures for SteriOss HA-coated 
threaded screws and unthreaded cylinders as well as SteriOss TPS-coated cylinders and 
machined-surface narrow-diameter titanium screw.512 Comparisons made in this paper were 
unreliable due to the range of implant types, sites and healing periods included; however, 
titanium screws had the lowest success rate overall (88.5%) whereas HA-coated screws 
achieved 97.6% and TPS-coated cylinders 99.2%. No statistical analysis was attempted. 
Buchs et al (1995) also reported life table analysis of SteriOss implants, focussing on 
threaded HA-coated implants after 5 years. For the 2062 implants placed and restored the 
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cumulative percent survival was 96%.513 Similar analysis of 316 HA-coated cylinders after six 
years found a survival rate of 97.8%.514 
Jones and coworkers (1999) designed a prospective RCT to compare HA-coated and TPS 
cylinders over five years.515 Overall success rate was 95.3%; more TPS implants failed but 
this was not significant. The authors did not find that HA-coating gave superior clinical 
success to TPS-coating (for equivalent macro-structure) in poor quality bone. 
1. 7 .4. Hydroxyapatite as a surface material - meta-analyses of clinical trials. 
More recently, systematic review and meta-analysis was used to study HA-coated implant 
survival.516 Of the 45 studies located by Lee et al. (2002) using their search technique, only 11 
met the inclusion criteria (follow-up of> 10 subjects for ::::: 6 months, ~ 5% of patients lost to 
follow-up, % survival or life-table analysis used, no barrier membranes used). Only one study 
was a randomised prospective clinical trial. Six studies reported on Integral HA-coated 
cylinders, two reported IMZ cylinders, three reported SteriOss implants and one reported 
Sterngold/Implamed implants. 
Unfortunately, although non-HA coated implants in the Implamed study were excluded, non-
HA-coated screws and TPS-coated cylinders in on SteriOss study were all included and listed 
as HA-coated; in fact, the non-HA screws had a markedly lower success rate (see: Saadoun 
and Le Gall 1996512). In general, cumulative survival rates for Integral cylinders ranged from 
79.5 to 94.9% and IMZ cylinders from 79.2 to 98.5%. By way of comparison, cumulative 
survival for Branemark machined-surface titanium screws were 93% at 5 years, 88% at 10 
years, and 82% at 15 years.424 Lee et al. (2002)281 concluded that "detailed analysis of these 
clinical trials did not show that HA-coating compromises the long-term survival of dental 
implants". 
In 1991 the Dental Implant Clinical Research Group (DICRG) commenced two randomized, 
prospective multidisciplinary, multicentre studies, based from 30 Veterans Administration 
Medical centres and two universities. More than 3000 implants from the Spectra-System 
(Core-Vent Corporation) were placed in 800 patients. Peri-implant soft-tissue conditions 
were summarised by this group for >2,900 implants after 36 months service.517 Mucosa! 
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recession, probing depth, attachment level, width of keratinized mucosa and gingival, plaque, 
calculus and suppuration indices were recorded at three-month intervals commencing three 
months after stage two (implant uncovering). Data was reported separately for mandible and 
maxilla and for posterior and anterior regions. 
Two surface types (hydroxyapatite-coated and acid-etched titanium alloy) were compared. 
Probing depths and attachment levels were slightly deeper at all time intervals for HA-coated 
implants in the maxilla and the posterior mandible; the opposite pattern was found in the 
anterior mandible. In some cases these recordings were statistically significant although the 
authors dismissed them as clinically insignificant. No difference was detected in periodontal 
indices by site or surface. There was no convincing evidence in this three-year study that HA 
surfaces are any more vulnerable to peri-implant inflammatory disease than titanium surfaces. 
1.7.5. Hydroxyapatite as a surface material- more vulnerable to bacterial infection? 
A different wiew was expressed by the authors of an investigation using the rabbit tibial 
model, who found that "bacteria were more likely to grow onto or next to the hydroxyapatite 
implants than on titanium implants and resulted in a more severe histopathological 
characterization of infection".518 In this study, HA-coated and non-coated titanium implants 
were placed into osteotomy sites deliberately contaminated with increasing concentrations of 
Staphylococcus aureus. Animals were killed after 4 weeks and bacterial infection and HMA 
of %BIC measured. There was a correlation between decreased %BIC and increasing 
infection, with HA surfaces more prone to this effect. 
This was a very short-term study, focused on an organism more often associated with failure 
of orthopaedic prostheses and reportedly only found in a minority of failing implants sites.519 
However, studies of Branemark two-stage implants that failed to integrate during the 
unloaded and submerged phase found that, along with the periodontopathogens P gingivalis 
and B jorsythus, S aureaus antibody titre was significantly associated with the outcome of 
implant procedures. These investigators suggested that this may explain dental implant 
failures during the early healing phase.362• 429 
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1.7.6. Hydroxyapatite-coated implants: cylinders versus screws. 
Much of the early literature regarding hydroxyapatite involved unthreaded, cylindrical "press-
fit" implants with HA plasma-sprayed surfaces. It is unclear to what extent these different 
results for survival / success are due to the microscopic implant surface (HA versus machined 
or roughened titanium) as opposed to the macroscopic configuration (cylinders versus 
threaded screws). 
To explore this, Tillmanns et al. (1997, 1998) evaluated three different implant surfaces 
clinically, histologically and microbiologically in a dog ligature-induced peri-implantitis 
model.331 ' 333 This group placed 28 HA-coated cylinders, 28 TPS-coated cylinders, and 28 
machined-finish titanium-alloy screws bilaterally in the healed post-extraction ridge of 14 
dogs. After three months integration and one month post-abutment healing, ligature-induced 
periodontitis was instituted on the test side whilst oral hygiene was maintained on the control 
side. Six animals were killed after a total implantation time of 7 months, and 8 after 10 
months. 
No clinically relevant differences were found for clinical attachment level, probing pocket 
depth or mobility between surfaces, although both control and experimental machined-surface 
titanium screws were more mobile than TPS or HA-coated implants. Neither DNA probe 
analysis of microbial flora, nor computer-assisted densitometric image analysis (CADIA) of 
· radiographs for changes in peri-implant density, could distinguish between the three types of 
implant. No significant differences were noted for histometric analysis of alveolar crestal 
bone loss, except that TPS implants with peri-implantitis showed a significant increase in 
vertical bone loss after 6 months. The supra-alveolar thickness of HA-coatings was also 
significantly decreased at peri-implantitis sites. All implant surfaces and configurations 
seemed equally susceptible to peri-implantitis in this animal model. 
Other researchers have shown a 16% decrease in thickness of highly-crystalline HA-coatings 
on unloaded cylindrical implants in a dog femoral model over 28 weeks, increasing to 24% 
loss in low-crystallinity HA coatings.520 This occurred in the intra-osseous and integrated 
portion of the implant - no part of these implants were supra-alveolar or exposed to the 
external environment. No significant difference in pullout resistance or histomorphometric 
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measurement of % BIC was found between HA-coatings of different crystallinity. 
Biomechanical and HMA measurements were significantly higher for HA-coated compared 
with uncoated titanium implants. The authors concluded that the dissolution of HA surface 
coatings did not change in vivo osseous responses to the implants in this short-term, 
submerged, unloaded, non-oral animal model. However, this issue has yet to be resolved and 
remains the incentive for continuing research into alternative methods to bind calcium ions 
onto titanium surfaces. 
Although the best short-term bone-implant response is the chemico-mechanical bond which is 
formed when the implant is coated with calcific substrates such as hydroxypatite, doubts 
persist as to the long-term stability of this surface.521 ' 494 As one researcher commented, "the 
main problems using plasma-sprayed hydroxyapatite (HA) as a coating material on metallic 
implants are its porosity, low fatigue strength, and weak adherence to the metallic 
substrate". 305 
1.7.7. Animal models and HA-coated implants. 
HA-coated implants have been examined in a variety of animal models. The Gothenburg 
group mainly uses the rabbit tibia/femur as their animal model522 and have examined HA- and 
ceramic-coated implants. Most recently their studies have shifted from hydroxyapatite coating 
to oxidisation of the titanium surface with deposition of calcium ions.409 
When HA plasma-sprayed implants were placed in rabbit tibiae, %BIC was higher for HA at 
6 weeks but this was not continued long term; HA surfaces had significantly less % BIC after 
one year.376 No significant difference between SteriOss titanium and HA-coated threaded 
implants was seen in rabbit tibiae after 6 months,523 whereas IMZ HA-coated cylinders were 
superior to uncoated cylinders after 6 months in the same model.387 In the latter study, areas 
of HA surface resorption were noted. 
When Branemark titanium screws, coated electrophoretically with CaP and sintered, were 
placed in rabbit femurs and tibiae, the HA surfaces had significantly higher %BIC compared 
with non-coated Branemark implants after one month but not after 6 months.524 No significant 
differences were found for Branemark titanium implants ionically-coated with HA and 
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compared with machined-surface implants after one week, one month and four months in 
rabbit tibiae.525 
Unthreaded press-fit cylinders that were sputter-coated with CaP and placed for 2 weeks and 
3 months in rabbit tibiae and femora demonstrated significantly higher %BIC for rough 
compared with smooth surfaces.526 There were no differences between between CaP-coated 
and uncoated surfaces in the tibiae but CaP surfaces (both rough and smooth) were 
significantly superior to their uncoated controls in the femur. These results suggest that 
comparisons of HA-coated and non-coated surfaces vary according to the degree of 
roughness of the surface and may differ when a different skeletal site is used. Others have 
compared HA plasma-sprayed with grit-blasted implants in rabbit tibiae for 3 and 12 weeks 
and found no significant differences.527 
Early studies comparing 6 different types of implants placed in a dog mandibular model for 2 
years found that uncoated titanium surfaces achieved better %BIC long-term than ceramic 
implants or surfaces.528-53° Calcitek Integral cylindrical implants with a plasma-sprayed HA 
coating retrieved from dogs after 12, 16, 24 and 34 weeks integration revealed that HA-
coated implants had significantly better %BIC at all time points. The authors noted that the 
HA-coated implants appeared to exhibit a vulnerability to crestal bone loss, apical migration 
of infection and loss of surface coating.340 
Comparisons of HA-coated titanium screws placed into dog jaws for 3 months, using either 
an immediate or a delayed surgical protocol, found significantly higher % BIC in the maxilla 
for HA-coated (51 %) compared with non-coated implants (44%). In the mandible, %BIC for 
HA-coated implants was not significantly higher (64%) than non-coated implants (62%).373 
Again, the skeletal site appeared to be a factor in the superiority or otherwise of the HA 
coating. 
Immediate loading of HA-coated or TPS implants in dog mandibles revealed no significant 
differences.531 HA-coated cylindrical implants compared with machined-surface titanium 
screws for four or six months in the dog mandible, both loaded and unloaded, showed no 
significant differences in % BIC.532 A similar experiment comparing HA-coated and 
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machined titanium screws for 7 and 13 months, with or without loading, also found no 
significant difference after histomorphometric analysis.533 However, a comparison of 
Branemark screws, Interpore TPS-coated cylinders and Calcitek HA-coated cylinders in dog 
mandibles for three months reported that HA-cylinders had significantly more % BIC than the 
other two implants.534 
Using minipig tibial and femoral sites, Buser et al (1991) has compared unthreaded hollow-
cylinder implants with various surfaces including HA plasma-spray. After 3 or 6 weeks 
healing, HA surfaces achieved the highest percent BIC of all the surfaces considered.410 
1.7.8. HA-coated implants in goat femurs and maxillae. 
Research groups at the Universities of Nijmegen and Leiden have published extensively using 
their well-established goat models.298 Comparison of grit-blasted and ceramic-coated 
cylinders in the goat femur and humerus revealed that FA and HA had significantly higher 
integration than rough-surfaced titanium implants after 12 weeks healing but after 25 weeks 
there were no significant differences between Ti-alloy and HA, and both were significantly 
lower than other ceramic surfaces.304 HA-coated and fluorapatite- (FA-) coated cylinders 
placed in goat femurs for 3 months had significantly higher %BIC than grit-blasted controls, 
although the authors noted that all ceramic coatings showed a reduction in thickness over 
time.298 
Branemark titanium dental implants coated with HA or FA have also been studied using the 
healed maxillary ridges of goats. The implants were left unloaded for 6 months and then had 
abutments placed for 4 months. 288' 289 Implant losses were high (25 % ) with significantly more 
uncoated Branemark implants than HA-coated implants being lost. HA-coated implants had 
approximately twice as many threads in contact with bone as uncoated implants and %BIC 
was three times higher. 
In another comparison of uncoated or grit-blasted and ceramic plasma-coated implants in goat 
maxillae, unloaded for 3 and 6 months, HA-coating achieved twice the %BIC as machined-
surface titanium.290 Again, HA-coating thickness was noticeably reduced after 6 months. This 
group also investigated the response to the same implants in a goat extra-oral mandibular 
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model. Cylindrical titanium alloy implants were grit blasted and HA- or FA-plasma-sprayed. 
After 12 weeks, no significant differences were found between surfaces, although ceramic 
coated implants had higher %BIC than machined titanium. Results in this model were 
complicated by consistent penetration of the mandibular canal.535 
Threaded implants, grit-blasted and plasma-sprayed with various CaP compounds including 
HA and placed into goat femurs for I month and 3 months showed significantly higher %BIC 
for the HA/FA-coated implants, except in areas with dense cortical bone.300• 301 All regions 
around the HA/FA-coated implants had higher% bone density (mineralised bone/area). 
Machined-surface, TPS-coated or TPS plus HA-coated titanium implants placed into goat 
maxillae for three months, again revealed that HA-coated implants gained significantly 
greater %BIC compared to the other surfaces.291 TPS implants showed no advantage over 
machined-surface implants in this same animal model. The authors pointed out that, in this 
experiment, HA-coating induced a significant increase in bone-implant contact that could not 
be attributed to the physical roughness of the HA surface alone, and must therefore be due to 
the bioactivity of the HA surface. 
Caulier et al. (1997) compared the results from two experiments that employed different 
skeletal sites within the goat.535 Cylindrical, unthreaded titanium alloy implants were placed 
into the angle of the mandible from an extra-oral approach. Implants had a grit-blasted 
surface alone (control) or either a hydroxyapatite- (HA), a fluoroapatite (FA) or a heat-treated 
hydroxyapatite (HAHT) surface. Histomorphometric analysis of the unloaded implants after 3 
months healing were contrasted with the results of an experiment using identical implants, 
placed for the same length of time, into the medial and lateral condyles of the goat femur.298 
Caulier et al. (1997) described the mandibular sites as consisting of a thin layer of trabecular 
bone surrounded by dense cortical bone and the femoral condyle as consisting mainly of 
trabecular bone with only a very thin layer of cortical bone present.535 In addition, the femoral 
trabecular bone was described as having a spongy appearance, while the mandibular 
trabecular bone had a lamellar appearance. The authors suggested that the composition of 
mandibular bone might have resulted in a better initial stability of implants, independent of 
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the implant surface morphology. Thus, the use of a non-oral site in long bones in this animal 
model gave a different result to that found in an oral model in the same species. 
This becomes even more apparent when one also considers the results of an third experiment 
by the same researchers using implants with the same surfaces, but this time placed into the 
healed post-extraction maxillae of goats from an intra-oral approach for 3 months. 289 Figure 
1. 7 shows a comparison of histomorphometric analysis of bone-implant contact for the three 
animal models. It can be seen that the different surfaces responded differently in all three sites 
and that the results were markedly lower in the type IV bone of the maxilla. 
It should be noted however that there were significant differences between the protocols for 
these three experiments. Thus (1) the implants placed into the maxilla were threaded 
Branemark Mark II implants, coated with different ceramic coatings, rather than unthreaded 
cylinders as for the other two experiments; (2) the maxillary control implants were non-grit-
blasted (ie: machined-surface) titanium; (3) the threaded implants were sectioned 
longitudinally and only the best three threads analysed, whilst the femoral implants were 
sectioned cross-sectionally (across the long-axis of the cylinder) and had% BIC measured for 
the all implant sections; by contrast, the mandibular implants were sectioned cross-sectionally 
and two sections each from the cortical and the cancellous areas were measured, ie: partial 
implant recordings (4) the maxillary implants were placed from an intra-oral approach and the 
mandibular implants extra-orally; and (5) many of the mandibular implants penetrated the 
inferior dental nerve canal resulting in mobility and inflammation. These experiments would 
have provided more convincing evidence of the differences between different skeletal sites 
had they been performed using identical protocol and implants, placed at the same time, in 
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(medial) (lateral) 
• Tia 60.8 49.3 
• FAb 82.4 72.8 
C 
80.6 HAI-IT 77.0 
• HA d 83.3 74.0 
n Titanium surface 
b Fluoroapatite-coated titanium 
c Coated with heat-treated hydroxyapatite 
d Hydroxyapatite-coated 
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Skeletal site 
Figure 1.7. Histomorphometric analysis of percent bone-implant contact around 
titanium and ceramic-surfaced implants in the femurs, mandibles and maxillae of 
goats (Caulier et al. 1995, 1997a&b).297, 534297 
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1.7.9. HA-coated implants in sheep limb models. 
Investigators at Bologna University have published orthopaedic implant research using the 
tibia and femurs of sheep as their animal model.396 Comparisons of TPS, HA- and FA-
plasma-sprayed threaded cylindrical titanium, placed into sheep tibia and femurs for 2 weeks, 
1 month, 3 months and 9 months revealed that FA-coated implants had significantly higher% 
BIC than TPS at 14 days; there were no other significant differences at 14 days, 1 month or 3 
months although % BIC for TPS was lower than HA surfaces. At 9 months, TPS had 
significantly lower % BIC than either HA-coated group. The only failures occurred in the 
TPS-coated implants.398 
HA plasma-sprayed screws have also been compared with machined, etched, blasted/etched 
or oxidised/Ca ionised surfaces, placed in sheep femurs for 8 and 12 weeks. HA-coated and 
oxidised/Ca ionised surfaces had increased %EiC short-term whereas sandblasted & etched 
surfaces had their major effect at 3 months.403• 315' 316 Others have shown that HA-coated 
implants in sheep tibiae, when compared with machined or grit-blasted implants, exhibited 
significantly improved resistance to biomechanical testing (8 and 12 weeks healing) and had 
higher% BIC at 4 weeks.401 •402 
1.7.10. HA-coated implants - histological evidence from primates and humans. 
Limited histological evidence is available for hydroxyapatite-coated implants in non-human 
primate (NHP) models or for human patients. Carr et al (1997) placed SteriOss HA-coated 
implants into baboon mandibles and maxillae and reported increased %EiC for HA-coated 
implants after 3 months.536 HA plasma-sprayed cylinders placed into Macaque mandibles for 
3 months537 or 6 months538 integration had superior results for HA coating short-term, but 
percent BIC appeared to drop slightly after 3 months loading. 
Iamoni et al. (1999) placed double-sided machined/HA-plasma-sprayed implants in the 
mandibles of human volunteers for time periods ranging from 1 to 12 months.539 Percent BIC 
for HA surfaces was almost double the machined titanium surface at 1 month however this 
difference was progressively reduced over 12 months healing. 
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Post-mortem histomorphometric analysis of an HA-coated cylinder 37 months after 
placement that showed 75.3% bone-implant contact.540 Retrieval analysis of 135 HA-coated 
implants showed that, prior to 1990 most failed due to fibrous encapsulation, whereas after 
this period most failed due to implant fracture.541 This report noted that retrieved HA-coated 
acetabular prostheses showed quite a different pattern of catastrophic HA delamination, 
suggesting differences in the cause and mode of failure between HA-coated dental and 
orthopaedic devices. 
1.7.11. Hydroxyapatite and titanium surfaces - healing in bone marrow. 
The biophysical mechanism by which Ca-P coating modulates increased osseointegration is 
unknown. It has been suggested that the extracellular matrix formed by the cells and the 
protein interface between the cells and implant are a logical bridge between adhesion 
molecules and Ca-P coating and that, whilst machined-surface implants perform well in 
cortical bone, HA-coated implants might perform better in trabecular bone, as a result of the 
mesenchymal stem cells, osteoblastic accessory cells and hematopoietic growth factors found 
in the marrow spaces of spongy bone.542 
To investigate the possibility that Ca-P coatings selectively favour adherence of cell types 
favouring osseointegration, 12mm titanium discs with as-machined, grit-blasted or grit-
blasted and Ca-P coated surfaces were placed into cultures of human bone marrow cells for 
24 hours. Although analysis of marrow from different human donors showed a wide 
heterogeneity in the expression of adhesion molecules, in vitro only a subfraction of bone 
marrow cells attached to titanium coated with ceramic hydroxyapatite. Grit-blasted surfaces 
had the highest levels of cell adhesion, however the authors suggested that many of these cell 
types (eg: fat cells) might be unimportant or obstructive in the integration process. 
Hydroxyapatite surfaces were selective in cell recruitment from the bone marrow, possibly 
explaining the differences found in vivo for these coatings compared with uncoated titanium. 
Others also investigated the response of bone marrow to titanium mini-implants placed into 
the femurs of mice543' 544 and concluded that titanium surfaces in direct contact with bone 
marrow cells are well tolerated, a process these authors referred to as "myelointegration." 
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1.7.12. Hydroxyapatite-coated implants - Summary. 
The evidence suggests that hydroxyapatite surfaces could be expected to obtain the best 
integration, as measured by percent bone-implant, when placed into a type IV-bone animal 
model. As such this surface should provide a positive control for establishing the parameters 
of an animal model. 
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1.8. Bone grafting to augment implant sites. 
A review of techniques for optimising implant stability in low-density bone was recent 
published by Martinez et al. (2001).473 These authors grouped the techniques into (1) site 
preparation, (2) implant design, and (3) implant surface texture. Under site preparation they 
advocated bone condensation with osteotomes, bicortical anchorage and minimal or no 
countersinking. (The latter results in an implant deliberately placed in a submerged position 
with the collar positioned supra-crestally.) Implant design or anatomy includes the use of 
tapered and conical implants (for example Frialit-1 and -2, SteriOss Replace, Osseotite XP, 
and Branemark Mark IV); wide-bodied implants (eg.: Branemark, ITI, 3i) and double-spiral 
thread (Branemark Mark IV). 
Under surface textures they listed hydroxyapatite (HA), titanium plasma-spray (TPS), acid-
etching alone and sand-blasted ± acid etching. It should be noted that the use of bicortical 
anchorage is controversial; one study linked this to a four-fold increase in implant failure and 
three-fold increase in implant fracture compared with mono-cortically anchored implants431 
although there were no changes in marginal bone remodelling. Finite element modelling 
analysis has suggested that bicortical anchorage may increase stress concentrations within the 
implant but stress within crestal bone remains either constant or is slightly reduced.545• 432 
Thus, one technique for developing or improving implant integration is the use of hard-tissue 
grafting. Bone grafting may be performed using autogenous, allogenic or xenogenic grafts, 
demineralised or not, fresh or freeze-dried, along or in combination with membranes or other 
regenerative techniques, as a block or in particulate form, harvested from the osteotomy site 
or from other intra-oral or extra-oral sites, placed using an onlay or an inlay technique, and 
performed either prior to, along with are subsequent to implant placement . The use of non-
bone alloplastic substitutes has also been reported. The objective of bone grafting is to 
increase bone volume in a horizontal (buccolingual) or vertical direction. The latter includes 
both supra-crestal and intra-sinus augmentation. Bone grafting has been recommended for 
horizontal546 or vertical547 ridge augmentation, alone or in combination with implant 
placement. 548 
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1.8.2. Bone grafts- harvesting techniques. 
Reports have detailed techniques for harvesting grafts from the mandibular symphysis,549 the 
mandibular ramus547' 550 and through the use of suction-linked bone traps during osteotomy 
preparation and bone-block harvesting.439• Simple bone traps of various designs are available 
including the Osseous Coagulum Trap (now marketed by Salvin Dental Specialities Inc., 
Charlotte, NC USA).551 • 552 The bone traps have a cylindrical drum connected at one end to the 
suction tube and at the other to a suction tip; within the drum is a metal or plastic mesh that 
traps fragments of bone aspirated during the osteotomy. The Osseous Coagulum Trap has a 
plastic collecting net with a pore size of 0.17 x 0.17mm which is a smaller pore size than 
other models. Kainulainen and Oikarinen (1998) concluded that this device is ideal for 
collecting bone during implant osteotomy preparation.552 
The percentage of viable bone cells present in particulate grafts obtained by chipping ± 
milling or from osteotomy drills has been investigated.553 The sites for harvesting were 
trabecular or cortical bone of the mandible or the iliac crest. Unmilled bone particles had an 
average size of 5mm3 reduced by milling to 2mm3 • Drill sludge averaged lmm3 • Bone milling 
reduced the counts of viable cells. Spongy bone chips had greater viable cell counts than 
cortical bone chips and drill sludge had the least amount of viable osteoblasts. 
1.8.3. Intramembranous versus endochondral bone. 
The healing of autogenous bone grafts, harvested from sites where ossification occurred via 
an intramembranous versus endochondral process, have been compared.554 Parietal CSDs in 
rabbits were grafted with either cranial bone grafts (intramembranous) or tiibial bone grafts 
(endochondral). Controsls consisted of rabbit skin collagen or empty defects. The rabbits 
were killed after two weeks. Quantitative analysis detected no bone in either the untreated or 
collagen-treated control groups. Defects grafted with intramembranous bone had 166% more 
new bone than those grafted with endochondral bone, a highly significant difference. These 
results suggest that bone of intramembranous origin produced more rapid osseous healing 
than endochondral bone, when grafted into maxillofacial sites. 
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1.8.4. Demineralised bone versus autografts. 
Recovering and grinding a patient's own bone tissue during surgery requires an additional 
incision, which means a longer surgical procedure, and an increased risk of surgical 
complications, without any assurance that the autograft will be osteoinductive, or that enough 
live bone cells will be transferred to have any real effect. Mineralized allograft bone powders 
offer an alternative but they are not osteoinductive - bone must be demineralised to expose 
the osteoinductive proteins. The demineralisation process must be carefully controlled to 
prevent denaturisation of inductive proteins, and even with the most assiduous attention to 
processing details, and to the appropriateness of patients selected for these procedures, 
demineralised bone matrix (DBM) from some donors simply does not work as well as that 
from others.555 At least 10% of screened cadaveric bone exhibits no activity whatsoever. 
According to one major bone-bank (AlloSource, Denver CO) this accounts for the disparities 
in previous outcomes research into DBM,555 whereas using demineralised grafts that had been 
screened with a radiolabeled bioassay for bone growth potential gave results comparable to 
autogenous bone-grafts.556 
1.8.5. Implant survival in bone-grafted sites: reviews and meta-analyses. 
Implant survival for 35 Branemark machined-surface implants placed into anterior maxilla 
sites of 17 subjects that had been augmented with onlay block bone grafts harvested from the 
mandibular symphysis was reported to be 97.1 % after 74 -283 weeks loading.557 
However, a retrospective analysis of implant success in 25 patients with maxillary sinuses 
augmented horizontally and laterally by onlay and inlay techniques using iliac crest or 
mandibular autogenous bone blocks ± particulate grafts found different results for machined-
surface (Branemark) and rough-surfaced (ITI SLA) implants.558 Implants were placed using a 
delayed two-stage procedure 4.5 months after grafting and abutments connected after 8 
months; patients were reviewed clinically and radiographically for 20 to 67 months post-
implantation. Clinical and histological analysis showed modification of type IV bone (at 
grafting) to type III (at implantation); 21 of 25 patients had type II bone in the implant site at 
abutment connection. 
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In this study, a total of 158 implants were placed in augmented bone, with sites divided 
between 39 maxillary sinuses in 22 patients and in the premaxilla of 14 patients. 4 of 25 
patients (16%) had osteoporosis; 7 of 15 Branemark implants failed in two patients (43.75%) 
and no ITI implants failed in the other two. Overall, 15 Branemark implants were lost (seven 
before loading) to give a survival rate of 81 %; two ITI implants were lost at abutment 
connection giving a survival rate of 98%. Although this clinical study had a relatively small 
number of subjects and the treatment protocols were less standardised than animal 
experiments, the result suggest that bone grafting modifies the original bone density of the 
implanted sites and further, that the type of implant surface also affects success in grafted 
areas. 
A retrospective review of 1,313 implants in 542 patients revealed that 4.4% of patients 
required site preparation, with the requirement for grafts occurring more frequently in the 
maxilla. 559 
Another literature review, covering the period 1976 - 94 for implants in grafted bone, 
reported on 2,315 implants in 591 patients with 733 grafted sites.560 Graft types included 
block autogenous bone (nonvascularized or vascularized), and particulate grafts (autogenous, 
allograft or alloplastic), placed using an onlay or inlay/interpositional technique into either 
jaw with immediate or delayed implant placement. Block grafts appeared more successful 
than particulate grafts in the mandible compared with the maxilla and vice versa. In the 
mandible, the overall implant survival rate was 93%; block grafts (292/303 implants in 87 
grafts, 96%) were more successful than particulate grafts (73/90 in 67 grafts, 81 % ). 
No difference was found between immediate and delayed implants in this review.560 In the 
maxilla, a total of 1,738 implants were placed in 546 grafts with an implant survival rate of 
89%. Particulate grafts (94% implant survival) were more successful than block grafts (91 % ). 
Generally, immediate implants were more successful than delayed implants when placed into 
in particulate grafts. Sinus grafting was generally much more successful than maxillary onlay 
and inlay block grafts. Maxillary inlay particulate grafts were not a common procedure. 
Wound dehiscence seemed to have the most deleterious effect on implant survival rate. 
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Another recent review employed a different methodology.561 Panoramic radiographs and 
survival data over a three year post-operative period were collected from 15 surgeons. Of 900 
cases, only 100 patients fit the inclusion criteria, with 145 sinus grafts combined with 349 
implants. Alloplasts, allografts, xenografts, and intra-oral or extra-oral autografts were used 
alone or in various combinations. The combination of intra-oral autograft and alloplast (n=57) 
showed the least loss of graft bulk radiographically over three years, whereas allografts 
(n=36) showed the greatest. Intra-oral autografts (± alloplasts) had better graft survival in the 
maxilla than extra-oral (iliac crest) autografts (± alloplasts). Implants survival appeared to be 
related weakly to the amount of residual bone before grafting and strongly to smoking; the 
relationship between type of graft and implant survival was not explored. 
Branemark titanium microimplants retrieved from the lateral wall of augmented maxillary 
sinuses in 9 human patients after 6-14 months have been analysed histomorphometrically.562 
Autogenous bone-grafted sites displayed a normal morphology of bone and bone marrow, 
including formation of bone on the surfaces of the grafted particles and remodeling of newly 
formed as well as grafted bone. The allografted sites had a mixed morphologic appearance of 
newly formed bone and nonviable allograft particles (about 75% of the total bone area) in 
loose connective tissue. Significantly more bone was found at the autografted than at the 
allografted implants. Bone-implant contact was low irrespective of graft type. 
One systematic search of combined maxillary sinus grafting and implant placement identified 
28 studies, of which 10 met the inclusion criteria for meta-analysis.563 Implant survival rates 
were reported to be similar for autogenous bone, HA/autogenous bone mix, HA/DFDB, and 
HA alone, and are reproduced below (table 1.13). 
Table 1.15. Meta-analysis of implant survival in grafted sinuses (Tong et al. 1998)563 
autogenous bone 90 484 130 6 - 60 
HA+ autogenous 94 363 104 18 
DFDB plus HA 98 215 50 7 - 60 
HA 87 30 11 18 
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A systematic review of 18 studies reporting dental implant survival rates in patients treated 
with ridge augmentation or preservation techniques found a high level of implant survival, 
similar to rates for implants placed in pre-exisiting bone.564 A similar review of studies where 
grafted sinus floors were analysed histomorphometrically reported on 12 studies.565 The graft 
types reported included autogenous bone blocks (12) or particulate grafts (18) either alone or 
in combination with other materials; other experiments reported results for bovine bone 
material, bioactive glass, hydroxyapatite, demineralized freeze-dried bone allograft or 
tricalcium phosphate. Autogenous bone without anorganic additives resulted in the highest 
amount of bone after a 4-6 months healing period, whereas hydroxyapatite and bovine bone 
mineral, gave the lowest amount. 
A systematic review of randomised clinical trials investigating success, function, morbidity 
and patient satisfaction following different bone augmentation techniques for dental implant 
treatment could only identify four RCTs as suitable for inclusion.566 The RCTs considered 
onlay grafting ± membrane, grafting with a resorbable or non-resorbable membrane, and 
membranes for guided bone regeneration (GBR). No evidence was found from the small 
number of suitable studies to support one or other of the alternative techniques. There was 
weak evidence that non-resorbable membranes may improve healing over bone grafts. 
However, a systematic review and meta-regression of studies analysing the contribution of 
different grafting variables to implant survival identified 43 studies for inclusion.567 Grafting 
variables included block versus particulate grafting, variations in implant surfaces and graft 
materials, and the use of a membrane over the lateral window. Survival rates for implants 
placed in augmented sinuses ranged from 61.7% to 100%. The average survival rate of 91.8% 
compared favourably to reported survival rates for implants placed in non-grafted posterior 
maxillary sites. 
Rough-surfaced implants had a higher survival rate than machine-surfaced implants in grafted 
sinuses and particulate grafts resulted in better survival than block grafts. Use of a membrane 
also increased survival, whereas the use of autogenous bone on its own or in combination 
with allograft had no effect. There was no statistical difference between simultaneous versus 
delayed implant placement, types of rough-surfaced implants, or length of follow-up. The 
evidence level of each trial (eg: RCT versus case study) also made no statistical difference.567 
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1.8.6. Histological results from human patients. 
Clinical and histological comparisons of autogenous bone grafts, human demineralised bone 
matrix (DBM) grafts and BMP-7 (OP-1) / collagen carrier grafts for sinus lifts in human 
patients have been presented.568 ' 569 Sinuses were biopsied during preparation of implant 
osteotomies six months after grafting. The mineral apposition rate (MAR) in mm/day was 
calculated using fluorescence microscopy following double labelling using ledermycin at 1 O-
day intervals five months after grafting. Results showed that the growth factor/collagen graft 
produced a greater percent bone volume (33.7%) than either autogenous bone (26.3%) or 
bone allograft (27.8%) although all groups produced less bone volume than ungrafted normal 
bone ( 42.1 % ). There was no great difference between the three grafting groups with respect 
to mineral apposition rate which overall in the grafted human maxillary sinus seemed to be 
approximately 0.7mm/day. 
Histomorphometric analyses of iliac crest grafts to the maxillary sinus in four human patients 
have been compared with resorbable tricalcium phosphate alloplast in the contralateral 
sinus.570 After six months healing, two biopsies from each side (four per patient) were 
obtained from the implant osteotomy site during implant placement. Final results 
distinguished between graft, bone and soft tissue as a percentage of the total biopsy area. 
There was no statistical comparison, but the percent bone/area in core biopsies for autogenous 
bone (37%) appeared superior to the alloplastic material (29% ). 
1.8.7. Bone grafting and implant placement in animal models. 
Buser et al. (1998)216 compared 4 different filling materials for bone augmentation with empty 
defects filled with blood (negative control) or autogenous bone (positive control). The model 
used was the angle of the mandible in mini-pigs approached extra-orally; three rhomboidal 
defects/jaw were created measuring 12mm x 10mm x 12mm x 6mm deep. Graft materials 
consisted of (1) blood clot only; (2) 1-3mm2 particulate bone autograft harvested from the 
mandibular cortex during defect preparation; (3) porcine collagen sponge (4) 25- to 500 µm2 
demineralised freeze-dried porcine bone alllograft; (5) 0.7 to l.4mm2 tricalcium phosphate 
(TCP) granular alloplast; and (5) 0.4 to l .0mm2 coralline hydroxyapatite (HA) alloplast. All 
sites were covered with screw-fixed Teflon membranes. Healing periods were 4, 12 and 24 
weeks. 
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HMA of ground sections was performed stereologically to estimate the proportions of bone, 
graft and soft tissue in the defect (point counting) and the proportion of new bone to fibrous 
tissue on the surface of the graft materials (line intercept technique). The histological 
description of autograft healing noted that in this model, the surfaces of the bone chips were 
lined with woven bone after 4 weeks; after 24 weeks the defects were completely filled with 
lamellar bone, with remnants of bone graft chips located centrally within the defect. 
Histomorphometric analysis after 4 weeks revealed that bone autograft achieved the most 
bone matrix (39.1 %) followed by blood clot (33.8%) and then collagen (30.1 %); at 12 weeks, 
all materials except DFDBA and HA were similar with bone matrix of 59 to 64%; after 6 
months, all sites showed decreases except HA and TCP; TCP resulted in significantly more 
bone matrix (70%) after 24 weeks healing. It was also noted that approximately 11 % of the 
autograft bone chips persisted throughout the experiment. The proportion of bone on the 
grafted particles was the best with bone autograft throughout the experiment, suggesting that 
autogenous bone had superior osteoconductivity. The authors noted that this study was 
skewed towards success; they commented that the pig has "an impressive osteogenic 
potential", which was further enhanced by the use of a five-walled, acute, surgical, non-
critical-sized defect, with membrane exclusion to prevent soft-tissue ingrowth. 
Slotte et al. (2003) conducted a similar study to compare autogenous bone with bovine bone 
allograft.571 A machined-surface hollow titanium cylinder, inner diameter 6mm x 4.5mm high, 
with an occlusive titanium lid, was screwed to the parietal bones of rabbits. The cylinders 
protruded externally from the skull surface and therefore tested vertical bone augmentation 
adjacent to a titanium surface. Graft materials placed within the test chambers were either 
cortical bone autograft (harvested by scraping), BioOss cancellous 0.25mm2 - lmm2 particles, 
or blood clot (control). Animals were killed after 12 weeks healing. Histometric and 
histomorphometric analyses of ground sections were conducted to determine percent bone 
fill, bone density, bone-titanium contact and percent bone in contact with graft material. 
The two types of graft achieved similar fill (autograft 93%, BioOss 94%) which was 
significantly better than the control (55% ). Most of the grafted bone resorbed; a small amount 
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of necrotic bone remained in the "non-mineralised marrow-like tissue in the uppermost part 
of the experimental space". BioOss was enclosed in mineralised bone in the lower 2/ 3 of the 
chamber and by fibrous CT in the upper 1 I 3• Vertical augmentation of bone was significantly 
greater for the two test groups; bone-implant contact was higher for the autogenous bone graft 
group but not significantly so. 
Histomorphometric analysis of bone-implant contact around TPS-coated ITI implants placed 
into the maxillary sinuses of beagle dogs compared the results following sinus grafting with 
demineralized freeze-dried human cortical bone (DFDBA), resorbable hydroxyapatite 
alloplast (Osteogen) or anorganic bovine bone alloplast (Bio-Oss).572 The animals were killed 
after 5 months healing. There was no new bone around the exposed portion of implants 
grafted with DFDB xenografts. Implants grafted with Osteogen or BioOss demonstrated 
newly formed bone with direct contact at the implant surface. The mean percentage of 
denuded implant surface covered with new lamellar bone ranged from 0.0% (DFDB) to 
25±10.6% (Osteogen) to 27% ± 8.8% (BioOss). 
A study considering the effect of crestal peri-implant bone grafting used dual-sided 
machined/Osseotite implants, placed into the iliac wing of two dogs.573 A 2mm empty space 
around the coronal 5 mm of the implants was filled with particulate autogenous bone graft, 
covered by an resorbable membrane, and left to heal for 5 months. The Osseotite surface 
gained a significantly higher %BIC than the machined surface, in both the regenerated and 
the basal bone areas. The use of autogenous bone graft resulted in significantly higher %BIC 
values in the regenerated area than in the basal bone area itself, for both implant surfaces. 
In another study, Frialit-2 implants were placed bilaterally into dog maxillary sinuses filled 
with autogenous bone( cortical particles harvested form the lateral mandible and milled to 
0.7mm2 ) or with Bio-Oss.574 Animals were killed 3 and 6 months after implant placement. 
After 3 months, %BIC for BioOss was 34.3 ± 9.6% and for autogenous grafts, 58.1 ± 4.6%. 
Necrosis of the bone particles was only seen in one animal. After 6 months, %BIC for Bio-Oss 
was 57.6 ± 9.6%) and for bone grafted implants, 32.1 ±14.5%). In three animals the grafted 
area could not be distinguished form the original bone of the sinus. The authors concluded 
that both techniques were successful but that implants placed into sites grafted with 
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autogenous bone needed to be loaded earlier than 6 months in order to reduce atrophic 
resorption of the grafted sinus, whereas BioOss-grafted sinuses seemed more resistant to such 
resorption. 
1.8.8. Bone grafting and implant placement in monkeys. 
Hiirzeler, Quinones and co-workers have conducted a series of experiments investigating the 
use of different grafting materials in combination with implant placement in non-human 
primate models. For the initial experiment, BioOss anorganic bovine bone matrix was placed 
into the maxillary sinuses of four rhesus monkeys.575 Pairs of IMZ TPS-coated unthreaded 
cylindrical implants were placed immediately as well as after four months healing, so that 
there was an immediate-placement and a delayed-placement group. These implants were 
uncovered after four months healing and loaded for six months, after which the animals were 
killed. On the opposite side of the jaw, the same protocol was followed except that the 
implants were not exposed or loaded. Thus there were four groups: loaded, immediate 
placement (15 months healing); loaded, delayed placement (11 months healing); immediate 
placement (8 months healing); unloaded, delayed placement (4 months healing). 
Bone-to-implant contact was measured histomorphometrically and was greater for the 
delayed implant-placement groups than for the implants installed simultaneously with the 
sinus augmentation, despite the longer healing time. Generally % BIC for the residual bone in 
the coronal area was 1.2 to 1.9 times greater than the grafted apical %BIC. It was concluded 
that anorganic bovine bone matrix facilitated bone apposition and implant osseointegration in 
the augmented sinuses. 
The same protocol was repeated in a further four monkeys, this time grafting with porous, 
non-resorbable hydroxyapatite (Interpore 200).576 Porous hydroxyapatite graft particles 
appeared to become integrated into the new bone. Again, %BIC around the augmented 
implant apices was greater when implant placement was delayed than when placed 
immediately. Loading seemed to affect %BIC in the residual maxillary bone more than a 
delay in placement. 
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In a third experiment, Htirzeler et al ( 1997b) grafted autogenous bone mixed with porous 
hydroxyapatite (Interpore 200) in a ratio of 3: 1577 and in a final experiment, Interpore 200 
hydroxyapatite grafts were combined with HA-coated implants.578 
Overall the following comments may be made about these experiments. In grafted areas 
around TPS-surface implants, either delaying the placement of the implant or loading it 
immediately had equal and similar effects upon % bone-implant contact. However, grafted 
areas around HA-surface implants were different, in that loading has much more of an effect 
than the timing of implant placement. Porous ceramic grafts gave the best apical % BIC and 
this was reduced rather than increased by the addition of autogenous bone (composite graft). 
Autogenous bone combined with ceramic grafts were equivalent to anorganic bovine 
xenografts. HA-coated implants grafted with porous HA-ceramic graft performed better than 
TPS-coated cylinders performed with any type of graft and this was most noticeable with the 
loaded implants. Bone-implant contact in the apical,grafted region was on average 70% of the 
coronal (range 52 to 82%). Unexpectedly, grafting the apex of TPS implants with ceramic 
grafts seemed to increase% BIC of the coronal portion. 
The Htirzeler group also carried out augmentation studies in a different animal model, this 
time using the mandible of beagle dogs.579 The effect of a calcium hydroxide paste called 
Osteoinductal (composed of 25% CaOH2, 25% triglyceride and 50% vaseline) on the 
osseointegration of implants was investigated. Three cylindrical unthreaded TPS implants 
were placed either side of the healed post-extraction mandible in 8 dogs. The paste was 
placed within the osteotomy sites on one side. Two animals were sacrificed after 1, 2, and 4 
weeks and the final two animals after 3 months. Percentages of mineralised tissue and 
inflammatory-cell infiltrated tissue in contact with the implant surface were measured at 1 
and 2 weeks; percentage bone, bone marrow and fibrous tissue was measured for 4 week and 
3 month specimens. 
The Osteoinductal paste had a substantial negative effect on osseointegration at all time 
points. In the histological evaluation an intense inflammatory reaction towards the calcium 
hydroxide suspension was found leading to a destruction of the bone surrounding the 
implants after 1 and 2 weeks. A giant cell reaction against the test material was visible at 4 
weeks but after 3 months the inflammatory and giant cell reactions were no longer present. 
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Early mean % BIC and % inflammatory cell to implant contact showed no differences 
between test and control group. Surprisingly, the large difference between test and control for 
% BIC at the two later time points (especially after 3 months) was not statistically significant 
- at three months% BIC was 10.5 ± 12.7 % for test and 60.7 ± 13.7% for control (no paste) 
sites! The authors concluded that "the use of the calcium hydroxide suspension Osteoinductal 
has a detrimental effect on wound healing and osseointegration of dental implants and cannot 
be recommended for use 11 • 
1.8.9. Bone grafting combined with osteoinductive growth factors. 
The osteoinductive properties of Bio-Oss, a bovine deproteinised bone, has been compared 
with the osteoinductive properties of recombinant human osetogenic protein-I (rhOP-1) for 
maxillary sinus augmentation and simultaneous implant placement, using a miniature pig 
model.580 BioOss acted as a carrier for the growth factor. Both sides of five pigs received 
12mm-long solid-screw ITI TPS-coated implants, inserted through the lateral wall of the 
maxilla by an extra-oral approach- the implants were not inserted though the maxillary 
dentoalveolar process and the dentition was left intact. BioOss was packed around the implant 
apices using a lateral (external) approach to the sinuses; on one side the graft included OP-1. 
The animals were sacrificed after 6 months healing and ground sections prepared. Percentage 
bone-implant contact was determined for the grafted areas. 
After six months, most of the BioOss was resorbed but some osteoclasts were still present. 
On the control side (bone alloplast only), some areas had unresorbed graft particles 
encapsulated in fibrous tissue with evidence of a chronic, foreign-body inflammatory 
reaction. Active bone resorption of the adjacent maxillary cancellous bone was also seen in 
some areas. There was significantly more bone on the OP-1 grafted side (mean% BIC 80.0 ± 
8.7%) compared with the BioOss-alone side (38.6 ± 27.5%). 
1.8.10. A maxillary sinus-grafting model in sheep. 
Haas, Watzek and co-workers at Vienna University have developed a model using the 
maxillary sinus of mountain sheep, for testing sinus grafting materials in association with 
dental implants.307• 308• 581-585 One draw-back to this model is that it is not in intra-oral model -
the sinus is approached via an extra-oral incision -and thus does not permit loading of the 
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implants. The model used cylindrical, unthreaded TPS-coated Fratec implants placed laterally 
into the sinus in a one-stage approach, simultaneous with sinus augmentation. The different 
grafting materials tested included ungrafted controls, particulate autogenous cancellous bone 
harvested from the iliac crest, bovine bone mineral (Bio-Oss), coralline non-resorbable 
porous hydroxyapatite (Interpore) and both human and sheep decalcified freeze-dried bone 
allograft (DFDBA). The sinus window was not covered with a membrane. The sheep were 
killed after 12,16 and 26 weeks (3, 4 and 6 months). In each experiment, pairs of implants 
were placed bilaterally. One of each pair was tested biomechanically (pull-out tests) and one 
was sectioned longitudinally for histomorphometric analysis. Although fluorescent labelling 
was used, mineral apposition rate (MAR) was not reported. 
Percent bone-implant contact was significantly higher at 12 weeks for autogenous bone in the 
grafted apical portion (16.8%) compared with ungrafted controls (6.4%) but not Bio-Oss 
(16.4%).307 Bone-implant contact increased with healing time although more of the 
autogenous graft mass was resorbed over time than the Bio-Oss graft. Biomechanical testing 
tended to match the histological results. There was little difference between autogenous grafts 
and ungrafted controls at 12 weeks whilst Bio-Oss sites had significantly greater mechanical 
strength; however, the autogenous grafted sites rapidly increased in strength with time and 
had the highest resistance at 26 week, although not significantly higher than Bio-Oss.308 
Interpore non-resorbable HA graft had superior % BIC (implant apical region =22.9% ) than 
autogenous bone (16.8%) or ungrafted control (6.4%) at 12 weeks, and this difference was 
maintained at 26 weeks (34.6, 24.0 and 7 .9% resepctively).581 Grafted groups had higher 
biomechanical resistance than controls and this increased over time, although a large 
statistical deviation reduced the significance of results. In this study the time course of 
developing resistance to pull-out forces did not match the increases in bone-implant contact 
as convincingly as in the other studies by this research group.584 
In a third set of experiments, demineralised freeze-dried sheep bone and human bone 
allografts were tested against autogenous grafts and ungrafted controls. In theory, 
demineralisation of bone grafts exposes the bound deposits of growth factors of the 
transforming growth factor super-family, making these grafts potentially both 
osteoconductive and osteoinductive.586' 587 Sheep and human grafts were compared to discover 
differences between homografts and xenografts. In this study, histomorphometric analysis 
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showed that the autografted groups gained significantly more bone-implant contact than 
either the ungrafted controls or the two DFDBA groups.582 In these studies, mean %BIC for 
sheep DFDBA ranged from 16.1 % to 19.0% from 12 to 26 weeks; human DFDBA ranged 
from 25% to 15.8% over the same interval, whereas autografted groups had an overall mean 
of 32.8% and ungrafted controls, 22.2%. 
The authors postulated that grafting as a two-stage procedure and loading of the implants 
might have increased bone-implant contact. The results of this histological examination in 
sheep did not provide evidence of an osteoinductive activity for demineralised bone. Both 
DFDBA grafts showed evidence of chronic inflammatory resorption of the graft material by 
multinucleated giant cells, especially the xenograft of human origin. However, biomechanical 
testing found equivalent and significantly superior resistance in the autografted and sheep 
DFDBA groups, whereas the human DFDBA and ungrafted controls were equivalent.583 
1.8.11. Bone grafting and platelet-rich plasma as a source of growth factors. 
A further experiment by the Vienna University group considered the effectiveness of platelet-
rich plasma (PRP) in augmenting the regenerative capacity of autogenous particulate bone 
grafts in the sheep sinus.585 • The use of autogenous bone grafts alone proved superior to the 
combination of bone grafts and growth factors in the sheep sinus implant model. These 
researchers also studied the effect of PRP in various mini-pig models. Addition of PRP was 
shown to increase bone-implant contact of implants placed into the mandibles of minipigs,588 
however there was no additional gain in bone-implant contact around machined-surface 
implants when BioOss and PRP was compared with PRP alone in the maxillary sinuses of 
minipigs (approached extra-orally,589 nor when PRP alone was placed onto machined-surface, 
HA-coated or anodised (TiUnite) implants placed immediately into mandibular extraction 
sockets in minipigs.590 
In the PRP technique, the supernatant from washed, calcium-chloride and thrombin-activated, 
allogenic, platelet-rich plasma cells, obtained after centrifugation of autologous whole blood, 
forms a fibrinogen-gel with a high concentration of platelets and growth factors including 
platelet-derived growth factor (PDGF),transforming growth factor-B (TGF-B), platelet-
derived epidermal growth factor (PDEGF), platelet-derived angiogenesis factor (PDAF), 
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insulin-like growth factor 1 (IGF-1) and platelet factor 4 (PF-4). The gel can be used as a 
graft, a membrane, or to bind and enhance the effect of bone allografts and alloplasts.591 • 592 
A systematic review by Sanchez et al. (2003)593 found only six studies where PRP was used in 
conjunction with dental implants, five of them case series or reports; they concluded that this 
technique still lacks controlled studies that demonstrate evidence of efficacy. Results have 
varied using other animal models for autogenous bone grafts combined with PRP. The 
addition of PRP enhanced regeneration of a segmental defect in the mandibular angle of the 
goat using particulate bone grafts after 6 and 12 weeks594 but failed to enhance healing with 
similar grafts in a canine mandibular discontinuity model.595 
1.8.12. Sheep bone grafts, collagen and growth factors. 
Collagen has been added to bone graft materials (xenografts and allografts) to reduce 
haemorrhage from the surgical site and improve retention of the graft within the wound.596• 597 
Collagen isolated from human tendon, skin, or bone, has been added to demineralised bone 
allograft in the ratio 60% collagen and 40% DFDBA, to form a composite spongelike 
implant.597 When this was placed into the mouse thigh pouch, a higher rate of calcification 
and bone formation was produced in the composite graft implant compared to DFDBA alone. 
The use of collagen alone and collagen as a carrier for recombinant human bone 
morphogenetic protein-2 (rhBMP2) has also been compared with bone autografts for bone 
regeneration in a rabbit tibial CSD.598 Defects received one of four treatments: untreated 
control, corticocancellous bone autograft, absorbable collagen sponge (ACS) or ACS+ 205.9 
µg/ml rhBMP-2 (total dose 35µg). The collagen sponge was cross-linked type 1 bovine 
atelopeptide sourced from CollaTech and is commonly used as a haemostatic dressing. The 
bone graft consisted of replacing the bone removed from the ostectomy site; screws or other 
stabilisatio1! agents were not used. Animals were killed after four and eight weeks. Analysis 
included computer-assisted radiomorphometry (RMA) at two-week intervals (high-contrast 
mammography film was used to quantify % radiopacity) and histomorphometry (HMA) of 
ground sections (to determine total regenerated bone in mm2). 
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Opacity of BMP-treated sites increased during from two to four weeks and then remained 
stable. Both RMA and HMA showed that autografts produced more bone than BMP but 
differences were not significant; both the bone and BMP-grafts produced significantly more 
bone than either control treatments. Collagen alone gave the radiographic appearance of bone 
fill, but histologically caused no more bone formation than the blood clot in the untreated 
CSD. The authors reported no evidence of immunological reaction to the collagen garrier, but 
noted that such reactions have been reported and occur unpredicatably depending upon the 
donor and recipient species and tissues. 
An alternative, tissue-engineering approach to the use of collagen has been adopted by one 
manufacturer.599 The product "Pep-Gen Pl5" consists of synthetic P-15 (a 15-amino acid 
sequence from type 1 collagen that binds to osetoprogenitor cells) as an isolated protein, 
in-eversibly bound to anorganic bovine bone mineral. P15 is described by the manufacturer as 
"a combination of OsteoGraf/N and a synthetic peptide (P-15) that mimics the cell-binding 
domain of Type-I collagen responsible for cell migration, differentiation, and proliferation" .600 
OsteoGraf/N is a xenograft produced from bovine bone by a combination of high-pressure 
steam, salt solution, particle sizing, and sequential sintering that yields a completely naturally 
porous HA matrix, free of organic remnants, with particle sizes of 250 - 420 µm.601 This 
material is a resorbable bone graft similar to BioOss and has been shown to produce superior 
results to autogenous bone when combined with bone grafting for sinus elevation.602 
Theoretically the added peptide P-15 binds osteoprogenitor cells and stimulates release of 
growth factors, thus intiating the osteogenic cascade.603-605 It is claimed that PepGen P-15 
mimics the actions of autogenous bone grafts and is statistically and clinically superior to 
both demineralised freeze-dried bone allograft (DFDBA) and anorganic bovine bone mineral 
(ABM). PepGen P-15 appears to be superior to ABM alone, DFDBA or debridement for 
short-term606• 607 and long-term (Yukna et al. 2000) defect fill and clinical attachment gain in 
periodontal defects as well as histological evidence of periodontal regeneration.608 
Histomorphometric analyses of isolated sinus augmentation cases using PepGen P-15 found 
similar bone formation to a composite graft (40% OsteoGraf/N, 40% DFDBA, 20% 
autogenous bone) in half the time, without requiring an additional donor site for autogenous 
bone.600 The healed site consisted of 45% vital bone, compared with 13% when anorganic 
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bovine material alone was grafted.609 Whether such a synthetic graft is superior to other 
bioactive peptides such as growth factors is currently unknown. 
The use of collagen combined with bone autograft or with dental implants has also been 
investigated. In one experiment, fusion of spinal vertebrae in a rabbit arthrodesis model was 
investigated using three grafts.610 Autogenous bone graft (corticocancellous bone from the 
iliac crest) was combined with bovine bone allograft and compared with bovine allograft plus 
type 1 collagen or bovine allograft plus collagen as a carrier for lOOµm bone morphogenetic 
protein (rhBMP). Analysis after 6 weeks included clinical, radiographic, biomechanical and 
histological examination. Bovine bone coated with Type I collagen as a carrier for rhBMP-2 
resulted in a higher fusion rate than autograft alone. 
Schlegel et al. (2003)611 also studied the use of collagen to enhance osseointegration. Their 
animal model used the frontal skull bone of pigs with an extra-oral approach. Sixteen 
implants/animal were placed into type II or III bone with the following treatments: (1) control 
(machined-surface Ankylos dental implant in standard osteotomy); (2) osteotomy prepared 
using osteotomes and a lateral condensation technique; (3) platelet-rich plasma placed into 
osteotomy after drilling and layered onto implants before placement, or ( 4) 20 mg bovine 
collagen layered onto the implant surface before placement into the drilled osteotomy. 
The authors stated that bovine collagen was used because it "leads to local adhesion and 
aggregation of thrombocytes". Animals were killed after 2, 4, or 8 weeks. Ground thick 
sections were subjected to histomorphometric analysis of %bone-implant contact and bone 
density using microradiographs. Results for the four techniques were well separated in this 
animal model at 2 weeks but converged to show no significant difference for either %BIC or 
% density after 8 weeks. Condensation followed by collagen were the most effective 
techniques at two weeks and this was maintained by collagen through to 8 weeks. 
Hanisch et al. (1997) evaluated bone-implant contact around paired, solid-screw, machined-
surface implants placed into the sinuses of four monkeys that had been grafted using 0.43 
mg/ml rhBMP-2 in an absorbable collagen sponge (ACS) three months prior to implant 
placement.612 In this experiment, implant placed into sinuses grafted with collagen only and 
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implants placed into ungrafted non-sinus maxillary sites were included as negative and 
positive controls respectively. Animals were killed after three months healing. Mean vertical 
(linear) bone gain, percent bone density and percent bone-implant contact was measured 
around the exposed implant apices as well as around the coronal portion within residual 
maxillary bone using computerised image analysis. Percent bone area was measured within a 
standardised rectangular area (approximately height of new or residual bone x 2mm wide) 
located 0.85mm lateral to the implant threads. 
Linear bone gain was significantly greater for rhBMP-2 (6.0mm) compared with collagen 
carrier-only sites (2.6mm). Bone density in rhBMP-2 sites (14.4%) showed no significant 
differences from collagen only (13.9%) or ungrafted maxilla (14.1 %). Surgical implantation 
of rhBMP-2 increased vertical bone height in the sub-antral space, allowing placement of 
dental implants. The newly formed bone was of similar density to the normal maxillary bone 
but bone-implant contact was not significantly enhanced. 
1.8.13. Implant site preparation by impaction of autogenous bone grafts: particulate 
impaction grafting in a sheep animal model. 
Long term success has been reported for impaction of particulate autogenous bone grafts into 
femora to support hip joint prostheses.613 ' 614 To evaluate impaction autografts, an ovine 
orthopaedic model was developed. 615 In this model, 15mm diameter x 15mm deep unicortical 
defects were created in sheep tibial and femoral sites. Autogenous bone from osteotomy 
preparation was then condensed into a pellet, impacted into the defect, and retained by 
covering the graft with polymethylmethacrylate. Fluorescent bone labeling was performed 
using oxytetracyline and alizarin complexone at 4 and 12 weeks to determine mineral 
apposition rates (MARs) and percent bone fill was determined by histomorphometric analysis 
of ground sections. 
The authors reported that new bone represented 89% and 94% of mineralised tissue within 
the defects after 7 and 14 weeks, respectively. Tibial defects contained less bone than femoral 
defects at 7 but not 14 weeks. Increased osteoproduction in femoral compared with tibial sites 
was considered to be due to the higher percentage of cancellous bone in femoral sites. The 
authors advocated the use of a Latin square design in treatment allocation to reduce the effect 
of differences between sites. Mineral apposition rates (MAR) werel.88 ± 0.11 and 2.1 ± 0.07 
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µm/day at 7 and 14 weeks, respectively. MAR in defects were 40 to 50% higher than those 
measured in matched adjacent intact cortex (non-operated control) at the same period (1.54 ± 
0.19 and 1.57 ± 0.09 µm/day at 7 and 14 weeks). MAR measured at 4 weeks were greater at 
the center than at the periphery of the defect. It is likely that this represents greater maturity in 
the peripheral bone; in unicortical bone defects, bone growth proceeds from the periphery 
toward the center. 
1.8.14. Impaction grafting in human posterior maxillary sites. 
An alternative technique has been developed for augmentation of low density bone in 
posterior maxillary sites. This involves the impaction grafting of block and particulate 
autogenous bone, allograft or alloplast. Initially described as part of the osteotome sinus floor 
elevation technique,433 the technique involves a crestal approach and impaction of a 
trephinated block of bone616' 617 and/or particulate grafts.618-620· 616' 621 Survival rates for implants 
placed simulateously with impaction grafting in human patients of 95% after 30 months, 
slightly lower than lateral sinus grafting, has been reported.618 A retrospective study with a 
heterogenous collection of 174 threaded and unthreaded implants with various surfaces 
placed into 101 patients using osteotomes and various autografts, allografts, or xenografts and 
loaded for 5 to 66 months reported a survival rate of 85.7% (initial bone height :::;4 mm) to 
>96% (initial bone height :2:: 5 mm).619 A prospective study of immediately-placed one- and 
two-stage ITI implants grafted with BioOss + autologous bone reported a 96% survival 
rate.622 
1.8.15. Summary of bone grafting and the use of collagen. 
Bone autografting has been described as "the gold standard for bone reconstruction".581· 571 
Particulate bone grafts may reduce necrosis and facilitate graft nutrition by provding space for 
(initially) diffusion, followed by angiogenesis; additionally, morseling the bone may promote 
the release of osteoinductive substances within the bone matrix.571 The literature supports 
the use of particulate bone autografts for augmentation of various maxillofacial sites, either 
prior to or at the same time as implant placement. Such grafts may be placed into the sinus by 
impaction. Impaction of particulate autografts into the marrow space of long-bones is an 
orthopaedic procedure which has been used in humans and tested in a sheep long-bone model, 
but has not been attempted in animal maxillofacial models. 
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Evidence also exists suggesting that the use of collagen with bone grafts or with dental 
implants may improve bone healing, particularly if used as a carrier for growth factors. 
Hypothesis: "particulate autogenous bone graft harvested by suction-linked bone trap from 
an osteotomy site, mixed with type I collagen and impacted into the osteotomy site will 
improve the bone density and ossoeintegration of rough-surfaced implants." 
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1.9. The use of biological mediators with dental implants. 
An alternative to the biophysical modification of the implant surface, or modification of the 
implant site by grafting, is the use of biological mediators such as growth factors and bone 
morphogenetic proteins, to accelerate and increase early bone-implant contact.623-627 
1.9.2. Undemineralised autografts versus demineralised allografts: growth factors. 
Bone grafts are thought to induce bone through three modes of action (1) the direct grafting 
of viable osteoblasts into the site (2) the provision of an appropriate collagenous matrix to 
support inward migration of capillary buds and potentially osteogenic cells (osteoconduction) 
and (3) release of inductive substances bound within the bone matrix. A major drawback to 
autografts is the need to harvest bone from a second surgical donor site within the patient's 
own body. Methods to avoid this have included the use of allografts (bone harvested from 
donors of the same species), xenografts (donor is a different species) or alloplasts (artificially 
constructed graft).628 
Over a century ago Senn (1889) transplanted decalcified bone from one human to another and 
reported healing in large, "non-healing" osseous wounds.629 Decalcification in acid was 
thought to sterilise the bone and possibly reduce the number of cross-reacting epitopes 
associated with graft rejection, as well as exposing the osteogenic substances within the 
matrix. In 1965, Urist demonstrated that demineralised bone matrix implanted in extraskeletal 
sites induces rat mesenchymal cells to change their phenotype, firstly to cartilage and then 
bone, in a process replicating endochondral ossification.586 However, bone matrix also 
contains species-specific antigens that may reduce or eliminate the effectiveness of xenogenic 
bone grafts.630• 631 Although demineralised freeze-dried bone allografts (DFDBA) are now 
widely employed for orthopaedic and dental uses,632-635 ' 148 responses are variable and may 
include resorption, chronic inflammation and poor osteoinduction, particularly in higher 
animals and in man. 636-638 
Researchers responded to the poor inductive potential of DFDBA by extracting, purifying and 
characterising the active elements within the matrix. These were subsequently named Bone 
Morphogenetic Proteins (BMPs).639' 640 Reddi (1998, 2001) has recently reviewed the history 
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of BMPs, from demineralised bone grafts to the production of recombinant human BMP.641 • 642 
Many other bioactive polypeptide cytokines have also now been characterised, some of which 
- bone morphogenetic proteins, transforming growth factor, platelet-derived growth factor 
and insulin-like growth factor - have demonstrated osteogenic potential. This section will 
review two of these growth factors (GFs) and formulate a hypothesis for their use in a sheep 
model of dental implantology. 
1.9.3. Review of growth factors. 
Peptide growth factors are multifactoral signalling factors which should be regarded as "the 
alphabet or symbols of a biological regulatory language".643 • Synonyms for the term growth 
factor include "interleukin", "lymphokine", "cytokine" and "colony stimulating factor". Some, 
such as platelet-derived growth factor, are named after the first cells found to synthesize 
them. Others, such as transforming growth factor-beta (TGF-B), are named after the first 
function associated with them, although other synthesizing cells and functions have since 
been described. Many growth factors function as autocrine or paracrine hormones; some also 
modify the actions of endocrine hormones such as steroids and insulin. Growth factors act on 
a range of target cells. The action of any one factor on one cell depends on the local tissue 
context - the cell type, the presence of other effector substances and receptors, the local 
extracellular matrix. This can lead to contradictory results from in vitro investigations, since 
minor modifications in the components of the assay system may have a marked effect on the 
response of the target cell to the factor under investigation. 
Growth factors have a major role in the regulation of gene expression. Pathways have yet to 
be fully clarified, however there have been major advances in the last decade (for a review 
see: Schmitt et al. 1999644). Growth factors also play important roles along with extracellular 
matrix macromolecules such as fibronectin, laminin and collagen, in mediating intercellular 
signalling. Control of extracellular matrix production and degradation rests with peptide 
growth factors. Growth factors are essential to the processes of embryogenesis, growth and 
development and play a central role in inflammation, angiogenesis, tissue repair and 
tumorigenesis. Growth factors have important potential applications in repair of maxillofacial 
osseous defects, osseointegration of endosseous implants, and regeneration of the damaged 
periodontium. 645-648 
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1.9.4. Bone morphogenetic proteins (BMPs). 
Bone morphogenetic proteins are a family of 30-40 kDa dimeric molecules joined by 
disulphide bonds. Many different factors have been identified, including BMP2, BMP3 
(osteogenin) and BMP7 (osteogenic-protein 1 or OP-1). BMP's 2-7 (but not BMPl) are 
members of the Transforming Growth Factor-B Superfamily. This superfamily also includes 
the growth factor TGF-B as well as a variety of chondrogenic and regulatory substances and 
have been comprehensively reviewed.649• 650• 644• 642 651 ) There appears to be multiple 
redundancies, since BMP 2, 3, 4 and 7 all initiate de nova cartilage and bone.652• 653 
Unlike demineralised bone matrix, purified species-specific BMP's stimulate bone induction 
and growth in animals of another species - there is considerable homology between rat, 
rabbit, porcine, bovine and human BMP's.654' 655 Both BMPs and TGF-B require dimerisation 
(disulphide-linkage) and cleavage of pro-regions for activation from a latent state. BMPs are 
pleiotrophic, ie; they have multiple regulatory actions. Of particular interest here is the central 
role of BMPs in the development of skeletal cartilage, bone and marrow, the induction of 
extraskeletal morphogenesis, and the repair of bony injuries.656-658 
Examples of the use of BMPs include the treatment of non-healing segmental defects in 
rats,659 dogs,660• 661 and humans, 154• 662 spinal fusion, 663 repair of craniotomy lesions in rabbits,664 
dogs,136 sheep,152' 174' 173' 665 baboons,666• 667 and monkeys;668 periodontal regeneration 669-673 and 
promotion of osseointegration for dental implants (Rutherford et al. 1992); Xiang et al. 1993). 
Specific critical size defects designed to examine the use of growth factors including the rat 
periodontal fenestration defect674, and the critical-size supra-alveolar periodontal138 and peri-
implant defects.675 In their review of the animal models used by their research group (which 
have included peri-implantitis defects, alveolar ridge defects and the maxillary sinus, in both 
dogs and non-human primates) Wikesjo et al. (2001) emphasised the discriminating power of 
their supra-alveolar ablation defects. These require regeneration in a vertical direction around 
the full-width of the dog mandibular premolar or mandibular implant.676 
1.9.5. The importance of the carrier for growth factors. 
Release of growth factors at the right time in the right place677 depends on the use of an 
appropriate carrier/delivery system with amenable handling properties that is capable of 
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binding and then releasing the growth factor(s) in an active form and appropriate 
concentration within the wound.678-680' 419 Carriers that have been used include demineralised 
bone,681 ' 682 antigen-extracted autolysed allogenic bone,666 ' 683 cancellous bone,154 
hydroxyapatite with684' 685 or without added collagen type 1,686' 667' 687 plaster of paris,688 B-
tricalcium phosphate,689 polylactic acid or polylactic/polyglycolic acid copolymers, either 
alone663' 690 or combined with demineralised bone matrix691 ' 661 ' 692 gelatin680 collagen spong,e693 
calcium phosphate putty,680 carboxymethyl cellulose and Gelfilm,694 pluronic F-127 gel,213 or 
collagen gels and membranes.695, 669 
Siggurdsson et al. (1996) eveluated multiple different carriers including demineralized bone 
matrix (DBM), Bio-Oss, absorbable type I bovine collagen sponge (ACS), poly(D,L-lactide-
co-glycolide) microparticles (PLGA), and polylactic acid granules.696 All cariers were 
combined with rhBMP2 and tested against the dog supra-alveolar premolar defect: DBM and 
BioOss were superior after 8 weeks healing. 
1.9.6. Transforming growth factor-fl (TGF-6). 
In our Department, testing has been conducted using transforming-growth-factor-B (TGF-B) 
in a sheep premolar defect model.211 ' 213 The same gowth factor was used in the current work 
to examine the response of a sheep mandibular implant model; the remainder of this review 
concerns TGF-B. 
1.9.7. Characterisation and activity of TGF-6. 
The initial investigations into transforming growth factor-B (TGFB) have been 
comprehensively reviewed.697-700 Three isoforms, TGF-Bl, B2 and B3 exist in mammals and all 
play critical roles in the regulation of growth and development. Each isoform is encoded by a 
unique gene on different chromosomes and are secreted by most cell types, generally in a 
latent form, requiring activation before they can exert biological activity. Activation may 
involve plasmin, thrombospondin and possibly acidic microenvironments; this appears to be a 
crucial regulatory step in controlling TGF-B activity. 
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The TGF-Bs possess three major activities: they inhibit proliferation of most cells, but can 
stimulate some mesenchymal cells including those found in cartilage and bone; they exert 
immunosuppressive effects; and they enhance the formation of extracellular matrix. In the 
intact organism the TGF-Bs are involved in wound repair processes, as well as starting and 
resolving inflammatory reactions.701 All TGF-B have a site for N-linked glycosylation, a 
recognition site for fibronectin/vitronectin, a final processed peptide length of 112 amino 
acids, nine conserved cystein residues, a C terminus, and are 60-80% identical. 
Transforming growth factor-Bs are the prototypical members of the TGFJJ supergene family 
and have sequence homology with bone morphogenetic proteins. 699 They have similar actions 
to platelet-derived growth factor (PDGF) despite having no sequence identity, however this 
may be explained on the basis of topological similarity between the crystal structure of PDGF 
and TGFB2.702 There are three classes of receptor for TGFB. Class III receptors are most 
abundant and bind all species of TGFB. The dimeric receptors are composed of proteoglycans 
subunits, mainly heparan sulphate glycosaminoglycans with chondroitin or dermatan 
sulphate, attached to a 100-149 kDa core protein. 
TGFB receptors thus differ from all other growth factor receptors, which are tyrosine kinases 
stimulated by ligand binding. TGFB interferes with the action of other mitogens including 
PDGF, insulin-like growth factor (IGF-I) and epithelial growth factor (EGF) possibly by 
reacting against their receptors.699 Class III receptors may also be involved in binding to 
extracellular matrix components and in the organisation of the cell cytoskeleton, thus linking 
two of the elements essential for directed cell movement. 
TGF-B may be purified from platelets or bone in an activated form, however the TGF-B 
produced by most cells or stored in platelets is inactive. Latent TGFB is activated by 
dimerisation and separation from a bound modulator protein (Bonewald & Mundy 1989). In 
serum, TGFB is bound to B-macroglobulin. Stored TGFB needs to be kept in a latent form 
since most cells have receptors and TGFB is a "powerful, multipotent regulator of cellular 
activity" .697 Activation of TGFB occurs as a result of decreased pH, increased temperature, 
and proteolysis- complete dissociation occurs at pH2, but activation of some TGFB occurs at 
pHS-6.103 
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TGFB has multiple and sometimes contradictory effects on cells in vivo and in vitro. This is 
partly determined by the cell phenotype, the extracellular matrix constituents and also varies 
temporally depending on the age or maturity of the cells or tissue.704' 705 ' 699 In vitro 
experiments often utilize cells of varying origin, obtained from homogenized tissues with a 
mixture of phenotypes present. The reaction of a given cell type at a given period in its life 
span to any one GF is also be modified by the presence of other GFs. For these reasons, in 
vitro investigations of isolated growth factors in cell tissue culture should be viewed with 
caution and confirmed in vivo. 
However, in vitro tests led one group to suggest that 11 BMP and TGFB may both be essential 
for the process of osteogenesis, with BMP influencing the initial differentiation of 
mesenchymal cells and TGFB further differentiating these cells for the generation of mature, 
functional osteoblasts 11 •706 TGFB plays a role both during embryogenesis707 ' 704 and in adult 
tissue643 where it is involved in the regulation of the extracellular matrix, in myogenesis, 
skeletal development, in maintenance, and in inflammatory and immune responses. 
TGFB inhibits epithelial growth and affects steroid-producing tissues, the endometrium and 
hepatic cells. Mechanisms of action include stimulation of glucose uptake, increased 
transmembrane amino acid transport, increased synthesis of prostaglandin and cytoplasmic 
actin, modulation of receptors for other growth factors or hormones, transcriptional control of 
genes including those for collagen, fibronectin, collagenase and tissue inhibitor of 
metalloproteinases (TIMP), and mediation of the action of retinoids and steroids including 
oestrogen and dexamethasone.708, 643 
TGF-B activities include the stimulation of extracellular matrix synthesis by increasing 
transcription of collagen types I, II, IV and V and decreasing matrix degradation via 
alterations in the protease/TIMP balance.709 TGF-B is chemotactic for many mesenchymal 
cells including fibroblasts and osteoblasts,710 stimulates production of collagen and 
fibronectin, mediates cell adhesion to the extracellular matrix and is thought to be central to 
the directed repopulation of wound sites in many tissues.711 Increasing TGF-B concentrations 
in a pig epidermal wound model caused epidermal thinning, increased dermal cellularity and 
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thickness, increased numbers of mononuclear inflammatory cells and acclerated 
angiogenesis.711 
Localising TGF-B irnrnunohistochernically in tissue sections allows identification of the 
presence of this growth factor during healing and repair. However, this is complicated by the 
difficulty in generating high-titre antibodies to TGF-B, due to the highly conserved nature of 
this growth factor. Three aspects of morphogenesis have been investigated: ernbryogenesis, 
repair, and regeneration (ie: extraskeletal endochondral bone induction). TGF-B has been 
demonstrated during tooth morphogenesis and eruption.707• 704 Bone is the most abundant 
source of TGF-B, typically at a concentration of 0.3rng/kg ( other soft tissues contain 
approximately 3-5µg/kg). TGFB is chernotactic and rnitogenic for osteoblasts, and may 
inhibit formation and activation of osteoclasts.697 ' 703• 699 TGF-B plays a central role in the 
coupling of bone resorption and formation. 
Production of TGF-B is suppressed by inflammatory mediators such as interleukin- I, 
prostaglandin E2 and tumour necrosis factor-a, whilst osteoclastic resorption is increased. 
TGF-B is activated from its latent, bound form by the low pH within the ruffled border of 
activated osteoclasts. This down-regulates osteoclastic resorption whilst simultaneously 
stimulating bone matrix secretion and mineralisation. Progressive mineralisation binds and 
inactivates free TGF-B thus releasing osteoclasts from inhibition and allowing resorption to 
start again.712 
1.9.8. Bone induction by the Growth Factors TGFB and BMPs. 
BMPs and TGFB play different roles in bone induction. Schmitt et al. (1999)644 divided 
osetoprogenitor cells into Determined Osteoprogenitor Cells (DOPCs) and Inducible 
Osteoprogenitor Cells (IOPCs). DOPCs are osseous stern cells located in the cambium layer 
of the periosteurn and endosteurn and are stimulated by BMPs.656 TGF-B injected 
subperiosteally increased the rate and amount of chondrogenesis and subsequent ossification, 
posisbly also due to stimulation of DOPCs.705 IOPCs provide a supplementary source of 
osteoprogenitor cells that become particularly important when an intact periosteurn is not 
present. They appear at the wounded site within 3-5 days after injury via capillary sprouts. 
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Most IOPCs appear to be pericytes, mesenchymal cells with "multiple branching cytoplasmic 
processes that partly encircle capillaries and postcapillary micro vessels 11 •713• 714 Angiogenesis 
is thus an essential part of osteogenesis.218 TGF-B is a potent stimulator of angiogenesis, 
acting principally on endothelial cells.699 Where bone marrow is involved, marrow-derived 
cells may also contribute.715 These cells may develop into either chondrocytes or osteoblasts, 
"depending upon the presence of environmental cues such as nutrient supply, BMP 
concentrations, growth factors, blood vessels, and mechanical stability" .644 
BMPs have been shown to induce bone formation in a rat extraskeletal bioassay; other growth 
factors (TGF-B, PDGF, IGF, EGF, FGF) do not. 640 Urist et al. (1983) has suggested that BMP 
and other GFs "act in a coefficient fashion" .587 Interactions between TGF-B and BMP may 
therefore accelerate osteoinduction. 
1.9.9. Collagen as a carrier for TGF6 and BMPs. 
TGF-B and other GFs are also though to play a part in promoting and maintaining the 
osteogenic cascade after induction by BMPs.658' 716 BMPs have also been shown to stimulate 
the production of other growth factors. Osteogenin and recombinant BMP-2B are chemotactic 
for monocytes and stimulate these cells to produce TGF-B.717 Purified BMP implanted by 
itself needs milligram amounts to produce clinically useful amounts of new bone. Combined 
with the collagenous residue of demineralised bone matrix, microgram amounts produce 
relatively large amounts of new bone.587 
A combined graft of purified porcine TGF-Bl and the BMP human OP-1 has been shown to 
act synergistically in inducing large bone ossicles in a heterostopic (rectus abdominis) site in 
baboons.718 There are two possible reasons for this. Firstly, BMP-3 and TGF-B both bind 
avidly to type IV collagen,719' 720 a major constituent of basement membranes.721 Collagen may 
act as a sequestration and delivery system, protecting BMPs and TGF-B from proteolysis, 
modulating controlled release, and orientating the molecules in an optimal factor.652• 658 649 
Since both BMPs and TGF-B also bind to type I collagen (although less avidly than type IV), 
collagen gel or demineralised bone matrix is often used as a slow release delivery system.656• 
664
• 
722 Thus, appropriate delivery vehicles are required to protect and orient GFs and BMPs for 
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optimal activity (see recent reviews 723 Ripamonti1999;724 419' 725). A second reason for reduced 
activity of purified BMPs and GFs may be contamination by unwanted cytokines. To 
eliminate this, recombinant human BMP (rhBMP)726' 727 and recombinant human TGF-B728' 729 
have been produced. Recombinant BMP is 10 times more potent than non-recombinant in an 
in vivo bioassay, and induces bone (although in lesser amounts) without a matrix. Rh-BMP 
has been used successfully for mandibular reconstruction of segmented defects in dogs,730 
rats659 and now humans.662 
1.9.10. Other properties of TGF6. 
TGF-B has other effects with important therapeutic implications. Firstly, it has growth 
inhibitory effects on epithelial cells in vitro. Secondly, it has protean effects on inflammation 
and the immune system; as an immunosuppressant TGF-B may be more potent than 
cyclosporine A. 698'737 This permits IL-1 and other monokines to exert control over 
angiogenesis and tissue repair whilst limiting lymphocytic acceleration of inflammation. 
TGF-B supresses both T cell function738 and B-cell production of immunoglobulin739 • 
TGF-B is released from platelets as one of the earliest events after injury, where it is 
chemotactic for fibroblasts and inflammatory cells and promotes angiogenesis and formation 
of granulation tissue. Similar events occur when TGF-B is injected or implanted 
subcutaneously in extraskeletal sites.740-742'711 '734 TGF-B 1s chemotactic for 
monocyte/macrophages in femtomolar concentrations and with low receptor saturation, 
implying a highly selective gradient, and activates monocytes to release latent, stored TGF-B 
as well as increased production and secretion of interleukin-I (IL-1), platelet-derived growth 
factor (PDGF), fibroblast growth factor (FGF) and tumour necrosis factor (TNF). Three 
mechanisms by which TGF-B is regulated include secretion in latent form, binding and 
sequestration within collagenous or mineralized matrices, and down regulation of cell 
membrane receptor for TGF-B following the differentiation of monocytes into 
macrophages. 698 
1.9.11. Animal models for investigating bone induction by TGFB. 
The classical model for bone induction is the heterotopic induction of bone in rat 
mesenchymal tissue. Implantation of TGF-B in these sites failed to induce new bone. 
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Immunohistochemical and radioreceptor techniques localised the TGF-B present in 
demineralized bone matrix (DBM) before implantation but the growth factor became 
undetectable three days following extraskeletal implantation of DBM in rats and then re-
appeared between 9-21 days, tightly bound into mineralised tissue731 coinciding with 
vascularisation of the matrix and calcification of cartilage. 
A second in vivo model for bone stimulation by growth factors, involves placing the cytokine 
in close proximity to periosteum and allowing TGF-B to stimulate DOPC in the periosteal 
cambrium. Injection of lµg porcine TGF-Bl, and TGF-B2 onto the outer surface of the 
periosteum of neonatal rat parietal bones over 12 days resulted in formation of mineralized 
woven bone and a doubling of the bone thickness.732 Platelet-derived growth factor (PDGF) 
and basic fibroblast growth factor (bFGF) did not induce bone following a similar protocol. A 
single application of recombinant human TGF-B adjacent to cartilage within rabbit ear full-
thickness skin wounds resulted in new bone.733 The best results were found using lO0ng 
TGF-B in a 3% methylcellulose gel carrier. No new bone formed if the perichondrium was 
left intact and TGF-B placed external to it.734 Subperiosteal injections of rhTGF-B in neonatal 
and adult rats caused proliferation of osteoprogenitor cells, increased intramembranous 
ossification and thickened parietal bone in neonates. In adults, TGF-B increased the number 
of chondrocytes, with subsequent endochondral ossification and formation of marrow.735 
TGF-B has been localised during fracture repair. In a rat femur model, TGF-B reaching peak 
concentrations in soft callus at 13 days and in hard callus at 5 days (intramembranous bone 
formation) and at 15 days (endochondral ossification).705 Addition of exogenous TGF-B in 
vitro to callus explanted at different stages of healing had different effects, confirming that 
the effect of TGF-B on cells depends on their phenotype and degree of maturation. In biopsies 
of human fracture callus, TGF-Bl was present in the haematoma in low levels, rose to a peak 
during mesenchymal proliferation and chondrogenesis, fell during cartilage cell hypertrophy 
and matrix calcification, and rose again during the stages of vascular invasion and 
osteogenesis.736 
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1.9.12. Therapeutic potential of growth factors for dental implantology 
Initial work using ITI press-fit cylindrical implants inserted into dog mandibles, accompanied 
by recombinant PDGF-BB and IGF-I in methylcellulose gel, demonstrated increased bone 
within the peri-implant spaces compared with vehicle-only and untreated controls. Only 
short-term healing (one and three weeks) was examined.743 The authors suggested that growth 
factors may increase the rate of osseointegration, a therapy which might be improve success 
rates for implants placed in poor quality or type IV bone. 
However, there were serious methodological flaws in this study. The authors agreed that a 
better balance between numbers of control and test sites and a -larger sample size was 
required. 
Subesquent studies considered Nobelpharma Branemark machined-surface implants placed 
directly into fresh extraction sockets in dogs.637 A buccal dehiscence defect around the 
implants was treated with GoreTex teflon membranes alone or combined with either human 
DFDBA or PDGF combined with IGF- in methylcellulose gel. Results after 18 weeks 
revealed a thin shell of buccal cortical bone beneath the membranes; membrane plus DFDBA 
sits varied from no bone to large amounts of bone but unresorbed graft was present in most 
sites. There was no evidence that the bone morphogenic protein (BMP) within the DFDBA 
graft induced osteogenesis. Membrane plus GF sites had more bone in contact with the 
implant and denser bone, indicating both a qualitative and quantitative change in peri-implant 
osseous healing. One aspect of this study was flawed, in that the decalcified freeze dried bone 
was of human origin which may have caused a poor response in this dog model. 
The therapeutic use of growth factors in orthopaedics and in dentistry is now attracting a great 
deal of interest.724 ' 744 ' 642 In implant dentistry, two applications appear promising: (1) 
regeneration of bone around implants, due to either a lack of bone, or the loss of bone 
following, for example, peri-implantitis745 and (2) acceleration and/or augmentation of 
osseointegration, ie: the amount of bone in contact with the implant surface.627 
140 
The growth factors with the best overall results in these applications seem to have been Bone 
Morphogenetic Proteins (BMPs), in particular BMP-2, BMP-4, Osteogenin (BMP-3), and the 
Osteogenic proteins 1 to 3 (OP-I or BMP-7, OP-2 & 3 or BMP-8).644• 642 Applied using a type 
I bovine collagen carrier or in a resorbable collagen sponge, rhBMP has successfully been 
used to induce bone around implants placed into tooth extractions sockets and into narrow 
alveolar ridges, firstly in a dog model624•625 and then in human patients.746 
Unfortunately, histological evidence of successful regeneration of bone around implants in 
human patients is scanty and of poor quality. Becker et al. (1998) carried out 
histomorphometric analysis after grafting extraction sockets with either xenogenic bovine 
bone, demineralized freeze-dried bone (DFDBA), intra-oral autologous bone, or human bone 
morphogenetic proteins in an osteocalcein/osteonectin carrier (hBMP/NCP).747 They 
concluded that "DFDBA, anorganic bone, or intraoral autologous grafts cannot be 
recommended to enhance extraction socket healing or to promote bone formation for implant 
support" whereas "the 2 sites which received hBMP/NCP demonstrated clinically significant 
amounts of new bone formation". 
It shoulf be noted that the design of this study was flawed. Thirteen sockets in five patients 
received various types of grafts. Two sites in two patients had BMPs; three sites in three 
patients ( one with a BMP-grafted socket) had autologous bone. Healing times ranged from 3 
to six months. The two BMP sites developed woven and lamellar bone after 3-4 months. The 
autologous grafts also showed new bone after 4-6 months, but the graft particles in 2 of 3 
patients were not resorbed. BMPs seemed superior to autologous bone for promoting socket 
healing. An additional three patients received 5mm x 2mm titanium micro-implants into their 
sockets as well as grafts. No patient received BMPs around their titanium implant. One 
microscrew was grafted with autologous bone; this implant was surrounded by new bone, but 
separated from it by connective tissue except for three small areas of bone-implant contact 
and percent BIC was not quantified. Unfortunately this experiment does not permit any valid 
conclusions in comparing BMPs versus autologous bone grafts for bone regeneration around 
implants. 
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1.9.13. Growth factors in animal models of dental implantology. 
A group of Chinese researchers tried using titanium implants themselves as the carrier for 
BMPs.748-750 Purified bovine BMP was placed within the apical hole of threaded solid-screw 
titanium implants without any other carrier and inserted into dog mandibles for 1,2,4,8 and 12 
weeks. The authors claimed that BMP accelerated the rate and extent of osseointegration; 
however, histology was limited to descriptions of demineralised, paraffin-embedded sections 
with the implant removed. There was no attempt to quantify the effect. However, Kawai et al. 
(1993) concluded that titanium is a poor carrier for BMPs.751 
A maxillofacial model in goats has been used to study rhBMP-2, applied in an absorbable 
collagen sponge within the maxillary sinus. 188' 292 ' 293• 189 Healing with mineralised bone 
occurred, however, bone grafts were not compared with growth factors, and implants were 
not placed. Biopsies comparing sinuses grafted with BioOss or with rhBMP-7, also known as 
osteogenic protein-I (rhOP-1) in chimpanzees after 3.5, 5.5 and 7.5 months showed increased 
bone with the growth factors although this was only apparent after 7 .5 months. Type I bovine 
bone collagen was used as a carrier; negative controls (collagen with no OP-1) also generated 
new bone although in much lower amounts.752 
Sinus augmentation in monkey sinuses comparing rhBMP-2 in an absorbable collagen sponge 
(ACS) or vehicle + ACS alone, was followed by implant placement three months later.612 
Two implants were placed into each augmented sinus, and one additional implant was placed 
immediately anterior to the sinus into ungrafted maxillary bone. Animals were killed after 
three months healing. Percent BIC ranged from 46.8% (control non-sinus maxilla) to 41.4% 
(BMP, sinus) to 38.9% (collagen sponge alone, sinus);% bone density was 14.1%, 14.4% and 
13.9% respectively. RhBMP-2 did not augment the density of bone nor the amount of contact 
with the implant but more than doubled the height of bone in the sinus, making it possible to 
place the implant. 
In human patients, sinus grafting with rhBMP7 in collagen carrier compared with autogenous 
bone grafts revealed good results in some patients however results with the BMP-7 were 
unpredictable.569 The same growth factor and carrier was investigated in a dog femoral peri-
implant CSD model.753 Unloaded cylindrical titanium implants (some HA-coated) surrounded 
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by a 3-mm gap; were grafted and animals killed 6 weeks later. Percent BIC and % bone 
density in the gap increased 3-fold for OP-1 groups when compared with empty controls, but 
no difference was found between OP-1 groups and collagen matrix groups. This experiment 
failed to determine whether OP-1 or the collagen carrier alone was responsible for the 
enhanced bone ongrowth. Despite occasional reports of antigenic reactions to bovine type I 
collagen,754· 755 collagen has long been regarded as a suitable delivery vehicle for bone 
morphogenetic proteins.695, 756,669,693, 757 
1.9.14. Impaction grafting of bone plus collagen and/or growth factors in the dog. 
An ablative, supra-alveolar, peri-implant CSD model in the dog mandible has been developed 
by Wikesjo et al. (1999).758'759 This model has been used to compare three different strategies 
thought to enhance osseointegration around titanium implants: growth factors, bone grafting 
and hydroxyapatite surface-coating.758 Threaded, cylindrical, HA-coated titanium implants 
were centralised within an oversized osteotomy, using titanium washers at either end to 
maintain a 3mm gap around the circumference of the implant. Cortico-cancellous bone chips 
were obtained from another dog (ie: an allograft), combined rhOP-1 and bovine type 1 
collagen and impacted into the gap surrounding the implants. The contralateral humerus in 
each dog received only bone allograft combined with collagen. All animals were killed after 6 
weeks. 
Biomechanical testing found no significant differences. Histomorphometric analysis (HMA) 
using a line-intercept (stereology) technique determined % BIC and percent bone =s; 1.5mm 
from the implant surface and =s; 1.5mm from the outer margin of the osteotomy. The addition 
of OP-1 reduced %bone-implant contact (in a non-significant fashion) in both groups. This 
experiment did not include an untreated control, so the normal amount of bone fill adjacent to 
the HA surface in this model is unknown. However, similar experiments in goat femora183· 184 
gave results for ungrafted peri-implant defects around HA-coated implants that were 
considerably lower than the grafted results in the dog humerus, suggesting that an un-grafted 
HA-coated control in dogs (if it had been included in thisexperiment) would have had a 
poorer result than the grafted implants. Lind et al (2001) concluded that OP-1 in this delivery 
system has, at best, only a modest osteoinductive effect upon bone around HA-coated 
implants.758 
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The dog peri-implant CSD759 has also been used to compare either rhBMP-2 in a type I 
bovine collagen carrier or the carrier alone, around Branemark machined-surface implants.624 
HMA after 16 weeks healing revealed significant vertical bone regeneration in the rhBMP 
group although the newly-regenerated bone had low bone-implant contact; the small amount 
of regenerated bone on the collagen control sites had double the % BIC. 
A subsequent experiment used the same protocol, except that a different carrier (BioOss) was 
used and in a two-stage procedure the reduced alveolar ridge was allowed to regenerate for 8-
16 weeks before placing ITI TPS-surface hollow-cylinder implants.626 No negative control 
(BioOss alone) was used. Animals were killed at 24 weeks (8 or 16 weeks integration); HMA 
showed non-significant increased density in the induced versus residual bone and no 
differences for % BIC between the two sites and for different timepoints. How much of the 
successful result is due to the Bio-Oss versus BMP could not be discerned in this experiment 
due to the lack of a control group. 
Circumferential peri-implant gap defects 1.5mm wide x 4mm deep around the coronal half of 
ITI solid-screw implants with an SLA (sandblasted, acid-etched) surface in dog mandibles 
have been used to compare BMP-2 with Goretex membranes.625 There were four groups: 
BMP in collagen sponge + membrane, BMP and collagen + no membrane, collagen alone + 
membrane only, and collagen alone + no membrane. Animals were killed after after one and 
three months. 
HMA using stereological analysis found that rhBMP-2 doubled bone-implant contact 
compared with controls at both time points, and this was statistically significant after 12 
weeks; with a membrane present these differences still existed and approached but did not 
achieve statistical significance at either time point. Combined data showed that addition of 
rhBMP significantly increased % BIC compared with collagen carrier alone at both time 
points whereas addition of a membrane did not. 
The membranes slowed early osseous healing when BMP was used, and had no additional 
benefit for later healing; the authors suggest that the membrane may have prevented the 
recruitment of osteoprogenitor cells by the growth factor. They also noted that the collagen 
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carrier in many cases acted as a space-maintainer, thus allowing more bone regeneration than 
would have occurred had the control defects been left empty. Similar experiments on peri-
implant buccal dehiscence defects in dogs compared GoreTex membrane with membrane + 
autogenous bone harvested form the osteotomy sites. After 16 weeks, the membranes 
appeared to retard healing and reduce % BIC and % BA to a significant degree. Autogenous 
bone did not significantly improve osseointegration beneath a membrane.392 
1.9.15. TGF6 action alone and synergeistic actions of TGF6 combined with OP-1. 
Much of the work using TGF-B comes out of the laboratory of Professor Ripamonti in South 
Africa. Since a single application of TGF-B 1 in the primate did not induce bone formation in 
calvarial defects but did result in endochondral ossification in heterotopic sites in baboons, 
Duneas et al. (1998)718 concluded that the bone inductive activity of TGF-Bl is site and tissue 
specific. When TGF-B 1 and rhOP-1 were combined in the same heterotopic site, they 
interacted synergistically to induce larger ossicles; similar results were found for calvarial 
sites. Ripamonti et al. (2000)760 then showed similar results for recombinant human TGF-B2. 
The results of these experiments and others have recently been reviewed in depth by 
Riparnonti and co-workers724• 761 •762' 417 and are summarised below (Table 1.16). 
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Table 1.16. Summary of experiments from the laboratory of Ripamonti: TGF-B implanted 
into baboons.n4, 761,762,417 
muscle 
5, 25 & 125µg Abdominal 8 128 Endochondral bone day 30 
muscle 
0.5,1.5 & 5µg Abdominal 2 8 Ossicle day 30 
muscle 
1, 5 & 25µg Abdominal 4 32 Large corticalised ossicle 
muscle day90 
rhOl>-:J + pTOF-Bf 25µg + 0.5, 1.5 Abdominal 8 96 Large ossicles 
&5µg muscle 
25µg + 0.5, 1.5 Abdominal 6 72 Large ossicles 
&5µg muscle 
Abdominal 4 16 Bone induced without GFs 
muscle day 90 
SPHA 6+ thTGF- Abdominal 4 16 Bone induced 
B2 7 muscle 
i,•bo:r-1, bOP-f. 1 0.18 & 20 µg Cranial defect 26& 10 8&40 Copious mineralised bone 
day 30 
0.01, 0.05, 0.25 Cranial defect 14 56 Complete regeneration 
µg (25µg) 
10 Jtg Cranial defect 8 32 Complete regeneration 
10 µg Cranial defect 8 32 Pericranial bone formation 
only 
rhOP.:J +:rhTGF- lOµg+0.5 & Cranial defect 8 32 Large ossicle day 30 & 90 
Bl·5 0.15 µg 
SPHA. 6 Cranial defect 4 16 Considerable bone 
differentation day 90 
SPHA+rhOP:..l 2 0.01, 0.05, Cranial defect 12 48 Extensive peri- & 
0.25µg endocranial bone day 30 
CDHA 8 Cranial defect 24&8 96&32 ~ GF loaded day 30, << 
day90 9 
CDHA+ rhOP-1 + 15µg Cranial defect 8 32 >> control (no GF) but<< 
rhTGF-Bl 5 SPHAday 90 
1. b"bOP-1 = purified baboon osteogenic protein- I (BMP 7); bOP-1 = purified bovine OP-1 
2. rhOP-1 = recombinant human OP-1 (Stryker Biotech "Novus"). 
3. pTGF-Bl = purified porcine platelt transforming growth factor- beta I 
4. hTGF-B2 = purified human TGF-B2 (Genzyme Corp, USA) 
5. rhTGF-Bl = recombinant human TGF-Bl (Genentech Inc., USA) 
6. SPHA = non-resorbable sintered porous hydroxyapatite 
7. rhTGF-B2 = recombinant human TGF-B2 
8. CDHA = resorbable coral-derived hydroxyapatite 
9. Results given in Ripamonti et al. 1992. 
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1.9.16. Biomaterials with Intrinsic Osteoinductive Activity? 
An important issue in tissue regeneration is the potential of biomimetic biomaterials to 
optimally deliver biologically active BMPs and related growth factors. Ripamonti and Tasker 
(2000) suggest that optimal bone induction depends on the combined action of (1) 
morphogens such as BMPs and TGF-Bs, (2) other soluble cytokines, and (3) a complementary 
substratum which they term "the insoluble signal".762 
After showing that porous coral-derived hydroxyapatite are effective as delivery systems for 
BMPs, further experiments suggested that some biomaterials have an intrinsic osteoinductive 
activity related to their surface geometry.761 • 763 Sintered hydroxyapatite discs with concavities 
of 800 and 1600 µm diameter implanted in the rectus abdominis of the baboon show 
histological evidence of de nova bone formation exclusively within the concavities. 
Subsequently, bone formation with associated marrow was found in 41 % of porous HA 
implants. 
Calvarial specimens also showed substantial bone formation, culminating in complete 
penetration of bone within the porous spaces. Immunolocalization of BMP-3 and OP-1/BMP-
7 in cellular material at the hydroxyapatite interface suggests that the ceramic may act as a 
solid-state matrix for adsorption of endogenously produced BMPs. These experiments 
demonstrate intrinsic osteoinductivity by monolythic and porous sintered hydroxyapatites 
implanted in heterotopic sites of adult primates. This intrinsic osteoinductivity of novel smart 
biomaterials will help to engineer morphogenetic responses for therapeutic osteogenesis and 
tissue engineering in clinical contexts, optimizing low doses of recombinant human 
BMPs/OPs. 
Further work has shown that HA-coated titanium dental implants with similar surface 
concavities, placed into edentulous mandibular ridges in baboons, develop continuous (100%) 
bone-implant contact after one and three month healing intervals.417 The authors ascribed this 
in part to the well-known osteoconductive properties of the ceramic coating, but also 
suggested that the "concavities of the substratum are geometric regulators endowed with 
shape memory" which recapitulate embryonic osseous development. This regulation in part 
consists of adsorption and concentration of specific biomolecular factors within the 
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concavities (including BMPs and TGF-Bs), and possible also the provision of a protected and 
specifically-shaped nidus - mimicking to the events that occur within type I collagen during 
chondrogenesis and endochondral bone formation.764 · 
Partial confirmation of these theories was provided by Schwartz et al. (1997)484 who listed 
four characteristics of an implanted biomaterial - surface energy, chemistry, topography and 
surface roughness - that directly influence cellular responses and thus dictate the nature and 
rate of contiguous tissue regeneration. This group evaluated the effect of chemistry and 
roughness upon cell response and local cytokine production, by growing costochondral 
chondrocytes in vitro on tissue culture plastic dishes that had been sputter-coated with 
different materials including titanium and calcium phosphate. Results indicated that surface 
materials can elicit differential responses in cell metabolism and phenotypic expression. 
In a second study765 , the effect of titanium surface roughness on osteoblast-like cell behavior 
was examined by comparing acid-washed, electropolished, coarse-grit (SLA) or fine-grit-
blasted and double acid-etched, or titanium plasma-sprayed (TPS) titanium discs placed into 
the base of tissue culture wells and cultivated with osteoblast-like cells. Surface roughness 
was found to alter differentiation of cells into osteoblasts and their proliferation and matrix 
production in vitro. Production of PGE2 and TGF-B by these cells increased as surface 
roughness increased. TPS surfaces resulted in greater amounts of TGF-B and slightly less 
collagen than SLA, but there were essentially no differences between the two; however both 
surfaces differed significantly from acid-washed, electropolished and fine-grit balsted discs. 
Thus the substrate surface roughness also affected cytokine and growth factor production. 
Bone regenerates from distant sites towards the implant surface. Schwartz et al. (1997, 
2001 )484• 765 hypothesized that osteoblasts growing on the surf ace of the implant produce local 
factors that affect this bone healing process and that the nature of the osteoblasts and their 
production of growth factors is modified by surface roughness. 
Others have shown that human gingival epithelial cells attach, spread and proliferate best on 
polished titanium surfaces and most poorly on plasma-sprayed surfaces.766 By contrast, 
human maxillary osteoblasts seeded as secondary suspension cultures attached very well to 
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all three differently textured titanium surfaces and showed identical growth patterns 
independent of the titanium surface structure. Similar experiments showed that attachment 
and proliferation of human mandibular osteoblasts is enhanced by increasing surface 
roughness.767 Implantation of machined-surface titanium implants into a different tissue, bone 
marrow, does not induce formation of new bone. In a mouse femoral maITow model, there 
was evidence of macrophages and giant multinucleated cells543 but no adverse effects were 
seen following this "myelointegration" process.544 Whether roughened surfaces or so-called 
"smart" biomaterials would show the same response in ma1Tow is unknown. 
1.9.17. Is TGF6 osteoinductive by itself? 
According to Ripamonti and Tasker (2000), the de novo induction of bone formation, 
originally and solely ascribed to the BMP family members, may now be extended to other 
TGF-B family members.762 However, although TGFBs induced bone in abdominal muscle, 
when implanted subcutaneously in rats only granulation tissue with marked fibrosis was 
found. Before TGF-B proteins can be routinely used in in human patients, investigators need 
to identify unresponsive or negatively-responding tissues and anatomical locations.762 
1.9.18. TGF6 combined with bone grafts and implants. 
Other authors have also reported increased and/or accelerated healing in_ orthopaedic and 
periodontal sites following the application of TGF-B. RhTGF-Bl adsorbed on to grit-blasted, 
TCP-coated titanium alloy cylindrical implants and placed into the femurs of with an 0.75 
mm gap had signifcantly higher %BIC (59%) compared with controls (22%) although 
biomechanical push-out tests showed no difference in fixation of the implant between the two 
groups.768 Purified bovine TGF-B in a cancellous bone carrier placed into a 1.5cm segmental 
CSD in rabbit radii bridged the defect after 12 weeks; the controls remained unhealed.769 
Implantation of HA- or TCP-coated titanium rods in dog humerii with a surrounding 3mm 
gap showed a threefold increase in %BIC with low-dose rhTGF-Bl after 1 month compared 
with controls, but no significant increase with higher doses.770 Results were similar to the 
increase found after impacting autogenous cancellous bone-grafts in the same model.771 
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1.9.19. Is collagen a suitable carrier/release system for TGFB? 
A biodegradable controlled release system for recombinant simian TGF-Bl using poly(DL-
lactic-co-glycolic acid) (PLPG) with demineralized bone matrix (DBM) was compared to a 
calcium sulphate carrier, in a 9mm rat calvarial CSD. After 6 weeks the CaSO4 carrier 
resulted in 67.5% bone fill, whereas the PLPG carrier caused an inflammatory response with 
little mineralization or bone growth.772 
It has been suggested that collagen is a suitable delivery system for TGF-B2 and that this is 
significantly enhanced by covalently bonding the GF to the carrier.773 Others have used 
calcium phosphate bone cement,774' 775 or coral-derived calcium carbonate,776 as well as 
ceramics, demineralised bone matrix, hydroactive pastes, hydrogel, collagen, 
carboxymethylcellulose polymers such as poylactic acid, tricalcium 
phosphate/polycaprolactone-co-glycolide bone wax.636' 695 • 777 • 678• 694• 778 More recently, 
Schmidmaier et al. (2001a) developed a "cold coating technique" to produce a biodegradable, 
mechanically stable, slow- release system for growth factors on the surface of metallic 
implants.418 This PDLLA coating was found effective in fracture models in rats779 and pigs.780 
Not all authors have found TGF-Bl useful for osseous regeneration. Non-critical size 
fenestration defects in dogs showed better healing with the collagen carrier than with TGF-
B l.782 TGFBl in a bioabsorbable paste failed to enhance healing in a rat femur model.778 
Comparison of rhTGF-Bl in a CaCOihydroxyethyl starch carrier plus membrane GTR, with 
carrier alone plus membrane in the dog supraalveolar premolar CSD suggested that TGF-Bl 
had only restricted potential for enhancing alveolar bone regeneration even when combined 
with GTR.783 A similar experiment using rhTGF-beta 1 in a calcium carbonate carrier 
concluded that treatment of periodontal defects in beagle dogs with rhTGF-beta 1 was of 
limited clinical benefit.784 Poor results in the baboon calvarial model have also been 
reported. 785 
1.9.20. TGFB in a sheep CSD model. 
Experiments with sheep CSD have shown improved healing with TGF-B. Implantation of a 
2.5 cm tibial segmental CSD in sheep with rhTGF-Bl in a demineralised bone matrix carrier 
for three months resulted in complete bone bridging of the TGF-B I-treated defects and stress-
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strain curves similar to the normal contralateral limb, whereas carrier-only defects had 
unbridged gaps. 190 Periodontal regeneration of paired class II furcation defects in sheep 
mandibular premolar defects has been shown using recombinant simian TFG-B 1 in pluronic 
carrier.213 A comparison of titanium cages, titanium cages with autologous bone, cages with 
BMP-2 in a PLA carrier and cages with TGFB and IGF-1 in a PLA carrier, applied to a sheep 
spinal fusion model, concluded after biomechanical and histomorphometric analysis that 
BMP-2 and TGF-B/IGF-1 were equivalent and superior to grafts in promoting early fusion. 781 
1.9.21. TGF6 and dental implants. 
Application of TGF-Bl in a methylcellulose carrier to mandibular extraction sockets and the 
edentulous diastema of minipigs followed by the insertion of Branemark machined-surface 
implants was studied over 5, 9 and 14 week healing periods.786 The overall implant survival 
rate was 76% and several more implants were about to fail.The rank order for %BIC after 14 
weeks was TGF-B (edentulous ridge, 63%) >TGFB (socket, 57%) >no treatment (socket, 55-
56%) >carrier (socket & edentulous ridge, both 53% ). Numbers were very small, making it 
difficult draw conclusions, however the TGFB-grafted sites had consistently higher % BIC at 
all time points. Fluorochrome measurement of MAR ranged from 1.75 to 1.85µm/day. 
More recently, investigators have attempted to combine multiple growth factors (BMP-2, 
TGF-B, PDGF and bFGF) within a bioabsorbable, non-hydroxyapatite, calcium phosphate 
cement, applied topically to the osteotomy site improve implant osseointegration.787 
Oversized osteomy sites in a dog mandibular model were implanted with machined-surface 
implants; results after 3 months showed a significant improvement in %BIC. 
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1.9.22. Summary and hypothesis for bone-grafts, collagen carriers and TGF.6 with 
respect to enhancing dental implant osseointegration. 
The evidence presented above appears to support the following hypotheses: 
1. Autogenous bone grafts may act as a source of osteoinductive bone morphogenetic protein. 
2. Transforming growth factor applied to ostotomy sites in a collagenous carrier may increase 
integration of implants. 
3. The combination of TGF-B in a collagen carrier with autogenous bone grafts may result in 
greater bone-implant contact and bone density when impacted within the osteotomy site prior 
to implant placement, when compared with bone grafts plus collagen carrier alone. 
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1.10. Peri-implantitis. 
The vulnerability of implants to peri-implantitis when placed into a host with pre-existing 
periodontitis is controversial. Recent reviews of the disease entity peri-implantitis suggest 
that a microbiota similar to that found in periodontitis may become established around 
implants,788' 61 ' 62 ' 789 and may lead to late failure of implants,348' 790 possibly as a result of 
horizontal transmission from the periodontal pocket.791-795, 788 Case studies in human subjects 
report a high implant failure rate in patients with aggressive forms of periodontitis.796• 797 
Others have suggested that non-periodontal pathogens such as stapholococcus aureus and 
candida species may be as important.798•429 
A retrospective analysis of periodontal and peri-implant attachment loss in human patients 
found that implants had significantly less bone loss over time than teeth, and there was no 
significant relationship between periodontal parameters and peri-implant bone loss.799 The 
authors suggested that much of the bone loss found in animal models for peri-implantitis may 
be due to the foreign-body reaction caused by ligation of the implants. 
1.10.2. Animal models of peri-implantitis. 
Meta-analysis of treatment methods for experimentally-induced peri-implantitis in animals 
found that in 90% of studies, peri-implantitis lesions were lesions using ligatures; the 
remaining three studies attempted (unsuccessfully for 2/3) to induce peri-implantitis by 
occlusal overload.69 In this review, no researchers studied the results of implants placed into 
an animal model with pre-existing, spontaneous periodontitis. This meta-analysis also 
suggested that smooth screw-type implants were less susceptible to ligature-induced peri-
implant inflammation than cylindric implants. A meta-analysis of controlled clinical trials for 
treatment of peri-implantitis in humans suggested that rough-surfaced implants may be at 
higher risk of peri-implant infection.800 









806 Of paticular note is the existence of a naturally-ocuuring, non-ligature induced 
model for periodontits in sheep.199• 807-809• 127 
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1.10.3. Summary and hypothesis with respect to animal models of peri-implantitis. 
It would be desirable to have an animal model for spontaneous peri-implantitis. Most animal 
models for peri-implantitis induce disease through the use of acute, repetitive, peri-implant 
trauma. A model for spontaneous periodontitis already exists in sheep. The following 
hypothesis can be supported: that the presence of pre-exisiting periodontitis in this animal 
model modifies the process of osseointegration during the intial stages of healing of 






1.11. The use of systematic reviews and meta-analysis, for comparison of 
animal models of dental implantology. 
One method to validate a new model for dental implantology would be to compare the results 
for different implant experiments, with similar results in other animal models. Reviews of 
dental implant experiments have been discussed in other sections; more recently, two 
systematic reviews have been published497' 495 although neither attempted a meta-analysis of 
bone-implant contact or bone density. The differences between narrative and systematic 
reviews are summarised below (table 1. 15) and are well covered in textbooks such as the 
Cochrane Reviewers' Handbook810 ( also available online811 ' 812) • 
Table 1.17. Differences between Narrative and Systematic Reviews (after Mulrow & Cook, 
1998, p7).812 
Broad scope 
Not specified, potentially biased 
Not specified, potentially biased 
Qualitative summary 
May be evidence-based 
Comprehensive sources & explicit 
search strategy 
Criterion--based selection, uniformly 
applied 
Rigorous critical appraisal 
Quantitative summary (meta-analysis) 
Usually evidence based 
Controversies exist over the use of an "all-inclusive" versus a "selective" approach in 
deciding which studies to include in the meta-analysis. Some authorities argue for inclusion 
of all identified studies, whereas others call for exclusion of methodologically-weak studies 
or qualitative ranking through the use of a scoring system, ie: weighting "good" versus "poor" 
studies. An inclusive approach is more likely to eliminate bias, but may also place undue 
reliance upon otherwise unreliable results. Another issue is that of analyses based on the 
published results versus the original data; the latter is less prone to bias and may also allow 
regrouping of the data, but is very resource intensive and requires the co-operation of all 




1.11.2. A systematic review and meta-analysis of dental implants in human patients. 
There are few examples of a systematic review in the field of Oral Implantology. Cochran 
(1999) considered the published results for human clinical trials using different types of 
dental implants.488 The author regrouped published mean survival rates into II smooth 11 , 
"rough" and "hydroxyapatite" implant surfaces and performed a meta-analysis using the Peto 
method. He documented considerable heterogeneity in the methods used to determine implant 
success - criteria for success were found in the literature, used in different combinations by 
different research groups. 
Cochran summarised implant success rates as rank orders ( eg: where success rates for rough 
were greater than smooth, these were presented as R>S: see table 7, p 1536). Odd ratios for 
success were also compared statistically. Results were re-grouped into five groups - implants 
placed into edentulous, removable overdenture, partially-edentulous, single tooth and 
"multiple indication" patient groups - and further subdivided into mandibular and maxillary 
sites. In some cases results from one study also appeared under a second heading. The results 
of Cochran's study are summarised in Table 1.16. 
Table 1.18: Summary of Cochran (1999)488 ; Meta-analysis of implant success rates m 
humans by implant surface.,_ 
Total Smooth implants 
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p < 0.001 p > 0.24 (NS) 
b. Rank order of success shown where R=rough, S=smooth and HA=hydroxyapatite surfaces 
c. OR = odds ratio 
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Cochran (1999) interpreted these results as showing that "rough surfaces had significantly 
higher success rates compared to implants with more smooth surfaces, except in the case of 
single tooth replacements where the success rates were comparable". He also noted that 
implants placed in the mandible had "significantly higher success rates than implants placed 
in the maxilla", except that for single tooth implants (both rough and smooth) mandibular and 
maxillary sites were equally successful; HA-coated implants were likewise equally successful 
in both arches. He concluded that "implants in general with rough surfaces offer significant 
advantages over implants with more smooth surfaces and that implants placed in the mandible 
generally have higher success rates than implants placed in the maxilla regardless of the 
implant surface" .488 
This paper was subsequently strongly criticised by several groups, all experts in the field.489-491 
The main points of contention were: 
1. Failure to list all available published reports - some important trials may have been 
missed. 
2. Inclusion and exclusion criteria were described as inadequate "filtering of the material". 
Particular problems were the failure to limit data to randomised, clinical trials, and the 
broad criteria for "success". 
3. Inappropriate re-grouping of data and inappropriate comparisons. 
4. Incorrect conclusions based on these groupings. 
Cochran (2000) responded to these criticisms by pointing out the lack of suitable RCTs for 
inclusion.814 He stated that he had chosen a deliberately "inclusive" approach so as to avoid 
accusations of bias; "if an advantage existed for rough implant surfaces (versus smooth 
surfaces), the more stringent and scientific approach was to be as inclusive as possible". 
1.11.3. Methodology for a systematic review and meta-analysis of dental implants. 
In a discussion of the role of systematic reviews and meta-analyses for the evaluation of oral 
implants, Esposito et al. (2001) divided the literature assessing implant treatment into three 
groups: (1) in vitro and animal studies (which they termed indirect evidence); (2) case reports, 
retrospective and prospective studies, and randomised controlled clinical trials (primary 
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clinical research); and (3) reviews, systematic reviews and meta-analysis (secondary clinical 
research).815 They listed animal evidence as the second lowest of nine levels of evidence. 
Systematic reviews of original patient data (as opposed to mean results) and of multiple 
RCTs, consituted levels one and two. 
The authors concluded that "well structured critical systematic reviews and meta-analyses 
based on properly designed RCTs can be considered the gold standard of clinical research". 
They noted that data from non-randomised or uncontrolled studies might also be combined 
meta-analytically (for which Cochran, 2000, had been criticised) however they warned that 
11 greater care is needed when interpreting the results, since these data are more likely to be 
biased" and further, that "studies involving weaker designs, in general, tend to overestimate 
treatment effects". However, it has been pointed out that bias may influence results in either 
direction, and is therefore equally likely to underestimate the treatment effect. 816 
Esposito et al.( 2001) subsequently published an analysis of the quality of RCTs for oral 
implants.57 Seventy-four RCTs were identified, but many had multiple publications. For 43 
original trials, the study design was independently assessed by 3 researchers using a 
standardised list of 7 criteria. Appropriateness of statistical analysis was assessed separately 
by a statistician. Randomization and concealment allocation procedures were not described in 
30 articles (70% ); reasons for withdrawals were not given in 10 reports (23%) and no attempt 
at blinding was reported in 31 studies (72%). These authors concluded that the quality of 
RCTs of oral implants is generally poor and needs to be improved. 
Similar problems have been reported in the control of bias by RCTs published in 
Prosthodontic Journals.817 It is apparent that, even for the most exacting study design, the 
randomised controlled clinical trial, there are problems with quality. A more inclusive 
approach may be necessary since exclusion of trials by quality might result in a major 
reduction in available data; as the quality of trials improves, the "exclusivity" of meta-
analyses might also be expected to increase. Moreover, non-randomised clinical trials must 
currently also be included; according to Dumbrigue et al. (1999), only 1.7% of studies 
published in the major Prosthodontic Journals during the last decade met the minimum 
standards necessary to be considered an RCT.818 
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Within the field of animal research, many of these criticisms might also apply. For this reason 
the current work used a relatively inclusive approach to the literature (see Experiment 4b), 
whilst reserving the possibility of a more exclusive review and meta-analysis at a future data. 
Such a review may require that two independent reviewers assess the eligibility of the studies, 
furthermore, a "quality scale" for the assessment of the papers may need to be developed.57 
1.11.4. Implant "success" and animal studies. 
Esposito et al (2001) commented on the difference between "true" and "surrogate" endpoints 
or outcome measures for the analysis of implant success in human trials and defined a true 
outcome measure as showing "unequivocal evidence of tangible benefits for the patient" 
whilst a surrogate outcome was defined as "a measure of a disease process" .57 Of the major 
"true" outcomes they listed, only three - presence of implants / prostheses, no peri-implant 
radiolucency, and implant stability testing - are useful for animal research. Some surrogate 
measures - marginal bone changes, bleeding, probing depths, plaque, GCF & microbiology -
have also been employed for animal research. 
In the current work, the prime outcome variables were % BIC and % density. Implant 
survival was not used as the prime outcome variable as this did not distinguish between failed 
implants (implants lost) and failing implants (implants still in situ but with little or no bone-
implant contact).815 However, the issue of whether failed implants should be assigned 11 0 11 for 
% BIC remains unresolved and was eventually not adopted in this work; although intuitively 
a failed implant should be assigned the "worst" score for osseointegration, at the same time 
this means ascribing a measurement to an implant that has not actually been measured. In the 
current work, the term "acceptability" was used to describe implants that survived and had 
histological evidence bone-implant contact that suggested that they could have been 
successfully loaded. 
1.11.5. A meta-analysis of dental implant surgical protocol in human patients. 
Boioli et al. (2001) have recently published another meta-analysis of dental implant literature, 
this time considering the effect of the submerged (two-stage) versus non-submerged (one-
stage) approach.819 The criteria were deliberately established so as to be as inclusive as 
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possible, although limited to root-analogue threaded (solid-screw) titanium implants. Rough 
and smooth surfaces were not evaluated independently. 
Data regarding both early-failure of unloaded implants and cumulative survival rates for 
loaded implants were extracted from the publications that were included. Of the eligible 
studies, 65 reported on submerged implants, 18 on non-submerged and four covered two-part 
systems placed using a one-stage approach - a total of 87 clinical studies with human 
subjects. 
Early failures were calculated from a total of 16626 submerged and 4716 non-submerged 
implants; life table analyses were performed for 13049 submerged and 5515 non-submerged 
implants. Instead of average values, 95% confidence intervals for the cumulative survival 
rates were used. The average failure rate for submerged implants before loading was 3.26% 
and for non-submerged implants was 1.6%. 
Cumulative survival rate after 9-10 years was 0.927 to 0.937 for submerged, and 0.858 to 
0.915 for non-submerged implants. Thus, the variability in survival for the non-submerged 
implants was markedly more than submerged, reflecting the heterogeneity of this sample and 
the smaller sample size. It should also be noted that a large part of the non-submerged sample 
consisted of one system with a roughened surface, and a large part of the submerged were 
smooth-surfaced implants from a different manufacturer. In general, it is apparent that the 
non-submerged approach reduced early failures and resulted in a lower but still acceptable 
survival rate. Non-submerged implants may establish better osseointegration initially, but loss 
of osseointegration may continue to appear for a longer period of time over the service life of 
the implant. 
1.11.6. A meta-analysis of dental implants in animal models of peri-implantitis. 
The importance of systematic review and meta-analysis of animal-based research has already 
been highlighted.68 To date only one systematic review has been conducted of dental implant 
research in animals, that of Baron et al. (2000) looking at experimental peri-implantitis in 
animal models.69 Their literature search was limited to English and German studies published 
in internationally reviewed journals that considered experimental ligature-induced peri-
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implantitis, where the resultant bone defect was measured intraoperatively or 
histomorphometrically after randomised sampling. 
Only 1/3 of studies met the criteria for statistical analysis. Correlation analysis of the 
relationship between length of ligation and resultant defect depth was the sole meta-analysis 
performed. Of 96 studies identified, 87 studies met the search criteria with 29 being 
experimental studies of peri-implantitis; 11 of these were analysed statistically. Generally 
there was no relationship between length of ligation and defect depth, although a weak 
association was found for cylindrical unthreaded implants. The authors suggested that 
smooth-surfaced threaded implants may be less susceptible to ligature-induced peri-
implantitis. Of the different treatment methods, GBR combined with DFDB grafting appeared 
to give the best results, although data was scanty and weak. 
1.11.7. Summary of meta-analysis of dental implants animal models. 
Systematic review and meta-analysis of the percent bone-implant contact and percent bone 
density/unit area found in different animal models of implantology has yet to be attempted. 
Results from such an analysis would provide a useful validation when establishing a new 
animal model for dental implantology. 
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1.12.1. Summary of literature review. 
Different aspects of bone healing can be studied in animal models. Intra-orally, osseous 
healing can be analysed at a basic level by analysing bone healing in defects of a critical size. 
Critical size defect healing in different animal species has been reviewed. The critical size of 
defects for the sheep mandible is unknown. 
The different animal models that exist for the analysis of dental implant healing have also 
been reviewed. The long-bones of sheep have been used to model the healing of metallic 
implants, however, very little work has been done on the use of the maxillofacial sites in the 
sheep. Although there are well-established intra-oral mandibular models for dental 
implantology in dogs, pigs and primates, this is not the case for sheep. However, the literature 
supports the contention that the sheep is a suitable animal species for both critical size defect 
and for intra-oral dental implant research. 
Different techniques are available studying implant osseointegration. Implant survival, 
histomorphometric analysis of bone-implant contact and bone density, and biomechnical 
analysis of resistance to push-out or unscrewing forces are the major outcome variables 
reported in the literature. Biomechanical and histomorphometric analyses are not always 
equivalent, but are generally mutually exclusive of use for any one specimen. 
There are an increasing variety of variable affecting implant osseointegration, including (but 
not limited to) roughened or bioactive implant surfaces, the use of bone grafts and growth 
factors, two-stage versus one-stage protocols and the effect of pre-existing periodontitis; as 
many of these variables as possible should be compared in a novel model. 
The effect of different surfaces is well established as a critical factor in the success of dental 
implants in animal models and human subjects; a new animal model should be compared and 
validated against results for these surfaces in other animal models. 
A systematic review and meta-analysis would be an appropriate method for summarising the 
results in other animal models, to enable comparison and validation of a sheep mandibular 
model for dental implantology. 
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Chapter 2. Materials and Methods. 
Part 1: Critical Size Defects (CSD) in Sheep. 
2.1.1. Anatomical Site. 
Sheep have no upper incisors. Instead, a fleshy upper dental pad occludes with both the lower 
incisors and a lingually-positioned lower dental pad. Distal to the lower canines is an 
edentulous diastema extending in a posterior direction for 2 - 3 cm and terminating at the first 
premolar tooth (Figures 2.1 & 2.2). The dimensions of this area are approximately 45mm 
antero-posteriorly by 10mm bucco-lingually by 20mm corono-apically (vertical height). A 
preliminary histological investigation found that this region of the mandible comprises a thin 
(3 - 5mm in width) but dense cortex of lamellar bone surrounding a sparsely-trabeculated 
marrow cavity which is haematogenous in young sheep but becomes progressively more 
adipocytic as the animal ages. A prominent neurovascular bundle is centrally located with the 
artery lying medially (Figure 2.3). Longitudinal sections through this region show that sparse 
trabeculae of bone are also present although mainly confined to the superior and inferior 
portion of the marrow cavity (Figure 2.4). The lateral (buccal) surface of this edentulous 
region of the mandible was used to investigate bone healing following the creation of a large 
circular defect in the cortical bone, with a view towards the future use of the same anatomical 
region for dental implantology. 
2.2.1. Experiment 1: 8mm CSD after 6, 8 and 12 weeks. 
Ethical consent (ABC 34-94) was obtained. Three Romney wethers aged 4 - 5 years were 
purchased through the Dept. of Laboratory Animal Sciences (DLAS) at the University of 
Otago. Each animal had been quarantined and treated for internal parasites. The sheep were 
starved overnight and general anaesthesia induced with Thiopentone 20mg/kg (i.v.) and 
maintained with Halothane and Nitrous oxide. The muzzle and lower jaw was shorn, 
scrubbed with Betadine® and isolated. Aseptic techniques and sterile instruments were used 
throughout the procedure. Oxytetracycline (lOmg/kg i.m.) was administered pre- and post-
operatively. 
Under general and local anaesthesia, a compound mucoso-muscular flap was raised on the 
lateral (buccal) surface of the mandibular diastema. The buccally-placed incision ran midway 
between the superior and inferior borders of the mandible, starting just mesial to the first 
premolar and finished 5mm distal to the mental foramen. After blunt dissection of buccinator 
muscle, the periosteum was retracted and the underlying buccal cortical plate exposed 
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(Figure 2.5). A shallow groove outlining the defect was created on the surface of the cortical 
bone using an 8mm-diameter stainless steel and diamond trephine bur (Australasian 
Diamond Tools, Hamilton, NZ) in a dental handpiece, irrigated with copious chilled saline. 
To reduce thermal injury to the bone and prevent trauma to the intraosseous marrow, cutting 
was completed using the same 8mm-diameter trephine bur at slow speed in an orthopaedic 
hand-drill. The buccal cortical plate was detached using an Oschenbein bone chisel and a 
mallet, leaving a circular defect within which a vascular endosteal lining was visible (Figures 
2.6 -2.7). A matching defect was created on the contralateral side of each animal, so that 
there were two defects per sheep. The mucoperiosteal flaps were replaced over the defects 
and sutured in layers with 3-0 Dexon resorbable sutures. 
The sheep were penned for 7 days post-operatively before returning to pasture at a nearby 
breeding station. All animals were monitored daily during the first post-operative week to 
evaluate masticatory function, and received demethylchlortetracycline i.m. (20mg/kg/day for 
4 days) and chlorhexidine rinses (0.2%, 10cc) delivered twice daily to the surgical sites using 
a drenching gun. Post-operative analgesics were not required. 
One sheep was sacrificed by an overdose of intravenous pentobarbitone after each of 6, 8 and 
12 weeks. Block dissections of the surgical sites and adjacent buccal tissues were fixed in 
10% buffered formalin and decalcified in formic acid. Each block ( except the left side block 
from sheep one) was divided on a bucco-lingual, vertical plane through the centre of the 
residual defect as determined radiographically (Figure 2.8), and paraffin-embedded. 
Specimens from sheep one (left side) was divided in a bucco-lingual, horizontal plane. 7µm 
sections were obtained from near the centre of the defect from all blocks and stained with 
either hematoxylin and eosin or a trichrome stain (either Gomori, Mallory or Masson). 
Mounted histological slides were viewed through a low-power binocular microscope with a 
digital video camera attached. The image was captured and analysed using public domain 
image analysis software (NIH Image 1.52) on a Macintosh 6100AV computer. The distance 
between the regenerated margins of the bony cavity was measured and subtracted from the 
original defect diameter and expressed as percentage defect closure. Statistical analysis was 
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Figures 2.1 to 2.8. 2.1: Sheep skull showing mandibular premolars (red) and diastema 
(yellow). 2.2: Diastema region: limited mouth opening and stomach tube hinder access. 
2.3: Histological cross-section of diastema region. H&E stain. 2.4: Longitudinal section of 
diastema. H&E stain.2.5. Flap mesial to Pl in diastema. 2.6: 8mm trephine drill, mallet & 
Oschenbein chisel. 2.7: Drilling 8mm CSD. 2.8: Radiograph of 8mm unicortical CSD. 
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2.2.2. Experiment 2a: 12 mm CSD after 16 weeks. 
Ethical approval was obtained (AEC No, 101-94). Four adult Romney wethers aged 4-5 years 
were used. The surgical site and protocol was as discussed above (see Figures 2.9 to 2.16), 
with the following modifications: (a) the flap ran along the superior border of the mandible; 
(b) the periosteum was excised and discarded ("split-thickness flap"); (c) the defects were 
12mm in diameter; (d) 2mm bur holes were drilled adjacent to the defect along a horizontal 
line bisecting the midline of the CSD and dental amalgam placed in these holes to act as 
radiographic markers (Figure 2.9); (e) the defects were created bilaterally but one 
defect/animal was covered with a membrane (see below); (f) the healing period was extended 
to 16 weeks; and (g) sufficient animals were thus used over the same time period to allow 
valid statistical analysis. 
After 16 weeks, the animals were anaesthetised, block sections obtained of the experimental 
sites and the animals killed by anaesthetic overdose. The sections were then radiographed at 
standard magnification before being fixed and decalcified using in formic acid. The blocks 
were processed and sectioned through the centre of the defect, utilising the radiographic 
markers for orientation. The sections were stained with H&E and scanned into Image 1.52. 
Histological and histometric analysis was carried out and the amount of bony healing in the 
centre of the defect was measured as described above. 
2.2.3. Experiment 2b: 12mm CSD covered with a non-porous Teflon membrane, after 16 
weeks. 
In the 4 sheep used for experiment 2, one of the bilateral defects in each animal was chosen 
at random for Guided Bone Regeneration. GoreTex Soft Tissue Patch (GTSTP) was trimmed 
to approximately 16mm diameter and positioned over the defect (Figures 2.10 to 2.12 & 
2.16). No fixation of the membrane was attempted. The contra-lateral defect in each animal 
served as control. The flaps were replaced and sutured with Dexon resorbable sutures and 
post-operative care performed as previously discussed. 
After 16 weeks, the animals were killed and histological preparation and measurements 
performed as above. Statistical analysis between GTSTP and the contralateral control was 




Figures 2.9 to 2.16. 2.9: Sheep skull showing 12mm defect in diastema with amalgam 
markers. 2.10: Gore Tex Soft Tissue Patch (GTSTP). 2.11: SEM Gore Tex Periodontal 
Membrane x 80.2.12: SEM GTSTP x 80. 2.13: 12mm defect in diatema. 2.14: Using 
Oschenbein chisel to elevate bone. 2.15: Final unicortical 12mm CSD with markers. 2.16: 
GTSTP in place over unicortical 12mm CSD. 
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2.2.4. Experiment 3: Chronic 12mm CSD with implanted polytetrafluoroethylene discs. 
This experiment was caITied out in two stages; a pilot investigation (University of Otago AEC 
# 91-95) and a main experiment (AEC # 101-97). Teflon discs 11mm in diameter were cut 
using a drill press from a 3mm thick sheet of solid poly-tetrafluoroethylene using diamond-
coated trephine burs. Two small central holes were cut in each disc to facilitate fixation of the 
button-shaped discs to bone (Figure 2.17). The discs were cleaned and autoclaved before use. 
2.2.5. Pilot experiment, chronic CSD. 
Two Romney-cross ewes aged 4 years were used. Flaps were raised in the edentulous 
mandibular diastema and 12mm diameter defects created as previously discussed. Teflon 
discs measuring 11mm diameter were placed into the defects and retained by suturing them 
with 3-0 teflon sutures (W.L. Gore and Associates, Flagstaff, Arizona, USA) to suITounding 
bone through 2mm-diameter holes drilled into the cortical bone adjacent to and 
approximating the midline of the defect on the horizontal plane. A total of four discs were 
fixed thus in two sheep. All animals were sacrificed after 3 months healing with discs in situ. 
Blocks of mandibular bone from the implantation site were removed, the presence of the discs 
was verified and the discs removed. 
2.2.6. Main experiment, chronic CSD. 
Nine Romney-cross ewes aged 3 - 4 years were used. The defects were prepared and the 
discs sutured as for the pilot experiment, with the following modifications: (1) diathermy was 
used to remove the endosteal lining of the maITow tissue exposed by defect preparation and 
(2) only in the first 3 sheep were the discs sutured (Group A). The discs in the remaining 6 
sheep were retained by transosseous wiring (Group B). The firmly-bound lingual mucosa 
was elevated from the superior crest of the diastema using Oschenbein chisels, two small bur 
holes were drilled in the lingual cortical plate and an intermaxillary fixation wire was 
threaded bucco-lingual through successively the lingual plate, the marrow space and the 
Teflon disc. The flap was closed in layers using resorbable sutures and the animals cared for 
postoperatively as discussed previously. 
After 3 months healing, the animals were anaesthetised again and the surgical site was re-
exposed using the same surgical protocol as previously. The presence or absence of the disc 
was recorded, the disc was removed and soft-tissue within the wound debrided, re-exposing 
the bony margins of the defect. Where the disc had been lost the same procedure was 
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followed. Where the disc was still present, small bur-holes were made adjacent to the edge of 
each defect and amalgam placed as a marker. The mucoperiosteal flaps were again closed in 
layers over the defects. Eight sheep were permitted to heal for a further 3 months (Groups A 
& B). One animal was allowed to heal for a further 6 months (Group C). The experiment is 
demonstrated in in Figures 2.17 - 2.27 and the protocol summarised diagrammatically in 
Figure 2.25. 
2.2.7. Perfusion protocol. 
Under inhalational general anaesthesia, gradually increasing to a terminal plane, the animal 
was placed in a supine position with the neck slightly over-extended. The strap muscles of 
the neck were blunt dissected bilaterally, the common carotid arteries were cannulated and 
ligated and the jugular veins transected. The animal's head was then perfused under pressure 
with lL heparinised saline followed by lL fresh, chilled 10% formalin, per side. (Figures 
2.28 to 2.30). The area of interest was then dissected free en bloc using a hand-saw. Block 
dissections were further fixed in 10% formalin. 
2.2.8. Analysis of chronic defect specimens. 
Specimens from the 6-month animal were demineralised in formic acid, paraffin-embedded, 
serially sectioned and stained. Blocks from Groups A and B were defleshed and dried. An 
unoperated site was included as a control. Images of the blocks were digitised at a 
standardised magnification using a JVC TK1281 colour video camera fitted to an Olympus 
binocular microscope and stored in a Macintosh 5300ce Powerbook personal computer using 
AdobePhotoshop® 3.05 software. The resulting PICT files were analysed using the program 
NIH Image 1.59 to measure the area of the residual defect. 
The vertical height of each defect was also measured apico-coronally at the widest point. The 
drying process caused the separation of cortical bone in the lingual and apico-buccal areas 
into two layers when compared with the control specimen. The cut surface of the block 
nearest the margin of each residual or healed defect was inspected and the width of bone 








Figures 2.17 to 2.24. 2.17: Teflon discs, 11mm diameter. 2.18: Drilling 12mm defect in 
sheep mandibular diastema. 2.19: Elevating bony disc. 2.20 Diathermic ablation of 
endosteal lining. 2.21: Teflon disc sutured in place (Group A). 2.22: Exfoliated disc. 2.23: 











D = 12 mm buccal defect 
0 
Teflon disc sutured 
Group A 
Teflon disc removed 























C = cortex; M = marrow 
Transcortical wire 
11 mm Teflon disc 
Teflon disc removed 
H = Bone hypoplasia 
Figure 2.25: Diagram showing protocol for CSD Experiment 3 (Main). Chronic 12mm 
CSD with implanted polytetrafluoroethylene discs. (Left) Antero-posterior view of surgery, 
placement of discs and removal after 3 months, insertion of amalgam markers and sacrifice 
after a further 3 months; (Right) Cross-sectional view through diastema region of sheep 
mandible showing unicortical defect, transosseous fixation of 11mm Teflon disc, and bone 















Figures 2.26 to 2.33. 2.26: teflon disc after 3 months healing. 2.27: Chronic CSD after disc 
has been removed and amalgam markers placed. 2.28. Perfusion. Bilateral exposure of 
carotid arteries and jugular veins. 2.29. Detail of carotid artery. 2.30. Catheterisation of 
carotid artery. 2.31. Inset (a) dried specimen (b) Diagram showing measurement of hyper-
plasia. 2.32. Dentply ScrewVent surgical kit and implant. 2.33. Large animal theatre. 
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Part 2: Dental Implants in sheep. 
2.3. Introduction & Surgical protocols. 
This section details the materials and methods used in a series of experiments investigating 
novel models for the study of dental implants using the lower jaws of domestic sheep. The 
overall strategy and approximate timeline is shown in Figure 2.34. A series of protocols were 
developed for (a) the placement of different implant systems (b) the extraction of sheep 
mandibular premolars to create an edentulous ridge (c) post-operative care of implanted sheep 
(d) histological preparation of the implant specimens including teeth and (e) 
histomorphometric analysis of the ground sections. These protocols are detailed in appendices 
1-6. 
All surgery, histological preparation and histomorphometric analysis was performed by the 
author of this work. Separate ethical approval was obtained from the Otago Animal Ethics 
Committee for each experiment. All experimental surgery was performed in sterile 
conditions in an operating theatre under general anaesthesia with additional local anaesthetic 
andpost-operative pain relief. 
Initially, implants were placed into the diastema region; the surgical site was then changed to 
utilise the posterior mandible. An atraumatic protocol for surgical removal of mandibular 
premolar teeth was developed, the teeth removed and the edentulous ridge allowed to heal for 
two to three months before placement of the implants. For subsequent implant experiments 
the implants were placed using the drills supplied by the manufacturer and generally 
conformed to the recommended surgical protocols with appropriate modifications for this 
animal model. Details of the drills used for each experiment are shown in Figure 2.35. 
Details of the implants used in these experiments are discussed in the Appendix and are 
shown below in Table 2.1 and Figures 2.45 and 2.46. 
Post-operative antibiotics were used. For one experiment, this included the use of tetracycline 
for fluorescent bone labelling. Chlorhexidine 0.2% acqueous solution was applied in the 
week immediately following surgery. Animals were killed by bilateral carotid cannulation 
and perfusion of the head and neck with chilled formalin as described in the previous section. 
173 
2.3.2. Histological protocol. 
Tissue blocks were further fixed in formalin, dehydrated and embedded in 
methylmethacrylate, cut into 200-S00µm thick sections, mounted on plexiglass slide, and 
ground to a final thickness of 80-lO0µm (summarised in Figure 2.36). All sections were cut 
in a bucco-lingual direction along the long axis of the implant, with the exception of control 
implants in the final experiment, where a single, central mesio-distal section was obtained as 
well as bucco-lingual sections from the same implant. 
Figures 2.37 and 2.38 summarise the histological protocol for simultaneous production of 
longitudinal (mesio-distal) and cross-sectional (bucco-lingual) ground sections of teeth and 
implants respectively. Slides were surface stained with one part MacNeal's tetrachrome820 
(methylene blue, azur II and methyl violet) followed by two parts toluidine blue.821 Details of 
the formulation of these stains are given in the Appendices. Through this work, this 
combined stain is abbreviated to toluidine blue or TB. In some cases, 0.05% basic fuschin in 
water was used as a counterstain (abbreviated to TB&F).314•400• 377 
2.3.3. Histomorphometry techniques. 
Two to three representative (most central) sections were chosen for analysis from each block. 
All implant ground-sections were measured over a single period of time using the same 
technique and equipment for each. Two parameters of osseointegration were measured: the 
percentage bone-to-implant contact (%BIC) and the percentage of bone within a defined area 
adjacent to the implant surface (%density). Two different techniques were used for each 
parameter: stereological measurement and computer-assisted direct histomorphometric 
analysis (HMA).384 
Stereology HMA was carried out using an optically superimposed eyepiece cycloidal grid 
with 100 intercept points in a 10 x 10 array (Figures 2.39 and 2.40).822' 823• 377 Percent BIC was 
measured at the bone-implant interface (line-intercept technique) within the "cortical 
passage" 366 as well as the whole perimeter of the implant. To estimate %density of the 
surrounding bone, the grid was repositioned with the vertical margin parallel to the implant-
bone interface, at a distance measuring twice the depth of the implant thread from the base of 
the thread. This area was measured from first to last bone-implant contact within the cortical 
passage to estimate the percent of mineralised bone within an area. This measured the density 
174 
of bone within a region commencing immediately outside the "mirror-outfold region"524 and 
extending laterally for approximately lO00µm. 410 
Buccal and lingual surfaces were measured separately. Results were expressed as the percent 
of horizontal lines that intercepted bone (% bone-implant contact, %BIC) for "Cortical BIC" 
and "Whole implant BIC" respectively and as the percent of points that intercepted bone 
within the adjacent cortical bone (%density). Stereological measurements are shown 
diagramatically in Figures 2.41 and 2.42. Percent bone density in healed tooth sockets 
(controls) and lost-implant sites were examined stereologically using the same methodology 
(Figure 2.43). 
Computer-assisted direct HMA was carried out using digitised images of the same ground 
sections that had been measured stereologically. The three best consecutive threads on both 
buccal and lingual surfaces within the cortical passage were identified for each section,386• 366 
the perimeter was mapped within each thread between thread crests, and the bone-to-implant 
contact measured using the image analysis program NIH Image Vl.6.2 (Research Services 
Branch, NIH, Bethesda, MD, USA).824' 526 Results were expressed as the percent of the thread 
interface contacting mineralised bone and designated "Best-3 BIC". Using the same digitised 
images, the percentage of the total area of bone enclosed within each thread that was 
composed of mineralised bone (%density) was described as "Best-3 density". Computer-
assisted direct HMA measurements are shown diagramatically in Figure 2.44. 
One investigator, the author, performed all measurements. Blinding and concealment was 
attempted for the implant sites (anterior versus posterior) in the first experiment, for the 
implant type and treatment in the second experiment, and for implant type in the third 
experiment; this was only partially successful, as many of the implant types and treatments 
were distinctive at low and high-power magnification. Replicate measurements were 
conducted for a random selection of sections to determine measurement error. Error due to 
section orientation317 was tested by cutting both mesio-distal and bucco-lingual specimens 
from a group of implants in experiment three and comparing the measurements (see Figure 
2.38). Stereological and computer-assisted estimations of %BIC were compared as partial 
versus whole implant analysis and buccal versus lingual data. Buccal and lingual 
measurements were then combined and results expressed as a single mean ± standard 
deviation for each group. 
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2.3.4. Statistical analysis. 
Statistical analyses were performed using SPSS software (SPSS Inc., Chicago, IL, USA). 
Non-parametric one-way analysis of variance (Kruskal Wallis test) was used to determine 
differences between groups,638• 400 individual comparisons between groups were performed 
using the non-parametric Mann-Whitney test638' 400• 825' 826 and paired comparisons of implants 
within the same animal were performed using the non-parametric Wilcoxon Signed Ranks 
test523• 387• 388• 524• 389• 409• 377 • Meta-analysis of the sheep implant experiments in the current 
investigation was performed using mixed-model random effects GLS regression.410• 536 
The experiments performed in this work are summarised in Tables 2.1 to 2.3. Implant 






















Time Aims and Objectives 
Line 
1994 • Obtain funding . 
• Develop animal surgery infrastructure . 
1995 • Complete CSD experiments 
• Develop sheep surgical protocol. 
• Develop implant placement protocol. 
1996 • Develop histological protocol. 
1997 
• Obtain representative implants from the major implant 
manufacturers. 
1998 • Study effect of different implant surfaces in sheep model. 
• Test alternative strategies: bioactive surfaces and 
substances. 
• Study the effect of other variables - placement protocol, 
1999 site, periodontal disease, histological orientation 
• Complete histological preparation 
2000 
• Develop histomorphometric protocols. 
2002 • Complete statistical analysis 
2003 
• Systematic review and meta-analysis 
• Validate model 
• Write up results 004 
Figure 2.34. Timeline for developing infrastructure and performing 

















Figure 2.35. Drills used for preparation of 
implant osteotomies in these experiments. 
a. Dentsply titanium nitride-coated intemal-
-ly irrigated stainless steel reusable spade 
drills, tap and counter-sink. 
b. SteriOss titanium-nitride-coated round 
and twist drill, spade drills, disposable 
2.7mm to 3.25mm guide drill, counter-
-bore and threadformer. 
c. 3i reusable stainless steel round bur, 2.0 
to 3.25 mm twist drills and pilot drill. 
d. Southern disposable 2.0mm twist drill, 
pilot drill and 3.07 mm twist drill. 
e. Nobel Biocare disposable drill kit, 3.15 
mm twist drill and tap. 
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f. Straumann ITI reusable pilot, 2.8 and 













Figure 2.36. Ground Section Protocol 
a. Specimens were embedded in 
plastic inside glass jars which 
were then fractured away from 
the acrylic blocks. 
b. Blocks trimmed prior to sawing. 
c. Varicut rotary sectioning saw 
from front and side views. 
d. Close-up view showing the 
trimmed block clamped in 
the saw and a thick section 
being cut with the diamond-
edged blade. 
e. Two views of the press used 
to mount the thick section to 
acrylic slides with cyanoacrylate 
glue. 
f. 1mm thick sections mounted on 
acrylic slides. 
g. Automated grinding machine 
used to reduce thick sections to 
120µm semi-thick sections. 
h. Rotary polishing machine 
used to reduce sections to 
50 - 80µm, followed by final 
polishing. 
i. Acrylic slide holder designed 
by author. 
j. Semi-thick sections were 
cleaned and etched in an 
ultrasonic bath before staining. 




Figure 2.37. Protocol for simultaneous cross-sectional and longitudinal ground sections 







a. Mandible sectioned en bloc 
and plastic-embedded 
b. Specimen sectioned in a longitud-
-inal orientation (mesio-distally). 
c. Single, 500 µm mid-sagittal M-D 
section removed, mounted on an 
acrylic slide, ground to 80µm 
thick, polished and stained. 
d. Separated blocks re-aligned and 
glued to an inter-positioned 
500µm-thick acrylic slide. 
e. Specimen sectioned in a buccal 
to lingual, cross-sectional 
orientation. 
f. Exhaustive serial bucco-lingual 
ground sections mounted, 





Figure 2.38. Protocol for simulatenous cross-sectional and longitudinal ground sections 






a. Mandible sectioned en bloc with 
implant in situ . 
b. Specimen sectioned in a buccal 
to lingual, cross-sectional 
orientation. 
c. Single, 500 µm mid-sagittal B-L 
section removed, mounted on an 
acrylic slide, ground to 80µm 
thick, polished and stained. 
d. Separated blocks re-aligned and 
glued to an inter-positioned 
500µm-thick acrylic slide. 
e. Specimen sectioned in a mesial 
to distal, longitudinally-sectioned 
orientation. 
f. Exhaustive serial mesio-distal 
ground sections mounted, 
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a. Cortical stereology 
% bone-imGlant 
contact (% IC) 
measured from first 
to last bone-implant 
contact within cortical 
passage. 
b. Stereology % density 
from first to last bone-
implant contact within 
cortical passage; 
d = 2x thread depth 
a 
b 
a. coronal socket margin 
b. apical socket margin 
c. mid-socket density: 
bone contacting grid in 
an area one grid wide x 
height a to b. 
d. density of adjacent 
cortical bone using the 
same technique. 
e. 1 o x 1 o cycloidal grid. 
m .. _ .... 
(SU -· 
II 




grid from first 
bone - implant 
contact to implant 
apex. 
a. Best 3 consecutive 
threads. 
b. %BIC: Bone-implant 
contact. 
c. %Density: % mineralised 
tissue within thread. 
d. Linear measurement of 
bone-implant contact 
(d,&d,). 
e. Linear measurement of 
total thread perimeter: 
e • d = b (pm'}. 
I. Delineation of perimeter 
from thread tip to Up. 
g. Bone wtthin thread. 
h. Area measurement of 
total thread area within 
lines h, & h2• 
i. Area measurement of 
non-mineralised spaces: 
2.44 h- i=g {pm'). 
2.46 
SV DS(ms) DS(tps) STEAi SIR{ms) SIL(rs) ITI 
(98)or(99) 
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Figures 2.39 to 2.46. 2.39: 100 point ocular grid. 2.40: Grid superimposed on ground section. 2.41: Stereology 
measurements within the cortical passage. (a) % bone-implant contact; (b) % density. 2.42: Stereological 
measurement of% bone-implant contact for the whole implant perimeter including marrow space. 2.43: Stereo-
-logical measurement of bone density within tooth socket and "lost-implant" sites. 2.44: Computer-assisted 
"Best-3-threads" measurement. (b) % bone-implant contact; (c) "within-threads"% density. 2.45. Implants 






Table 2.1: Details of implant types used in this work: 
Dentsply Screw Vent 
Dentsply Swede Vent 







Conical Mk II 
m Esthetic Plus 
Solid Screw 
Dentsply Implants, Machined 
Encino Ca. USA 














Southern Implants Sand-blasted acid-







Ivoclar (NZ) Ltd., Sand-blasted acid-
Auckland, NZ. etched 
1. Length below implant shoulder in mm 
2
· Width at implant shoulder in mm 
3
· Width mid-implant in mm 
4
· Experiment that implant was used in 
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Table 2.2. Summary of CSD and Implant experiments in this work: 
..  Defect size or Implant type No.of ... - No. Length of '"-"" Comments .... ,.,.... ..... 
No -~ fixtures Sheep healing 
Critical Size defects 
.., 1 34-94 8mm bilateral defect 3 6,8,12 Paraffin sections 
weeks Diastema site 
2a 101-94 12mm unilateral defect 4 16weeks Paraffin sections 
• 2b Goretex membrane over 12mm Diastema site 
unilateral defect 
3 91-95 Pilot study 11mm Teflon discs 2 3 months Paraffin sections (2) 
• bilaterally Dried skull prep (9) 
101-97 Main study 11 mm Teflon discs 9 6 mo1 (8) Diastema site 
bilaterally 9 mo_(l) 
• Implants 
Pilot 91 -95 Spectra-system Screw-Vent 12 6 3 mo (2) Paraffin sections 
,. machined titanium surface, 3.75 2,7,14, 28 Diastema site 
X 13mm days (1 ea) 
la 60-96 Dentsply Swede-Vent machined 16 8 3mo Ground section 
• titanium surface 15 x 3.75mm Extraction ridge site. 
Extraction socket as 
control on left side 
• lb 60-96 Dentsply Swede-Vent machined 6 3 6mo, Ground section titanium surface 15 x 3.75mm 2 &7 Extraction ridge site. 
days (1 ea) 
2 101-97 Dentsply Swede Vent TPS 27 9 2.5 mo (2) Use of TGFB graft 
surface 15 x 4.0mm 9 3 mo (7) Use of bone grafts 
.. Sterioss hydroxyapatite-plasma Ground sections 
sprayed surface 14mm x 3.8mm Extraction ridge site. 
3a 101-98 Dentsply Swede Vent TPS 16 16 3 mo 16 sheep for expt 4 .. surface 15 x 4.0mm 16 (submerged) and expt 
Southern Implants machined- 16 5 (one stage). 
titanium surface, 13 x 3.7 mm. 8 sheep with 
" 
3b Southern Implants SLA surface, 16 periodontal disease 
13 x 3.7 mm. 16 Ground sections '. 
\, 
Nobel Biocare Conical type II, 
machined surface, 15 x 3.7mm 
ITI Esthetic plus solid screw 
SLA surface 13.5 x 4.0mm .. 
4a NIA Meta-analysis of sheep implant 150 42 Meta-analysis of 
experiments results 
4b Meta-analysis of animal implant Results of systematic .. 
literature review 































2.4. Pilot study. Placement of Dentsply ScrewVent implants in the sheep 
diastema. 
The aim of this pilot study was two-fold: to investigate the suitability of the sheep mandibular 
diastema region for dental implant placement and to establish an appropriate surgical 
protocol. The hypothesis tested was "that the diastema region in sheep is suitable for the 
placement of dental implants" . 
The experimental site investigated in this experiment was the edentulous diastema region, 
based on the experience gained during the CSD experiments. Ethical approval (AEC 91-95) 
was obtained from the University of Otago Animal Ethics Committee. Six mature adult 
Romney-cross ewes aged four to five years were purchased through the Department of 
Laboratory Animal Sciences (DLAS) at the University of Otago. On~ Spectra-system Screw-
Vent titanium implant, 3.75 x 13 mm in size was placed according to the surgical protocols 
into the diastema on each side of the sheep (Figures 2.32 - 2.33 and 2.47 - 2.49) . 
The first two sheep were killed after three months healing and the subsequent four animals 
were sacrificed after two, seven, 14, and 28 days. Perfusion and fixation followed the 
protocol detailed in the appendices. Spade drills were used for the animals with healing times 
of 2 weeks, 1 and 3 months; twist drills were used for the 7 and 2 days-healing animals 
(Figures 2.35 a & c). After fixation, the mandibular blocks were radiographed and sectioned 
buccolingually to allow careful removal of the fixture (Figures 2.50 & 2.51).827 Mesial and 
distal segments were decalcified in formic acid or EDTA +/- daily microwaving for 5 min@ 
50°C, and then paraffin-embedded. 5-7 µm sections were stained with H&E, Masson' s 














Figures 2.47 to 2.54. 2.47: Osteotomy preparation for ScrewVent implant in diastema. 2.48: (a) Tapping site 
(b) Placing ScrewVent implant. 2.49: Implant placed. 2.50. (a) Post-mortem radiograph of implant anterior to 
first premolar; (b) radio graph showing limited vertical height of diastema site in some sheep. 2.51. Post-
-mortem: specimen split before removal of implant and demineralisation. 2.52. Extraction protocol: removal 
of 1st premolar. 2.53: Vertical sectioning and elevation of 2nd and 3rd premolars. 2.54. Edentulous ridge closed 
using resorbable sutures. 
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2.5. Experiment 1: Placement of Dentsply Swede Vent machined surface 
implants into the post-extraction mandible of the sheep. 
The aim of this study was to investigate the suitability of the post-extraction mandibular ridge 
in sheep for dental implant placement, to establish surgical and histological protocols for this 
model, to generate baseline histomorphometric data for machined-surface dental implants in 
this model, to study the effect of variations in healing time and surgical site on implant 
healing and to compare peri-implant osseous healing with the healing of tooth extraction 
sockets. The hypothesis tested was the post-extraction sheep mandible is a suitable model for 
the placement of dental implants. 
2.5.2. Pre-surgical anatomical study. 
The second experimental site investigated in sheep was the post-extraction mandibular 
premolar region. For placing implants, the anatomical dimensions of the mandibular premolar 
region were investigated using a combination of defleshed, demineralised paraffin-embedded 
and undemineralised plastic-embedded sheep's mandibles. Following this, a protocol was 
developed for the extraction of sheep mandibular premolar teeth to create a healed, 
edentulous ridge. Plastic-embedded specimens of premolar teeth and of the edentulous 
diastema region were prepared as follows. 
Sheep mandibles were obtained from perfused animals and embedded as described above 
(Figure 2.36). An initial antero-posterior mid-sagital section (approximately 1.0mm thick) 
was cut so to include all three premolars and the edentulous diastema. The resin-embedded 
buccal and lingual portions of this block were then re-apposed using cyanoacrylate adhesive, 
but with an intervening l.0mm-thick sheet of clear acrylic replacing the missing "slice" of 
tissue. The block was then re-oriented and a series of step-serial bucco-lingual 200 to 500 
µm-thick sections were cut, ground and polished as discussed above. Simultaneous analyses 
of bucco-lingual (cross-sectional) and mesio-distal (longitudinal) sections were then merged 
to give a 3-dimensional anatomical picture of the intended implant site (Figure 2.37). 
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2.5.3. Main study - Dentsply Swede Vent machined surface implants. 
Ethical approval was obtained (AEC # 60-96). Eight Romney-cross ewes aged between three 
and four years were selected from the University Research Farm. Premolar teeth were 
extracted, as described in the Appendix and shown in Figures 2.52 - 2.54. After three months 
healing, two Dentsply Swede-Vent machined surface titanium implants with dimensions 15 x 
4.0mm diameter were placed into the right mandibular quadrant without bicortical fixation, 
and allowed to integrate for three months. (Figure 2.55 and 2.56). At the same time, the left 
mandibular premolars were extracted. Animals were killed after three months healing and 
jaws processed for histomorphometric analysis. Three additional sheep were used to examine 
short-term and long-term healing (experiment lb). In one animal the paired implants were 
allowed to integrate for six months; for the other two animals, the healing periods were two 
days and seven days respectively. 
2.5.4. Histomorphometric analysis (HMA). 
Initial HMA analysis was performed at low magnification. Images of the most central section 
from each implant were digitised at 0.65 times magnification via a JVC TK1281 colour video 
camera (Victor, Japan) fitted to a low-power Olympus SZ40 binocular microscope (Olympus, 
Japan) and captured as PICT files using AdobePhotoshop® 3.05 software (Adobe Systems 
Inc., USA). on a Macintosh 5300ce Powerbook personal computer (Apple Computers, 
Cupertino, Ca, USA). Mesially- and distally-placed implants were analysed as a single group. 
Analysis was performed using the public-domain software NIH Image 1.59 (NIH, USA) at a 
final on-screen magnification of 7 times and expressed as a percentage of the total fixture 
perimeter (described at "Original S2 BIC"), percent titanium-to-implant contact within the 
three best threads buccally and lingually within the cortical passage ("Original B3 BIC") and 
area occupied by bone as a percentage of the total area enclosed within the three best threads 
of the cortical passage bucally and lingually ("Original B3 Density"). Subsequently these 
sections were re-analysed at high magnification using the protocol described above and in the 
Appendix. Mesially- and distally-placed implants (ie: anterior and posterior) were measured 








Figures 2.55 to 2.62. 2.55: insertion of paired Dentsply Swede Vent machined-surface implants into healed 
mandibular extraction ridge. 2.56: Post-mortem radiographs of (a) DS implant in situ; (b) extraction socket 
on contralateral side. 2.57: Bone trap for harvesting autogenous bone graft (a) dissasembled (b) assembled. 
2.58: Insertion of Southern Implants (rough surface). 2.59: (left to right) Branemark, Southern Implants 
(machined) and Dentsply Swede Vent (tps) in situ. 2.60: (left to right) Southern Implants (rough) and ITI 
implant in situ. 2.61: Intra-oral radiograph of Figure 2.59, fixed to implant head. 2.62: Radiograph of 2.60 
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2.6. Experiment 2: Comparison of Dentsply Swede Vent TPS-surface 
implants, SteriOss hydroxyapatite-surface implants, and TPS implants 
with bone grafts and TGFB. 
The aim of this study was to compare the osseointegration of dental implants where different 
techniques have been used to enhance bone-implant contact. These techniques included a 
roughened implant surface (titanium plasma-spray, TPS); a bioactive implant surgace 
(hydroxyapatite-coated, HA); the use of implacted autogenous bone grafts and the use of 
bone-grafts combined with transforming growth factor-B in a collagen carrier. 
In addition to considering the amount of bone-implant contact, an secondary aim was to 
examine the rate of osseous healing around dental implants. The hypotheses tested were that 
TPS surfaces result in greater osseointegration than found in the previous experiment using 
machined surfaces and that HA-coating, bone-grafting and bone-grafting with added growth 
factor result in further gains in bone-implant contact and/or bone density. The hypothesis 
tested was that the mineral apposition rate around dental implants in the sheep mandibular 
rmodel would be similar to that found in other animal models. 
2.6.2. Experiment 2: Protocol. 
Ethical approval was obtained (AEC # 101-97). Nine Romney-cross ewes aged between three 
and four years were selected from the University Research Farm. An edentulous ridge was 
prepared with the healing period reduced from three to two months. Four implants were 
placed into each animal, two on each side with each sheep receiving one of each of the 
implant treatments listed in Table 2.4. Implants were placed in accordance with a Latin 
Square design to ensure that all four sites (left anterior, left posterior, right anterior and right 
posterior) received each of the implant treatment at least twice (Table 2.5). After placement 
the identity of each implant treatment was masked until the histomorphometric analysis was 
completed. 
2.6.3. Experiment 2: preparation of bone graft. 
For the autogenous bone graft, an Osseous Coagulum Trap (Salvin Dental Specialties, Inc. 
Charlotte, NC USA) placed in series with the high-volume suction tip was used to harvest 
bone chips from each of the osteotomy sites during preparation (Figure 2.57). Bone was 
mixed with collagen carrier material and packed into the osteotomy site before placement of 
the implant at low revolutions as previously detailed. The collagen carrier material was 
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prepared prior to surgery using sterile containers under aseptic conditions by vortexing 4ml of 
5mM HCl (3.9ml distilled water+ 0.1ml 2M HCl) with 3.6 mg dried typel rat tail collagen 
(Sigma C7661). 200µ1 of this collagen carrier was combined with 100µ15mM HCl and 200µ1 
sterile saline and frozen at -20°C in sterile eppendorf tubes. One tube per sheep was thawed 
in theatre at room temperature and mixed with autogenous bone graft. 
2.6.4. Experiment 2: preparation of growth factor. 
The combined growth factor plus autogenous bone plus collagen carrier graft was prepared as 
follows. Recombinant simian transforming growth factor-beta one (rsTGFBl) had been 
previously supplied by Bristol-Myers Squibb (Lot 11/MPO4, BMS Pharmaceutical Research 
Institute, Seattle, WA, USA) for use in a project involving periodontal regeneration in a sheep 
model213 and was made available as a 1.0mg/ml solution suspended in 5mM HCL 200µ1 of 
type 1 rat-tail collagen carrier, prepared as before, was then combined with 100µ1 TGFBI and 
200µ1 sterile saline and frozen at -20°C in sterile eppendorf tubes. Final TGF-Bl 
concentration was 0.2mg/ml (200µg/ml). One tube per animal was thawed in theatre at room 
temperature and mixed with autogenous bone graft. 
2.6.5. Experiment 2: fluorescent bone labelling. 
Fluorescent bone labeling was performed at implant placement and 62 days later. The first 
label consisted of oxytetracycline delivered over four days, starting the day before implant 
surgery (l0mg/kg i.m.) followed by 15mg/kg as 3% solution by slow intravenous infusion 
during surgery and lOmg/kg i.m. for two days post-operatively. The second bone label 
consisted of Alizarin red diluted in NaCl and delivered by slow infusion under general 
anaesthetic. The initial concentration for Alizarin red was 2g 1100ml (0.2%) at 30 mg/kg. At 
this dosage rate the second sheep developed tetanic contractions. For this reason the solution 
was adjusted for the subsequent animals, the pH being modified from 5.0 to a neutral pH and 
the dosage levels changed to 25mg/kg. 
The first two sheep were killed shortly after the second label (at 9.5 weeks) and the remaining 
seven were perfused after 12 weeks. The timeline for this experiment is shown in Figure 2.74. 
Statistical comparisons were made between the different implant treatments for %BIC and 
%density for the 12 weeks healing group. 
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2.6.6. Experiment 2: Analysis. 
Tissue blocks were excised and processed for histomorphometric analysis. In addition to 
%BIC and % bone density, the appositional rate of bone was determined for the. 62 days 
interlabel period as follows. The best three consecutive threads on the buccal and on the 
lingual surface were digitised .. The same three consecutive threads on each side were then 
illuminated using a Nikon super-high pressure mercury lamp ((Meridian Instrument Co., 
South Kent, WA, USA) with B-2EIC FITC lens (excitation range 465-495nm) or g-2E1C Tx 
Red lens (range 540-580nm) at the same magnification. Exposures were increased 1.3 to 2.0 
times to ensure adequate fluorescence and images were digitised, saved, transferred and 
analysed using NIH Image. 
Labeled bone mostly appeared as circular coloured rings around the Haversian systems. The 
distance between the two fluorescent labels (inter-label distance) was measured at four sites 
spaced around the circumference of each Haversian system, corresponding to the 3, 6, 9 and 
12 o'clock positions. Measurements adjacent to each of the selected threads were made in 
three locations, corresponding to zones within the thread, <lOOOµm from the thread base and 
>2000µm from the implant surface (Figures 2.63 - 2.65). Mean inter-label distance (µm) for 
each zone was then divided by the 62-day inter-label period to determine the mineralisation 
apposition rate (MAR) in µm/day. Comparisons were made between the different implant 








Table 2.4. Types of implants placed in Experiment Two: 
Type ·oetaiis Abbrev~ , 
Test 1 TPS implant Dentsply Swede Vent TPS surface DS (TPS)(98) 
Test 2 TPS Implant + Dentsply Swede Vent TPS surface+ rsTGFBl + DS (TGB) 
growth factor bone graft + collagen carrier 
. Negative control TPS Implant + Dentsply Swede Vent TPS surface+ bone graft DS (Con) 
bone graft + collagen carrier 
. Positive control HA implant SteriOss hydroxyapatite-coated surface Steri 
Table 2.5. Latin-square matrix used to ensure all four implant treatments were equally 
distributed through the four potential surgical sites. 
Sheep no. . . -- Left anterior . Left posterior 
661 17.2.98 Dsa DS +BGb 
662 17.2.98 Steri-Oss HA DS 
660 18.2.98 DS +TGF-B Steri-Oss HA 
664 18.2.98 DS +BG DS +TGF-B 
666 19.2.98 DS DS +BG 
675 20.2.98 Steri-Oss HA DS 
665 19.2.98 DS + TGF-B Steri-Oss HA 
671 20.2.98 DS +BG DS +TGF-B 
670 20.2.98 DS DS +BG 
a DS = Dentsply implant with titanium plasma-sprayed surface 
b BG = Bone graft only 
0 TGF-B = growth factor plus bone graft 
ct HA = SteriOss implant with hydroxyapatite surface 
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Right anterior Right posterior 
DS +TGF-B C Steri-Oss HA ct 
DS + BG DS + TGF-B 
DS DS +BG 
Steri-Oss HA DS 
DS +TGF-B Steri-Oss HA 
DS +BG DS + TGF-B 
DS DS +BG 
Steri-Oss HA DS 
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Figure 2.63. Ground section from 
Experiment 2 at 4x magnification, 
demonstrating the three zones in 
which distance between fluorescent 
labels was measured to determine 
appositional bone rate. A:"within-
threads"; B: "adjacent" bone within 
an area extending from the tips of 
the implant threads to a distance of 
1 000µm from the thread bases; C: 
osteons labelled at a distance of 
> 2000µm from the thread bases. 
(Toluidine blue & acid fuschin) 
Figure 2.64. Fluorescent photo-
graph of the ground section shown 
above, demonstrating osteons 
located in the three zones. The light 
blue line (far left) demarcates the 
implant surface. Yellow/green fluo-
rescent lines have been labelled 
with oxytetracycline and red lines 
labelled with Alizarin red . 
Figure 2.65. View at higher 
magnification of labelled osteons 
within the three zones (x 20). 
A: "within-threads"; B: "adjacent" 
bone < lO00µm; C: "distant" bone 
~ 2000µm. D: Line diagram 
showing measurement of interlabel 
distances at four points around the 
circumference of an osteon. 
o n 
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2. 7. Experiment 3a: Comparison of Dentsply TPS-surface implants and 
Southern Implants machined surface and SLA-surface implants in 
periodontally healthy and diseased animals. 
The aim of this study was to compare the osseointegration of dental implants with different 
rough surfaces (TPS or blasted and acid-conditioned) or a machined-surface, placed into 
sheep with or without pre-exisiting periodontitis. The hypotheses tested were that the blasted, 
acid-conditioned surface resulted in greater osseointegration than either TPS or machined 
surfaces, and that the presence of active periodontitis reduces the integration of submerged 
implants. 
2.7.2. Experiment 3a: Protocol. 
Ethical approval was obtained (AEC # 101-98). Sixteen Romney-cross ewes aged between 
three and four years were selected, eight animals from a farm with no history of endemic 
spontaneous "broken-mouth" periodontitis and eight from a different farm where periodontitis 
was highly prevalent. Animals were included in the PDS group if they were missing one or 
more missing incisor. All animals were quarantined and quartered on the University Research 
Farm throughout the experiment. 
An edentulous ridge was prepared with a healing period of two months. Three implants were 
placed into each animal (Figures 2.58 - 2.60) as previously described. Southern Implants 
rough-surfaced (SIR) implant was always placed on the right and the Southern Implants 
machined-surface (SIL) was always placed on the left side of the mandible. One Dentsply 
TPS-surface implant (DS (99)) was placed on either the left or right side, anterior to a 
Southern Implants screw. Selection of left or right side depended on the anatomy of the site, 
in particular the vertical and horizontal quantity of bone present anterior to SIR/SIL and the 
location of the mental nerve foramen. Implant types and locations used in this experiment are 
shown in Table 2.6. Distribution of DS (99) implants by side is shown in Table 2.7. 
The animals received a second general anaesthetic, one month after installation of the 
implants, for clinical, radiographic, biomechancal and microbiological measurements; these 
measurements will not be discussed further in the present work (Figures 2.61 & 2.62). All 
sheep were perfused after a total of 12 weeks integration. The timeline for this experiment is 
shown at Figure 2.74. Tissue blocks were excised and processed and %BIC and %bone 
density determined using histomorphometric analysis as discussed previously. Comparisons 
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were made between the different implant surfaces and between periodontally healthy (HS) 
and diseased (PDS) sheep (Figures 2.68 & 2.69). 
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Table 2.6. Types of implants placed in Experiment Three (a). 
Test 1 Blasted & etched Southern Implants rough surface, right 
surface posterior 
Negative Machined surf ace Southern Implants machined surface, left 
control posterior 
Positive TPS surface Dentsply Swede Vent TPS surface, left or 
control right anterior 













2.8. Experiment 3b: Comparison of Nobel BioCare machined-surface and 
ITI Straumann SLA-surface transgingival implants placed using a one-
stage protocol in periodontally healthy and diseased animals 
The aim of this study was to compare the osseointegration of one-piece dental implants with a 
machined surface or a rough (sand-blasted, acid-etched; SLA) surface placed using a one-
stage transgingival protocol into into sheep with or without pre-exisiting periodontitis. The 
hypotheses tested were that implants could be placed using a one-stage protocol into this 
animal model with a similar osseous response as found with submerged (two-stage) implants, 
that the SLA surface would result in greater osseointegration than the machined surface, and 
that the presence of active periodontitis would reduce the integration of non-submerged 
implants. 
2.8.2. Experiment 3b: Protocol. 
This experiment used the same animals as above. One-stage implants were placed into each 
animal at the same time as the two-stage implants in experiment 3a. ITI SLA implants were 
placed transgingivally on the left and Branemark Mkll machined-surface inplants on the right 
(Table 2.8). The implants were processed for histology after 12 weeks healing as previously 
described. Multiple comparisons were made between the one-stage implants, between non-
submerged and submerged implants (3a versus 3b) and between implants in periodontally 
healthy (HS) and diseased (PDS) sheep. Details of the surgery is shown in Figures 2.58 -
2.62. The theatre set-up and surgical kits used for experiments 3a and 3b are shown in Figures 
2.67 and 2.68. The protocol for experiments 3a and 3b is shown in Figures 2.74 and 2.75. 
Table 2.8. Types of implants placed in Experiment Three (b ). 
Testl 
Test2 
SLA surface ITI Straumann SLA surface, left posterior 











Subtractive technique (grit blast/ acid etch) 
b = diameter of pits in (i) ITI SLA and (ii) SIL (rs) 
Additive technique (plasma-sprayed) 
a = diameter of (i) TPS & (ii) HA globules 
Machined surface implants 
c = intervals between grooves for 
(i) Branemark NBC and (ii) SIR (ms) 
Figures 2.66 to 2.73. 2.66: Large animal theatre. 2.67: Multiple implant surgical kits for 
Experiments 3a&b. 2.68: Transgingival implants in periodontally-diseased sheep; (a) NBC; 
(b) ITI imlant. 2.69: Healthy sheep; (a) NBC; (b) ITI implant. 2.70; Evaluation of implant 
geometry from SEMs. 2.71: SEM surface evaluation of TPS and HA-coated implants. 2.72: 
SEMs of blasted and etched implant surfaces. 2.73: SEMs of machined-surface implants. 
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2.9. Experiment 4(A): Meta-analysis of implants in sheep (results of 
Experiments 1-3) 
The aim of this experiment was to compare the results of the three sheep implant experiments 
described in this work with each other. The hypothesis tested was that the sheep mandibular 
model successfully distinguishes between implant surfaces. 
2.9.2. Scanning electron micrographic comparison of implant surfaces: 
For comparative purposes, scanning electron micrographs were made of the implants used in 
this investigation at 100 x magnification and 125,000 x magnification. Representative 
ScrewVent and SteriOss HA-coated implants were sputter-coated in gold; the remainder were 
mounted on stubs and scanned directly without sputter-coating. Micrographs were digitised 
and analysed using NIHimage as described below. 
The implants could be grouped into three groups: 
2. machined-surface implants demonstrating a planar surface with regular striations from 
machine tooling; 
3. plasma-sprayed surfaces where globules of the additive had been partially fused and 
melted onto the planar surface of the implant; 
4. grit-blasted and acid treated surfaces where the planar implant surface exhibited either 
irregular craters and/or regular circular pitting. 
The machined-surface implants used in investigating the sheep mandibular model were 
Branemark Mark II, Dentsply Swede Vent and Southern Implants. The implants treated by 
additive technologies were the Dentsply TPS and SteriOss HA - in the former, titanium beads 
were sintered onto the implant surface and in the latter, hydroxyapatite. Implants treated by a 
subtractive technology were Southern Implants (rs) and Straumann ITI SLA. 
For SEMs taken at 1 00x magnification, the angle of the thread wall to the base of the thread 
(the thread "flat"), the width of the cutting edge of the thread and the dimensions of the thread 
"flat" and the interpeak distance were established. A diagram illustrating the measurements is 
shown in Figure 2.70. 
For SEMs taken at x 1.25K magnification, ten measurements made at three different 
randomly-selected locations, of the following implant surface features: 
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I, 
a. Plasma-sprayed surfaces: diameters of unfused or partly-fused globules (Figure 2.71); 
b. Blasted/eroded surfaces: diameters of pits (Figure 2.72); 
c. Machined surface implants: distances between groups of vertical lines representing the 
grooves from machine finishing; for SI ms, distances between major and minor lines 
measured (Figure 2.73). 
2.9.3. Comparison of histomorphometric analyses for implants in the sheep mandible 
(Experiments 1-3) - Analysis by year of experiment 
The effect of surgeon experience and/or protocol refinement was examined by merging the 
clinical data (survival and success rates) and histomorphometric data(% BIC and % density) 
, into mean figures for each year in which implant experiments were performed. Results were 
categorised by year of experiment as follows: 
(1) "Year 1" (1997): anteriorly- and posteriorly-positioned Dentsply machined-surface 
implants in Experiment 1 (the short-term and the six-month implants were not 
included), 
(2) "Year 2" (1998): SteriOss, Dentsply TPS-surface, Dentsply plus TGFB and Dentsply 
plus Bone graft implants in Experiment 2 (both the 9 .5 week and 12 week implants 
were included), 
(3) "Year 3" (1999): Dentsply TPS-surface implants (measured twice, both bucco-
lingually and mesio-distally), and the rough & smooth-surfaced Southern Implants in 
Experiment 3a, as well as the ITI Straumann and Nobel Biocare implants in 
Experiment 3b. The healthy and periodontally-diseased subgroups were combined. 
2.9.4. Rank order for implants in the sheep mandible (Experiments 1-3). 
Mean results for % BIC and % density (cortical stereology and best-3-threads) were 
assembled in rank order and presented graphically. The relationship between the two 
measures of bone-implant contact within the cortical passage (stereology and best-3-threads) 
and the correlation between bone-implant contact and bone density (within-threads or 
outside-threads) was considered statisitically using non-parametric statistical analysis. 
2.9.5. Regression analysis for implants in the sheep mandible (Experiments 1-3). 
Overall statistical analysis of the effects of different variables upon the sheep mandibular 
animal model for dental implantology was performed by loading all data for bone-implant 
contact and bone density for all implant experiments into the program STAT A for Macintosh, 
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version 8 (StataCorp LP, Texas, USA). Statistical comparisons were made using a random 
effects Generalised Least Squares (GLS) regression model that considered the effect of 
operator experience (defined by the year the experiment took place), implant type, implant 
site/position, buccal versus lingual measurements, and the type of measurement technique 
(stereological -whole or partial- or computer-assisted lineal measurement) upon the primary 
output variables percent bone-implant contact and percent bone-density. Variables listed in 
this model are shown in Table 2.9. 
2.9.6. Grouping of results for comparison with other animal models. 
Mean results for implants from the current work were re-grouped into "smooth", "rough" and 
"ceramic" surfaces for comparison with the results of the systematic review of other animal 
implant models (see 2.10, below). 
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Table 2.9. Nested variables categorised and described for each implant in each animal over 















Positfon Anterior =J. 
Middle.= 2 Posterior ;3 
Side Left =O Right 2::1 








Sheep ear tag number. 
Different implant types: 
DS(ms) = Dentsply machined surface. 
Steri = SteriOss HA surface 
DS(tps'98) = Dentsply, TPS surface, 1998 experiment 
DS(TGF) = Dentsply TPS surface with Transforming Growth Factor B 
DS(BG) = Dentsply TPS surface with bone graft 
DS(tps b-1 '99) = Denstply TPS surface, 1999 experiment, sections cut in bucco-lingual 
orientation 
DS(tps m-d'99) = Denstply TPS surface, 1999 experiment, sections cut from implants as above 
but in mesio-distal orientation 
SI(rs)= Southern Implants, rough surface 
SI(ms)=Southem Implants, machined surface 
ITI= Straumann / International Team for lmplantology implants; rough (SLA) surface 
NBC=Nobel Biocare (Branemark) implants, machined surface 
HS = healthy sheep, PDS = periodontally-diseased sheep 
Position in jaw: Anterior (or mesial) Middle (1999 only) Posterior (or distal) 
Side of jaw 
Year experiment was conducted. Each experiment a discrete group of sheep & implants. 
Number of weeks healing. In most cases, this was 12 weeks; a very small number of animals 
during 1998 experiment healed for 9.5 weeks. 
Bone to implant contact, buccal side of implant, stereological measurement, cortical passage 
(upper part of implant within bone) only 
Bone to implant contact, lingual side of implant, stereological measurement, cortical passage 
(upper part of implant within bone) only 
Bone to implant contact, mean of buccal and lingual, stereological measurement, cortical 
passage (upper part of implant within bone) only 
Bone to implant contact, buccal side of implant, stereological measurement, whole implant 
(all of implant) 
Bone to implant contact, lingual side of implant, stereological measurement, whole implant 
(all of implant) 
BICALLS2 Bone to implant contact, mean of buccal and lingual, stereological measurement, whole 
implant (all of implant) 
BICbucB3 Bone to implant contact, buccal side of implant, best three threads only, high-power 
computer-assisted measurement 
BIClngB3 Bone to implant contact, lingual side of implant, best three threads only, high-power 
computer-assisted measurement 
BICB3ALL Bone to implant contact, mean of buccal and lingual, best three threads only, high-power 
. . . computer-assisted measurement 
OriginalBticcaLBest 3 B.IC Bone-implant contact, original (ie: first) measurement technique, best three buccal threads, 
(%) low-powered, computer-assisted. 
Original Lingual Best 3 Bone-implant contact, original (ie: first) measurement technique, best three lingual threads, 
BIC (%) low-powered, computer-assisted. 
Original B&LMean Best 3 Bone-implant contact, original (ie: first) measurement technique, mean of best 3 buccal + 
BIC (%) lingual threads, low-powered, computer-assisted. 
Original B.&L Mean Whole Bone-implant contact, original (ie: first) measurement technique, buccal + lingual mean of 
Implant BIC (%) whole implant perimeter , low-powered, computer-assisted. 
DenBucS1 Density of bone near implant, buccal surface only, stereological measurement 
DenLngS 1 Density of bone near implant, lingual surface only, stereological measurement 




· Original Best 3 B&L Mean 
Density(%) 
Density of bone within best 3 implant threads, buccal surface only, high-power computer-
assisted measurement 
Density of bone within best 3 implant threads, lingual surface only, high-power computer-
assisted measurement 
Density of bone within best 3 implant threads, mean of buccal & lingual, high-power 
computer-assisted measurement 
Density, original (ie: first) measurement technique, buccal + lingual mean of whole implant 
perimeter , low-powered, computer-assisted. 
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2.10. Experiment 4(B): Systematic review and preliminary meta-analysis of 
histomorphometric analyses in other animal models. 
The aim of this experiment was to undertake a systematic review and meta-analysis of results 
reported for various implant surfaces in other animal models, and to then compare this data 
with the results obtained in this work in the sheep mandible. The hypothesis tested was that 
the sheep mandibular model was that the results obtained for different implant surfaces in this 
animal model are comparable to other established animal models. 
2.10.2. Method: search strategy. 
A formal search strategy was established using a combination of online and library-based 
methods. The online search engines employed were Pubmed and Medline, websites 
respectively www.ncbi.nlm.nih.gov and gateway.ovid.com). Articles in Journals not locally 
available were obtained by Interloan. Hand-searching was conducted in the Otago University 
Medical and Dental Libraries, University of Washington Health Sciences, Engineering and 
Fisheries-Oceanography Libraries (catalog.lib.washington.edu/search/) and the Bibliotek of 
the Zahnmedizinische Kliniken der Universitat Bern (dent.unibe.ch/bibliothek/). Non-
English-language Journals were included. The titles of Journals that were hand-searched are 
listed in Table 2.10. Table 2.11 lists the key-word and key-word combinations used. 
The search was limited to the time periods "1966 to present" (Medline) or "1965 - present" 
(Pubmed); comprehensive searching was carried out up to 2002; some articles published 
since 2002 have also been included. Searches by author names were also conducted to find 
additional articles. Hand-searches were performed through references of references, through 
recent J Dent Res abstracts from IADR conferences and through relevant textbooks. The last 
10 years of the following Journals were also hand-searched by index, abstract and then text: 
Clin Oral Impl Res, Int J Oral & Maxillofac Impl, Impl Dent , Int J Perio & Rest Dent, 
Biomaterials, J Biomed Mater Res, J Periodont, J Clinical Periodont, J Periodont Res. 
Reports that appeared to duplicate results from other experiments were included. Where 
multiple measurements techniques were used to analyse the same data, all results were 
included (for example where both "Best-3-threads" and "whole implant" % BIC 
measurements were recorded). Reports that did not quantify and report osseointegration using 
histomorphometric techniques were excluded. Results of experiments using solid screw 
implants and solid or hollow unthreaded cylinders were tabulated separately. Data was not 
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limited to dental implants, ie: a small number of threaded solid-metal external fixation screws 
placed into long bones in sheep were included. The authors of reports that published results in 
graphic rather than tabulated form were written to and invited to provide the original data. 
Results were tabulated separately for % Bone to implant contact (% BIC) around machined-
surface ("Smooth"), titanium-plasma sprayed or acid-etched and/or grit-blasted surfaces 
("Rough") and hydroxyapatite-coated ("Ceramic/HA") implants. These were sub-categorised 
by animal species, surgical site and length of healing period. Animal species for which results 
were recorded were limited to rabbits, goats, sheep, dogs, pigs, non-human primates (NHP) 
and humans. Operative sites were limited to mandible, maxilla, tibia, and femur. To facilitate 
comparative analysis, healing periods were categorised as ~ 1 month, 1 ~ 3months, 3 ~ 6 
months, 6 ~ 12 months and >12 months. Where reported, statistical measures of spread 
(standard deviation or range) were recorded. 
"Within-thread" and "Outside-thread" percent bone density was also recorded for threaded 
solid-screw implants. For comparative purposes, bone-to-implant contact with ceramic-coated 
unthreaded (cylindrical) implants, hollow cylinder implants and solid cylindrical rough-
surfaced implants were also tabulated. A grand "Mean of means" was calculated for % Bone 
to implant contact (% BIC) for each healing period at each site in each animal species for 
threaded solid-screw implants separated into the three classes of implant surface (Smooth, 
Rough and HA). As this was only a preliminary meta-analysis, statistical analysis was limited 
to descriptive statistics and graphical comparison of these grand means. 
Results were compared graphically with similarly-grouped means for the implants placed in 
this work. 
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Table 2.10. Hand-searched Journals 
Biomaterials 
Clinical Oral Implants Research 
Clinical Orthopaedics and Related Research 
Implant Dentistry (formerly International Journal of Oral Implantology) 
International Journal of Oral & Maxillofacial Implants. 
International Journal of Oral & Maxillofacial Surgery 
International Journal of Periodontics & Restorative Dentistry 
Journal of Biomedical Materials Research 
Journal of Bone and Joint Surgery (American and British Volumes) 
Journal of Clinical Periodontology 
Journal of Orthopaedic Research 
Journal of Periodontal Research 
Journal of Periodontology. 
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 







(Dental OR Oral) AND Implant) AND (histomorphometric OR HMA or histological) 
(Dental OR Oral) AND Implant) AND Retrieved OR Retrieval 
(Dental OR Oral) AND Implant) AND "Animal Model" 
(Dental OR Oral) AND Implant) AND (Human AND Post-mortem) 
(Dental OR Oral) AND Implant) AND (Human AND Biopsy) 
(Dental OR Oral) AND Implant) AND Sheep 
(Dental OR Oral) AND Implant) AND Dog 
(Dental OR Oral) AND Implant) AND Rabbit 
(Dental OR Oral) AND Implant) AND Goat 
(Dental OR Oral) AND Implant) AND Pig 
(Dental OR Oral) AND Implant) AND (Monkey OR Primate) 
SLA AND "Animal model" 
(TPS OR "Titanium Plasma") AND "Animal Model" 
(Dental OR Oral) AND Implant) AND (Hydroxyapatite OR HA OR Ceramic) AND 
"Animal model" 
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2.11. Summary of experimental methodology. 
Sequential CSD experiments followed by seqential implant experiments were conducted, 
utilising the mandibular diastema and post-extraction ridge of the sheep. For the implant 
experiments, different implant strategies including surgical protocols, surfaces and bioactive 
substances were tested. The experimental sites and timelines are summarised in Figures 2.74 
and 2.75. 
A meta-analysis of the results obtained for the different implant experiments in the sheep 
mandible was performed. Results were then validated against of a formal systematic review 
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Figure 2.75a. Sheep mandible. 
Incisors (31,41 ), edentulous diastema 
and lower premolar teeth (Pl ,P2,P3) . 
Figure 2.75b. CSD Experiment 1. 
Residual size of 8mm unicortical 
Critical Size Defect (CSD) bilaterally 
in sheep mandibular diastema 
after healing for 6, 8 or12 weeks 
(3 sheep, l per time period) . 
Figure 2.75c. CSD Expts 2a & 2b. 
Residual size of 12mm unicortical CSD 
bilaterally in sheep mandibular diastema 
after healing for 16 weeks (4 sheep). 
Defects on one side (Expt 2b) treated by 
GBR using a GoreTex Soft Tissue patch 
(GTSTP). 
Figure 2.75d. CSD Experiment 3. 
Residual size of chronic 12mm unicort-
-ical CSD implanted for 3 months with 
11 mm polytetrafluoroethylene discs 
bilaterally in sheep mandibular diastema, 
after removal and healing for 3 months 
(9 sheep). 
Figure 2.75e. Implant Pilot Expt. 
Spectra-system ScrewVent implants 
bilaterally in the sheep mandibular 
diastema after 2, 7, 14, 28 & 90 days 
unloaded, submerged healing (6 sheep). 
Figure 2.75f. Implant Expt 1. 
Dentsply Swede Vent machined implants 
in the sheep post-extraction mandible 
compared with premolar sockets after 3 
months unloaded,submerged healing (8 
sheep) and after 2, 7 and180 days healing 
(3 sheep) 
Figure 2.75g. Implant Expt 2. 
SteriOss hydroxyapatite-surface implants, 
and Dentsply Swede Vent TPS-surface 
implants with/without TGFB +/- bone 
grafts in the sheep post-extraction mand-
-ible after 3 months unloaded submerged 
healing (9 sheep). 
Figure 2.75h. Implant Expts 3a &3b. 
DS TPS implants, Southern Implants 
(machined or rough surface), 3 months 
submerged healing; Branemark machined 
& m SLA-surface, 3 months non-sub-
-merged; post- extraction mandible of 8 
periodontally healthy and 8 diseased 
animals (16 sheep). 
Sheep mandibular animal models 
for dental implantology research. 
Volume2 
Warwick John Duncan 
A thesis submitted for the degree of 
Doctor of Philosophy 
at the University of Otago, Dunedin, 
New Zealand 
25 January 2005 
Chapter 3: Part 1: Results of CSD studies 
3.1.1. Experiment 1 results: 8cm CSD after 6, 8 and 12 weeks. 
The defects did not fully heal within the time periods used (see Figures 3.1 and 3.2). There 
was marked variability in the amount of healing, ranging from 20% to 73% (Table 3.1). No 
defect showed less than 10% closure. In the left-side six-week specimen which was sectioned 
horizontally, woven bone had extended from the cut edges of the cavity and from the lingual 
endosteal surface adjacent to the wound. In the 8 week specimens, woven bone extended from 
the entire endosteal surface of the marrow cavity particularly at the margins of the defect 
where the endosteal woven bone merged with the less exuberant periosteal reaction. By 12 
weeks, the defect was nearly closed in the right hand specimen. The endosteal callus appeared 
to mature before the periosteal callus. Isolated spicules of bone were seen calcifying within 
the soft-tissue that filled the defect. However, on the left side the neurovascular bundle had 
herniated into the defect and the en dos teal callus had formed a calcified bridge medially. 







69.75 ± 4.5 
59.35 ± 3.9 
3.1.2. Experiment 2a results: 12mm CSD after 16 weeks. 
Healing of the operative sites was uneventful. Results of the histometric analysis are 
described in Table 3.2. Complete healing of the defect was seen in two sheep. Mean defect 
closure after 16 weeks was 92.7 ± 8.4%. 










Histological examination showed variations in healing responses between animals (see 
Figures 3.3 to 3.6). Marked hyperplasia of the superior and inferior cortex occurred in all 
specimens. Sheep 1 had complete closure of the defect, although the area of regenerated bone 
comprising the lateral cortex is less mature and thinner than the lingual cortex. Sheep 2 had a 
thin but complete area of new bone bridging the defect. Both sub-periosteal and sub-
endosteal hyperplasia occurred in the lingual cortex opposite the wound. Sheep 3 had a patent 
defect with fibrous connective tissue filling the remaining gap, however the immature nature 
of the bone flanking the defect suggested that complete healing might eventually have taken 
place. Sub-endosteal hyperplasia was evident. Sheep 4 also had a patent defect. Fibrous 
connective tissue and neural tissue was present in the defect, suggesting that fmiher osseous 
healing was unlikely. 
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3.1.3. Experiment 2b results: 12mm CSD covered with a non-porous Teflon 
membrane, after 16 weeks healing. 
Healing of the operative sites was uneventful, however at sacrifice partial extrusion of one of 
the membranes was observed; histological exmination showed that this membrane had 
collapsed into the defect and the other three membranes has already been exfoliated. 
Complete bony closure was seen in two of the control and one of the membrane defects. 
Formation of a bony callus was observed in the newly-formed bone extending over the buccal 
aspect of the defect margin and occasionally, but to a lesser extent, within the marrow space. 
One of the membrane sites developed osteitis and sequestration with decreased closure of the 
defect. All other sites showed a minimal inflammatory infiltrate. 
Histometric analysis revealed that healing was greater in the control defects than those 
covered by the GTSTP membrane (table 3.3). Mean defect closure after 16 weeks of 
membrane-guided regeneration was 72.6 ± 27.1 % (compared with 92.7% for non-membrane 
defects) although this was not statistically significant (p<0.05). 












3.1.4. Experiment 3 results: Chronic 12mm CSD with 
polytetrafluoroethylene discs 
3.1.5. Pilot Experiment 3 results. 
Three discs remained in situ after 3 months although one was partly exfoliated. Post-mortem 
removal of the discs revealed bony cavities filled with soft connective tissue (Figure 3.7). No 
further analyses were performed. 
3.1.6. Main Experiment 3 results: Observations at re-entry surgery after three months: 
Group A: Four discs were fixed in two sheep using Teflon sutures. Two discs were lost before 
the re-entry surgery at three months. The mucosa had completely healed over one site; in the 
other site a sinus was found draining from a 14mm-diameter osseous defect. One disc was 
externalised and the oral mucosa had healed beneath it. One disc remained in situ after three 
months (Figure 2.24). 
Group B: In six sheep, 12 discs were wired transosseously to the lingual cortical plate of the 
mandible. Of these, five discs ( 41.6%) were still in situ after three months, including one 
which was so well integrated that it could not be found at second-stage surgery and thus was 
not removed (Figure 3.11. Two discs had mucosa! continuity re-established beneath the 
externalised discs (Figure 3.8), and five discs had been lost. 
Group C: The two discs sutured in one sheep had both been lost at re-entry after 6 months. 
3.1.7. Measurement of residual defect area and defect height after six months: 
The residual defect areas and heights are presented in the Appendix and examples illustrated 
in Figures 3.9 to 3. 13. Mean residual defect area of Group A after three months further 
healing was 19% of the original defect, representing a mean defect closure of 81 %. Measured 
vertically, the defect height showed a mean closure of 67%. Mean residual defect area after 
three months further healing for Group B was 48% of the original defect, representing a mean 
defect closure of 53%. However, it was considered that large residual defects recorded at two 
sites distorted the results; one because the Teflon disc had been retained in situ and one 
because an uncontrolled infection had destroyed most of the buccal plate. 
With these measurements excluded, the mean residual defect areq after three months healing 
was 16%, representing 84% closure of the original defect. Mean defect height revealed 71 % 
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of the wound had healed. As the differences between Groups A (teflon sutures) and B 
(transosseous wiring) were minor, the two groups were combined. Mean overall closure of the 
original defects was 83% of defect area and 70% of defect height. No histometric 
measurements were carried out for the animal that was permitted to heal for six months after 
re-entry surgery (Group C). Near complete restitution of bony architecture was observed, 
although the defect site had yet to regain pre-surgical cortical width. (Figure 3.16). 
Hyperplasia of the lingual and apico-buccal cortical bone was still present. 
3.1.8. Measurement of cortical bone hyperplasia. 
Data from Groups A and B was combined for measurement of the thickness of additional 
cortical bone on the lingual and apico-buccal surfaces (data shown in the Appendix). On 
average, 1. 78 ± 1.81 mm bone was found external to the pre-surgery lingual cortical bone, 





3.2a ~ · b 
3.7 
Figures 3.1 to 3.8. 3.1: 8mm x 6 weeks CSD, longitudinal section, Gomori. Residual defect indicated by black arrow. 3.2 
(a). 8mm x 8 weeks, Mallory, residual defect (arrow). (b). 8mm x 12 weeks, Masson, residual defect (arrow). 3.3: 12mm x 
16 weeks CSD, H&E; arrows show approx. original defect margins. (a). healed defect. (b). patent defect. 3.4. As for 3.3; 
healed defects. 3.5: 12mm CSD with GTSTP, H&E, patent defects, arrows= original defect margins. 3.6: As for 3.5. (a). 
membrane (M) present, collapsed into patent defect; Gomori stain (b). patent defect, H&E. 3.7: Experiment 3a; (a). Teflon 









Figures 3.9 to 3.16. 3.9: Accidentally-retained Teflon disc after 6 months in situ. 3.10: Unoperated control, 
diastema region, dried bone prep. 3.11: Healed defect, circle indicates original margins.3.12. Patent defect; 
circleshows original margins. 3.13: Defect almost fully healed; amalgam spots show original margins.3.14: 
Cross-section of dried bone prep. showing additional bone laid down at inferior (I) and lingual (L) borders. 
D = healed defect. 3.15: Addional bone laid down at inferior border (I). 3.16: light microscopic images of 
healed defect (D).(a) Gomori stain, (b) Massons trichrome. 
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3.1.9. Dimensions of the diastema and premolar regions of the sheep posterior mandible. 
The edentulous diastema region of the sheep extends from the canine tooth to the first 
premolar. The anterior portion of the diastema is approximately 1 cm in height and width, has 
a large mental foramen opening to the buccal and a lingually-placed fibrous connective tissue 
pad behind the mandibular incisors that occludes with the upper dental pad. This part of the 
diastema was not considered suitable for placing dental implants. 
The posterior part of the diastema extends from the mental foramen to the first premolar tooth 
(Pl), although frequently in this study Pl was not present. In cross-section this region consists 
of an outer cortex of compact bone composed of lamellar bone arranged in primary osteons, 
measuring approximately 3-5mm in vertical height on the superior and inferior surface and 2-
3mm in horizontal thickness on the lateral (buccal) and medial (lingual) surface. The outer 
cortex of lamellar bone surrounds a medullary cavity that contains mainly fatty bone marrow 
with sparse trabeculae of lamellar bone. The neurovascular bundle is located inferiorly and 
medially within the marrow cavity. The first premolar teeth were generally short (10-15mm 
verical height) and either single or dual-rooted; the second premolar (P2) measured 15-20mm 
in height and the third premolar (P3) was generally 20-25mm high. Both P2 and P3 varied 
between two and three roots. Cancellous trabecular of lamellar bone supported these teeth via 
a broad periodontal ligament. 
Histometric measurements of defleshed and dried specimens. demineralised paraffin-
embedded sections and undemineralised plastic-embedded ground sections obtained during 
the CSD experiments and from other sources (Figures 3.17-3.24) gave the following 
dimensions for the posterior sheep mandible (Table 3.4). The edentulous diastema region was 
of sufficient dimension to accommodate a single implant measureing 3 to 4mm diameter and 
up to 15mm long, although the primary retention for this implant would be a superior cortical 
bed of limited vertical dimension (3-5mm). Extraction of Pl & P2 would leave an edentulous 
mandibular ridge measuring 15-18mm in the antero-posterior dimension, with up to 7mm 
vertical height within the cortical bed; this would be sufficient to accommodate two implants 
of approximately 3.8mm diameter and 12 to 15mm length. If Pl to P3 were extracted, the 
edentulous ridge would measure approximately 23mm in A-P length with cortex 5-8mm high, 
sufficient to accommodate three implants of approximately 3.8mm diameter and 12 to 15mm 
length. 
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Table 3.4. Dimensions of the sheep posterior mandible in the edentulous diastema and 
premolar regions: 
Diastema* 15 - 18 9-12 3-5 10-15 
Pl 18-21 11-13 5-7 5-7 
P2 18-21 11-13 6-8 6-8 
P3 21-23 13-15 8-12 7-10 






1. I" Premolar 
2. 2nd Premolar 
3. 3ro Premolar 
4. Diastema region 
5. Superior border 
6. Marrow space 




1. Distal 3"' Premolar 
2. Furcation 3"' Premolar 
3. Mesia! 3"' Premolar 
4. Distal 2"" Premolar 
5. Distal 2"" Premolar 
6. Furcation 2"" Premolar 
7. Furcation 2"" Premolar 
8. Mesia! 2"" Premolar 
"--.-;--'"""""---r 9. Mesia! 2"" Premolar 
10. Mesia! 2"" Premolar 
11. Distal I" Premolar 
12. Furcation I " Premolar 
13. Mesia! l" Premolar 
14. Diastema region 
15. Diastema region 




removed. 3.18: Example of mid-
sagital longitudinal ground section. 3.19: Key to Fig. 3.18. 3.20: Location of cross-sections cut through Fig. 
3.18. 3.21: Cross-sectional ground sections (toluidine blue stain): (a) diastema; (b) l " premolar. 3.22: Cross-
sectional ground sections. (a) 2nd premolar (b) 3rd premolar. 3.23: Plastic emebedded ground sections, toluid-
-ine blue/acid fushin. (a) 1st premolar (b) 2nd premolar (c) 3rd premolar. 3.24: Paraffin-embedded demineral-
-ised sections, H&E stain. (a) 1st premolar; (b) 2nd premolar; (c) 3rd premolar. 
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Part 2: Results of Implant studies 
3.2. Pilot study results. Placement of ScrewVent implants in the sheep 
diastema. 
The implants placed in sheep for 3 months did not osseointegrate. One fixture was exfoliated 
and the other showed radiographic evidence of crestal bone loss. The placement protocol was 
changed for the shorter-term animals to reduce osseous trauma during fixture installation by 
substitution of twist drills for spade drills (see Appendix). 
For the short-term healing experiments the following was observed. After 2 days healing, the 
marrow was closely apposed to the fixture with little evidence of inflammation. The imprint 
of three fixture threads in soft tissue could be seen. After 7 days, a layer of collagen formed 
beneath a thin membrane of fibroblast-like cells. After 14 days, two layers were apparent. A 
layer of fibrous connective tissue was immediately adjacent to the fixture. Extending from the 
cortical bone into this tissue were thin trabeculae of osteoid. This was further advanced in the 
28-day animals. After 3 months the sole surviving fixture was surrounded by inflamed fibrous 
connective tissue, accompanied by a marked increase in the bucco-lingual dimensions of the 





Figures 3.25 to 3.32. 3.25: ScrewVent implant, arrows show imprint of implant threads. (a) 2 days healing, Van Giesons. (b) 7 days, 
Massons. 3.26: 14 days, H&E. Bone proliferating from cortex (c), subperiosteal (p) and into the marrow from the endosteal surface (e) 
towards the implant threads. 3.27: (a) 28 days, H&E. Inflammatory reaction within marrow next to implant surface. (b) 74 days, H&E. 
Implant has exfoliated, heavy chronic inflammatory infitrate present. 3.28: Radiograph of (a) I st premolar (b) tooth socket after 3 months 
healing (c) Dentsply Swede Vent implant after 3 months healing. Dotted line indicates hyperplasia. 3.29: Control socket healing. Toluidine 
blue {TB). 3.30. Control socket healing, toluidine blue and acid fushin (TB&AF). 3.31. Well-integrated Denstply machined-surface (ms) 
implants after 3 months healing, (a) (b) 3.32: (a) poorly integrated and (b) non-integrated DS (ms) implants after 3 months, 
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3.3. Experiment 1 results: Placement of DentSply Swede Vent machined 
surface implants into the post-extraction mandible of the sheep. 
3.3.2. Experiment 1: clinical results. 
No animal showed any evidence of distress or infection. All animals survived to the end of 
the experiment. All short-term implants, one of the 6-months healing and thirteen of the 
sixteen 3-months healing implants were present at sacrifice. The three lost implants were 
excluded from consideration during statistical analysis of %BIC and %density. 
3.3.3. Experiment 1: implant clinical survival rate. 
Twelve of 16 implants placed in 8 sheep and allowed to heal for 3 months survived (75%). 
3.3.4. Radiography of the implant site. 
Before extraction, the mandibular first premolar had an outer layer of dense cortical lamellar 
bone with trabeculae surrounding and apical to the tooth socket (Figure 3.28a). Few 
trabeculae could be seen in the central marrow space. Three months after tooth extraction the 
outline of the healing socket could still be distinguished (Figure 3.28b). After fixture 
placement there was a marked increase in the thickness of the cortical plate in the apical 
region (Figure 3.28c) similar to the hyperplastic reaction observed in CSD Experiment 3. 
3.3.5. Experiment 1: descriptive histology. 
After three months the control sites (premolar sockets) were partly healed with disorganised 
bony trabeculae filling the healing sockets (Figures 3.29 and 3.30). The response of the sheep 
to the placement of dental implants was extremely variable with bone-to-implant healing 
ranged from complete osseointegration (Figure 3.31) to complete non-integration (Figure 
3.32). 
Four specimens lost cover crews and had inflamed soft tissue within the screw-hole. Four 
implants were lost, two of them in the same sheep. In two other sheep, one fixture was lost 
and there was poor bone-implant contact around the remaining fixture in each animal. The 
two fixtures in another sheep were still in place but completely surrounded by fibrous 
connective tissue. Around eight fixtures in four sheep (50%), bone had healed in intimate 
contact with the threaded implant surface. Two of these specimens appeared to have achieved 
bicortical stabilisation following extension of the endosteal callus into contact with the 
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implant apex. A hyperplastic endosteal callus at the inferior border of the mandible was 
present in all specimens and was marked in those sheep where one implant had been lost. 
3.3.6. Definition of implant "acceptability". 
The criterion for implant "survival" was that the implant be present in the implantation site 
when the animal was sacrificed. However, some implants were clinically present at sacrifice 
but had so little bone-implant contact that it was likely that they would not have survived 
long-term. 
In human patients, a distinction is made between implant success and survival. The concept 
of implant "success" as defined for human patients is of questionable relevance in the context 
of a short-term cross-sectional study in an animal model. An additional category was 
therefore created. This was implant "acceptability", defined as "any implant that was present 
clinically after three months integration that also had percent bone-implant contact of e:::15% 
measured stereologically within the cortical passage". Survival rates and acceptability rates 
for the mesial, distal and combined sites in sheep after 3 months healing are compared in 
Table 3.5. This additional analysis suggested that more implants were likely to fail than was 
apparent by clinical examination alone. 
Table 3.5: Comparison of survival and success rates for implants after 3 months 








3.3.7. Experiment 1 results: Quantitative histomorphometric analysis of implants. 
Mean results bone-implant contact and bone density are shown in Tables 3.6 and 3.7. Mean 
results for buccal and lingual surfaces and for individual implants are listed in the 
Appendices. 
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Table 3.6: Mean results by implant type for Percent Bone-Implant contact 
\/,:','~,' ' '.>>: '{/}',' 
:SJ.week .. . 
,',,',·,, ",",",',' ,, ' 
Mesial 








50.0 ± 14.2 
31.1 ± 21.0 
26.0 ± 19.4 






11.6 ± 3.0 
11.3 ± 8.0 
8.6± 8.9 




19.8 ± 23.9 
11.4 ± 15.0 





39.2 ± 31.1 
17.6 ± 21.2 






22.6 ± 17.0 
22.0 ± 18.5 
22.3 ± 17.1 
Percent bone-implant contact is shown in Table 3.6. Mean results for the three animals that 
had shorter or longer healing periods (6 months and ::s;l week healing) are included in this 
analysis. Results suggest that %BIC was highest immediately after implant placement, 
became less after three months and then increased again after six months, however numbers 
of implants in the short-term and long-term groups were too small for meaningful statistical 
comparisons. Measurements were not statistically different for buccal and lingual surfaces 
except for cortical % BIC where the lower buccal measurement was of borderline significance 
(p=0.05). Bucal and lingual %BIC were combined into a single mean. There were no 
statistically signifcant difference in %BIC between mesial (anteriorly-placed) and distal 
(posteriorly-placed) implants; results were combined into a mean for the pair of implants. 
Different measurement techniques gave different results. The rank order for % BIC by 
measurement technique was "Cortical Stereology" > "Original Computer-assisted Best3" and 
"Whole" > "High resolution Best 3 computer-assisted" > "Stereology of the whole implant" 
and the differences between techniques were significant (non-parametric ANOVA, P>0.01). 
Of particular relevance was Cortical stereology and Best-3-threads %BIC, which are 
commonly-reported methods for measuring percent bone-implant contact within the cortical 
passage; the result using stereology was significantly higher (28.1 ± 19.3%) than Best-3 
(14.9±18.7%; p= 0.01). 
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Table 3. 7. Percent Bone Density - Mean results by implant type and for controls (premolar 
socket) sites. 
Mean Mean Mean Original 
Cortical Socket Best3 Mean 
%Density± %Density± %Density± Cortical 
SD SD SD %Density± 
SD 
79.0 
88.2 ± 11.1 
82.3 ± 4.6 43.4 ± 37.6 59.0 ± 35.5 
84.9 ± 5.7 40.4 ± 31.2 49.7 ± 33.6 
83.7 ± 5.1 49.4 ± 10.8 41.7 ± 32.4 53.6 ± 33.2 
Percent bone density is shown in table 3.7. Mean results for the three animals that had shorter 
or longer healing periods (6 months and ~1 week healing) are included in this analysis. There 
were some differences between buccal and lingual measurements of density measured using 
stereology but these were of borderline significance (p=0.05); there were no statisitically 
significant differences between buccal and lingual measures of Best-3 threads density. Buccal 
and lingual measures were combined into means for each implant. The location of the implant 
(anterior or posterior sites) did not make any statistically-significant difference to any density 
measurements; all measurements were combined to give a single mean for within-thread 
(best-3) and outside-thread (cortical) percent density. 
Bone density outside the threads was twice that found for bone within the threads (p=0.003); 
again, this result is tempered by the fact that different measurement techniques were used for 
each. The original low-powered computer-assisted HMA of bone within threads was 
intermediate between stereology and best-3 measurements and differed significantly from 
both. 
Density of bone in the sockets was greater than that in sites where implants had been lost 
(49.4 ± 10.8 versus 32.3 ± 32.5) but this was not statisitically significant. Density was 
significantly lower in healed sockets than in the cortical bone outside the implant threads 
(p=0.04). Although measured using a different technique, the density of healed sockets was 
similar and not statisitically distinguishable from the density of bone within the implant 
threads (P=0.7). 
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3.4. Experiment 2: Placement of DentSply Swede Vent titanium-plasma-
sprayed (TPS) and SteriOss HA-surface implants and Dentsply TPS 
implants with bone grafts or with bone grafts plus Transforming Growth 
Factor 8 (TGF8) into the post-extraction mandible of the sheep. 
3.4.2. Experiment 2: clinical results. 
Two animals showed evidence of progressive kidney failure after intravenous perfusion with 
Alizarin red. On the advice of the veterinarian these animals sacrificed 9 .5 weeks after 
placement of the implants. Histomorphometric measurements for these animals are presented 
below as a separate group. All other animals survived to the end of the 12-week healing 
period. 
3.4.3. Experiment 2: implant clinical survival rate. 
Four implants failed (11.1 % of all implants in this experiment). The overall implant survival 
rate was 88.9%; the survival rate by implant type was: SteriOss (100%), Dentsply TPS 
(100%), Dentsply TPS with growth factor (88.9%) and Dentsply TPS with bone graft 
(66.7%). 
3.4.4. Experiment 2: descriptive histology. 
Healing ranged from complete osseointegration to complete non-integration. Histological 
evidence of integration was assessed qualitatively by describing the degree of integration 
(bone-to-implant contact and bone density), the growth of endosteal trabeculae into the 
marrow space from the cortical region, the presence of inflammatory cells and abscesses and 
the inflammatory loss of peri-implant bone. Quality was divided into "good", "poor", "failing" 
(no or very little contact with the surrounding bone) and "failed" (implant exfoliated). The 
two animals killed after 9 .5 weeks and the 7 animals killed after 12 weeks were all grouped 
together for this analysis. 
Two SteriOss implants became exposed and developed a deep, peri-implantitis-like lesion 
(Figure 3.37). Other clinical and histological examples of implants from this experiment are 
shown in Figures 3.324 to 3.40. Two Dentsply implants with growth factor were found to 
have little or no bone contact and would have been exfoliated eventually (see Figure 3.39b); 
this would bring the failures in the growth factor and bone graft groups to an equal number. 
"Failing" and "failed" implants were therefore combined into a single category "fail". The 
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percentage of each implant type categorised as "good", "poor" or "fail" is shown in Figure 
3.41. 
The possibility that implant failures "cluster" in certain animals was also considered. The 
distribution of quality categories amongst individual animals (Figure 3.42) suggests that four 
animals accounted for a disproportionately high percentage of the failed and failing implants. 
Some animals (eg.: sheep numbers 1 and 4) appeared to always have "acceptable" implants 
irregardless of the surfaces treatment or implant type), whereas others (eg.: sheep 3, 6 and 9) 
always had failures (see Figures 3.34b and 3.37a. ) 
3.4.5. Experiment 2 results: implant "acceptability" rates. 
Categories used were "survival" (implant present at sacrifice) and "acceptable" (bone-implant 
contact within the cortex of >15%). These are compared in Table 3.8. The two time periods 
(9.5 weeks and 12 weeks healing) were pooled. SteriOss HA implants were 100% 
"acceptable" as defined histologically; success rates were lower for Dentsply TPS (88.9%). 
The use of TGF-B growth factors and bone grafts did not enhance the success of Dentsply 
implants. 
Table 3.8: Implant survival and success rates, 9.5 weeks and 12 weeks healing combined. 
Survive Success (BIC>15%) 





1 DS ;,,'Dentsply TPS surface implant 
2 DS + TGF = Dentsply TPS implant plus TGF-B growth factor in collagen/autogenous bone carrier 




























Figures 3.33 to 3.40. 3.33: Expt I, DS (ms) implant threads. 3.34: Expt 2, DS (tps) implants. (a) well-integrated, (b) poor 
integration. All implant sites in this sheep looked like this.3.35: DS (tps), TB stain. (a) Good and (b) poor (b) integration, 
mainly point-contacts, with coronal bone loss. 3.36: SteriOss HA implants. (a) high density, broad bone-implant contacts. 
(b) low-density, broad BIC. 3.37: SteriOss HA, (a) Same animal as 3.34a. Coronal bone loss. (b) Good BIC, coronal bone 
loss. 3.38: DS (tps) with graft & TGFB. BIC limited to coronal threads, inflammation around apical graft. 3.39. DS (tps), 
TGF6 & bone graft, (a) good integration (b) no integration. 3.40: DS (tps), bone graft only, (a) chronic inflammation, no 
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Figure 3.41. Percentage of implants in each group with osseointegration categorized 
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3.4.6. Experiment 2 results: quantitative histomorphometric analysis. 
Mean results for each implant type/treatment are presented in Tables 3.9 and 3.10. Mean 
results for individual implants are listed in the Appendices. There were no statistically-
significant differences between buccal and lingual measurements for any measurement 
technique; results were combined into means for each group of implants. 
3.4.7. Experiment 2: HMA of %BIC and %Density after 9.5 weeks. 
A total of six implants were placed into two sheep for 9 .5 weeks, of which two implants were 
lost. Dentsply TPS implants had greater %BIC and greater %density than SteriOss HA after 
9 .5 weeks, irrespective of measurement techniques; Dentsply plus TGF-B was similar to 
ungrafted Denstply implants whereas Dentsply with bone graft alone had less than half the % 
BIC of the ungrafted implants. Due to the small numbers involved, differences were not 
statistically significant. 
Table 3.9: Mean results by implant type for% Bone-Implant Contact and% Density after 9.5 
weeks 















37.7 ± 24.4 




















Best 3 % 
Density± 
SD 
45.9 ± 12.4 
77.8 ± 14.4 
3.4.8. Experiment 2: HMA of %BIC and %Density after 12 weeks. 
A total of 27 implants were placed into seven sheep for 12 weeks, of which two implants were 
lost. When the results for 9.5 weeks and 12 weeks healing are compared, irrespective of 
measurement technique, both the mean % BIC and % density increased for SteriOss and 
decreased for Dentsply TPS. These differences were not statistically significant due to the 
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small numbers in the 9.5 weeks group. The numbers in the other groups were too small for 
such comparisons to be meaningful. 
After 12 weeks healing, SteriOss implants had significantly greater %BIC than ungrafted 
Dentsply TPS implants (Cortical BIC: p=0.03; Whole BIC: p=0.007; Best 3 BIC: p=0.001). 
SteriOss implants also had greater % density, both within and outside threads, than any 
Densply TPS implants, but these differences were not statistically significant. 
SteriOss HA-surface implants had significantly greater %BIC than bone-grafted Dentsply 
implants (p<0.01 for all measures) and significantly greater %BIC (p<0.01) and %density 
(p<0.05) than Dentsply implants with TGF-B and bone-graft carrier. 
Although Dentsply TPS implants alone had higher % BIC compared with either grafted 
groups, especially when measured over the entire implant perimeter, this was not statistically 
significant. There were no differences in bone density outside the threads. There were no 
statistically significant differences between the bone-grafted and bone-graft plus TGF-B 
groups of implants. Bone-implant contact and bone density was not measured within the best-
3-threads of the bone graft and growth factor-treated groups. 
The implant site (left versus right side of jaw, or anterior versus middle versus posterior) did 
not alter bone-implant contact or bone density in any statistically-significant fashion. When 
best-3-threads analysis was compared with stereology of the cortical passage, %BIC increased 
for SteriOss HA-surfaces and decreased for Denstply TPS surfaces, but neither these nor% 
density differed in a statistically significant manner. Examples of the Best-3-threads that were 
analysed are shown in Figures 3.43 to 3.45. 
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Table 3.10: Mean results by implant type for Percent Bone-to-Implant contact and Percent 
Density after 12 weeks 
Bone-Implant contact Bone density 
Mean Mean Mean Mean Mean 
Cortical Whole Best 3 Cortical% Best 3 % 
%BIC± Implant %BIC± Density± Density± 
SD %BIC± SD SD SD 
SD 
77.1 ± 6.3 53.2 ± 12.3 84.7 ± 10.7 87.9 ± 9.1 71.4± 18.1 
55.3 ± 21.2 31.7 ± 13.9 46.1 ± 21.8 78.0 ± 18.3 60.9 ± 22.4 
43.5 ± 30.1 19.4±17.6 * 68.8 ± 30.4 
42.8 ± 27.7 19.9 ± 15.4 76.3 ± 20.0 
* measurement not performed 
3.4.7. Experiment 2 results: rate of bone apposition around implants in sheep 
Overall a mean of 91 ± 30 fluorescent inter-label measurements were made per implant, 
distributed approximately evenly between the three sites ie: within-thread, <lO00µm and 
>2000µm from the implan,t surface There were minor differences between Denstply TPS and 
SteriOss HA implants when inter-label distance was measured after 9.5 and 12 weeks healing, 
but none were statistically significant. After 12 weeks healing there were no significant 
differences in inter-label distances between the two implant surfaces. 
The implants were combined into a single group and the distances computed to show mineral 
appositional rate within the threads (MARthr ), adjacent to the implant at lO00µm (MARadj) 
and at a distance from the implant surface (MAR<list) after 12 weeks healing (Table 3.11). A 
gradient of bone apposition could be seen, with lowest MAR within the implant threads and 
highest within the basal (cortical) bone; differences in MAR between each location were 
statistically-significant (p>0.01 for all). The overall average MAR for sheep mandibular bone 
after dental implant placement was 0.37 ± 0.18 µm/day. Examples of fluorescent micrographs 
are shown in Figures 3.46 to 3.48. 
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Table 3.11. Mean rate of bone apposition for SteriOss hydroxyapatite-surface and Dentsply 
titanium-plasma-sprayed-surface implants in the sheep mandible after 12 weeks healing. 
MARthr MARadj MARdis Combined MAR 
(µm/day) (µm/day) (µm/day) 
(µm/day) 
0.28 ±0.04 0.38 ± 0.11 0.49 ± 0.13 0.38 ± 0.13 
0.24 ± 0.17 0.35 ± 0.19 0.47 ± 0.25 0.35 ± 0.22 






Figures 3.43 to 3.50. 3.43: SteriOss HA implant.(a)&(b): Broad-based and dense contacts within threads. 3.44: 
DS (tps) implant. (a)&(b): Point contact BIC, low bone density. 3.45: DS (tps). Increased BIC but still low bone-
implant contact on thread tips. P = Titanium particles within bone. 3.46: DS (tps) implant, fluorescent micro-
-graph; inset (b) = normal image. 3.47: SteriOss HA implant, fluorescent micrograph; inset (b) = normal image. 
3.48: Fluorescent micrograph, osteons in adjacent zone. (b) = normal image. 3.49: Mandibular incisors, perio-
-dontally-healthy sheep (HS). 3.50: Mandibular incisors, periodontally-diseased sheep (PDS). 
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3.5. Experiment 3a. Submerged (two-stage) Dentsply TPS-surface (DS) and 
Southern Implants machined- and rough-surfaced (SI ms & rs) in 
periodontally-healthy and diseased sheep (HS & PDS). 
3.5.2. Experiment 3a: clinical results. 
No animal showed any evidence of distress or infection. All animals survived to the end of 
the experiment. Clinical examples characteristic of the anterior dentition of periodontally-
healthy sheep (HS) and periodontally-diseased sheep (PDS) are shown in Figures 3.49 and 
3.50. 
3.5.3. Experiment 3a: implant clinical survival rate. 
No two-stage submerged implants failed. The overall survival rate was 100% of all implants 
in this experiment. The survival rate by implant type was 100% for TPS-surface Dentsply 
implants, rough-surfaced Southern Implants (SI rs) and machined-surfaced Southern Implants 
(SI ms). 
3.5.4. Experiment 3a: descriptive histology. 
Healing ranged from complete osseointegration to complete non-integration (one implant 
only). A total of 18 out of the 48 implants in this experiment (37.5%) had abscesses or 
epithelialisation around part of the implant, in most cases around the cover-screw, distributed 
as follows: 
Dentsply (n=16; HS=8, PDS=8). 
Seven implants (43.8%) had abscesses surrounding either the coronal (N=5), the apex (N=l) 
or the middle portion (N=l) of the implant. Ten implants (62.5%) appeared to have good 
bone-to-implant contact (BIC) although some of these also had abscesses. Three implants 
(18.8%) had little or no bone-implant contact and seemed likely to be lost. 
SI rs (n=16; HS=8, PDS=8). 
Two implants in PDS had perforated into the oral cavity, and an epithelial tract extended from 
the head of the implant in a coronal direction down to the start of the threads. A further two 
implants in HS had abscesses around the head of implant. Two implants had little or no BIC, 
equally distributed between HS and PDS. 
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SI ms (n=l6; HS=8, PDS=8). 
Seven (43.8%) implants showed evidence of epithelialisation or abscesses around the cover-
screw, although only in one implant did this extend to involve threads within the c01tical 
bone. Six of 8 machined-surfaced implants placed into PDS had abscesses compared with 
only one of 8 (12.5%) in HS. Overall, three of the 16 SI ms implants (18.8%) had poor 
integration and only four (12%) were recorded as unequivocally "good" integration. 
Altogether there were 8 abscesses around DS implants, four around SI rs and 7 around SI ms. 
These differences were not statistically significant (p=0.34). There was no significant 
difference when SI rs was compared with SI ms (p=0.28). Although no significant differences 
were found between HS and PDS for the incidence of abscess (p=0.15), there were 
significantly more abscesses in PDS sheep than HS around SI ms (machined-surface 
implants) (p=0.01). Low-power histological examples of implants from this experiment are 
shown in figures 3.51 to 3.63. 
3.5.5. Experiment 3a results: implant "acceptability" rates. 
Although all implants survived, (ie: were present in the animals as the time of sacrifice), 
histological observations suggested that not all implants could be considered as "acceptable". 
When implant "acceptability" was defined as an implant that survived and had cortical bone-
implant contact> 15%, it was found that all Southern Implants were "acceptable" but that two 
Dentsply implants ( one in HS and one in PDS) were not. Survival and "acceptability" rates 
are compared in table 3.12. Using this definition, the overall "acceptability" rate for two-
stage implants in this animal model was 95.8%. 
Table 3.12: Number and percent of implants surviving in all sheep and "acceptable" in 
healthy (HS), periodontally-diseased (PDS) sheep and all sheep, by implant type. 
Implant Type Survive Acceptable (BIC > 15 % ) 
N(%) HSN(%) PDS N (%) 
Dentsply TPS 16 (100%) 7 (87.5%) 7 (87.5%) 
Southern (rs) 16 (100%) 8 (100%) 8 (100%) 
Southern (ms) 8 (100%) 8 (100%) 
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3.5.6. Experiment 3a results: quantitative histomorphometric analysis. 
Overall mean results for each implant type/treatment are presented in Tables 3 .13 to 3 .15. 
Mean results for individual implants and for buccal and lingual surfaces are listed in the 
Appendices. Examples of the high-power images used for quantitative analysis are shown in 
Figures 3.64 to 3.74. 
3.5.7. Experiment 3a: HMA of implants in healthy and periodontally-diseased sheep. 
Comparison of buccal and lingual sec.tions ( or for DS TPS implants that were sectioned 
mesio-distally, mesial and distal) showed no statistically significant differences, with the 
exception of buccal and lingual measurements of % bone-implant contact for the whole 
implant perimeter. This showed highly significant differences (p<0.01 for each of the implant 
types) for buccal versus lingual but not mesial versus distal sections. As there were no 
differences between the key measurements (cortical and best-3-threads % BIC and all density 
measures), these were combined into a single mean for each implant. 
Comparison of two-stage submerged implants in HS and PDS revealed no significant 
differences for mean %BIC or mean %density except for stereological measurement of 
cortical % bone-implant contact around rough-surfaced Southern Implants, which was 
significantly higher in PDS (70.7±12.4%) than in HS (59.6± 13.2%, p=0.04). As a result of 
this, the rank order for bone-implant contact changed, with SI rs having the highest %BIC and 
% density in PDS and DS TPS the highest in HS. 
Comparison of the three different measurement techniques for percent bone-implant contact 
and the two techniques for percent bone density showed inconsistent results when each 
implant type was examined in the HS and PDS groups. Stereological measurements of %BIC 
in the cortical passage were almost twice the measurement over the whole implant (p<0.05) 
for each of the implant types, (individual paired comparisons in HS and in PDS). Best 3 BIC 
was significantly higher than Cortical stereological measurements for Dentsply TPS implants 
sectioned bucco-lingually in HS (71 versus 63%, p=0.03) but not significantly different in 
PDS. However, when the same implants were sectioned mesio-distally, no statistically 
significant difference could be detected between stereological and planar lineal (Best-3) 
measurements in either HS or PDS. Likewise, for rough-surfaced Southern Implants there was 
no significant difference between the two measures of cortical %BIC in either HS or PDS, 
whereas for the machined-surface Southern Implants, Best-3 % BIC was significantly lower 
than cortical stereology (p<0.05 for both HS and PDS). Percent density within threads (Best-
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3) was consistently and significantly lower than outside threads (stereology of cortical bone) 
for all implants in both HS and PDS (p<0.05) with the sole exception of mesio-distally 
sectioned Dentsply TPS implants in PDS. 
Comparisons of the effect of the section orientation (mesio-distal versus bucco-lingual 
sectioning techniques) on Dentsply TPS implants in HS and in PDS sheep revealed no 
statisitically significant differences except for cortical stereology of bone density. This was 
higher for bucco-lingual than mesio-distal sections in both groups although the difference was 
statistically significant only in PDS (88% versus 66%, p=0.04). 
Comparisons of different implant surfaces (machined, TPS, and grit-blasted/acid-conditioned) 
in HS and PDS revealed that Dentsply TPS occupied an intermediate position between the 
two SI implants for most measures and did not differ significantly from either SI implant for 
any measurement in either HS or PDS. Southern implants with machined surfaces differed 
from those with rough surfaces only in PDS sheep; all measures for % BIC were significantly 
higher (p<0.05) for rough-surfaced implants and the difference was highly significant when 
%BIC for best-3-threads was compared (75% versus 41 %, p= 0.006). There were no 
significant differences for either measurements of bone density. 
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Table 3.13: Mean results by implant type for percent Bone-to-Implant contact and percent 
bone density after 12 weeks for Healthy sheep (HS) only 
Bone-Implant contact Bone density 
Mean Mean Mean Mean Mean 
Cortical Whole Implant Best 3 Cortical% Best 3 % 
% BIC± SD % BIC ± SD % BIC ± SD Density± Density± 
SD SD 
63.4 ± 30.1 42.3 ± 21.9 71.1 ± 34.4 71.9 ± 28.4 65.2 ± 28.0 
58.6 ± 25.8 
59.6 ± 13.2 
64.4 ± 16.0 
43.8 ± 20.5 
39.6 ± 13.8 
41.3 ± 10.1 
54.2 ± 24.6 81.3 ± 22.8 69.5 ± 31.2 
1 Number of sheep in experiment 
2 Dentsply bucco-lingual sections 
3 Dentsply mesio-distal sections 
56.5 ± 22.6 86.4 ± 6.8 72.5 ± 8.5 
48.2 ± 18.3 87.4 ± 4.6 72.7 ± 14.6 
Table 3.14: Mean results by implant type for percent Bone-to-Implant contact and percent 
bone density after 12 weeks for Periodontally-diseased sheep (PDS) only 
Bone-Implant contact Bone density 
Mean Mean Mean Mean Mean 
Cortical Whole Implant Best 3 Cortical% Best 3 % 
% BIC± SD % BIC ± SD % BIC ± SD Density± Density± 
SD SD 
64.1 ± 29.8 35.1 ± 18.6 62.1 ± 31.5 66.3 ± 31.1 66.4 ± 27.1 
67.6 ± 28.0 
70.7 ± 12.4 
55.4±11.3 
1 Number of sheep in experiment 
2 Dentsply bucco-lingual sections 
3 Dentsply mesio-distal sections 
38.8 ± 19.3 
45.6 ± 11.1 
27.6 ± 15.6 
240 
59.1 ± 27.4 88.2 ± 10.6 63.7 ± 28.2 
75.1 ± 15.9 88.9 ± 4.6 74.3 ± 8.6 
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Figures 3.51 to 3.58. 3.51-3.55: DS tps implants (a)cross section and (b) A-P section, 3.51:Low density bone in HS, evidence 
of osteoconduction into marrow space. 3.52: Dense bone in HS but abscess in mid-cortical passage. 3.53: High % BIC and 
density in PDS, evidence of bone conduction into marrow space. 3.54: Abscess formation coronally in PDS, bone trabeculae 
extend into apical foramen. (b) shows osteoconduction into marrow space, (c) magnified detail of box. 3.55: Complete failure 
of integration in PDS. 3.56-3.58: Southern Implants machined surface (SI ms). 3.56: SI ms in HS. (a) Low BIC (b) high BIC. 
3.57: SI ms in HS. (a) high BIC, trabeculae extend into marrow (b) Similar appearance but with coronal abscess. 3.58: SI ms 











Figures 3.59 to 3.66. 3.59: SI ms in PDS. (a) high %BIC, coronal abscess; (b) failed integration. 3.60 SI rs in HS, (a)&(b) 
high BIC. 3.61: SI rs in HS; (a) low density bone, evidence of osteoconduction; (b) low density bone. 3.62: SI rs in PDS (a) 
high BIC; (b) coronal exposure and bone loss. 3.63: SI rs in PDS, (a)&(b) high BIC with evidence of apical osteoconduction. 
3.64: OS in HS (a) low density but high BIC due to osteoconductivity ofTPS; (b) dense bone with high BIC. 3.65 OS in 
PDS, (a) limited BIC (b) high BIC coronally, but inflammation present apically. 3.66: DS in HS: (a)&(b): active bone 
formation and high BIC. Rough TPS surface with (b) evidence of titanium particle migration. 
242 
3.5.8. Experiment 3a: HMA of implants in all sheep. 
The results for HS and PDS were combined into a single group of 16 sheep. (Table 3.15). 
When the two groups of sheep (healthy and diseased) were combined and each of the three 
types of implant compared, the mean percent bone-implant contact was very similar for 
Dentsply TPS and Southern rough-surfaced implants and could not be distinguished 
statistically. Southern rough-surfaced implants had higher %EiC than machined-surface 
implants and this was statisitically significant when the best-3-threads within the cortical 
passage were compared (66% versus 45%, p=0.003). 
The overall mean bone-implant contact for two-stage implants in the sheep mandibular model 
found in this experiment was 58% to 63% in the cortical passage (depending on the 
measurement technique used). Overall the use of stereology or direct computer-assisted 
measurements techniques did not find statistically different answers for bone-implant contact. 
Bone density measured outside the threads was slightly higher than within the best three 
threads but not significantly so. 
Table 3.15: Mean results by implant type for percent Bone-to-Implant contact and percent 
bone density after 12 weeks. Healthy sheep (HS) and Periodontally-diseased sheep (PDS) 
combined. 
Bone-Implant contact Bone density 
Mean Mean Mean Mean Mean 
Cortical Whole Implant Best 3 Cortical% Best 3 % 




·)!!l0i~~l~~ik .•• ', 
·. combined•· 
63.8 ± 29.0 
63.1 ± 26.4 
65.2 ± 13.6 
59.9 ± 14.2 
63 ± 21.5 
1 Number of sheep in experiment 
2 Dentsply bucco-lingual sections 
3 Dentsply mesio-distal sections 
4 Total number of implant sections combined 
38.7 ± 20.0 
41.3 ± 19.4 
42.6 ± 12.5 
34.5 ± 14.6 
39.2 ± 16.8 
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SD SD 
66.6 ± 32.2 84.7 ± 17.6 66.6 ± 28.9 
56.6 ± 25.3 69.1 ± 28.9 65.8 ± 26.6 
65.8 ± 21.2 87.6 ± 5.8 73.4 ± 8.3 
44.6 ± 19.2 83.9 ± 11.9 69.5 ± 16.8 
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Figures 3.67 to 3.74. 3.67 DS in HS. (a) Osteoconductive TPS (b) dense bone, high %BIC. 3.68:DS in PDS: trabeculae 
extend towards implant surface, low density bone, moderate BIC, Ti particles. 3.69 DS in PDS (a) dense bone, high BIC; 
(b) low density, high BIC; Ti particle loss. 3.70: SI (ms) in HS (a) bone extends into but doesn ' t fill threads (b) bone extends 
into threads but doesn't contact thread tips. 3.71: SI (ms) in PDS; bone doesn't contact thread tips; darker stain is 
remodelled bone. 3.72: SI ms (a) in HS(b) in PDS. Bone doesn't fill thread. 3.73: SI rs in (a) HS and (b) PDS. 
Osteoconductive surface.3.74: SI rs in (a) HS and (b) PDS. High bone density and high % BIC. 
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3.6. Experiment 3b. Transgingival ( one-stage, one-piece) Straumann ITI 
SLA-surface (ITI) and Nobel Biocare (NBC) Branemark machined-surface 
implants in periodontally-healthy and diseased sheep (HS & PDS). 
3.6.2. Experiment 3b: Clinical results. 
No animal showed any evidence of distress or infection. All animals survived to the end of 
the experiment. 
3.6.3. Experiment 3b: implant clinical survival rate. 
Five of 32 one-stage implants (15.6%) were lost before the animals were sacrificed. The 
overall implant survival rate was thus 84.4% (Table 7: 1). The survival rate by implant type 
for ITI implants was 93.8% and for Nobel Biocare (NBC) was 75%. Implant survival was 
slightly lower in PDS (81.3%) than HS (87.5%). Differences in survival rate between groups 
of sheep and between implant types were not statistically significant. 
Table 3.16. Clinically surviving one-stage ITI and Nobel Biocare (NBC) implants in 

















3.6.4. Experiment 3b: clinical and histological "acceptability" rates related to implant 
site preparation. 
Some problems were encountered following the extension of the extraction protocol to 
include the mandibular 3rd premolar. This tooth frequently has an undetected third root located 
to the distolingual; as a result, retained roots were found at 11 of 32 (34.4%) sites during 
implant placement. These roots were removed before drilling the osteotomy and placing the 
one-stage/transgingival Nobel Biocare (NBC) or ITI implants. Moreover, in 5 of 32 sites 
(15.6%) there were no residual roots but either suppuration from the P1 molar tooth or a large 
bony cavity was found, which in some cases caused the implant to be angled and/or unstable 
after placement. The total number of potentially compromised sites was 16 of 32 (50% ). 
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Overall "acceptability" rates and a comparison of the relationship between potentially 
compromised surgical sites at implant placement, clinically-evident implant failure and 
histologically-verified failure of osseointegration for the two implants types within all sheep 
is summarised in Table 3.17. Implant "acceptability" in this case was derived by including all 
implants present clinically after three months integration with stereologically-measured % 
BIC within the cortical passage of ~15%. "Ailing" implants were defined as those with less 
than 15% integration (including 0.0% Bone-implant contact); "failed" implants were those 
implants that had been lost. 
3.6.5. Clinical results for ITI implants. 
Five of 16 (31.3%) sheep had a retained root removed from the site immediately before 
placement of an ITI one-stage implant. One of 16 (6.3%) implants failed and this was 
associated with a retained root. This failure occurred in a diseased (PDS) sheep. No ITI 
implants failed in healthy (HS) sheep. The other four ITI implants associated with a retained 
root site had excellent integration ranging from 74% to 83% (measured stereologically within 
the cortical passage). 
Additionally, ITI implants were placed into three sites where there was a residual bone cavity, 
suppuration from the 1st molar, or the implant was angled or mobile after placement; none of 
these implants failed but one (in a healthy sheep) had very poor integration (6.0% bone-
implant contact) and was therefore deemed to be likely to fail. The other two angled and 
initially-mobile ITI implants had integration of 70% and 81 %. Both of the two ITI implants 
that were either exfoliated or has failed to integrate satisfactorily were associated with 
compromised sites. ITI implants placed into compromised sites appeared equally as likely to 
succeed as to fail. 
3.6.6. Clinical results for Nobel Biocare (NBC) implants. 
Six of 16 (37.5%) sheep had a retained root removed from the site immediately before 
placement of a Nobel Biocare (NBC) one-stage implant. Five NBC implants (31.5%) failed, 
of which four of 16 (25%) were associated with a retained root. Two failures occurred in HS 
and three in PDS. One NBC implant associated with a retained root survived and had 
excellent integration (79% ); the other had no integration (0.0%) and was being exfoliated 
from the site at the time the sheep was sacrificed. 
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The other two NBC implants that were lost were placed into sites where there was a residual 
bone cavity, suppuration from the 1st molar, or the implant was angled or mobile after 
placement. One other NBC implant was still in situ at sacrifice but had failed to integrate (0% 
BIC) and was not associated with either a retained root or poor site. Thus, of the eight NBC 
implants that had either been exfoliated or had failed to integrate, five (62.5%) had been 
placed into compromised surgical sites and three (37.5%) had not. NBC implants placed into 
compromised sites appeared to be seven time more likely to fail than to succeed (ie: be 
"acceptable"). 
Table 3.17. Number and percent of implants "acceptable" or failing m all sheep m 







2 (12.5%) 2 (12.5%) 
1 (6.3%) 7 (43.8%) 














3.6.7. Experiment 3b: summary of "acceptability" and failure rates. 
"Acceptability" rates were considerably lower than survival rates, since five implants were 
clinically present at sacrifice but proved to have little or no histological bone-to-implant 
contact. Ten of the one-stage implants were judged unacceptable (31.3% of the 32 implants in 
this experiment). The relationship between clinical survival and histological "acceptability" 
rates is shown in table 3.18. 
Table 3.18. Summary of survival and "acceptability" rates for one-piece non-submerged 














The overall implant "acceptability" rate was thus 68.8%. The "acceptability" rate by implant 
type for ITI implants was 87.5% and for Nobel Biocare (NBC) was 50%. "Acceptability" 
rates did not differ between healthy and diseased animals for either implant type (Table 3.19). 
Survival and "acceptable" integration of one-stage implants in the sheep model appears to 
depend upon an interaction between the health status of the intended implant site and the type 
of implant placed, but does not appear to depend upon the presence or absence of pre-existing 
periodontitis elsewhere in the oral cavity. 
Table 3.19. Number and percent of implants "acceptable" (%BIC>15%) in healthy (HS), 













Further sub-classification into "acceptable" "ail" or "fail" was undertaken, where 
"acceptable" was defined as "implant present & HMA%BIC>15%", "ailing" as "implant 
present, & HMA%BIC::s;15%"and "fail" as "implant not present". Alternative 
histomorphometric measures of bone-implant contact ("Cortical %EiC" "Whole implant 
%EiC" or "Best-3-threads % BIC") gave different totals for "acceptable", ailing and failing 
implants and the differences between each of these methods of classification were in most 
cases statistically significant. 
The worst case, that found when high-resolution, best-3-threads histomorphometric analysis 
was used to define "acceptability", is shown in Table 3.20. This illustrates the different 
responses of ITI SLA-surface and Branemark machined-surface implants to the presence of 
pre-existing periodontitis in a sheep mandibular model. ITI implants had a significantly better 
"acceptability" rate than NBC implants in periodontally-diseased animals (p=0.05) and 
overall in the sheep model (p=0.02). 
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Table 3.20. Number and percent of "acceptable", ailing and failing implants in healthy, 
diseased and all sheep, as defined computer-assisted best-three threads histomorphometric 


























Mean results for each implant type/treatment and each animal group are presented in Tables 
3.21. Mean results for individual implants and for buccal and lingual surfaces are listed in the 
Appendices. Examples of histology for NBC implants are shown in Figures 3.75 to 3.80 and 
for ITI implants, in Figures 3.81 to 3.90. 
3.6.9. Experiment 3b: HMA of implants in healthy and periodontally-diseased sheep and 
in all sheep combined. 
As there were no statistically-significant differences between buccal and lingual 
measurements for either of the implants types, the results were combined into means for each 
type of implant. There were no significant differences for either bone-implant contact or for 
bone density in HS and PDS per se. However, there was a difference in the osseous response 
to the two types of implants when periodontal disease was present. For ITI implants, %BIC 
was lower in HS than PDS (except for Best-3-threads measurements) and within threads 
density was higher. For NBC, both the % BIC and % density was lower in PDS (all 
measures). Due to the size of standard deviations and reduction in group sizes following 
implant losses, none of these differences were statistically significant. 
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When the animals were combined into a single group of 16 sheep, ITI implants had twice the 
percent bone-implant contact that machined-surface Branemark implants had, irrespective of 
the measurement technique (p<0.01 for all techniques). Bone was more dense around NBC 
implants but this difference was not statistically-significant. 
Table 3.21. Mean results by implant type for percent Bone-to-Implant contact and percent 
bone density after 12 weeks in Healthy sheep (HS), Periodontally-diseased sheep (PDS) and 
all sheep. 
Bone-Implant contact Bone density 
Mean Mean Mean Mean Mean 
Cortical Whole Best 3 Cortical% Best 3 % 
%BIC± Implant %BIC± Density± Density± 
SD %BIC± SD SD SD 
SD 
67.6 ± 25.3 46.6 ± 18.5 75.2 ± 13.3 68.4 ± 15.7 60.8 ± 21.8 
81.1±7.1 52.5 ± 13.8 70.6 ± 14.6 67.7 ± 18.0 53.6 ± 10.6 
73.9 ± 19.7 49.4 ± 16.1 72.9 ± 13.6 68.1 ± 16.2 57.2 ± 16.9 
NBC HS 41.0 ± 24.9 24.2 ± 15.5 37.0 ± 16.1 85.6 ± 3.1 78.6 ± 5.9 
PDS 33.0 ± 31.4 18.6 ± 20.8 21.5 ± 13.6 69.1 ± 20.0 59.2 ± 22.4 
36.6 ± 27.5 21.1 ± 18.0 29.3 ± 16.1 76.6 ± 16.7 68.9 ± 18.4 
One-stage 57.3 ± 27.6 38.0 ± 20.2 61.3 ± 23.5 75 ± 14.9 67.3 ± 19.4 
implants 58.9 ± 32.5 36.8 ± 24.2 52.8 ± 28.2 68.3 ± 18.2 55.6 ± 15.0 













Figures 3.75 to 3.82. 3.75: NBC in HS (a) sparse BIC and crestal bone loss (b) poor integration on buccal but no evidence 
of epithelial downgrowth. 3.76 NBC in PDS; (a) poor integration, apparent intrabony pocket has no epithelial lining. (b) 
good BIC but only at a few threads. 3.77: NBC in PDS (a) non-integration (b) implant being exfoliated. Neither shows 
signs of epithelial downgrowth. 3.78: (a) NBC in HS, poor integration, crestal bone loss; (b) NBC in PDS, intra-bony 
pocket; epithelium does not extend past first thread. 3.79: NBC in HS: bone within thread but not thread tips, Variable BIC. 
3.80: NBC in PDS: bone does not invest thread tips. 3.81: ITI in HS: low density but high BIC due to osetoconductive 













Figures 3.83 to 3.90. 3.83: ITI in HS, (a) high density, high% BIC (b) low density but high BIC, peri-implantitis present; 
osteoconductive nature of SLA surface visible in both figures. 3.84: ITI in PDS: (a) peri-implantitis, high %BIC (b) crestal 
bone loss, high BIC. 3.85: ITI in PDS. Two examples of peri-implantitis lesions. 3.86: ITI in PDS: examples of osteocond-
uctive surface. (a) high density and BIC (b) low density, high BIC. 3.87: ITI in PDS: (a) high density & BIC (b) low density, 
high BIC. 3.88: ITI in HS: (a) poor contact on thread tips (b) high density & BIC. 3.89: ITI in PDS: both show a thin layer 
of bone following the osteoconductive surface. 3.90: ITI in PDS. Dense bone with excellent % bone-implant contact. 
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3. 7. Experiment 4a. Meta-analysis of results in the sheep mandibular model 
for dental implants 
3.7.2. Comparison of implant surfaces. 
Scanning electron micrographs made of the seven principal implant types used in the current 
study at 100 x magnification andl25,000 x magnification are shown in Figure 3.91. Results of 
analysis of these micrographs are shown in Tables 3.21 and 3.22. 
Table 3.2Z. Surface features of implants from SEMs taken at lO0x magnification. 
Thread angle Thread cutting Flat width Peak-peak 
(pitch)1 edge (interthread distance (µm)5 
(degrees) width (µm) distance)1 (pm) 
120 70 60 0.5 
125 3 90 75 0.5 
Southern machinerr 120 80 70 0.5 
Southern rough 120 80 60 0.5 
SteriOss HA 110 (upper) 2 110 210 0.5 
135 (lower) 
120 80 120 0.5 
ITISLA 115 (upper) 2 120 750 4 1.1 
120 (lower) 
1. Cutting width and flat width are estimates and depend on angulation of implant in SEM. Flats are generally curved; rough-
surfaced implants also have "rounded-off" cutting edges. 
2
· Angulations for ITI and SteriOss HA were difficult to measure because threads are not straight-sided. The lower and upper 
parts of the thread were measured. 
3
· Dentsply TPS angulation were more difficult to read because of rough surface 
4
· Much wider flats for ITI - well-spaced threads. 
5
· Most peak-peak distances were approximately 530 µm. 



















3.9 ± 0.4 
3.27 - 4.65 
Plasma-sprayed Blasted/eroded 
Diameter of globules Diameter of pits 
(µm± SD) (µm±SD) 
range range 
3.9 ± 2.3 
1.6 - 11.3 
1.1 ± 0.5 
0.34 - 2.41 
1.9 ± 0.8 
1.2-3.9 
10.1 ± 7.5 
3.29-36.97 
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Figure 3.91. Scanning electron micrography of seven types of implants placed 
into sheep mandibles; (top) threads at l00x magnification; (bottom) surfaces at 
1.25K x magnification. 
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Both the Dentsply and the Branemark implant machined surfaces had vertical grooves 
although these were less prominent on the latter. The Southern machined implants had groups 
of prominent vertical grooves that were well spaced as well as closely-spaced finer grooves 
similar to Branemark implants; superimposed on these grooves was an irregular pattern of 
horizontal ridges, ranging from 0.62 to 1.39 µm in width (mean 0.9 ± 0.2 µm) which in 
combination with the straight vertical lines formed an irregular mesh-like surface pattern. 
SteriOss HA surfaces had smaller unmelted globules and more areas that were melted and 
fused compared with the titanium globules of the Dentsply TPS surface. The Southern blasted 
and acid-conditioned surface had square and parallel-sided or orthagonal pits abraded into the 
implant surface; the pits were larger and the surface was much more irregular than that of the 
ITI blasted and acid-etched surface. The latter had a relatively homogenous surface consisting 
of regular small rounded pits. 
3.7.3. Number of sections analysed for each experimental year. 
Table 3.23 shows the number of sections analysed for each experimental year. All analyses 
except Original BIC and Original Density (not shown in table) were performed at one time. 
Table 3.24: Number of sections analysed for each separate measurement technique 
Cortical Whole Implant Best3 Cortical Best3 
BIC BIC BIC Density Density 
12 12 12 11 12 
33 33 18 33 18 
90 90 86 90 86 
135 135 116 134 116 
3.7.4. Effect of experiment year and surgeon experience. 
Yearly means for survival/"acceptability" are shown in Figure 3.92. Of the 132 implants 
placed in three experiments over three years, 119 (90.2%) survived clinically and 106 (80.3%) 
















Year l submerged Year 2 submerged Year 3 submerged Year 3 non-submerged 
- survive 75.0% 88.9% 100.0% 84.4% 
- succeed 56.3% 80.6% 95.8% 68.8% 
Year of Experiment 
Figure 3.92: Percent of implants clinically surviving and histologically successful, 
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** = p<{).01 
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Year l ('97) Year 2 ('98) Year 3 ('99) 
28.0 ** 56.0 NS 61.6 
10.0 ** 33.0 NS 38.7 
15.0 ** 65.0 NS 58.l 
84.0 NS 79.0 NS 78.5 
42.0 ** 65.0 
~ .... 66.9 
Year ofExperiment(s) 
Figure 3.93: Mean %Bone-Implant contact and %Bone density from Year One to 
Year Three. 
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Statistical analysis of %BIC showed statistically-significant improvements (p<0.01) in bone-
implant contact from Year 1 to Year 2 for all three methods of analysis (Table 3.24 and 
Figure 3.93). Minor but insignificant improvements also occurred from Year 2 to 3 except for 
Best 3 % BIC which worsened slightly (but not significantly). 
Best 3 % density followed a similar pattern with significant improvements from Year 1 to 
Year 2 (p<0.01), and from Year 2 to Year 3 (p=0.04). Cortical density is a measurement that 
appears to have been relatively unaffected by surgery, a factor reinforced by the lack of 
difference across all three years. Density of the sheep mandibular bone at a distance from the 
implant threads appears to have been relatively homogenous. 
Experiment year and measurements of bone-implant contact and bone density had weak but 
statistically significant positive correlations (r=0.29 to 0.33, p<0.01) except for cortical bone 
density which showed almost no relationship at all (r=-0.06). Comparison of the only implant 
type that was constant between year 2 and 3, Dentsply TPS, showed no statistically-
significant differences for any measurement. 
Table 3.25: Mean of combined measurements for Bone-implant contact for all implants, 
grouped by year (Experiments 1-3). 
Bone-Implant contact 
1 N1 = Number of sheep 
2 N2 = Number of implants placed 




28.0 ± 19.0 10.0 ± 08.0 
[12] [12] 
56.0 ± 25.0 33.0 ± 20.0 
[33] [33] 
61.6 ± 24.0 38.7 ± 18.3 
[90] [90] 
5 Computer-assisted linear measurements 
6 DS measured twice (B-L and M-D); total N2 = 96 
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Best-35 
15.0 ± 19.0 
[12] 
65.0 ± 24.0 
[18] 





84.0 ± 05.0 42.0 ± 32.0 
[11] [12] 
79.0 ± 19.0 65.0± 20.0 
[33] [18] 
78.5 ± 18.9 66.9 ± 20.8 
[90] [86] 
3.7.5. Rank-order of percent bone-implant contact by implant surface. 
The rank-order by implant type for the two measurements of bone-implant contact within the 
cortical passage (cortical stereology and best-3-threads %BIC) showed a strong, positive and 
statistically-significant correlation (rho=0.79, p<0.01). This relationship is shown graphically 
in Figure 3.94. The rank order of implant surfaces by Best-3-threads percent bone-implant 
contact was (from poorest to best) was as follows (see Figure 3.95 for key to abbreviations): 
DS (ms)< NBC< DS (TPS) 98 < SI (ms)< DS (TPS) 99 < SI (rs)< ITI< Steri. 
3.7.6. Rank-order of percent density by implant surface. 
Within-threads density measured for the best-3-threads showed a moderate relationship to 
both measures of bone-implant contact; cortical%BIC (rho=0.45, p<0.01) and best-3-threads 
%BIC (rho=0.53, p<0.01). Outside-threads density was moderately correlated to within-
threads density (rho=0/49, p<0.01) but had only a weak relationship with the bone-implant 
contact (rho=::;0.033, p<0.01). 
The relationship between Best-3-threads %bone-implant contact and within-threads percent 
density is shown in figure 3.55. In this graph it can be seen that the two highest-ranked 
implant surfaces with respect to bone-implant contact, SteriOss HA and ITI SLA, are not 
accompanied by an equivalent increase in within-threads bone density. A similar pattern 
emerges when stereological measurements of bone-implant contact and bone density within 
the cortical passage are compared (Figure 3.56); in this case ITI implants appear to be the 
only implant surface to exert a marked negative effect on the lamellar bone of the cortex 
>l000µm from the implant surface. 
Ranking the implant types by mean differences between cortical %BIC - best-3 %BIC 
demonstrated a range (Figure 3.98), from marked disagreement between the two measures of 
bone-implant contact, as was seen with SteriOss HA and Southern machined, to implant 
surfaces where the two were very similar, such as Southern blasted/acid -conditioned and ITI 
blasted and acid-etched. The only surfaces with statistically significant differences were the 
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Figure 3.94. Rank order of implant types by percent bone-implant contact: 
agreement between stereology of cortical passage (BIC Sl) and best-3-threads 
(B3 BIC). 
100 -- -Key: ---------------------------------------------------------------------------------------
OS (ms) Dentsply machined surface 
90 
NBC Nobel Biocare Branemarl< machined surface 
- - ·os-(TPSJ 9g -oenlsplftitan7urii plasarii--sprayoo surface, -1 ggg - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
SI (ms) Southern Implants machined surface 
80 __ OS lTPSl 99 _Dentsp)Y titanium plasam-sprayed surfaceJ 1999 ••• _. ________________________ _ 
SI (rs) Southern implants, rough (blasted) surface 
ITI ITI sandblasted, acid-etched surface 
70 - - .Steri- - - - - - -SteriOss -hydroxyapatitesurface - - --- - - - - - - -- - -- - -- - - - - - - --- - -










DS (ms) NBC DS (TPS) 98 SI (ms) DS (TPS) 99 SI (rs) ITI Steri 
Implant Type 
Figure 3.95. Rank order of implant types by percent bone-implant contact (slope 
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Figure 3.96. Relationship between percent bone-implant contact (B3 BIC) and bone 
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Figure 3.97. Relationship between percent bone-implant contact (BIC SI) and bone 
density (S 1 Den) measured using stereological analysis within the cortical passage. 
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Steri DS (TPS) 99 SI (rs) ITI NBC DS (TPS) 98 DS (ms) SI (ms) 
Implant Types 
Figure 3.98. Implant types, rank order by mean difference between Cortical 
stereology and Best-3-threads % bone-implant contact. 
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3.7.7. Experiment 4a results: regression analysis of the sheep animal model. 
Using a mixed model ( combining fixed and random effects) of Generalised Least Squares 
(GLS) regression, the effects of different variables were investigated with respect to outcome 
measures for bone-implant contact and bone density. In this model, each outcome measure 
was tested for significance after adjusting for all other variables, with NBC machined-surface 
implants used as the reference. 
SteriOss and ITI implants both had significantly higher Cortical Stereological %BIC than 
Nobel Biocare machined surface implants (X2, P<0.01). Similar results were found for Whole 
Implant Stereology %BIC; SteriOss and ITI implants both had significantly greater %BIC 
(P<0.05 and P<0.01 respectively) whilst Dentsply TPS implants with either TGFB and/or 
bone grafts were significantly lower (P<0.05). For this outcome measure, placement of 
implants into the middle position (as opposed to posterior or anterior) also had a significant 
effect on bone-implant contact (P<0.05). 
For Best3-threads %BIC, ITI implants showed a significantly better performance (P<0.01) as 
did Dentsply TPS implants placed in 1999 (P<0.05); Dentsply TPS implants placed in 1998 
showed a significantly poorer performance (P<0.01). Year of surgery also had a significant 
interaction with best-3-threads % BIC (P<0.01). 
Outside-threads stereological measurement of percent bone density in the cortical passage 
showed no significant relationship to any of the variables including implant type. When bone 
density was considered within-threads, Dentsply machined surface implants had significantly 
less dense bone than the other implant surfaces (P<0.05). 
Data was then recoded into three groups: implants with machined ("smooth"), roughened 
("rough") and HA-coated surfaces ("ceramic"). The distribution of implants into these groups 
is discussed in the next section (see Table 3.30). The regression model was re-run for the 
three measures of percent bone-implant contact, firstly using smooth implants as the reference 
and then using ceramic implants. 
Results showed that there were statistically significant differences between the different 
implant groups for all three measures of BIC irrespective of the other variables interacting 
with the model. With smooth-surfaced implants as reference, ceramic implants were 
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significantly higher than smooth implants both for cortical stereology %BIC (P=0.001) and 
whole implant stereology %BIC (P=0.000). The year of surgery also significantly affected 
whole implant %BIC measurements, with year 3 significantly higher than year 1 (P=0.007). 
When the output measurement Best-3-threads was considered, both rough and ceramic 
implants had much higher% BIC and this was statistically significant (P=0.04 and P=0.000 
respectively). 
The model was also run using ceramic implants as reference. Unlike smooth implants which 
grouped Denstply ms, Noble Biocare and Southern ms implants, ceramic implants consisted 
only of SteriOss HA-surface implants and unsurprisingly comprised a more homogenous 
group. Differences between the three groups of surfaces were more pronounced. For cortical 
stereology, both machined and rough implants had significantly lower% BIC than ceramic 
(P<0.01 for both) and likewise for whole implant stereology (P=0.000 for both pair-wise 
comparisons). In the latter, year of surgery was again significant (P=0.007). Smooth and 
rough implants also had significantly lower best-3-threads % BIC than ceramic (P<0.01 for 
both). 
Overall, regression analysis suggested that the observed differences in bone-implant contact 
between implants in the sheep mandibular model, grouped by implant types or surfaces, 
represents real differences between these implants. Bone-implant contact in this animal model 
appears to be relatively independent of other variables. 
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3.8. Experiment 4b. Systematic literature search and partial meta-analysis 
of solid titanium screw implants with "smooth", "rough" or "ceramic" 
surfaces placed into different animal species and compared with dental 
implants in the sheep mandible. 
The multiple search strategies yielded > 1000 papers and abstracts. The literature was 
reviewed comprehensively from 1966 to mid-2002; additional papers from mid-2002 to mid-
2004 were also included but the literature during this period was not exhaustively scrutinised. 
3.8.2 Experiment 4b: papers included in the meta-analysis. 
For threaded, solid-screw implants, data was tabulated from 78 papers for smooth-surfaced 
implants, 50 papers for rough-surfaced implants and 28 papers for ceramic-surfaced implants 
(Table 3.26). The distribution of papers, implants and animals by species and is shown in 
Table 3.27. A total of 108 papers contained histomorphometric analyses that were tabulated. 
This is lower than the total shown in Table 3.26; some papers listed data for multiple surfaces 
and a small number of papers included data for multiple species. This data is an estimate of 
the total number of data entries. In some cases multiple results were included for the same 
implant, and in some experiments multiple implants were placed into the same animal. 
Data for unthreaded cylindrical solid- and hollow-screw implants were tabulated as shown in 
tables 3.28 and 3.29. For comparison, the total distribution of data from implants placed into 
the sheep mandibular model in this work is shown in table 3.30. 
Table 3.26. Total papers reviewed, showing implant surface type and the total numbers of 
implants and animals in those papers, for solid screw implants. 
Implant.group N Papers N Implants N animals 
Total smooth 78 1282 957 
Total :rough 50 1098 901 
Totalcerarriic 28 649 549 
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Table 3.27. Total of papers, implants and animals reviewed, broken down by animal species; 
solid screw implants. 
N Papers N Implants N animals 
50 1165 1118 
20 294 152 
11 231 255 
36 719 434 
4 105 84 
6 154 67 
5 66 50 
24 295 247 
265 
Table 3.28. Total papers reviewed, showing implant surface types and the total number of 













Table 3.29. Total of papers, implants and animals reviewed, broken down by animal species, 
for cylindrical unthreaded implants. 
N Papers N Implants N animals 
3 60 18 
2 520 24 
Goat 5 275 345 
Dog 10 198 100 
Pig 1 120 3 
Non-:humanprimate 4 50 103 
Human 2 6 5 
Table 3.30. Total number solid-screw implants placed into sheep in experiments in this work, 














3.8.3. Experiment 4b: data extracted for meta-analysis. 
Percent bone-to-implant contact and bone density derived from the histomorphometric 
analysis of solid titanium screw implants placed into sheep mandibles in the current 
investigation, regrouped for meta-analysis into "smooth", "rough" and "ceramic" surfaces, are 
shown in table 3.31. 
Percent bone-implant contact for solid-screw implants in various animal models identified by 
the systematic review and separated into "smooth", "rough" and "ceramic" surfaces are 
shown in the Appendices (tables 8 to 10 respectively). Percent bone density within implant 
threads of solid screw implants is shown in Appendix table 11. Percent bone density 
measured outside implant threads is shown in table Appendic table 12 
Data frompapers where implants were placed in various skeletal sites in sheep are shown in 
Appendix table 13. Bone-to-implant contact for ceramic coated unthreaded (cylindrical) 
implants is shown in Appendix table 14, for hollow cylinder implants in Appendix table 15 
and for solid cylindrical rough-surfaced implants, in Appendix table 16. 
Table 3.31 Implants placed into sheep mandibles in this work, reclassified into "smooth", 
"rough" or "ceramic" for meta-analysis, showing mean percent BIC, mean percent within-












3.8.4. Experiment 4b: graphic comparisons with other animal models. 
To facilitate inter-species comparison, results were grouped by healing period into less than 
one month, one to three months, three to six months, six to twelve months, and greater than 
twelve months healing. Means were then calculated for each healing period for the three 
implant surface types in different animals species and sites. Means derived using this 
methodology for implants placed into sheep mandibles, as part of this work, are shown in 
Figures 3.99 to 3.101. 
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3.8.5. Experiment 4b: Results for limb versus skeletal models in sheep and goats. 
Both ovine and caprine models showed clear differences between the reported results for 
limbs and intra-oral skeletal sites. Mean bone-implant contact in sheep maxilla and sheep 
limbs, where healing time "t" in months was 1 <t:::;3, compared with the results for the sheep 
mandibular model, is shown in Figure 3.102. Figures for "rough" implants in sheep maxilla 
were not available for this time period, however the degree of separation of ceramic and 
smooth surfaces is similar in the maxilla and mandible whereas results in the sheep long-
bones are more homogenous. 
Comparison of bone-implant contact in the goat maxillary and goat femoral models show 
even more marked differences (Figure 3.103). Outside-threads bone density also shows a 
different response to implant surfaces when the results in this investigation for the sheep 
mandible are compared with results in sheep limbs (Figure 3.104). 
3.8.6. Experiment 4b: Bone-implant contact in different animal models and in humans. 
Bone-implant contact for threaded implants generally reflected the same rank order for 
surfaces as was found for the sheep mandibular model in the current study, namely 
ceramic>rough>smooth. In rabbit limb models, bone-implant contact peaked for ceramic 
surfaces at approximately 3 months and then dropped to a level below that of implants with 
rough surfaces. %BIC for smooth surfaced implants reached a plateau after approximately 6 
month (Figure 3.105). 
In sheep limb models, ceramic surfaces peaked later (at approximately 6 months) and then 
dropped, but were still superior to rough surfaces at approx. 12 months. Smooth surfaces 
dropped dramatically after about 12 months (Figure 3.106). 
In the dog jaw (Figure 3.107), ceramic implants had the highest initial bone-implant contact 
but this dropped steadily over time to be the lowest of the three surfaces at times greater than 
12 months. Smooth surfaces showed the opposite trend, increasing steadily over time, 
whereas rough surfaces remained intermediate between smooth and ceramic surfaces up to 
around 12 months, at which time the differences between smooth and rough became 
negligible. 
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Non-human primate jaw models (Figure 3.108) suggest that rough surfaces have better bone-
implant contact than smooth or ceramic after 3 months. Smooth surfaces steadily increased in 
% BIC over time but rough surfaces did not; both fell away at time intervals > 12 months, 
Ceramic surfaces appeared to continue to increase after 12 months. 
Results for human subjects (Figure 3.109) are based on a heterogenous collection of post-
mortem retrievals, retrieved failing implants and implants biopsied during a formal 
prospective study. The latter is represented by a very small number of implants. Overall, 
smooth surfaces seemed to have lower initial bone-implant contact but this increased over 
time. Rough surfaces appeared to have higher %BIC that was maintained at time intervals 
greater than 1 year. Ceramic implants had the highest % BIC but this peaked at approximately 
12 months and then decreased to a lower level than the other surfaces, at time intervals greater 
than 12 months. The degree of separation between the different surfaces is more marked than 
is seen in the animal models. 
3.8.7. Experiment 4b: Bone-implant contact by implant surfaces in different animal 
species and sites after 3 months healing, compared to implants in the sheep mandible. 
Results were compared by grouping implants by surfaces and comparing animal models either 
for either threaded implants alone, (Figure 3.110) or with unthreaded cylinders included, 
(Figure 3 .111) after approx. 3 months healing - corresponding to the healing period for the 
sheep mandibular model. Results for implants in the sheep mandibular model (from the 
current investigation) are shown on the far left of the graphs. 
There was clearly a wide separation between the reported histological data for smooth, rough 
and ceramic surfaces in human subjects. The differences between surfaces in rabbits are less 
marked, particularly for smooth and rough surfaces; in the rabbit model, small differences 
may be accentuated due to the inbred nature of the animals and the reduced between-animal 
variability. 
Goat maxillae gave an aberrant result due to the poor performance of rough-surfaced 
implants. Ceramic implants appear to perform worse than or only slightly better than rough-
surfaced implants in non-human primate (NHP) models. 
All other models resembled the rank order seen in the sheep mandible, ie: ceramic surfaces > 
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rough surfaces >smooth surfaces. Dog jaw models did not distinguish between implant 
surfaces as clearly as the sheep mandibular model. Results were similar when cylindrical 
unthreaded implants were included. 
Previously-published results for sheep maxilla and mandible appeared anomalous. The results 
for implants placed in sheep mandibles in this study most closely resembled the results 
reported for the pig and for rabbit limbs. Sheep limbs appeared to be a poorer model for 
distinguishing between different implant surfaces than the sheep mandible. 
3.8.8. Experiment 4b: Rank-order of bone-implant contact for smooth, rough and 
· ceramic-surfaced implants in different animal models. 
The mean bone-implant contact for smooth, rough, ceramic and for all surfaces combined, 
after three months healing, were grouped by rank order and compared graphically with results 
for the sheep mandibular model after three months healing (Figures 3.112 to 3.115) In these 
graphs, the inclusion of cylindrical unthreaded implants in the mean data is indicated by an 
asterix (*). Data is ranked in descending order from left to right but with results for the sheep 
mandible from this work located on the far left column and highlighted with a bold colour. 
Implants in the sheep mandibular model appeared to behave in a similar fashion to other 
animal models. There were encouraging similarities to the responses of implants in non-
human primate animal models and in humans subjects, especially for rough-surfaced and 
ceramic-surfaced implants. 
3.8.9. Experiment 4b: Within-threads density in different animal models. 
Within-thread bone density tended to increase with time in most species. Density within the 
threads of smooth surfaced-implants tended to be superior to rough, and rough superior to 
ceramic, for humans, dogs and rabbits, but not for sheep limbs or the sheep mandibular model 
(data not shown graphically). Both within- and outside-thread density may depend more upon 
the species and site into which the implant is placed, than upon the implant surface. When 
within-thread density was combined and the mean of "smooth" plus "rough" plus "ceramic" 
compared for different species over time, the general tendency for within-thread bone density 
to increase over time was confirmed. (Figure 3.116). 
3.8.10. Experiment 4b: Outside-thread bone density in different animal models. 
Comparison of the combined (smooth + rough + ceramic) outside-thread bone density for 
270 
different species showed differences in the response of the bony site over time (Figure 3.117). 
Both sheep limbs and sheep mandibular bone (the latter indicated by an asterix and red arrow 
in the graph) appeared markedly more dense than other animal species. Rabbit bone appeared 
to become slightly more dense between 1-3 months and then returned to a baseline level. Goat 
bone was of low density and did not change over time; human bone became less dense; dog 
bone was more dense than goat or human with little change over time; non-human primate 
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Figure 3.107: Bone-implant contact over time by implant 
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Chapter 4: Discussion 
4.1. Critical size defects in sheep mandibular model. 
In the current study, experiments were conducted to gain insight into the healing 
characteristics of the edentulous diastema region of the sheep mandible. Unilateral, 
unicortical, criticial size defects (CSD) of differing size and chronicity were created. The 
sheep demonstrated a high rate and degree of healing within mandibular bone wounds. Access 
for surgical procedures was good and the animals tolerated surgery well. A feature of healing 
was an increase in the thickness of the cortex lingual and apical to the defect that was created 
on the buccal of the mandibular diastema. The most likely explanation is that this hyperplastic 
response occurred in order to restore the resistance of the mandible to bending forces during 
grazing and mastication that had been reduced following wounding. Wolffs Law479• 872 states 
that "every change in the form and the function of a bone or of their function alone is 
followed by certain definite changes in their external architecture, and equally definite 
secondary changes in their external conformation, in accordance with mathematical laws". 
The results of these experiments support the following conclusions: 
(1) the critical size for a unicortical, circular, acute defect in sheep mandibular bone is 
greater than 12mm; 
(2) unstabilised GoreTex Soft Tissue Patch retards healing rather than accelerating it; 
(3) placement of a Teflon disc to convert the defect to a chronic healing model was 
unsuccessful. 
The superior-to-inferior height of the sheep mandible in this region is approximately 15mm. 
Due to these anatomical limitations, defects with a larger diameter could not be created in this 
skeletal site. Attempts to convert the defect into a chronic wound by implanting Teflon discs 
were unsuccessful, although the impressive healing around the implanted biomaterials was 
encouraging with respect to the potential of the site for placement of titanium endosseous 
dental implants. 
The creation of a bicortical defect in this site was considered. However, the floor of the mouth 
terminates near the superior border of the mandible in this region. In addition, a bicortical 
defect would require the ablation of the central marrow including the inferior dental 
neurovascular structures. It was considered that a bicortical defect could not be created in this 
anatomical location without unacceptable consequences for the animal. A pilot study 
investigating the suitability of the angle of the sheep mandible for a through-and-through 
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defect similar to that employed in rats134 was also unsuccessful; others have since attempted to 
use this site in sheep and reported complications.305• 535 
4.1.2. Anatomical studies. 
Following the critical size defect experiments, further anatomical studies were undertaken. 
These suggested that either a non-extraction model (sheep edentulous mandibular diastema) 
or a healed-post extraction model could be used to test dental implants. The initial pilot 
experiment examined a non-extraction model utilising the edentulous diastema. Two reports 
exist regarding the use of this region, both published subsequent to the pilot experiment 
undertaken in the current investigation. Rodrigues Y Baena et al. (1998) placed one Dentsply 
ScrewVent implant into the mandibular diastema of one sheep and reported that it was 
unsuccessful;141 Frisken et al. (2002) reported that machined-surface Branemark implants 
were 83% successful when placed into the sheep mandibular diastema for four or twelve 
weeks.306 No histological investigation undertaken in either paper. 
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4.2. Discussion: dental implants in sheep mandibular model. 
The results of the pilot study in this study showed that Dentsply Screw-Vent machined-
surface implants performed poorly in this animal model. Possible reasons for this were (1) 
internally-irrigated spade drills caused overheating in the dense cortical bone of the diastema 
region, (2) there was insufficient cortical bone to retain an implant and (3) the implant design 
worked poorly in this animal model, especially when the unthreaded head of the implant was 
the only part of the implant lodged within cortical bone. 
The decision was made to use a healed post-extraction ridge model, as this would provide 
more antero-posterior length (accommodating more implants/animal) as well as greater 
cortical bone height. In addition, the surgical protocol was changed. A clone of a proven 
implant design (Swede-Vent clone of Branemark mark II machined-surface implant) was 
employed and externally-irrigated disposable twist drills were used to prepare the osteotomy. 
It has been reported that Screw-Vent implants have a seven-year success rate of 65.2% for 
mandibular and 43.5% for maxillary implants in human patients and that these implants failed 
to meet the success criteria proposed by the European Academy for Periodontology.35 
Maximum stress in a finite-element model was reported to located within the implant collar 
immediately below the bony crest in these implants,873 which would account for the high 
failure rate in the pilot study. 
4.2.2. Machined-surface implants in a healed, post-extraction ridge 
In the first full implant experiment, paired Denstply SwedeVent machined surface implants 
were compared with tooth sockets in the healed extraction ridge. Clinical survival rates were 
poor (75% ). In this experiment, protocols for ground-section histology were developed and 
various histomorphometric analysis techniques were tried. Initial ("Original") low-resolution 
computer-assisted HMA measurements seemed to over-estimate bone-implant contact. Use of 
high-resolution stereology and computer-assisted HMA (Best-3-threads) was therefore 
justified. 
There was marked variability in% bone-implant contact and% bone density amongst the five 
methods of analysis. Mean %BIC ranged from 9.7 to 28.1 % and density ranged from 41.7 to 
83.7%. Measurements varied due to a combination of the magnification/ resolution of the 
implant/bone interface and the different sites measured (all threads versus cortical threads 
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versus representative best 3 threads %BIC; within-thread versus outside-thread %density). 
The most accurate method would have been to measure all the threads, over the whole 
implant, using high-resolution computer-assisted histomorphometric analysis (as used for the 
later "Best 3 threads" technique). However, this would have been prohibitively expensive in 
terms of time and labour. As has been shown elsewhere, caution is required in comparing 
results derived from studies where different measurement protocols have been used.385 
A feature of this experiment was the finding that, in some animals, all implants integrated 
well, in other animals all the implants integrated poorly, and in some sheep, all implants failed 
and were lost. This clustering phenomenon has been reported in human populations treated 
with dental implants. 874' 454' 875' 876 Major factors responsible for clusters of implant failures in 
human subjects appear to be smoking, bruxism and lack of bone support.877 The reasons for 
this clustering of failures in some sheep and not others are unknown, but may be related to 
microbiological flora and antibody titres. 127 
A similar degree of healing was found within tooth sockets and around dental implants after 
three months healing. The presence of the implants in the sheep mandible did not appear to 
retard bone healing. However, clinical survival of implants and histological percent bone-
implant contact for machined-surface implants appeared to be poor in this animal model. 
Possible reasons for this included (1) the type of implant surface and (2) that this animal 
model was inappropriate for testing dental implant. To distinguish between these two 
possibilities, a further experiment was performed using implants from the same manufacturer, 
but with rough (TPS) surfaces. Implants from a different manufacturer with a bioactive (HA) 
surface were also studied, to provide a positive control since the HA surface was expected to 
inetrgate well. In addition, the possibility that growth factors and/or bone grafts might 
enhance implant integration was studied using an impaction bone-grafting technique. 
4.2.3. The effect of different surfaces (rough or ceramic), bone grafts and growth factor. 
In the second experiment, Dentsply TPS-surface implants were compared with SteriOss HA-
surface implants and with Dentsply TPS implants accompanied by either bone grafting or 
bone grafts plus the growth factor TGF-B. Overall, the rate of clinical survival was 88.9% and 
"acceptability" (a surrogate measure of success) was 80.6%. This was better than the previous 
experiment. Survival and "acceptability" rates for SteriOss HA (100% for each) were 
particularly good. 
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Percent BIC and % density increased around SteriOss HA-surface implants with increasing 
healing time (from 9.5 to 12 weeks) but decreased around Dentsply TPS-surfaces during the 
same period of time in the same animals. Results for HA-coated Sterioss were more 
homogeneous across all sheep (as seen in a lower standard deviation). SteriOss implants with 
HA surfaces developed more percent bone-implant contact, as measured using three different 
techniques, when compared with the titanium plasma-sprayed surfaces. The relatively high 
survival rate and bone-implant contact of both TPS and HA-coated commercially-available 
implants was encouraging, as this suggested that poor results in the previous experiment were 
related more to the surface of the implants (machined versus TPS or HA) than any inherent 
deficiencies in the animal model. 
The use of a blinded, Latin-Square distribution for the implants in this experiment confirmed 
that bone-implant contact and bone density is independent of site (either left versus right side 
or anterior versus posterior location in the jaw). The two measurement techniques -
stereological measurement of the cortical passage and computer-assisted lineal analysis of 
best-3-threads - appeared to give similar data. 
Both bone grafting and bone-grafting plus TGF-B gave poorer results than Dentsply TPS 
implants without grafting, although the statistical significance of these results was masked by 
high standard deviations. Grafted implants were also more likely to fail. The utility of the 
sheep mandible as a model for impaction grafting and/or growth factor application remains to 
be verified. Although type 1 collagen combined with demineralised bone is considered a safe 
and efficacious carrier for bone morphogenetic proteins,878 the effect of combining 
autogenous bone and transforming-growth factor B is unknown. Possible reasons for poor 
performance in this sheep model include an immunological reaction stimulated by the 
xenogenic type 1 collagen or bacterial contamination of the graft during harvesting. The TGF-
B used in this experiment had previously been used in sheep mandibular bone without ill-
effect. 
4.2.4. Mineral apposition rate in the sheep mandible, 
The mineral apposition rate or MAR for sheep was similar for both HA-coated and TPS-
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coated implants and ranged from 0.26 µm/day close to the implant surface, to 0.48µm/day at a 
distance from the osteotomy site. Others have reported that the MAR for sheep femurs 
implanted with machined-surface implants after 3 months healing was l .38µm/day adjacent 
to the implant and 0.98µm/day at a distance.314 After 6 months there was little change 
(MAR-adj= 1.18 and MARdist = 0.88 µm/day). Other have shown a range for MAR in sheep 
long-bones in response to different implant surfaces. Results ranged from 0.52 to 1.38 µm/day 
after 8 weeks healing, to 0.76 to l.46µm/day after 12 weeks.403• 315 
It has been suggested that the average mineral apposition rates in humans varies from 
5µm/day in cortical bone to 500µm/day in medullary bone.879• 880 In rabbit tibiae, the average 
MAR around titanium-alloy screw-type implants after 12 weeks healing ranged from 1.82 to 
2.35 µm/day in original bone and 2.55 to 2.80µm/day in newly-formed bone. 344 The mean 
MAR for long bones in dogs has been given as 0.9 ± 0.2 µm/day. 881 
The rate of healing in the sheep mandibular model seems to be lower than sheep limbs over a 
comparable healing period. The relevance of the differences between this MAR and those 
reported for other animal species and for human subjects is unclear. 
4.2.5. Rough- or machined-surfaced implants placed in sheep with periodontitis. 
In the third implant experiment, rough-surface, machined-surface and TPS-surface two-stage 
implants were placed in healthy (HS) and periodontally-diseased (PDS) sheep. Clinically, 
there were significantly more abscesses in PDS sheep than around Southern machined-surface 
implants (SI ms), suggesting that diseased sheep may be more vulnerable to infections around 
submerged two-stage implants with smooth surfaces, but that this vulnerability is nullified 
when the implants have a rough surface. This may be related to the microbial flora and/or 
antibody response of periodontally-diseased sheep. Microbiological testing in these same 
animals has demonstrated higher levels of periodontopathogens and differences in antibody 
responses in the periodontitis-affected sheep. 807-809' 127 Overall survival and "acceptability" 
rates for all implants improved to 100% and to 95.8% respectively in this animal model, 
which is encouraging. 
Results of the histomorphometric analysis again showed that the amount of bone-implant 
contact and bone density varies, depending on the type of measurement technique used and 
the area examined. The overall mean percent BIC and density within the cortical passage was 
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consistent, irrespective of the measurement technique used. Bone density within the best-3 
threads was lower compared with bone density outside the threads, suggesting that the process 
of lamellar compaction around the implants was not yet complete. Rougher-surfaced implants 
generally seemed to have better bone-implant contact than the machined-surface implants but 
the type of surface did not affect bone density within- or outside the threads. 
The stereological and best-3 technique used to measure cortical bone-implant contact and 
bone density in this study are not directly comparable, since different sites were examined. It 
is possible to measure digitised images of best-3 threads stereologically using a plug-in for 
NIH Image. Unfortunately the freeware plug-in was incompatible with Macintosh operating 
systems and the commercially-available version was financially prohibitive. It would be 
valuable to compare stereology with computer-assisted HMA for measurement of bone-
implant contact and bone density within "best 3" threads and within adjacent / mirror outfold 
bone, as other have questioned the relationship between results derived using these two 
different technigues.385 
Changes in the orientation of the implant sectioning technique (mesio-distal versus bucco-
lingual) had little discernible effect on percent bone-implant contact or on the bone density 
immediately abutting the implant surface, although this varied slightly, depending on the type 
of measurement technique. A similar finding has been reported in rabbit tibia.317 
Anatomically, the buccal and lingual implant surfaces face dense cortical bone, whereas the 
mesial and distal surfaces face cancellous trabecular bone; this was evident in the 
significantly different results found for mesio-distal and bucco-lingual "outside-threads" 
density. 
The major effect of the variable "pre-existing periodontal disease" seemed to be to increase 
bone-implant contact around rough-surfaced Southern implants and to decrease BIC around 
machined-surface implants. Differences between these two surfaces were less marked in 
healthy sheep. One possible reason would be that rough-surfaced implants elicits a stronger 
osteoconductive response in animals with pre-existing periodontal disease. The alternative 
possibility is that this difference was due to genetic differences between the two groups of 
sheep (sourced from different farms) and not related to the presence of periodontitis at all. 
Differentiating between these two explanations would require an additional control group of 
non-diseased animals from the same farm as the PDS sheep. 
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Statistical analysis of these implants was masked by variability of response in individual 
animals. The sheep used in these experiments are not inbred laboratory animals but are 
outbred farm animals, and thus have a greater variability in response. The size of the standard 
deviation for measurements around Dentsply TPS implants (irrespective of section 
orientation) was higher than either of the two types of Southern Implants. 
4.2.6. One-stage, rough- and machined-surface implants 
In a second part to the third implant experiment, the animal model was extended to include 
one-stage implants. The implants were obtained from the two manufacturers with the longest 
history of implant research, Branemark (Nobel Biocare) and Straumann ITI. 1•2 These two 
implant types have a slightly different thread conformation but are both cylindrical screws 
fabricated from titanium. The Branemark mark II conical implant882 was chosen as it was (at 
that time) the sole product from this company with an extended neck, allowing it to be placed 
transgingivally without the additional variable of a micro-gap between implant platform and 
abutment.336• 883• 884 The ITI implant also has a single-piece structure. Implants with two very 
different surfaces were selected. The Branemark implants had the original machined surface 
and the ITI implants had a new type of rough surface that had been sandblasted with large-
diameter grit and acid-etched (SLA).469 Subsequent to this experiment, Nobel Biocare has 
developed a new, roughened-surface conformation, TiUnite, and is in now in the process of 
discontinuing the production of their machined surface. 
The overall survival rate (84.4%) and "acceptability" rates (68.8%) for one-stage implants in 
sheep were poorer than all previous implant experiments in this animal model. In part this 
appeared related to problems in obtaining an infection-free, healed edentulous ridge. This 
problem can be avoided in future experiments by modifying the extraction protocol to include 
intra-operative radiographs of the ridge after tooth removal and by allowing the ridge to heal 
for at least three months. The "acceptability" rates for ITI SLA-surface implants of 93.8% and 
87 .5% respectively were better than the overall rates achieved for two-stage implants in 
experiments one and two. 
Attempts to categorise implant success in terms of successful, ailing and failing implants have 
focused on diagnosis and treatment strategies in human patients, with the goal of turning the 
"ailing" implant into a successful implant by appropriate intervention.347' 885-887 Listgarten 
( 1997)875 has pointed out that in routine dental practice, implant survival rates may fall below 
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the >85% rate described in clinical trials. He commented further that "since "surviving" 
implants may exhibit characteristics likely to lead to eventual loss of the implant, for example 
severe osseous defects, such implants may not necessarily be considered successful". In the 
current investigation, an attempt was made to combine clinical and histological data in order 
to gain information on the likelihood of an "acceptable" clinical outcome for different 
implants in different "patient" groups. The results of for one-stage implant seemed to suggest 
a relationship between implant surface, the presence of pre-existing periodontitis and whether 
implants are "acceptable", ailing or clinically fail. The rough surfaced ITI implants had 
significantly better "acceptability" rates than machined-surface Branemark implants m 
periodontally-diseased animals; the difference was not statistically significant in 
periodontally-healthy animals. 
Differences were also apparent following histomorphometric analysis of bone-implant contact 
for ITI SLA-surface and Branemark machined-surface implants, in healthy and periodontally-
diseased sheep, although the statistical significance of these differences was masked by the 
reduction in group sizes due to implant losses. Overall, the differences between the two types 
of one-stage, one-piece implants, when healthy and diseased animals were considered as a 
single group, was marked and highly significant. 
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4.3. Characterisation of implants used, response in candidate model and 
comparison with other animal models. 
Scanning electron microscopic examination of the macroscopic conformation of the implants 
used in this study demonstrated similarities between most of them, with the exceptions of 
SteriOss and ITI. Both of the latter implant types had lower thread pitches and wider inter-
thread distances. It is possible that these differences in implant shape contributed to the 
superior performance of these two implants in the sheep mandibular model. 
The microscopic surface conformation is also of critical importance in optimising bone-
implant contact. As noted in the introduction, it has been recommended that characterisation 
of implant surfaces be performed using optical profilometry .496-498 Figures for Branemark, ITI 
and roughened Southern implant surfaces have been published.411 ' 888' 889 Other authors have 
described machined and rough-surfaced implants using scanning electron micro graphs. 828' 473 , 
888 Hydroxyapatite and titanium plasma-spayed surfaces have been described as having a 
"globular topography" whilst grit-blasted surfaces appeared "cratered" and acid-etched 
surfaces had a "regular distribution of small peaks and valleys". 473 
Analysis of the surfaces of the implants used in the current study revealed differences 
between all three groups of implant surface (machined, plasma-sprayed and blasted/eroded). 
The Southern machined implants proved to have a slightly roughened surface with an 
embossed grid of horizontal and vertical grooves; this may account for the improved 
performance of this "smooth" implant compared with Dentsply and Branemark machined 
implants. The large titanium globules of the Dentsply TPS surface seemed poorly fused to the 
implant surface. Histological evidence was found in this study of titanium particles detached 
from the surface of these implant following insertion into sheep mandibles; some have 
suggested that this may result in a foreign-body inflammatory reaction and reduced 
osseointegration. 393' 312' 493 
The Southern blasted and acid-conditioned surfaces had square and parallel-sided or 
orthagonal pits abraded into the implant surface; the pits were larger and the surface was 
much more irregular than that of the ITI blasted and acid-etched surface. The latter had a 
relatively homogenous surface consisting of regular small rounded pits. Li et al. (2002) 
describe this as "roughness at two levels, microscopic pits superimposed on a sandblasted 
macro-rough texture". 888 
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Equivalence of surface type should be treated with suspicion and cannot be used to justify an 
assumption of equivalence in performance, either in humans or in animal studies. For this 
reason it is important to consider the behaviour of each new implant surface, shape or 
biomaterial, initially in an appropriate animal model. The current study is the first to consider 
the histological response to Southern Implants, either machined or roughened. The results of 
the SEM analysis suggested that these implants were likely to respond differently from others 
with superficially similar surfaces. 
4.3.2 Meta-analysis of implant experiments in the sheep mandible. 
Both implant survival and "acceptability" increased over the three years of animal experiment 
conducted as part of this investigation. Both survival and "acceptability" then decreased 
markedly following the introduction of the technically-demanding and hitherto untried non-
submerged (one-stage) protocol in sheep. 
Clinical survival and histological "acceptability" showed a similar relationship to each other 
from year to year; "acceptability" was lower than survival since this figure excludes implants 
that were clinically present but which had otherwise undetected poor or non-integration. It is 
likely that a considerable proportion of the improvement in survival seen from year to year is 
due to the use of multiple different implant surfaces and types, some of which may have 
conferred additional advantages for encouraging integration. However, when Year 3 implants 
were separated into "submerged" and "non-submerged", both survival and "acceptability" 
declined for the latter. 
This suggests that an element of the improvement in all implant indices may have been due to 
improvements in the experience of the surgeon and/or refinement of the surgical protocol. The 
Year 3 non-submerged implants marked the adoption of a new and untried protocol, with 
further demands upon the surgeon. It has been suggested that surgeon experience and 
modifications to the surgical protocol may be more important in achieving consistent success 
with human subjects than the implant surface or design. 890 Meta-analysis of results for the 
current investigation suggest that improvements in operator experience and/or modifications 
and improvements to the surgical protocol had some influence on the outcomes of the 
experiments. 
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Bone-implant contact and bone-density for all implants grouped by year of placement showed 
a similar pattern of improvement for most measurement techniques except outside-threads 
cortical bone density. This was consistently unaffected by the type of implant placed or the 
year of experiment, suggesting that the sheep mandible offers a reliably consistent "test-bed" 
for different implants. 
Meta-analysis and graphical comparison of percent bone-implant contact achieved for the 
different implant types placed into the sheep mandibular model in this investigation supported 
the following conclusions: 
1. The use of a hydroxyapatite-surfaced implant to establish a positive control or "gold 
standard" was vindicated. The HA surface was statistically superior to every implant in one or 
more parameter except for the ITI SLA, where the superiority of the HA surface approached 
but did not reach significance for "best-3" bone-implant contact. 
2. A similar comment may be made about the Dentsply machined-surface as a negative 
control. The effect of an "operator learning curve" with respect to implant surgery must also 
be considered, since the DS (ms) were the first implants placed into sheep. 
3. Machined surfaces performed more poorly in periodontally-diseased sheep. Rough surfaces 
(TPS, SI & ITI SLA) actually improved their bone-implant contact when placed into diseased 
sheep. The latter finding merits further exploration. 
Mixed-model regression analysis was adopted to consider the relative influence of both fixed 
and random variables upon the model. In this case, implant surfaces emerged as the major 
variables when all other factors were controlled. There was some impact from antero-
posterior positioning on whole-implant stereological bone-implant contact measures, probably 
reflecting the reduced amount of cortical bone available when more anterior sites were 
utilised. The use of bone grafts with or without growth factors had a strong negative effect in 
this model. 
Regrouping the implants into "smooth", "rough" and "ceramic" surfaces for regression 
analysis demonstrated marked and statistically-significant differences for bone-implant 
contact between the three groups, irrespective of the type of measurement technique used and 
largely independent of other variables. Only the experiment year showed a significant 
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interaction, and then only with whole implant bone-implant contact. Reasons for this have 
already been discussed. This statistical analysis seemed to confirm that this animal model 
separates and distinguishes between implant types and surfaces with respect to the bone-
implant contact achieved after 3 months healing in a robust manner, further validating the 
model as appropriate for this kind of investigation. 
Elwood (1998) described meta-analysis as "a method of combining the results from a number 
of studies of similar design, to produce an overall estimate of effect which incorporates the 
information provided by all the studies" .816 He provided a checklist of the "components of a 
meta-analysis II which is reproduced below along with the corresponding steps taken as part of 
this work (Table 4.1) 
4.3.3. Meta-analysis of implant experiments in other animal models. 
This investigation represents the first attempt to conduct a full systematic review of dental 
implants placed into animal models. For logistic reasons, only a partial survey of the literature 
was conducted between mid 2002-2004, however the results are representative of the different 
implant types and surfaces. 
As noted in the introductory chapter, systematic reviews may take an "all-inclusive" or a 
"selective" approach in choosing studies. In this work, the approach adopted was all-
inclusive. It has also been recommended that data recorded from studies be ranked or 
weighted. No weighting was performed for the present study. Completion of the meta-
analysis presented here would require the recording of additional data from papers not 
covered during the 2002-2004 period, and application of weighting to the completed dataset. 
Weighted mean difference is the preferred technique for continuous data such as the outcome 
measures used in this investigation (% bone-implant contact and % bone area) and is 
discussed in the Cochrane Reviewers' Handbook.810 To do this, the number of subjects in each 
group, the mean value for the outcome in each group and the standard deviation for each 
mean needs to be recorded. Unfortunately, standard deviations are often not reported in 
published papers, as often proved to be the case in the data reviewed here. Typically, the 
weight given to each study is the inverse of its variance, i.e. more precise estimates (from 
larger studies with more events) are given more weight.891 However, it has also been noted 
during the current investigation that some sites and some animals (eg: rabbit limb models) 
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have lower standard deviations for other reasons, such as inbreeding the animals used, that are 
not necessarily indicative of a "better" investigative technique. 
An alternative technique for generating weighted means requires that each cell be multiplied 
by its n and then divided by the total n. 892 Both approaches depend the fact that "studies with 
larger within-study sample sizes will give more accurate estimates of population parameters 
than studies with smaller sample sizes" (Shadish and Haddock, 1994)893 • A grand weighted 
mean may then be calculated from the grouped means, the data tested for heterogeneity and a 
multifactorial analysis of variance computed. 894 A summary X or X2 statistic can then be 
generated using either the Mantel-Haenszel or the Peto method. The same can be achieved 
using the mixed-model approach that was employed in this study to meta-analyse the results 
of implants placed in the sheep mandibular model; this remains to be completed for the 
systematic review of published dental implant animal models. 
Other attempts to conduct such reviews have limited their results to tabulation of all 
experiments by animal species. 497' 495 The present study is the first report where a protocol was 
developed to group animal implant experiments by surface roughness - smooth, rough or 
ceramic - as well as grouping results into implant healing periods. The groupings adopted are 
the same as those used by Cochran488 in his systematic review of implant surfaces in human 
subjects, although he limited his analysis to rank-order for smooth, rough and hydroxyapatite 
surfaces. Although such a grouping has been criticised by some researchers,489-491 it 
c01Tesponds to the broad grouping of implant surfaces current within the literature and seems 
a valid starting point for an overview of animal model implantology. The grouping of animal 
studies by time periods might also be criticised; different groupings would no doubt give 
different results. 
In this study, both whole and partial recordings of the same implants were recorded; a more 
rigorous approach might choose to exclude one or more of these. The difficulty lies in 
deciding whether partial recordings (such as "cortical passage" or "best-three-threads" 
measures of bone-implant contact) are more valid than measurement over the entire implant 
surface. The sheep mandibular data for bone-implant contact that was compared with other 
animal models was calculated from the mean of two measures: stereology within the cortical 
passage and computer-assisted measurement of the best three consecutive threads. The third 
measure, stereology over the whole implant perimeter, was not included, as this had been 
shown for each of the experiments to be significantly lower than the two partial recordings. 
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However, both partial and whole-implant recordings were used in the meta-analysis of the 
literature. 
When all three recordings are used to calculate means for smooth, rough and ceramic surfaces 
in the sheep mandibular model, a slightly closer grouping is seen, but the rank order and 
separation between the three groups remains similar (see Figure 4.1). It is likely that the 
inclusion of both partial and whole-implant recordings in the meta-analysis of experiments in 
other animal models has a similar effect. 
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Table 4.1. Components of a meta-analysis and steps taken in this work to include them 
(derived from Elwood, 1998).816 
1. Define the question 
2, Define the criteria for 
inclusion ofstudies 
3. Find all eligible studies 
4. Review the methods 
and results of each study 
5. Summarise the results 
of each study in a 
standard format 
6;Apply sta.tistical 
method.s to. produce a 
summary result 
7. Assess variation 
between studies 
(heterogeneity) 
8. Review and interpret 
findings, and report them. 
"What is the percent bone to implant contact around implants? " 
"What is the percent bone density in areas adjacent to implants?" 
"What is the percent bone density within implant threads?" 
"How do these measures differ for different implant surfaces after different 
healing periods in different animal species and at different skeletal sites 
within the same species?" 
Animal studies or human studies 
Histological determination of% BIC & % density 
Blade implants excluded 
Implants with therapeutic intervention to surrounding bone excluded ( eg: 
GTR, GFs) but control implant data included. 
Pubmed search 
Medline search 
Hand search ("references of references", textbooks, abstracts) 
Non-English references included 
Write to authors for original data if presented graphically 
Summarised as a written review for each paper - summaries not presented 
in this work. 
No qualitative ranking, weighting or exclusion of studies at this stage ("all-
inclusive approach") 
Included non-randomised, uncontrolled and un-blinded trials. 
Unit of analysis was mean results for each group of implants presented in 
the paper (ie: not data from individual animals or implants). 
Tabulated by implant surface and type: 
Smooth surface, solid screw % BIC 
Rough surface, solid screw % BIC 
Ceramic surface, solid screw % BIC 
All implants in sheep models % BIC 
Rough surface, hollow cylinder % BIC 
Rough surface, solid cylinder % BIC 
Ceramic surface, solid cylinders % BIC 
"Within-thread" % density 
"Outside-thread" % density 
Details recorded: 
mean, 
standard deviation or range, 
animal species and skeletal site, 
integration period, 
implant manufacturer/subtype, 
number of implants and number of animals 
method(s) of analysis 
X2 statistic not calculated at this stage. Overall "mean of means" plotted 
graphically to indicate trends, but firm conclusions based on quantitative 
evidence not possible without further weighting of evidence and statistical 
analysis. 
Q1 not calculated at this stage. Overall SD for groups of data gave some 
indication of heterogeneity. 
Trends for different surface types in different animal species compared with 
results of work experiments for sheep. 
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4.3.4. Systematic review- conclusions 
The overall conclusions for the systematic review and partial meta-analysis were as follows: 
1. Implants behave differently in different animal species 
2. Implants behave differently when placed into different skeletal sites within the same 
animal species. 
3. A broadly similar response in bone-implant contact was seen across all animal species 
for the three types of implants surfaces, as healing time increased. 
4. Implants with smooth surfaces had lower initial bone-implant contact. This increased 
with time to reach a steady state or (in some cases) then gradually worsened. 
5. Implants with rough surfaces started with superior bone-implant contact and this 
increased with time. In some species, rough-surfaces eventually rduced to reach a 
similar level of bone-implant contact as smooth-surfaced implants. In other species, 
rough surfaces remained superior. 
6. Implants with ceramic surfaces also started superior to smooth - and in some cases 
rough - surfaces, increased in time to a peak and then tended to worsen in a more 
marked fashion than other surfaces. Peak bone-implant contact varied from early in 
rabbit and dog models to later in sheep and non-human primate models and in human 
subjects. 
7. Bone-implant contact for the three surface types were similar in the sheep mandibular 
model to established models such as dogs and in non-human primates and seemed more 
closely related to results in human subjects than findings from rabbit limb and sheep 
limb models. 
8. Within-threads bone density seemed to show a weak relationship to the type of implant 
surface in some animal models but this was not consistent across species. 
9. There was a wide range in variability in the density of bone within-threads between 
different animal species. In most models, within-thread density increased with time. 
10. Outside-threads bone density varied between species, showed no relationship to implant 
surface type and did not change in any systematic fashion over time. There was weak 
evidence that sheep bone is denser than any of the other species for which data was 
recorded. 
It remains for these preliminary conclusions to be confirmed statistically. However, this 
partial meta-analysis strongly supports the hypothesis that the sheep mandibular model for 
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dental implantology is at least as valid a model for the human situation as any other animal 













~ --.... 70 C,j 
13 
= 0 60 C,j 
..... 
= c,: 50 -Q., e ·-I 40 ~ 
= 0 
.,Q 





mean (Sl,S2,B3) mean (Sl,B3) 
Data used for mean BIC 
Figure 4.1: Comparison of mean bone-implant contact for implants in the sheep 
mandible (results from this thesis) calculated using partial recordings only (S l&B3) 
or including whole-implant recordings (S2). 
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4.3.5. The sheep mandibular model - summary. 
Differences between the sheep mandibular model and human subjects include the very dense 
cortical bone found in the sheep mandible, which resembles that also seen in the sheep limb. 
Problems were encountered in the pilot experiment as a result of overheating during 
osteotomy preparation that seemed to be related to this increased density. It has been 
suggested elsewhere that sheep are a less valid animal model for orthopaedic manipulations 
due to anatomical differences between sheep and human cortical bone. 79 It should also be 
considered that most of these investigations were carried out in one gender only ie: female 
animals; the possibility of gender differences affecting outcomes would require a study 
balanced between male and female animals. 74 The earlier studies into critical size defect 
healing also suggested that the long, slender sheep mandible may be exposed to greater 
bending moments during occlusion than might be expected in human subjects and might 
respond to this with an exaggerated healing response. 
Of the eight implant types placed in this work, only two are still on the market unchanged 
(Southern implants surface enhanced and ITI SLA). The SteriOss HA implant surface is still 
available from Nobel Biocare but in a different configuration (Replace Select HA) as is the 
Branemark machined surface (now Mark III rather than Mark II and no longer available as a 
one-piece conical implant). Dentsply no longer markets ScrewVent or SwedeVent implants; 
these were re-purchased by the original owner and marketed as Paragon before selling the 
implant system to Sulzer Medica. Both straight-sided and tapered versions of Screw Vent 
implants are still available but these now have either a blasted ("MTX") or HA-coated 
surface. Other companies, for example Lifecore Biomedical, still market treaded implants 
with machined, HA and TPS surfaces. However, 95% of the market now consists of 
roughened-surface implants; for many of these there is only limited published data. 895 The 
results presented here are still relevant to the field of clinical implant dentistry. 
One aspect that sheep and humans have in common is the occurrence of naturally-occurring 
periodontitis. This work only considered the effect of pre-existing periodontitis on the initial 
healing of one- and two-stage implants. The finding that roughened-surface implants may 
gain superior bone-implant contact in animals with periodontitis was unexpected and merits 
further investigation. Whether naturally-occurring periodontitis in sheep can be employed as 
an animal model for peri-implantitis requires an examination of transmucosal implants over a 
much longer period, preferably greater than 12 months; the utility of such a model remains to 
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be proven. However, the relative success of ITI rough-surfaced implants placed using a one-
stage protocol and exposed to immediate partial loading suggests that the model can be 
further expanded to consider the effect of immediate loading on bone-implant contact. Other 
directions that this model could potentially be expanded include the placement of dental 
implants into sheep with simulated osteoporosis. Ideally such examinations should also 
include biomechanical as well as histomorphometric examination. It would also be useful to 
consider the differences when paired implants are placed simultaneously into long-bone and 
mandibular skeletal sites in sheep. 
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4.4. Final Conclusions. 
A series of investigations were conducted to ascertain the usefulness of the sheep mandible as 
an animal model for dental implant experimentation. Initial studies ruled out the 
establishment of a critical size defect model on the lateral surface of the edentulous 
mandibular diastema. This site was also poorly suited to dental implant placement. A model 
using the healed post-extraction mandible in sheep was developed and tested against a variety 
of implant surfaces, treatments and placement protocols, in periodontally-healthy and 
diseased animals. Histomorphometric analysis of peri-implant osseous healing in these sheep 
was compared with a partial meta-analysis of comparable results in other animal models. The 
sheep mandibular model showed sufficient similarity with other animal species and with 
human subjects to validate it as a model for dental implantology. 
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Appendix 1: Measurement data for CSD Experiment 3 
Appendix Table 1: Area and height of residual defect and dimensions of bone hyperplasia in 
the sheep mandible, three months after removal of polytetrafluoroethylene discs. 
1 A R80 Right 21.88 3.00 3.0 
2 A R82 Left 39.40 6.46 2.0 
.2 A R82 Right 2.38 0.81 2.0 
3 B R83 Left 47.56 6.19 1.0 
3 B R83 Right 4.72 2.27 4.0 
4 B R85 Left 143.00 d 3.0 
4 B R85 Right 1.16 0.76 0.0 
5 B R86 Right 4.29 2.11 4.5 
5 B R86 Left 250.00 d 9.0 
6 B R89 Left 1.07 0.61 1.0 
6 B R89 Right 53.28 8.20 7.0 
7 B R93 Left 4.41 1.61 1.0 
7 B R93 Right 1.14 1.58 1.0 
8 B R94 Left 19.10 4.18 1.0 
8 B R94 Right 14.76 4.36 2.0 
" Group A: four Teflon discs sutured into mandibular defects in two sheep using Teflon sutures. 
b Group B: 12 Teflon discs wired into mandibular defects in six sheep using transosseous wiring. 
















d Specimens with extremely large residual defects due to inflammation or retained disc (R85 and R86) did not 
have vertical height recorded and were excluded in calculation of mean values for area of residual defect. 
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Appendix 2: Results for buccal and lingual surfaces of implants. 
Appendix Table 2: Percent bone implant contact for buccal and lingual surfaces, all implants 
and sheep, all measurement techniques. 
82 ·· Dentsply machined HS Ant Left 1997 12 0.0 60.3 0.0 28.5 1.1 0.0 23.5 88.9 
83 Dentsply machined HS Ant Left 1997 12 35.2 53.9 8.6 7.4 9.3 14.8 0.0 28.6 
85 Dentsply machined HS Ant Left 1997 12 20.3 30.7 11.8 13.6 13.0 44.1 29.8 71.9 
86 Dentsply · machined HS Ant Left 1997 12 
89 Dentsply machined HS Ant Left 1997 12 
93 Dentsply machined HS Ant Left 1997 12 58.3 52.1 25.3 18.0 58.5 55.8 88.2 60.9 
94 Dentsply machined HS Ant Left 1997 12 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
80 Dentsply machined HS Post Left 1997 12 25.9 41.4 12.3 6.0 19.4 0.0 4.6 22.6 
82 Dentsply machined HS Post Left 1997 12 7.1 0.0 1.3 0.0 0.0 0.0 0.0 0.0 
83 Dentsply machined HS Post Left 1997 12 43.3 47.0 11.2 10.0 13.7 17.7 38.4 15.9 
85 Dentsply machined HS Post Left 1997 12 29.5 26.1 12.1 8.3 6.9 4.6 13.5 27.6 
86 Dentsply machined HS Post Left 1997 12 I I.I 30.0 2.5 4.0 0.0 9.9 0.0 4.8 
89 Dentsply machined HS Post Left 1997 12 
93 Dentsply machined HS Post Left 1997 12 46.3 55.4 30.4 21.7 27.2 58.7 68.1 49.0 
94 Dentsply machined HS Post Left 1997 12 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
660 SteriOss hydroxyapatite HS Post Left 1998 12 83.6 72.8 45.7 67.3 91.1 93.0 
661 SteriOss hydroxyapatite HS Post Right 1998 9.5 81.6 67.2 58.6 51.2 97.3 62.7 
662 SteriOss hydroxyapatite HS Ant Left 1998 9.5 48.1 72.5 17.1 23.8 22.6 68.1 
664 SteriOss hydroxyapatite HS Ant Right 1998 12 84.1 70.4 28.9 33.0 69.2 66.0 
665 SteriOss hydroxyapatite HS Post Left 1998 12 67.1 88.9 49.6 82.7 97.8 97.9 
666 SteriOss hydroxyapatite HS Post Right 1998 12 68.3 66.0 40.6 48.4 76.8 97.9 
670 SteriOss hydroxyapatite HS Post Right 1998 12 73.1 74.6 50.0 58.3 62.4 85.9 
671 SteriOss hydroxyapatite HS Ant Right 1998 12 89.6 87.2 43.7 87.9 85.0 98.8 
675 SteriOss hydroxyap.itite HS Ant Left 1998 12 81.6 71.7 79.3 29.7 92.1 72.0 
660 Dentsply TPS' HS Ant Right 1998 12 59.2 58.5 31.9 28.3 31.0 31.5 
661 Dentsply. TPS HS Ant Left 1998 9.5 67.1 75.4 34.1 43.8 61.6 72.7 
662. Dentsply TPS HS Post Left 1998 9.5 74.5 77.5 47.7 77.5 69.8 83.0 
664 Dentsply TPS HS Post Right 1998 12 52.1 45.3 16.7 21.0 61.6 33.2 
665 Dentsply TPS HS Ant Right 1998 12 27.3 0.0 12.4 12.0 9.2 0.0 
666 Dentsply TPS HS Ant Left 1998 12 86.4 77.2 40.2 60.9 59.6 51.3 
670 Dentsply TPS HS Ant Left 1998 12 75.7 62.0 47.0 41.9 88.8 52.3 
671 Dentsply TPS HS Post Right 1998 12 59.0 57.0 31.1 48.4 43.5 67.2 
675 Dentsply TPS HS Post Left 1998 12 50.9 63.7 27.4 24.5 60.7 53.2 
660 Dentsply TPS+TGFB HS Post Right I 998 12 67.0 64.7 40.1 53.5 
661 Dentsply TPS+TGFB HS Post Left 1998 9.5 63.0 67.6 39.2 41.0 
662 Dentsply TPS +TGFB HS Ant Right 1998 9.5 
664 Dentsply TPS +TGFB HS Ant Left 1998 12 56.8 59.2 18.9 26.5 
665 Dentsply TPS.+TGFB HS Post Right 1998 12 62.0 73.2 25.4 21.6 
666. Dentsply TPS *TGFB HS Post Left 1998 12 0.0 0.0 0.0 0.0 
670 Dentsply .. TPS.+TGFB HS Post Left 1998 12 48.5 55.2 32.4 36.0 
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671 Dentsply TPS + TGFB 
675 Dentsply TPS + TGFB 
660 Dentsply TPS + carrier 
661 Dentsply TPS + carrier 
662 Dentsply TPS + carrier 
664 Dentsply TPS + carrier 
665 Dentsply TPS + carrier 
HS Ant Left 1998 
HS Ant Right 1998 
HS Ant Left l 998 
HS Ant Right 1998 
HS Ant Right 1998 
HS Post Left 1998 
HS Ant Left 1998 
666 Dentsply TPS + carrier HS 
670 Dentsply TPS + carrier· HS 
_671 Dentsply TPS +carrier HS 
675 Dentsply TPS .+ carrier HS 
Ant Right 1998 
Ant Right 1998 
Post Left 1998 
Post Right 1998 
Ant Left 1999 
Ant Left 1999 
Ant Left 1999 
Ant Left 1999 
Ant Left 1999 
Ant Left 1999 
152 Dentsply .TPS B-Li, HS 



































HS Ant Left 1999 
HS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left I 999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
HS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
PDS Ant Left 1999 
HS Mid Left l 999 
HS Mid Left 1999 
HS Mid Left 1999 
HS Mid Left 1999 
HS Mid Left 1999 
HS Mid Left l 999 



































































































HS Mid Left 1999 12 













































































































































































































































































60.0 43.0 43.0 89.2 54.5 
72.0 41.0 71.0 97.1 95.3 
205 Southern . blasted 
207 Southern blasted 

















169 Southern machined 
171 Southern machined 
174 . Southern .machined 
































































165 Branemark machined 
166 Branerriark. machined 
169 Branemark machined 
171 Branemark. machined 
174 Branemark machined 
178 Branemark machined 
204 Branemark . machined 
205 Branemark machined 
207 Braneinark machined 
208 Branemark machined 
209 Braue.mark machined 
PDS Mid Left 1999 12 
PDS Mid Left 1999 12 
PDS Mid Left 1999 12 
PDS Mid Left 1999 
PDS Mid Left 1999 
PDS Mid Left I 999 
PDS Mid Left 1999 
HS Mid Right 1999 
HS Mid Right 1999 
HS Mid Right 1999 









HS Mid Right 1999 12 
HS Mid Right 1999 12 
HS Mid Right 1999 12 
HS Mid Right 1999 12 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
PDS Mid Right 1999 
HS Post Left 1999 
HS Post Left 1999 












HS Post Left 1999 12 
HS Post Left 1999 12 
HS Post Left 1999 12 
HS Post Left I 999 I 2 
HS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 12 
PDS Post Left 1999 
PDS Post Left 1999 
HS Post Right 1999 





HS Post Right 1999 12 
HS Post Right 1999 12 
HS Post Right 1999 12 
HS Post Right 1999 12 
HS Post Right 1999 12 
HS Post Right 1999 12 
PDS Post Right 1999 12 
PDS Post Right 1999 12 
PDS Post Right 1999 12 
PDS Post Right 1999 12 












































































38.0 41.0 83.0 83.1 
38.0 25.0 72.2 82.1 

































45.0 53.0 50.4 80.2 
47.0 37.0 45.2 71.2 
22.0 23.0 0.0 13.6 











































80.0 59.0 50.0 77.4 96.9 
68.0 60.0 57.0 68.9 52.7 
75.0 62.0 58.0 94.3 78.3 
87.0 40.0 60.0 66.1 78.0 
61.0 45.0 41.0 61.0 51.9 
85.0 46.0 63.0 75.3 49.2 
83.0 36.0 40.0 32.1 67.0 
86.0 64.0 70.0 72.6 71.3 
72.0 43.0 46.0 68.8 69.1 














70.0 34.0 48.0 57.8 48.0 
50.0 25.0 38.0 61.5 35.5 
56.0 32.0 26.0 23.5 24.8 







16.0 8.0 0.0 13.8 
0.0 0.0 
48.0 63.0 38.9 36.3 
12.0 42.0 33.2 
210 Briinemark !Ilachined 
211 Branemark machined 
212 Briinemark machined 
a titanium plasma-sprayed 
b bucco-lingual 
c mesio-distal 
d blasted, acid-conditioned 
PDS Post Right 1999 12 
PDS Post Right 1999 12 
PDS Post Right 1999 12 
e large-grit blasted, acid-etched 
19.0 50.0 8.0 26.0 
r periodontal disease status: HS (healthy sheep) or PDS (periodontally-diseased sheep) 
g position on edentulous ridge: ant (anterior), mid (middle) or post (posterior). 
h no recording since implant had been exfoliated 
i Experiment 1 only; no recordings for subsequent experiments 
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18.9 10.0 
Appendix Table 3: Percent bone density for buccal and lingual surfaces, all implants and 











































































































































































































>·Dentsply· 79.0 90.0 
665 Dentsply•·. 88.5 87.0 
Del}tsply· 
· Dentsply 90.0 91.5 
671 Dentsply 56.0 84.5 
675 Dentsply 76.5 0.0 
92.0 90.0 85.3 89.5 
93.0 96.0 92.1 92.9 
93.0 92.0 92.3 86.6 
91.0 90.0 88.4 90.8 
88.0 96.0 80.4 77.6 
9.0 47.0 0.0 0.0 
93.0 89.0 68.2 42.8 
72.0 69.0 46.3 78.3 
86.0 91.0 81.8 92.8 
68.0 59.0 0.0 0.0 
95.0 98.0 67.7 41.3 
86.0 98.9 81.4 87.7 
90.0 99.0 73.2 83.5 
Dentsply 93.0 94.0 76.6 74.3 
211 Dentsply 83.0 87.0 67.2 56.4 
212 Dentsply 94.0 90.0 68.8 70.7 
Dentsply 90.0 73.0 76.3 65.6 
Dentsply. 83.0 84.0 75.9 89.3 
Dentsply 92.0 53.8 87.8 
Dentsply 81.0 89.0 
Dentsply 79.0 77.8 58.7 86.0 
171 Dentsply 4.0 0.0 0.0 
174 Dentsply 64.1 70.0 60.9 55.9 
178 Dentsply 88.0 72.2 85.5 
204 Dentsply 95.0 69.6 82.9 
205 Dentsply 0.0 0.0 0.0 
Dentsply 70.8 66.0 61.9 88.5 
Dentsply 68.0 88.0 81.0 76.9 
Dentsply 80.0 88.6 70.6 85.5 
Dc;ntsply 83.0 76.0 79.3 78.5 
Dentsply 83.0 83.1 52.0 
Dentsply 82.0 85.0 76.6 80.8 
Southern 81.5 82.0 69.5 81.0 
Southern 94.5 94.5 70.0 69.6 
Southern 77.5 78.0 67.2 59.2 
Southern 91.0 96.0 80.7 86.4 
Southern 91.0 86.0 83.6 85.1 
Southern 85.0 68.5 77.5 46.7 
Southern. 91.0 87.0 77.8 69.4 
Southern 92.5 85.5 78.8 60.7 
204 Southern 95.0 89.0 83.0 92.9 
205 Southern 85.0 90.0 82.2 73.4 
207 Soutliern 88.0 76.0 68.0 54.1 
208 Southern 88.0 96.0 82.5 68.3 
209 S.outhem 68.5 95.5 41.2 86.9 
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88.5 91.5 71.7 74.2 
92.5 94.5 84.8 77.0 
93.0 91.5 82.2 66.7 
88.5 88.0 81.1 92.1 
84.0 85.0 73.5 30.9 
92.5 93.5 85.6 85.6 
91.0 92.5 79.4 86.5 
84.5 94.5 49.9 54.9 
83.5 76.5 67.8 77.6 
91.7 88.0 78.3 53.5 
71.5 93.0 81.5 86.2 
96.0 88.5 76.8 81.2 
73.0 52.0 86.3 60.5 
83.5 93.5 72.2 12.2 
86.5 96.5 78.7 82.0 
10.5 87.0 19.5 43.3 
82.0 90.0 76.6 80.0 
83.5 95.0 70.8 82.5 
88.0 81.0 70.5 70.6 
ITI 43.0 62.7 42.3 56.2 
ITI 48.5 27.0 
ITI 92.5 52.0 78.9 72.8 
ITI 90.5 70.5 82.9 82.2 
ITI 77.0 76.0 34.0 20.5 
ITI 80.5 69.5 78.3 67.5 
]TI 77.0 93.0 71.2 84.9 
ITI 80.5 54.5 37.0 42.5 
204 ITI 61.0 95.0 82.2 42.4 
205 ITI 
207 ITI 55.0 46.0 11.7 62.2 
208 ITI 74.0 85.0 61.3 47.6 
209 ITI 44.5 28.0 57.3 34.5 
210 ITI 89.5 83.0 43.1 64.2 
211 ITI 38.0 95.5 53.7 83.6 
212 ITI 81.7 71.3 51.8 59.6 
Branemark 
Brahernark 90.0 88.0 
Bra11eniark 70.5 95.5 79.6 86.6 
Brahemark 76.0 97.5 80.9 85.9 
Branemark 
Branemark 90.7 72.7 78.0 76.3 
Branemark 93.0 82.0 76.8 64.8 
178 . Branemark 
204 Branemark 90.0 67.0 
205 Branemark 76.0 50.0 33.3 56.5 
207 Branemark 17.5 45.5 
208 Branemark 83.0 84.0 79.6 78.1 
209 Branemark 52.0 95.0 80.0 
210 Branemark 
211 Branemark 84.0 84.5 29.3 41.6 
212 Branemark 
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Appendix Table 4: Mineral apposition rate (MAR) SteriOss and Dentsply TPS implants 
661 SteriOss 0.42 0.32 
662 SteriOss 0.29 0.30 0.43 0.34 
664 SteriOss 0.32 0.37 0.39 0.36 
665 SteriOss 0.23 0.32 0.43 0.33 
666 SteriOss 0.28 0.29 0.34 0.30 
670 SteriOss 0.24 0.39 0.62 0.42 
671 SteriOss .. 0.25 0.30 0.38 0.31 
675 SteriOss 0.34 0.62 0.65 0.54 
660 Dentsply (TPS) 0.39 0.42 0.61 0.47 
661 Dentsply (TPS) 0.29 0.29 0.34 0.31 
662 Dentsply (TPS) 0.30 0.31 0.42 0.35 
664 Dentsply (TPS) 0.37 0.37 0.40 0.38 
665 Dentsply (TPS) 0.27 0.25 0.54 0.35 
666 Dentsply (TPS) 0.00 0.00 0.00 0.00 
670 Dentsply (TPS) 0.37 0.62 0.70 0.56 
671 Dentsply (TPS) 0.00 0.32 0.34 0.33 
675 Dentsply (TPS) 0.31 0.47 0.69 0.49 
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Appendix Table 5: Percent bone-implant contact and percent density at buccal and lingual 
surfaces for Experiment lb, short-term (<1 week) .and long term (>6 months) healing. 













Appendix 3: Implant systems and funding 
Implant Systems 
The implant systems were used for these experiments are discussed below. Except where 
otherwise stated, the surgical armamentarium employed and the installation / implantation 
protocols followed were those supplied and recommended by the various implant 
manufacturers. 
Dentsply Screw-Vent and Swede-Vent Implants 
The Core-Vent system of dental implants originated as a hollow-basket system designed, 
manufactured and distributed by Dr G. Niznick.896 The system was subsequently expanded to 
include three other types of titanium root-form implants: Screw-Vent (threaded solid-screw), 
Bio-Vent (solid press-fit cylinder) and Micro-Vent (hollow, finned cylinder). These devices 
have been reviewed by Truhlar et al (1997) and Manz (2000).897• 898 The Core-Vent/Spectra 
system was expanded to include a licensed clone of the Branemark system - the Swede-Vent 
implant - in 1988.899 Initially this was only offered with a machined surface but a titanium-
plasma sprayed version was also made available and in 1995, an acid-etched version. In April 
1991, the Core-Vent Corporation (Las Vegas, NV) entered into an exclusive worldwide 
marketing and distribution agreement with Dentsply International, Inc (Denstply Implants, 
Encino, CA). Dr. Niznick remained the sole owner of Core-Vent and had responsibility under 
the contract to perform the R&D and manufacturing functions. In 1998, following mutual 
litigation, an arbitrator cancelled the Dentsply /Core-Vent contract. (Denstply subsequently 
re-entered the dental implant market by acquiring Friadent900). Core-Vent re-emerged as the 
Paragon Implant Company, with the implants manufactured by Core-Vent Bio-Engineering. 
Dr Niznick remained the president of both Paragon and Core-Vent. Screw-Vent implants 
remained part of the product range but and Swede-Vent was discontinued. In January 2001, 
Sulzer Calcitek, Inc. acquired Paragon. They continue to manufacture and market Screw-Vent 
implants along with their own Calcitec systems. 
The Screw-Vent implant was used for the pilot study. This is an endosseous implant with 
externally-threaded body, internal hex-thread connection and a pronounced, unthreaded collar 
that is larger than the implant body (3.75mm diameter). The final drill size for these implants 
is 3.2mm From the three options available - commercially pure titanium (cp-Ti), titanium 
alloy (Ti alloy) and hydroxyapatite-coated (HA-coated) - cp-Ti ScrewVent implants, length 
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13mm and diameters 3.5mm were chosen. 
The Swede-Vent implant was chosen for Experiments 1, 2 and 3. This is an endosseous 
implant with an externally-threaded cp-Ti body below a collar, above which extends the 
external hex connection. According to the manufacturer, this implant "matches the original 
Branemark [sic] fixture in material, design and dimensions" (Core-Vent Corp Brochure). 
Both of the two surface options available were used; the "as machined-surface" (15mm long x 
3.75mm diameter, 4.0mm collar) and the titanium-plasma sprayed (TPS) surface (15mm long 
x 4.0mm diameter, 4.0mm collar). 
Steri-Oss Implants 
The Steri-Oss system of implants originated in the mid-80s.901 Steri-Oss was purchased by 
Bausch & Lomb but later sold to an investment group in 1996. In 1998 Steri-Oss purchased 
another implant company, IMZ, and then merged with Nobel Biocare, to become the largest 
manufacturer of dental implants in the world. The product range consists of threaded and non-
threaded cylindrical implants with the option of an external hex. A range of diameters and 
lengths and three surface options are available; titanium (later modified to etched titanium), 
hydroxylapatite-coated (HA-coated) titanium, and titanium plasma spray (TPS). A tapered 
immediate implant system called "Replace" is also offered. 
The Steri-Oss HA-coated implant was used in Experiment 2. This implant was introduced in 
1989902, 513 ' 38 and was "the first threaded implant to incorporate this surface option" (Nobel 
Biocare website). The HA-coating is plasma-spayed as 100% crystalline powder. The thread 
design differs from most other systems and according to the manufacturer "distributes vertical 
occlusal loads throughout the bone, while maximizing the volume of bone between the 
threads .. . [which is] ... 32% greater than between common "V" thread designs" (NBC 
website). The engineering mechanics of this implant have been discussed by Hurson 
(1994).903 The selected implant was 14mm long x 3.8mm diameter with a 4.1mm diameter 
polished titanium collar. 
Branemark / Nobel Biocare implants 
In 1952 Professor Per-Ingvar Branemark discovered that living bone forms a biological bond 
to titanium. From this he developed the Branemark titanium dental implant system.1' 3 In 
1981, Bofors Nobelpharma (later Nobelpharma) was established to manufacture and market 
these implants and in 1996 the company name changed to Nobel Biocare. Until recently, the 
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product range was limited to commercially pure titanium solid-screw implants with smooth 
(machined) surfaces, placed using a two-stage approach; many other manufacturers now 
produce replicas or clones of this system.904• 905 Recently a roughened smface has been added 
to the original range472• 458 which accounted for 46% of the total Branemark System implant 
sales in the first nine months of 2001. 
The Nobel Biocare Conical Mark II implant was examined in Experiment 3b. This is a one-
piece, machined-surface, solid-screw, self-tapping cp-Ti Branemark implant. These fixtures 
were originally developed for simultaneous fixation of onlay bone grafts906[Kahnberg, 1989 
#387 and have a smooth 4mm-high conical neck and an external hex. The implant that was 
used measured 15mm in length x 3.75mm diameter, and was 4.1mm wide at the neck. 
Straumann implants and the International Team for Implantology 
The ITI Dental Implant system originated in the 1970s as a collaboration between Professor 
A Schroeder of the University of Berne and Dr F Straumann of the privately-owned Research 
Institute Straumann in Waldenberg, Switzerland.[Scacchi, 2000 #713] In 1980 the 
International Team for Oral Implantology (ITI) was founded and today, it consists of more 
than two hundred members from around the globe. Research is supported by the ITI 
Foundation, founded in 1988. Initially the system consisted of an unthreaded, Hollow 
Cylinder implant with a titanium-plasma spray (TPS) surface; subsequent designs included a 
hollow-screw and the solid screw design known as the TPS or Swiss Screw implant.907 
Developmental work for the TPS Implant was can-ied out using ovine tibial and femoral 
models.908• 909• 312 The original one-part concept was further modified into a two-part system 
with addition of the 8 degree Morse-taper internal abutment connection. All three implants 
configurations (hollow cylinder, hollow screw, solid screw) were amalgamated into an 
integrated system, the "Bonefit" concept,910 characterised by transmucosal non-submerged 
healing, cold-worked grade 4 titanium, TPS-coating, smooth machined neck, and a Morse 
tapered internal connection. In 1998, a new acid-etched and large-grit sandblasted surface 
(SLA) surface was added to the inventory470 that has gradually superseded the TPS surface. 
100% of the 65,000 ITI implants sold in early 1998 were TPS-surfaced; by the end of 2000, 
75% of the 110,000 implants sold had an SLA surface. An additional series of solid-cylinder 
and hollow-cylinder implants were manufactured to facilitate the subgingival positioning of 
the abutment/implant interface - the "micro-gap" - without causing apical relocation of the 
peri-implant "biological width". On these Esthetic Plus implants the roughened surface 
extends further coronally, reducing the dimensions of the polished transgingival collar from 
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2.8mm to l.8mm.911 
The ITI Esthetic Plus Solid Screw implant was used in Experiment 3b. This cp-Ti implant 
measures 13.8mm long, divided into a threaded body with SLA-surface (12.0mm) and a 
polished collar (1.8mm), and is 4.0mm in diameter (4.75mm at the flared platform). The apex 
is rounded and non-self tapping. The threads are designed to maximise inter-thread bone and 
the thread depth of 0.35mm, pitch of 1.25mm and inclination of 75 degrees to the screw axis 
all differ markedly from other implant systems. 
Southern Implants 
The South African dental implant company Southern Implants was established in 1987 by G 
Blackbeard and manufactures a range of titanium medical devices including cardiac products, 
TMJ prostheses, extra-oral implants, a spinal fixation system, cranio-facial plating and dental 
implants. The latter is an extensive range of clones based on major systems including Steri-
Oss, Branemark and ITI/Straumann that were developed for the domestic market as a result 
of the 1977-1994 embargo. Modified implant systems are now marketed in Australia, New 
Zealand, Israel and the United Kingdom. 
Two Southern Implants "Branemark-clone" implants were selected for use in Experiment 3a. 
The IB Externally Hexed implant is a Grade 3 cp-Ti, machined-surface, self-tapping, solid-
screw implant measuring 15mm long by 3.75mm diameter (including a 2mm high by 4.07mm 
diameter platform). It has a "unique spark eroded fluting, which gives an improved cutting 
edge" ((Southern Implants website, 2002). The JBS Surface Enhanced implant is identical 
except that it has a blasted and acid-conditioned surface. The surface roughness of Nobel-
Biocare Branemark machined-surface implants and Southern Implants surface-enhanced 
(blasted and etched) implants have been investigated using a confocal optical profilometer as 
part of a systematic review and meta-analysis of implant loading.56 The following results were 
reported: 
364 
Appendix Table 6: Profilometric characterisation of Branemark machined-surface and 
Southern Implants roughened-surface implants (from Esposito et al. 2003) .56 
12.18 
a average height deviation 
b average wavelength 
c developed surface area 
Funding 
1.43 50 
turned implant with visible marks from the cutting 
tool 
very similar to Branemark implants but with a 
modified surface 
Support for these projects in the main was obtained from the implant manufacturers. Neither 
the author of this thesis nor his supervisors have any relationship, financial or otherwise, with 
any of these implant companies or their distributors. The following material and financial 
support was supplied: 
1. Dentsply (USA) Inc.: US$15,000 per year plus implant engines, hand-pieces, surgical 
kits, drills; 14 Screw Vent fixtures and cover-screws; 66 Swede Vent implants and 
cover-screws. Total value approximately NZ$127,000. 
2. SteriOss Implants (via Implants New Zealand Ltd.): Two surgical kits including drills, 
three Salvin autogenous bone traps, 12 Steri-Oss HA-coated implants and cover-
screws. Total value approximately NZ$15,000. 
3. Noble Biocare Australia Ltd. Eighteen drill kits and 18 Branemark Conical Mark II 
implants with cover-screws. Total value approximately NZ$10,769. 
4. Southern Implants, South Africa (Ltd). One surgical kit, 18 sets of drills, 18 external 
hex implants, 18 surface-enhanced implants, 36 cover-screws. Approximate value 
NZ$13,297. 
5. ITI Foundation SGA Grant 148/1998. NZ$41,000. 
6. Bristol-Myers Squibb Pharmaceutical Research Institute (PRI), (Lawrenceville, New 
Jersey U.S.A.). Recombinant simian TGF-Bl (rsTGF-Bl) (concentration 80µg/ml) 
was provided free of charge to A/Prof A. Pack, who generously made this available 
for Experiment 3. 
7. Otago Research Committee grant, 1994-98. Purchase of additional equipment 
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including Branemark system drills and surgical instruments, surgical armamentarium, 
radiographic and photographic equipment. Value NZ $13,878 
8. Histological preparation was undertaken at the University of Berne in 1997, 1998 and 
2000, supported by grants from the Clinical Research Foundation for the Promotion of 
Oral Health, Berne, Switzerland to the approximate value of NZ$ 42,900. 
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Appendix 4: Tooth extraction protocol for sheep mandibular premolars 
The following protocol was developed for the surgical removal of ovine mandibular premolar 
teeth and the creating of an edentulous ridge. It should be noted that access to the posterior 
teeth of sheep is very limited due to the inelasticity of the cheeks,912' 913 however at no time 
was the Danesh-Meyer cheek-slash approach207 used. Under general and local anaesthesia, a 
crevicular incision was made using a number 15 disposable blade in a Bard-Parker handle 
around the mandibular premolars, extending 0.5cm anteriorly into the edentulous diastema 
region. Full-thickness buccal and lingual flaps were raised, exposing the crest of the alveolar 
ridge. Using a tungsten-carbide straight fissure bur in a high-speed handpiece with chilled 
irrigation (Dynasurg Economy Electric Implantology Handpiece System, Dentsply, USA), a 
shallow circum-dental osteotomy was created within the superficial portion of the relatively 
wide periodontal ligament. The 1st premolar was frequently absent; when present, it could be 
cautiously elevated in a mesial direction using a Coupland's #1 dental luxator (Shalfoon 
Dental Ltd, Auckland, NZ). The combination of brittle, spindly-rooted teeth, aberrant 
accessory root anatomy and extremely dense, inelastic mandibular bone resulted in a high 
frequency of root fractures during the initial development of this protocol. The straight fissure 
bur was then employed to section the 2nd and 3rd premolars vertically from the most coronal 
point of the premolar, midway between mesial and distal interproximal surfaces, and 
extending as far apically as possible towards the furcation region. Sectioning of the teeth was 
completed using a straight chisel and mallet, after which the distal, followed by the mesial 
portions were elevated, using a combination of straight and curved (Cryer's) luxators 
(Shalfoon Dental Ltd, Auckland, NZ). The flaps were then closed with 30 resorbable surtures, 
initially polyglycolic acid (Dexon: Davis and Geck) and later polyglactin 910 (Vicryl: 
Ethicon). The mandibularl st and 2nd premolars were removed for Experiments 1 and 2; this 
was extended to include the mandibular 3rd premolars for Experiments 3a and 3b. The 
edentulous ridges were allowed to heal for three months (Experiment 1) or two months 
(Experiments 2 and 3) before placement of dental implants. Figures 2.52 to 2.54 illustrate this 
protocol. 
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Appendix 5: Basic implant placement protocol for sheep: 
All animals were starved, intubated, anaesthetised, draped and prepared as detailed in Chapter 
2, Materials and Methods. A flap was raised using a mid-crestal incision exposing the 
edentulous diastema region (for subsequent experiments, the initial incision was modified to a 
layered split incision as per Buser et al.1994).227 The tissue is very tightly bound to bone on 
the crest of the diastema and the floor of the mouth in sheep is very shallow. A chisel was 
used to raise a full-thickness flap in this region, but no attempt was made to further flatten the 
superior border of the alveolus. The site of the osteotomy was established using a 1/4 round 
bur, then prepared using an 18:1 implant hand-piece (Dynasurg DY-18) in a DynaSurg 
implant motor (DYMI-220) at 50,000+ revolutions, accompanied by copious internal and 
external irrigation. 
For the pilot experiment, internally-irrigated spade drills supplied as part of the Spectra 
ScrewVent system were used as per the manufacturer's instructions (SVD2, SVD2S, SVD3, 
SVD3S; Dentsply Inc, Encino, Ca, USA). Initially the osteotomies tapped using a machine-
driven tap (STD) at low revolutions, however it was immediately apparent that this was 
causing neurological damage to the inferior dental nerve, and several brisk arterial bleeds 
were also encountered. The protocol was modified so that only the superior cortex was tapped 
by hand. Experience with the first animals also suggested that the reusable spade drills were 
not sharp enough and risked causing thermal damage to the extremely hard mandibular 
cortical bone. Subsequently the protocol was modified after the purchase of externally-
irrigated Branemark drill kits and a drill countersink (SDIB 004 and SDIB 181) which 
provided superior cutting. The implants were placed with copious irrigation using a machine 
driver and 280: 1 reduction handpiece (Dynasurg DY280) at low revolutions (20/minute) until 
fully seated. A cover-screw was applied and the surgical site then closed using Dexon 3-0 
sutures. 
For Experiments 1 & 2, countersunk osteotomies for Swede Vent implants were prepared 
using externally-irrigated drills purchased from 3i Implants (RDlO0, TD215, PDlO0, TD315, 
CDlOO; 3i Implant Innovations, Gunz NZ). For Experiment 2, SteriOss implants were 
installed as per the manufacturer's instructions using the disposable twist drills and internally-
irrigated posterior drills as supplied (1.5mm Twist #2139, 2mm Pilot #2004, Guide Drill 
#2399, 2.7, 3.25 & 3.8mm Depth drills # 2418, 2202 & 2180, Counterbore 2203, & 
Threadformer 2204). 
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For Experiment 3a, drill kits supplied by Southern Implants (NZ) were used for both the 
SwedeVent implants and Southern Implants fixtures (Round bur D-RB-M, 2.0mm twist D-
20T-M15, Counterbore D-CB-F, 3.0mm twist D-30T-M15, Countersink D-CSS-F, Tap D-
T AP _PIO; Southern Implants Ltd, Irene, South Africa). Implants were machine-driven until 
the tapped threads were engaged and then driven home using a hand-driver. 
For Experiment 3b, osteotomies for Branemark conical fixtures were installed as per the 
manufacturer's instructions using the disposable drills as supplied (Drill kit #25028, 3.0mm 
twist# 25010, 3.15 twist# 25004, Countersink 25036, Screw Tap SDIB 206; Nobel BioCare 
Australia Ltd., Chatswood, NSW, Aust.). Fixtures were installed by machine and hand-driver 
as above, with the transition from threaded portion to smooth conical neck positioned at the 
alveolar crest. A coverscrew was applied and the tissues adapted and sutured with resorbable 
3-0 Dexon sutures around the transgingival portion of this one-piece system. The coverscrew 
"micro-gap" was thus supra-gingival. Osteotomies for the ITI implants were prepared using 
the appropriate Straumann drills, purchased from I voclar NZ and placed following the 
manufacturer's instructions (round bur # 044.022, 2.2mm Pilot #044.028, 2.8mm Pilot # 
044.038, 3.5mm Twist# 044.043, 3.5mm Profile# 044.078). ITI Esthetic Plus implants were 
inserted by hand-wrench with irrigation and positioned with the transition from threaded, 
roughened (SLA) portion to smooth conical neck at the alveolar crest. A 1.5mm high Octa 
abutment (# 048.404) followed by a 4.0mm high plastic Octa protective cap (# 048.020) was 
screwed into the internal, morse-taper connection and the soft-tissue adapted and sutured 
around the transmucosal portion of this one-piece system using 3-0 Dexon sutures. The Octa 
cap "micro-gap" was supra-gingival. 
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Appendix 6: Post-operative care after sheep surgery. 
Before and after implant placement, animals received post-operative antibiotics as shown 
below (Appendix Table 7). Antiseptic control consisted of 10cc 0.2% chlorhexidine gluconate 
as aqueous solution applied twice daily to the surgical sites using a drenching gun. Post-
operative analgesics consisted of 0.005 mg/kg buprenorphine i.m., administered at the 
discretion of the veterinarian. 
Appendix Table 7: Antibiotic protocols for sheep surgery. 
All stages: Penicillin/Streptomycin 3 cc. i.m. immediately before surgery and 
. every other day for 3 days postoperatively. 
Stage 1 (tooth extractions): Penicillin/streptomycin 3ml i.m. immediately before 
surgery and every other day for 3 days postop. 
Stage 2 (implants): Oxytetracycline lOmg/kg i.m. on the day before surgery; 
5mg/kg as 3% solution i.v. slow infusion during GA and lOmg/kg i.m. 2 days 
after surgery. 
3a,b All stages: Penicillin/streptomycin 3ml i.m. immediately before surgery. Post-
operative antibiotics were not used. 
370 
Appendix 7: Plastic embedding and staining protocols. 
The following method was used for preparing undemineralised ground sections in 1997: 
1. Perfused all sheep bilaterally through the carotid arteries with IL 0.9% chilled NaCl plus 
1ml heparin per side. 
2. Perfused bilaterally with fresh 10% formalin (formaldehyde 4% ). IL per side at room 
temperature. 
3. Sectioned specimens en bloc, each block approx 4-5 cm x 15mmx15mm. 
4. Placed specimens in formalin at room temperature for 3 days. 
5. All specimens had duplicate occlusal radiographs taken. 
6. Thermostatic probe-controlled microwaving at 55°C for 5 minutes. 
7. Transfer specimens to alcohol. 
8. Specimens in 40% and then 75% alcohol, 2 days x 2 changes. 
9. Specimens in 95% alcohol, 2 days x 2 changes. 
10. Specimens reduced in size to approx 5mm thickness (implants & teeth) or 10mm 
thickness (control site), thus specimen size 5mm x 15mm x 10mm. 
11. All specimens radiographed. 
12. Specimens placed in 100% alcohol (isopropanol) x 1 day x 2 changes each. 
13. Specimens placed in 100% isopropanol x 2 days for transport. 
14. Transported in zip-loc plastic bag in fresh isopropanol, placed in plastic jar with more 
isopropanol-soaked gauze, then placed in another bag (3 jars per bag), then 5-6 bags 
placed in another bag, packed in padded box, placed in zip-loc bag & transported for 
30+ hours by aeroplane @ 10,000m (in pressurised cabin) and by train. 
15. Specimens placed in 100% isopropanol x 2 days x last change (Switzerland). 
16. Specimens in xylol x 2 days x 2 changes in fume cupboard in rotating basket. Use glass 
jars as xylol dissolves plastic containers. Two specimens per jar. 
17. Wash in MMA monomer and discard monomer (keep in a jar with used MMA II & III -
will set solid). Transfer to MMA I x 2 days in the same jars, rotating basket. 
18. Prepare MMA III bases same day, approx 6-12mm per jar, and place in plastic light-proof 
container part-filled with water. Leave without disturbing two days. Method for MMA 
I: 
4 parts MMA (Fluka) 480ml 
1 part Dibutylphenol (Merck 800919) 6g 
1 % Perkadox 16 (Merck) 120ml 
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This makes 600ml; approx. 10ml per jar = 60 jars. 
If not completely set after two days, place in 40°C oven for 3-5 hours. 
DO NOT VIBRATE as this will cause formation of bubbles. 
19. Transfer to MMA II x 2 days same jar. Method for MMA II: 
4 parts MMA 1680ml 
0.5% Perkadox 16 10.5g 
1 part Dibutylphenol 420ml 
This makes 2100ml, = 70ml for 30 jars (some specimens still 2 per jar at this stage). 
20. Transfer to MMA III, with pre-set bases, separate jar for each specimen. Place a paper ID 
tag with each specimen. Orient specimen flat on bottom of jar,- must not touch sides of 
jar. Use the same paper label (stays with specimen throughout). Place jar in water bath 
within light-tight container, at room temp in fume cupboard and leave undisturbed 2 
days. Method for MMA III: 
Small jar= ~50ml (30 jars) 






4parts MMA = 1920ml 
1 Part Dibutylphenol = 480ml 
1 % Perkadox 16 = 24g 
This makes 2400ml. 
21. Once specimen has set, fracture glass away from sample using a hammer. Wrap glass jar 
in towel to protect yourself. 
22. Grind margins flat using Struers grinder with waterproof Silicon Carbide Paper in grit 
sizes ranging from #320 to #4000 (Struers GmbH, ZNL Schweiz Birmensdorf) to aid 
retention in VariCut saw. Orient vertically and make cuts. Record number of sections. 
Number each section with indelible pen as it is removed. Check under microscope as to 
proper orientation- widest part of implant uppermost. Briefly polish section (20sec) with 
4000 paper, then wipe with ether on gauze and glue to acrylic plate using cyanoacrylate 
glue. Number the base of the acrylic plate using a diamond pen. 
23. Place mounted thick-section in Exact grinding machine. Set minimum size to 150µm and 
reduce using progressively finer papers. Remove and complete grinding on Struers 
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grinder to between 90-lO0µm with 1000 paper, measuring with dial caliper 
(micrometer) as you do so. 
24. Complete polishing with 2400 and 4000 paper for 5-10 min each on Struers grinder. 
25. Stain with MacNeals Tetrachrome & Toluidine blue (see below). 
The following modification were made to the original protocol to facilitate embedding 






Placed in formalin at room temp, 7 days. 
20 & 75% alcohol 2 days x 2 changes. 
95% alcohol 2 days x 2 changes. 
Reduce specimens in size to approx 5mm thickness and then radiograph. 
Specimens in 100% alcohol (isopropanol) x 1 day x 2 changes each 
Steps 12-16. Specimens placed in 100% isopropanol x 2 days x last change then xylol x 2 
days x 2 changes in fume cupboard in basket on vibrating bed in fume hood. A 
vibrating device designed previously by the author was used (Duncan, 1992, 
pp 65 and 70).206 
Step 17-18: Wash in MMA monomer and discard. Transfer to MMA x 2 days same jars, 
on oscillating bed in fume hood. This required 6 x 500ml jars for 3L Methylmethacrylate. 
Prepare MMA III bases on the same day, approx 6-12mm depth in the base of each jar. Place 
in plastic light-proof container part-filled with water. Leave without disturbing for two days. 
Method for MMA III: 
Step 19: 
Step 20: 
4 parts MMA 960ml 
1 part dibutylphthalate 240 ml 
1 % benzoyl peroxide 60 g 
This makes 1200 ml, and allow the manufacture of approximately 140 jars 
with bases. 
Transfer specimens to MMA II x 2 days in the same jars. Method for MMA II: 
4 parts MMA 1.6L 
0.5% dibutylphthalate 400ml 
1 part benzoyl peroxide 20g 
This makes 2L methylmethacrylate. 
Transfer to specimens to MMA III, with pre-set bases. Use a separate jar for 
each specimen. Paper ID tag with each specimen. Orient specimen flat on bottom, must not 
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touch sides of jar. Use label which has stayed with specimen throughout. Place in water bath 
within light-tight container, at room temp in fume cupboard, leave undisturbed 2 days. 
Method for MMA III: 
4partsMMA 
1 part dibutylphthalate 








MacNeal's Tetrachrome combined with Toluidine Blue solution 
Reference: Romeis (1989).820 
Acknowledgement: Ms Monika Aeberhard School of Dentistry, Berne University, Berne, 
Switzerland. 
Solution A: 
0.5 g Methylene blue (Merck 15943) 
0.8 g Azur II (Merck 9211) 
0. lg Methyl violet 2B (Sigma M 0527) 
250 ml Methanol 
250 ml Glycerol 
Add all together. Stir with magnetic stirrer until clear and no precipitate. 
Leave for 12 hours @ 50°C then 3 days @ 37 °C. 
Filter and store in dark (light-tight) bottle or wrapped in tin foil. 
Solution B: 
1.0 g Toluidine blue in 100 ml distilled water + 1.0 g borax. 
Store in dark (light-tight) bottle or wrap in tin foil. 
Combine solutions A+ B: 
10 ml solution A 
5 ml solution B 
- Stir and make up to 100ml using distilled water. 
- Store in dark (light-tight) bottle or wrap in tin foil. 
Staining protocol: 
BLUE STAIN ONLY: 
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1. Place slides in 40% Ethanol in staining (Coplin) jar. 
2. Place in ultrasonic bath for 5 minutes. 
3. Do not rinse. 
4. Replace ethanol with 0.1 % Formic acid for 5 minutes in ultrasonic bath. 
5. Wash with tap water. 
6. Cover section on slide with MacNeal's Tetrachrome plus Toluidine blue solution 
(SOLUTIONS A + B) using eyedropper for 5 minutes. 
7. Rinse with distilled water for 5 minutes. 
8. Air dry. 
9. NO COVERSLIP REQUIRED 
BLUE STAIN (SOFT TISSUE) WITH RED COUNTER-STAIN FOR BONE: 
10. As above except do not dry after final rinse. 
11. Cover section on slide with 0.05% basic Fuschin (in water) for 1-2min. 
12. ( exact time needs to be judged by testing. If too dark, acid red can be removed using 40% 
ethanol). 
13. Clean with distilled water. 
14. Air dry. 
15. NO COVERSLIP REQUIRED. 
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Appendix 8: Tabulated data from a systematic review of dental implants in 
other animal models. 
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Appendix Table 8. Percent bone-to-implant "smooth" -surface solid titanium screws, grouped by animal model. 
"J(~\J,t'{, v""'' '"'""'';'\;{),i•;::•i"',~;'', Y~i$~~I1 _:_;::i:: .. •>,' 
>1?£Unloacle 
Rabbit tibia 6 weeks Machined surface Ti 4 (4) Best 4 threads 
Rabbit tibia 6 weeks Machined surface Ti 8 (4) Best 3 threads 
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73.6 ±9.5 (52.2 - 83.2) Rabbit tibia 1 year Machined surface Ti 10 (5) Best 3 threads 
Johansson et al. 366 1991 34.7±13.5 Rabbit tibia 3 months Branemark 7(7) Best 3 threads 
Gottlander & 1992 75.4±11.1 Rabbit tibia 6 months Sterioss 6 (6) Best 3 threads 
Albrektsson523 
50.7±11.8 Rabbit tibia 6 months Sterioss 6 (6) All threads 
Sennerby et al. 283 1992 18.8 ± 14.6 Rabbit tibia 6 weeks Modified Branemark g 6 (6) All threads 
30.0 ± 6.4 Rabbit tibia 3 months Modified Branemark 6 (6) All threads 
37.8 ± 11.4 Rabbit tibia 6 months Modified Branemark 6 (6) All threads 
Gotfredsen et al/28 1995 9.7 ± 2.2 Rabbit tibia 3 weeks Machined surface Ti 6 (6) Whole implant 
12.5 ±4.2 Rabbit tibia 12 weeks Machined surface Ti 6 (6) Whole implant 
•· Wennerberg et al.380 1995 19.9 (8.7-33.7) Rabbit tibia 12 weeks Turned titanium 10 (10) All threads d 
w 
34.5 Rabbit tibia 12 weeks Turned titanium 10 (10) --l Best 3 threads e 00 
Ivanoff et al.455 1996az 35.1 ± 15.3 Rabbit tibia 12 weeks Branemark 7 (7) Whole implant 
Gottlander et al.524 1997 4.9 ±1.7 Rabbit tibia 4 weeks Branemark 6 (6) Whole implant f 
35.5±11.6 Rabbit tibia 6 months Branemark 9 (9) Whole implant 
Michaels et al.371 1997 22.22± 1.15 Rabbit tibia 6 weeks Sterioss ti alloy 2 (I) Best 4 threads 
.. 32.66 ± 12.96 Rabbit tibia 18 weeks (12 weeks) Sterioss ti alloy 16 (8) Best 4 threads 
• Wennerberg et al.465 1997 19 Rabbit tibia 11 weeks Turned titanium 1 (1) Whole implant 
27 Best 3 threads 
26 Rabbit tibia 16 weeks Turned titanium 1 (1) Whole implant 
48 Best 3 threads 
50 ± 14 Rabbit tibia 1 year Turned titanium 9 (9) Whole implant 
64 ± 12 Best 3 threads 
Johansson et al.829 1998 10 ± 5.9 Rabbit tibia 1 month Turned titanium 9 (9) Whole implant 
20± 10 Best 3 threads 
7 ±4.5 Rabbit tibia 1 month Turned titanium alloy 9 (9) Whole implant 
17 ± 8.6 Best 3 threads 
27 ± 6.2 Rabbit tibia 6 months Turned titanium 11 (11) Whole implant 
42 ± 8.1 Best 3 threads 
24 ± 7.8 Rabbit tibia 6 months Turned titanium alloy 11 (11) Whole implant 
39 ±11.3 Best 3 threads 
31 ± 6.3 Rabbit tibia 1 year Turned titanium 10 (10) Whole implant 
43 ± 9.5 Best 3 threads 
22 ±4.9 Rabbit tibia 1 year Turned titanium alloy 10 (10) Whole implant 
41 ± 8.5 Best 3 threads 
Wennerberget al.389 1998 11 ± 6 Rabbit tibia 12 weeks Custom - half machined 10 (10) Whole implant 
18 ± 10 Best 3 threads 
12 ± 11 Rabbit tibia 12 weeks Custom - half machined 10 (10) Whole implant 
23 ± 19 Best 3 threads 
Cordioli et al.467 2000 48.6 ± 8.44 (40 -62) Rabbit tibia 5 weeks 3i machined cp-Ti 5 (5) Whole implant 
Johansson& 1.991 37.2±10.1 Rabbit tibia 3 months Machined surface Ti 7 (6) Best 3 threads 
Albrektsson386 &femur 
Sul et al. 830• 409 2001, 20 ± 9 (9-42)) Rabbit tibia & femur 6 weeks Branemark turned 10(10) Whole implant 
31 ± 14 (13-63) Rabbit tibia & femur 6 weeks Branemark turned 10(10) Best-3-threads 
Carlsson et al. 282 1989 40.25 ± 6.24 Rabbit femur 6 weeks Machined surface Ti 4 (4) Whole implant 
Ivanoff et al.455 1996a2 34.4 ± 14.6 Rabbit femur 12 weeks Branemark 7 (7) Whole implant 
'.Vennerberg et al.463 1996b 19.1 Rabbit femur 12 weeks Turned titanium 10 (10) Whole implant 
29.1 Best 3 threads 
Y oshinari et al. 525 1996 81 Rabbit femur 4 months Branemark 4? (4/' "Upper 3 threads" 
Gottlander et al.524 1997 16.2±12.6 Rabbit femur 4 weeks Branemark 6 (6) Whole implant 
48.0±5.8 Rabbit femur 6 months Branemark 8 (8) Whole implant 
Sul et al.831 2003¥ · 18 ± 8 (6-44) Rabbit femur 6 weeks Branemark turned 10(10) Whole implant 
Sennerby et. al. 283 1992 38.5 ± 15.0 Rabbit knee joint 6 weeks Modified Briinemark 6 (6) All threads 
38.4 ± 3.2 Rabbit knee joint 3 months Modified Briinemark 6 (6) All threads 
t,,; 
--.1 55.1 ± 9.7 Rabbit knee joint 6 months Modified Briinemark 6 (6) All threads 
\0 
Carr et al.536 1997a. 33.2 Baboon maxilla 3 months Sterioss cp Ti 4 (4) c-s Whole implant 
Piattelli et aL 832 1998e: · 5.1 ± 0.9 Rabbit knee joint 1 week Lifecore machined Ti 8 (8) All threads (?)" 
15.1 ± 1.7 Rabbit knee joint 2 weeks Lifecore machined Ti 8 (8) All threads (?) 
30 ± 1.8 Rabbit knee joint 3 weeks Lifecore machined Ti 8 (8) All threads (?) 
45 ± 1.6 Rabbit knee joint 4 weeks Lifecore machined Ti 8 (8) All threads (?) 
51 ± 1.9 Rabbit knee joint 8 weeks Lifecore machined Ti 8 (8) All threads (?) 
Brunski et al.221 1979 56.7 ± 20.8 Dog mandible 8 months Branemark 5 (3) Whole implant 
57.6 ± 23.5 Dog mandible 8 months (1 week) Branemark 5 (3) Whole implant 
Hipp et al.833 1987 59 Dog mandible 4-7 months Biotes 10 (?) Whole implant 
Kohri et al.532 1990 50.8 ± 6.1 (44.1 - 61.9) Dog mandible 4 months (2 months) Osseodent 6 (3) Whole implant 
47.2 ± 13.9 (33.9 - 62.6) Dog mandible 4 months Osseodent 3 (3) Whole implant 
Gotfredsen et al?75 1992 69.0 ±3.7 Dog mandible 12 weeks Astra 2(2) All threads -stereology 
68.0 ± 3.6 All threads - computerised i 
Weinlander et al.534 1992 45.66 ± 16.42 Dog mandible 3 month Branemark 7 (7) Whole implant 
PatT et al. 834 1993 60.3±3.0 Dog mandible 5 months Sterioss 2 (3) Whole implant 
Eriqsson et al. 835 1994 39.4 ± 22 (10.7 - 60.8) Dog mandible 2 months Astra 10 (5) Best 3 threads 
42.9±31.2 (0.0 - 74.2) Dog mandible 4 months Astra 10 (5) Best 3 threads 
85.6 Dog mandible 9 months (5 months) Branemark 10 (5) Whole implant# 
83.0 Dog mandible 9 months (5 months) Branemark 10 (5) Whole implant
00 
89.8 Dog mandible 3 months Branemark 5 (5) Whole implant§ 
68.3 ± 7.6 Dog mandible 7 months (3 months) Implant innovations 8 (4) Middle 1/3 
59.8 ± 14.0 Dog mandible 7 months Implant innovations 4 (4) Middle 1/3 
69.8 ± 5.9 Dog mandible 13 months (6 months) Implant innovations 8 (4) Middle 1/3 
57.6 ± 9.1 Dog mandible 13 months Implant innovations 4 (4) Middle 1/3 
Steflik: et al. 530 1996 51.7±4.1 Dog mandible 5 month Sterioss 1 stage 6 (3) Whole implant 
54.7 ± 2 .. 2 Dog mandible 11 months (6 months) Sterioss !stage 6 (3) Whole implant 
50.1 ± 10.1 Dog mandible 17 months (12 month) Sterioss 1 stage 6 (3) Whole implant 
58.6 ± 9.1 Dog mandible 23 months (18 month) Sterioss 1 stage 6 (3) Whole implant 
59.6 ± 6.5 Dog mandible 29 months (24 month) Sterioss lstage 6 (3) Whole implant 
65.6 ±4.9 Dog mandible 5 month Sterioss 2stage 6 (3) Whole implant 
58.0 ± 2.2 Dog mandible 11 months (6 months) Sterioss 2stage 6 (3) Whole implant 
57.3 ± 8.8 Dog mandible 17 months (12 month) Sterioss 2stage 6 (3) Whole implant 
63.3 ± 5.7 Dog mandible 23 months (18 month) Sterioss 2stage 6 (3) Whole implant 
64.0 ±7.8 Dog mandible 29 months (24 month) Sterioss 2stage 6 (3) Whole implant 
27.1±4.7 Dog mandible' 6 months Implant innovations 4 (2) Whole implant 
39.3 ± 4.7 Dog mandible' 6 months Implant innovations 4 (2) Whole implant 
34.6 ± 6.0 Dog mandible 1 6 months Implant innovations 4 (2) Whole implant 
Aldmoto.et al.159 1999 38.8 ±9.8 Dog mandible 12 weeks Branemark 18 (10) Coronal 4 threads 
35.2 ±13.6 Apical 4 threads 
Meraw ~t.al'.559 1999 30.0 ± 14.9 o Dog mandible 1 month Branemark 12 (6) Whole implant 
w Abrahamsson et al.390 2001 58.05±3.51 Dog mandible 6 months (3 months) 3i turned implant 10(5) Whole implant 
gg \ ··•· Ji 56.13±3.69 Dog mandible 6 months (3 months) 3i turned implant 10(5) Apical half only 
•Weng et aL499 2003 39.5±13.0 Dog mandible 4 months 3i Machined Ti screw 10(5) Apical 1/3 
Abrahamsson et al.837 2004 13.9 Dog mandible 1 week ITI with bone chamber in 10(5) Whole implant 
21 2 weeks thread - turned surface Whole implant 
23.1 4 weeks Whole implant 
43 6 weeks Whole implant 
34.9 8 weeks Whole implant 
35.7 12 weeks Whole implant 
Parr et al. 834 1993 46.3 ± 22.7 Dog maxilla 5 months Sterioss 11 (3) Whole implant 
Brunsld et al.221 1979 55.6 ± 22.2 Dog radius 4.5 months Branemark 5 (6) Whole implant 
46.4 ± 25.4 Dog radius 4.5 months (1 week) Branemark 5 (6) Whole implant 
Hipp et a]. 833 1987 49 Dog radius 4-7 months Biotes 10 (?) Whole implant 
Hale et al. 838 1991 33.09 ± 14.4 Pig mandible 6 weeks Branemark 3 (3) Whole implant 
35.12±16.9 Pig mandible 18 weeks Branemark 4 (4) Whole implant 
Basquill et.al.839 1994 47.72 ± 18.39 (10.32 - Pig mandible 14 weeks Branemark 30 (9) Whole implant 
77.53) 
Fuerst et al. 588 2003 38.9 ±4.1 Pig lateral mandible 4 weeks Machined surface 7(7) Whole implant 
Branemark flanged 
29.6 ±5.4 Pig lateral mandible 8 weeks Machined surface 7(7) Whole implant 
Caulier etal:289 1997b 11 ± 13 (0 - 30) Goat maxilla 3 months 
Branemark flanged 
Machined ti 10(10) Whole implant 
15 ± 26 (0 - 45) Goat maxilla 6 months Branemark 3 (6) Best 3 threads 
',y 
. Caulieret al.288 1997a 26.5 ± 16.2 Goat maxilla 10 months (4 months) Branemark 6 (16) Best 3 threads 
Vercaigne et al. 291 1998a 11.4 ± 10.5 (0 - 31.5) Goat maxilla 3 months HA - coated Ti 10(10) Whole implant 
Lill et al:312 1992 19 Sheep radii 4 weeks Branemark 6 (2) All threads 
Huie et al.311 1996 60.42 ± 7.94 Sheep femur 6 months Eurotechnika 6 (2) All threads 
56.02 ± 5.80 Sheep femur 6 months Branemark 4 (2) All threads 
Lucchini et al. 313 1996 68.0 ± 11.6 Sheep femur 12 weeks Serf 5(2) 6 threads for all implant h 
61.0 ± 11.7 Sheep femur 12 weeks Branemark 5(2) 6 threads for all implant h 
C;happard et al.314 1999 57.9 ± 3.37 Sheep femur 3 months Branemark 24(6) Best 3 threads 
85.5 ± 2.0 Sheep femur 6 months Euroteknika 24(6) Best 3 threads 
57.9 ± 3.37 Sheep femur 3 months Branemark 24(6) Best 3 threads 
85.5 ± 2.0 Sheep femur 6 months Euroteknika 24(6) Best 3 threads 
. Giavaresi et al.315• 316 2003a&b 59.8±8.9 Sheep femur 8 weeks Machined Ti screw 4(4) Best 3 threads 
75.3±7.8 Sheep femur 12 weeks Machined Ti screw 4(4) Best 3 threads 
Fini et al. 126 2002 75.79 ± 12.17 Sheep tibia 3 months Ti alloy 9(3) All threads 
.Carr et al.536 1997a; 48.3 Baboon mandible 3 months Ti alloy 3 (3) c-s Whole implant j 
49.0 Baboon mandible 3 months Sterioss cp Ti 3 (3) c-s Whole implant j 
Carr et al. 840 1997b u 53.85 (47.4 - 61.2) Baboon mandible 3 - 4 months (1 day - 1 Ti alloy 22 (6) c-s Whole implant 
month) 
Carr et al. 824 2000 60.8 Baboon mandible 6 months Sterioss cp ti 4 (4) c-s Whole implant 
60.6 Baboon mandible 6 months Sterioss Ti alloy 4 (4) c-s Whole implant 
· Carr et al.536 1997a; 33.8 Baboon maxilla 3 months Ti alloy 4 (4) c-s Whole implant 
~ C~rret al.824 2000 51.5 Baboon maxilla· 6 months Sterioss cp ti 4 (4) c-s Whole implant - 49.8 Baboon maxilla 6 months Sterioss Ti alloy 4 (4) c-s Whole implant 
.Hiirzeler et al. 332 1998 64.8 ± 12.3 Macaque mandible 12 months Branemark 5 (5) Whole implant in bonez 
73.6 ± 13.3 Macaque mandible 12 months Branemark 5 (5) Best 2 threadsz 
Isidor et al. 841 1998 V 26.4 w (0 - 72.8) Macaque mandible 24 months (18 Astratech 6 (3) Whole implant 
months) 
48 X (28 - 66) Macaque mandible 24 months (18 Astratech 10 (4) Whole implant 
months) 
Albrektsson et al. 842 1993 81.67 (41.5 -100) Human mandible 2.5 - 8 year (2 - 7.5 Branemark 17 (7) Best 3 threads/ All threads Y 
years) 
87.6 (74.3 - 99.2) Human mandible 9 - 16 years Branemark 6 (4) Best 3 threads/ All threads Y 
1994 
(8.5 - 15.5 years) 
Palmer et aL843 20 ± 31 Human mandible 5 months Branemark 6 (6) Linguo-coronal 3 threads 
24 ± 21 Human mandible 5 months Branemark 6 (6) Linguo-apical 3 threads 
Palmer et al. 844 1998 28 ± 27 Human mandible 17 months (12 Branemark 6 (10) Linguo-coronal 3 threads 
months) 
49 ±25 Human mandible 17 months (12 Branemark 6 (10) Linguo-apical 3 threads 
months) 
iamoni efal.539 ··1999. 43.76 (44.71 - 48.81) Human mandible 1 month Custom - half machined 2 (2) All threads 
37.37 (24.37 - 50.37) Human mandible 3 month Custom - half machined 2 (2) All threads 
56.59 (50.26 - 62.92) Human mandible 6 month Custom - half machined 2 (2) All threads 
70.70 Human mandible 12 month 
Roh.rer etal.845 1999 65.4 ± 3.9 Human mandible 85 months 
Ivanoff et al.472 2003 15 ± 14 Human mandible 3.5 months 
Albrektsson et al.842 1993. 70 .1 ( 46.3 - 82.8) Human maxilla 6 months 
75.2 Human maxilla 1 year (6 months) 
77.95 (43 - 92.2) Human maxilla 9 - 16 years 
(8.5 - 15.5 years) 
Jensen et al. 562 1998 9 ± 10 Human maxilla 6 to 14 months 
(allografted sinus) 
16 ±8 Human maxilla 6 to 12 months 
(autografted sinus) 
Lazzara et al. 367 1999 33.98 ± 31.04 Human maxilla 6 months 
72.96±25.13 Human maxilla 6 months 
Trisi et aL 2002 35.3 ± 27.9 Human maxilla 6 months 
Ivanoff et al.472 2003 13 ± 12 Human maxilla 6.6 months 
.Trisiet aL846 2003a 10.0 ± 14.7 Human maxilla 2 months 
g; · Trisiet al. 847 2003b 34.6 ± 24.6 Human maxilla 6 months 
tv Lateral sinus wall 
29.9 ± 16.6 Human maxilla 6 months 
Alveolar crest 
Sennerby et al.848 1991 56.5 - 85.8 Human jaws I -16 years 
Piattelli et al.849 1998b; 71.83 ± 4.96 Human jaws 6 months 
( 4 years - mean) 
6.2 ± 1.6 Human jaws 
3.5 ± 5.0 Human jaws 
6.7 ± 2.1 Human jaws 
a range given where published or if SD not stated. 
b healing period unloaded (if loaded before histometric analyses, time given in brackets). 
c number of fixtures (number of animals in brackets). 
d bone-implant contact calculated as % of total fixture perimeter (threaded portion). 
e bone-implant contact calculated as% of best 3-4 consecutive threads in cortical bone ("cortical passage"). 
f bone-implant contact calculated as% of total fixture perimeter (whole of fixture). 
g modified Branemark fixture 
h bone-implant contact calculated as % of fixture surface for index threads in 6 areas representing the whole implant. 
i results grouped for all fixture threads 
j bone-implant contact calculated as% of total fixture perimeter (cross-sections of fixtures) 




Custom - half machined 1 (1) All threads 
Branemark 5 (1) All threads 
Branemark (mini- 11 (11) All threads' 
implant) 
Branemark 3 (1) Best 3 threads/ All threads Y 
Branemark 1 (1) Best 3 threads/ All threads Y 
Branemark 6 (5) Best 3 threads/ All threads Y 
Ti Mini-implant 6 (4) All threads (mainly represents 
cortical contact) 
Ti Mini-implant 6 (5) All threads ( cortical & graft 
contact) 
31 modified 11 (11) All threads 
Custom, machined Ti 11 (11) All threads 
2 sided (machined vs 11 (11) All threads 
Osseotite). 
Branemark (mini- 9 (9) All threads 
implant) 
2 sided (machined vs 11(11) All threads 
Osseotite ). 
2 sided machined vs 6 (6) All threads 
MTX 
2 sided machined vs 3 (3) All threads 
MTX 
Branemark 6 (4) Thread to tissue k 
Branemark 5 (5) All threads (?) 
Custom, machined Ti 2 (2) All threads 
Custom, machined Ti 2 (2) All threads 
Custom, machined Ti 2 (2) All threads 
1 bone implant contact for coronal 4mm 
m bone-implant contact for apical 4mm 
n implants with bone-implant contact= 0 excluded from analysis. Figures become 33.1 (14.9) and 31.7 (17) for coronal and apical areas when BIC=0 included. 
0 immediate implants in extraction sockets 
P BIC for cortical passage (non-threaded part) and cancellous bone (threaded part) measured separately 
q immediately loaded 
r immediate implants in extraction sockets with GT AM 
s immediate implants in extraction sockets with GTAM + HA (Osteogen) 
t immediate implants in extraction sockets with GTAM + DFDBA 
u combined figure for "fit" and "misfit" prosthesis 
v combined figure for AstraTech Tio2-blasted and machined-surface implants 
w 18 months occlusal overload 
w x 18 months ligature-induced plaque accumulation 
E'.l Y 3-best-threads on each side, or all threads if <3 threads available 
z control implants only 
# Acrylic-veneered superstructure 
00 
Ceramo-metal superstructure 
§ unloaded control 
ll 1ost implants counted as 0 
t combined Sul et al. 2001 & 2002a; two-sided (machined vs oxidised) implants 
¥ includes Sul et al. 2002a; two-sided (machined vs oxidised) implants 
6 exact numbers or measurement technique unclear from text 
Appendix Table 9. Percent bone-to-implant "rough"-surface solid titanium screws, grouped by animal model. 
w 
•·· \Y ennerberg et al.380 
. Wennerberg et al. 462 
Wennerberg et al.463 
Wennerberg et al.464 








Wennerberg etal.389 1998 
20.7 ±4.2 





















46 ± 8 
56 ±12.5 
53 ±10.3 
24 ± 8 
33 ± 9 
30 ± 6.1 
44± 18 
31 ± 17 
47 ±21 
43 ± 14 
35 ± 10 
44 ± 14 
25 ± 12 
17 ± 11 
26 ± 12 
Rabbit tibia 3 weeks TiO2-blasted 
Rabbit tibia 12 weeks TiO2-blasted 
Rabbit tibia 12 weeks TiO2-blasted 
Rabbit tibia 12 weeks TiO2-blasted 
Rabbit tibia 12 weeks 25µm Alz03- blasted 
Rabbit tibia 12 weeks 75µm Alz03- blasted 
Rabbit tibia 12 weeks 25µm Alz03- blasted 
Rabbit tibia 12 weeks 75µm Al2O3- blasted 
Rabbit tibia 12 weeks 25µm TiO2- blasted 
Rabbit tibia 12 weeks 25µm Al2O3- blasted 
Rabbit tibia 12 weeks 25µm TiO2- blasted 
Rabbit tibia 12 weeks 25µm Al2O3- blasted 
Rabbit tibia 4 weeks 25µm TiO2- blasted 
Rabbit tibia 4 weeks 250µm TiO2- blasted 
Rabbit tibia 4 weeks 25µm TiO2- blasted 
Rabbit tibia 4 weeks 250µm TiO2- blasted 
Rabbit tibia 11 weeks 25µm Alz03- blasted 
Rabbit tibia 16 weeks 25µm Alz03- blasted 
Rabbit tibia 1 year 25J,tm Al2O3- blasted 
Rabbit tibia 11 weeks 25µm Alz03- blasted 
Rabbit tibia 16 weeks 25 µm Alz03- blasted 
Rabbit tibia 1 year 25µm Alz03- blasted 
Rabbit tibia 3 months 25µm-blasted Ti 
Rabbit tibia 3 months 75µm-blasted Ti 
Rabbit tibia 3 months 75µm-blasted Ti alloy 
Rabbit tibia 3 months 25µm-blasted Ti 
Rabbit tibia 3 months 75µm-blasted Ti 
Rabbit tibia 3 months 75µm-blasted Ti alloy 
Rabbit tibia 12 weeks 25µmA1203 -blasted 
Rabbit tibia 12 weeks 25µm Al203 -blasted 
Rabbit tibia 12 weeks 25µm Al203 -blasted 
Rabbit tibia 12 weeks 75µm A1203 -blasted 
Rabbit tibia 12 weeks 250µmA1 203 -blasted 
Rabbit tibia 12 weeks 250µm Al203 -blasted 
Rabbit tibia 12 weeks 25 µm Al203 -blasted 
Rabbit tibia 12 weeks 25µm Al203 -blasted 
Rabbit tibia 12 weeks 25µm Al203 -blasted 
Whole implant 
6 (6) Whole implant 
6 (6) Whole implant 
10 (10) All threads 
10 (10) Best 3 threads 
9 (9) Whole implant 
9 (9) Whole implant 
9 (9) Best 3 threads 
9 (9) Best 3 threads 
10 (10) Whole implant 
10 (10) Whole implant 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
9 (9) Whole implant 
9 (9) Whole implant 
9 (9) Best 3 threads 
9 (9) Best 3 threads 
1 (1) Whole implant 
1 (1) Whole implant 
9 (9) Whole implant 
1 (1) Best 3 threads 
1 (1) Best 3 threads 
9 (9) Best 3 threads 
9 (9) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
9 (9) Whole implant 
10 (10) Whole implant 
10 (10) Whole implant 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Best 3 threads 
10 (10) Whole implant 
10 (10) Whole implant 
10 (10) Whole implant 
25 ± 10 Rabbit tibia 12 weeks 75µm Al203 -blasted 10 (10) Whole implant 
21 ± 9 Rabbit tibia 12 weeks 250µm Al203 -blasted 10 (10) Whole implant 
23 ± 10 Rabbit tibia 12 weeks 250µm Al203 -blasted 10 (10) Whole implant 
Cordioli et al.467 2000 54.80 ± 10.96 (45 - 71) Rabbit tibia 5 weeks TiO2-blasted 5 (5) Whole implant 
56.80 ± 10.96 (43 - 73) Rabbit tibia 5 weeks TPS 5 (5) Whole implant 
72.40 ± 9.83 (64 - 88) Rabbit tibia 5 weeks Osseotite acid-etched 5 (5) Whole implant 
Kim et al. 851 2003 23.1± 8.7 Rabbit tibia 4 weeks Blasted 12 (6) Best 3 threads 
33.3 ± 11.9 Rabbit tibia 4 weeks Blasted & oxidised 12 (6) Best 3 threads 
57.6 ± 13.5 Rabbit tibia 12 weeks Blasted 12 (6) Best 3 threads 
58.2 ± 12.8 Rabbit tibia 12 weeks Blasted & oxidised 12 (6) Best 3 threads 
Sul et al.409 2002a 49±12 (31-64) Rabbit tibia & femur 6 weeks Branemark Ca2= oxidised 10(10) Best-3-threads 
Sul et al. 412 2002b 24±12 (12-44) Rabbit tibia & femur 6 weeks Branemark oxidised (600- 10(10) Whole implant 
1000nm) 
43 ± 11 (16-64) Rabbit tibia & femur 6 weeks Branemark oxidised (600- 10(10) Best-3-threads 
Wennerberg et al. 463 
1000nm) 
1996b 38.4 Rabbit femur 12 weeks 75µm Alz03- blasted 10 (10) Whole implant 
49.9 Rabbit femur 12 weeks 75µm AlzOr blasted 10 (10) Best 3 threads 
H.an et al. 8.50 1998 40±8 Rabbit femur 3 months 25µm-blasted Ti6AL4V 9 (9) Best 3 threads 
alloy 
21 ± 7 Rabbit femur 3 months 25µm-blasted Ti6AL4V 9 (9) Whole implant 
v.> Hayakawa et al.526 
alloy 
2000 76.4 ± 3.4 Rabbit femur 12 weeks machined cp-Ti 6 (6) Whole implant 
B; Sul et al.831 2003 39 ± 12 (21-52) Rabbit femur 6 weeks Branemark S oxidised 10(10) Best-3-threads 
44 ± 10 (35-60) Rabbit femur 6 weeks Branemark P oxidised 10(10) Best-3-threads 
Piattelli et· al. 832 19Q8e. 5.1 ± 1.1 Rabbit knee joint 1 week Lifecore sandblasted Ti 8 (8) All threads (?) 
17 ± 4.5 Rabbit knee joint 2 weeks Lifecore sandblasted Ti 8 (8) All threads (?) 
42±2.8 Rabbit knee joint 3 weeks Lifecore sandblasted Ti 8 (8) All threads (?) 
54± 2.6 Rabbit knee joint 4 weeks Lifecore sandblasted Ti 8 (8) All threads (?) 
60 ± 1.4 Rabbit knee joint 8 weeks Lifecore sandblasted Ti 8 (8) All threads (?) 
Hipp .et al. 833 1987 59 Dog mandible 4-7 months Biotes 10 (?) Whole implant 
Gotfredsen. et al. 375 1992 69.0 ±3.7 Dog mandible 12 weeks Astra TiO2- blasted 2(2) All threads -stereology 
68.0 ± 3.6 Dog mandible 12 weeks Astra TiO2- blasted 2(2) All threads - computerised 
Parr et al. 834 1993 60.3±3.0 Dog mandible 5 months SteriOss 2 (3) Whole implant 
E;icsson et al.835 1994 40.5 ± 14.8 (23.3 - 55.7) Dog mandible 2 months Astra TiO2- blasted 10 (5) Best 3 threads 
65.1 ± 17.3 (37.2 - 84.7) Dog mandible 4 months Astra TiO2- blasted 10 (5) Best 3 threads 
Barbier & Schepers343 1997 52.9 Dog mandible 5 months (7 weeks) IMZTPS 4 (5) Whole implant 
Corso et al. 852 1997 39.15 ±9.61 q Dog mandible 6 months TPS-coated 10 (4) Control implants 
Abrahamsson et al.342 1999 66.71 ± 9.67 Dog mandible 9 months (6 Asta TiO2- blasted 2- 6 (6) threaded (cancellous) part 
months) stage 
61.38 ± 4.90 Dog mandible 9 months (9 Asta TiO2- blasted 1- 6 (6) threaded (cancellous) part 
months) stage 
.Karabuda.et al.853 1999 51.35 ± 12.1 (30.1 - 70.6) Dog mandible 0 8 weeks Pitt-Easy Bio-Oss TPS 3 (2) Whole implant 
71.79±5.48 Dog mandible 6 months (3 3i Osseotite 10(5) Whole implant Abrahamsson et al.390 2001 months) 
76.70±4.88 Dog mandible 6 months (3 3i Osseotite 10(5) Apical half only months) 
'vVeng et al.499 2003 62.9±12.4 Dog mandible 4 months 3i Osseotite 10(5) Apical 1/3 
Abrahamsson et al. 837 2004 24.9 Dog mandible 1 week ITI & SLA bone chamber 10(5 Whole implant 
50.5 Dog mandible 2 weeks ITI & SLA bone chamber 10(5 Whole implant 
65 Dog mandible 4 weeks ITI & SLA bone chamber 10(5 Whole implant 
63.9 Dog mandible 6 weeks ITI & SLA bone chamber 10(5 Whole implant 
62.6 Dog mandible 8 weeks ITI & SLA bone chamber 10(5 Whole implant 
58.6 Dog mandible 12 weeks ITI & SLA bone chamber 10(5 Whole implant 
Rohner et al.319 2004 35.2 ± 11.5 Pig fibula 3 weeks ITISLA 6 (6) Whole implant 
44.4 ± 10.9 Pig fibula 6 weeks ITISLA 6 (6) Whole implant 
46.8 ± 12.6 Pig fibula 12 weeks ITI SLA 6 (6) Whole implant 
Rohner et aL319 2004 63.7 ± 6.8 Pig scapula 3 weeks ITI SLA 6 (6) Whole implant 
73.8 ± 8.2 Pig scapula 6 weeks ITI SLA 6 (6) Whole implant 
74.2 ± 6.5 Pig scapula 12 weeks ITI SLA 6 (6) Whole implant 
Rohner et al?19 2004 24.2 ± 10.9 Pig iliac crest 3 weeks ITI SLA 6 (6) Whole implant 
44.2 ± 10.6 Pig iliac crest 6 weeks ITI SLA 6 (6) Whole implant 
52.5 ± 11.2 Pig iliac crest 12 weeks ITI SLA 6 (6) Whole implant 
ii\3 Hulshoff et al.301 1997b 24.96 ± 12.14 Goat femur 24 days cp-Ti Biocomp screw 5 (5) Whole implant mean 
0\ 41.56 ± 31.46 Goat femur 24 days cp-Ti Biocomp screw 5 (5) Coronal-3-threads 
Vercaigne etaL303 2000 69 ± 13 Goat femur 6 weeks Astra TiO2- blasted 6 (6) First 4 coronal threads 
46 ± 13 Goat femur 6 weeks Astra TiO2- blasted 6 (6) Middle 5 threads 
51 ± 12 Goat femur 6 weeks Astra TiO2- blasted 6 (6) Whole implant 
53 ± 19 Goat femur 12 weeks Astra TiO2- blasted 6 (6) First 4 coronal threads 
48 ± 16 Goat femur 12 weeks Astra TiO2- blasted 6 (6) Middle 5 threads 
49 ± 15 Goat femur 12 weeks Astra TiO2- blasted 6 (6) Whole implant 
Vercaigne et aL291 1998a 10.1 ± 8.8 (1.6 - 25.2) Goat maxilla 3 months TPS - coated Ti 10(10) Whole implant 
8.8 ± 7.1 (0 - 20.9) Goat maxilla 3 months Acid treated TPS - coated 10(10) Whole implant 
Ti 
Giavaresi et al.403 2002 59.2 ± 3.1 Sheep femur 8 weeks Blasted & etched Ti screw 4(4) Best3 threads 
87.4±8.1 Sheep femur 12 weeks Blasted & etched Ti screw 4(4) Best3 threads 
Giavaresi et al.315• 316 2003a&b 49.1±8,6 Sheep femur 8 weeks Acid-etched Ti screw 4(4) Best 3 threads 
50.9±7.8 Sheep femur 12 weeks Acid-etched Ti screw 4(4) Best 3 threads 
Moroni et al, 396 1996 26 ± 15 Sheep tibia 6 weeks (6 weeks) TPS-coated s.s. ext 6 (6) Transverse sections, both 
(9 - 54) fixation screw cortical passage only 
Rocca.et ai:398 1998 15.51 ± 16.93 Sheep femur & tibia 2 weeks TPS-coated threaded 7 (3) Transverse sections, cortical 
cylindrical screw passage only 
34.48 ± 17.3 Sheep femur & tibia 1 month TPS-coated threaded 7 (3) Transverse sections, cortical 




7 (3) Transverse sections, cortical 
cylindrical screw passage only 
76.86 ± 15.87 Sheep femur & tibia 9 months TPS-coated threaded 7 (3) Transverse sections, cortical 
cylindrical screw passage only 
Moroni et a!.399 1999 34 Sheep tibia / femur 1 month TPS titanium screw 2 (2) Cortical passage only 
51 Sheep tibia/ femur 3 months TPS titanium screw 2 (2) Cortical passage only 
Carr et al. 824 • 2000 60.9 Baboon mandible 6 months SteriOss TPS 4 (4) c-s Whole implant 
51.1 Baboon maxilla 6 months SteriOss TPS 4 (4) c-s Whole implant 
Isidor et al. 841 1998 26.4 (0 - 72.8) Macaque mandible 24 months (18 AstraTech (machined & 6 (3) Whole implant 
months) TiO2 combined) 
48 (28 - 66) Macaque mandible 24 months (18 AstraTech (machined & 10 (4) Whole implant 
months) TiO2 combined) 
Piattelli et al. 854 1998f 55.8 ± 6.5 Monkey mandible 9 months PHI TPS screws 12 (6) Whole implant 
73.2 ± 5.9 Monkey mandible 9 months (9 months) PHI TPS screws 12 (6) Whole implant 
Romanos et al. 855 2002 67.93 ± 1.6 Macaque mandible 6 months (2 months) Ankylos cp-Ti, blasted 18 (6) Whole implant 
64.25 ± 0.65 Macaque mandible 3 months (2 months) Ankylos cp-Ti, blasted 18 (6) Whole implant 
PiatteI!i et al. 854 1998f 54.5 ± 3.3 Monkey maxilla 9 months PHI TPS screws 12 (6) Whole implant 
67.3 ± 7.6 Monkey maxilla 9 months (9 PHI TPS screws 12 (6) Whole implant 
months) 
Wehrbein et al. 856 1998 68.0 ± 5.0 Human mandible 11 to 24 months Straumann Orthosystem 2 (1) All threads 
SLA 
Ivanoffet al.472 . 2003 31 ± 11 Human mandible 3.5 months Branemark (mini-implant) 11 (11) All threads 
TiUnite oxidised 
ix5 Lazzara et aL 367 1999· 72.96 ± 25.13 Human maxilla 6 months 3I modified Osseotite 39 (11) All threads 
--.l ( acid etched) 
33.98 ± 31.04 Human maxilla 6 months Custom, Osseotite acid 11 (11) All threads 
etched 
Trisi et al. 2002 72.4 ± 24.1 Human maxilla 6 months 2 sided machined vs 11(11) All threads 
Osseotite 
Ivanoffet al.472 2003 29 ± 15 Human maxilla 6.6 months Branemark (mini-implant) 8 (8) All threads 
TiUnite oxidised 
Trisi et al. 846 2003a 47.8 ± 14.0 Human maxilla 2 months 2 sided (machined vs 11(11) All threads 
Osseotite 
Wilson etal.857 1998 56.25 ± 14.7 (32.05 - Human mandible & maxilla 6 months ITI TPS-coated solid- 3 (1) All threads 
72.14 screw 
Trisi et al. 500 1999 58.9 ± 5.1 Human maxilla & mandible 3 months Custom, Grit blasted 2 (2) All threads 
72.9 ± 12.2 Human maxilla & mandible 6 months Custom, Grit blasted 2 (2) All threads 
76.7 ± 12.7 Human maxilla & mandible 12 months Custom, Grit blasted 2 (2) All threads 
Trisi et al. 847 2003b 70.3±17.1 Human maxilla Lateral sinus 6 months 2 sided machined vs 6 (6) All threads 
wall MTX 
76.8 ± 16.4 Human maxilla Alveolar crest 6 months 2 sided machined vs 3 (3) All threads 
MTX 
Wehrbein et al.856 1998 79.3 ± 18.9 Human palate 19 to 24 months Straumann Orthosystem 4 (4) All threads 
SLA 
Appendix Table 10. Percent bone-to-implant "ceramic"-surface solid titanium screws, grouped by animal model. 
59.2 ± 12.2 (37.1 - 76.2) Rabbit tibia 1 year HA-coated Ti screw 10 (5) Best 3 threads 
Gottl3:nd.er & 1992 56.4 ± 13.7 Rabbit tibia 6 months SteriOss HA screw 6 (6) All threads 
Albrektsson523 
76.6 ± 9.3 Rabbit tibia 6 months SteriOss HA screw 6 (6) Best 3 threads 
· Jansen et aL 858 .• 1993 91.7 ± 2.9 Rabbit tibia 12 weeks HA 75µm 6 (6) Whole implant 
88.5 ± 6.9 Rabbit tibia 12 weeks HA 125µm 6 (6) Whole implant 
91.8 ± 6.6 Rabbit tibia 12 weeks HA dried 6 (6) Whole implant 
Gotfredsen et al. 828 1995 25.8 ± 4.1 Rabbit tibia 3 weeks HA 6 (6) Whole implant 
24.1 ± 3.8 Rabbit tibia 12 weeks HA 6 (6) Whole implant 
Gottlander et al.388 1997a · 19.4 ± 6.6 Rabbit tibia 1 month HA plasma-sprayed NBC 6 (6) All threads 
52.2 ± 11.4 Rabbit tibia 6 month HA plasma-sprayed NBC 9 (9) All threads 
Gottlahder et al.524 19.97b 17.4±10.5 Rabbit tibia 1 month Ca-P-coated NBC 9 (9) All threads 
37.8 ± 14.4 Rabbit tibia 6 month Ca-P-coated NBC 8 (8) All threads 
30.8 ± 15.3 Rabbit tibia 1 month Ca-P-coated NBC 9 (9) Best 3 threads 
58.0 ± 17.4 Rabbit tibia 6 month Ca-P-coated NBC 8 (8) Best 3 threads 
Y oshinari et al. 525 1996 90 Rabbit femur 4 months HA-coated Branemark 4? (4) "Upper 3 threads" 
Gottlander et al.388 1997a 29.9 ± 9.7 Rabbit femur 1 month HA plasma-sprayed NBC 6 (6) All threads 
\;.) 
56.3 ± 9.2 Rabbit femur 6 month HA plasma-sprayed NBC 8 (8) All threads 00 
00 
Gottlander et al.524 1997b 21.0 ± 7.8 Rabbit femur 1 month Ca-P-coated NBC 9 (9) All threads 
47.3 ± 16.6 Rabbit femur 6 month Ca-P-coated NBC 8 (8) All threads 
35.9 ± 11.2 Rabbit femur 1 month Ca-P-coated NBC 9 (9) Best 3 threads 
63.4 ± 21.1 Rabbit femur 6 month Ca-P-coated NBC 8 (8) Best 3 threads 
Evans et al.533 1996 64.4 ± 14.5 Dog mandible 7 months (3 months) Implant Innovations HA 8 (4) Middle 1/3 
52.4 ± 12.3 Dog mandible 7 months Implant Innovations HA 4 (4) Middle 1/3 
73.3 ± 11.7 Dog mandible 13 months (6 months) Implant Innovations HA 8 (4) Middle 1/3 
38.3 ± 15.5 Dog mandible 13 months Implant Innovations HA 4 (4) Middle 1/3 
Stef!iket al.530 1996 41.5 ± 1.5 Dog mandible 5 month Bioceram 1 stage 6 (3) Whole implant 
20.8 ± 2.1 Dog mandible 11 months (6 months) Bioceram 1 stage 6 (3) Whole implant 
33.0 ± 4.6 Dog mandible 17 months (12 month) Bioceram 1 stage 6 (3) Whole implant 
38.5 ± 8.4 Dog mandible 23 months (18 month) Bioceram 1 stage 6 (3) Whole implant 
30.5 ± 1.2 Dog mandible 29 months (24 month) Bioceram 1 stage 6 (3) Whole implant 
20.5 ±0.2 Dog mandible 5 month Bioceram 2 stage 6 (3) Whole implant 
41.5 ± 10.1 Dog mandible 11 months (6 months) Bioceram 2 stage 6 (3) Whole implant 
21.4 ± 6.2 Dog mandible 17 months (12 month) Bioceram 2 stage 6 (3) Whole implant 
45.7 ± 6.1 Dog mandible 23 months (18 month) Bioceram 2 stage 6 (3) Whole implant 
37.1 ± 4.5 Dog mandible 29 months (24 month) Bioceram 2 stage 6 (3) Whole implant 
Kohal et al. 859 1999 70.3 ± 2.9 Dog mandible 6 months Paragon ScrewVent (Non- 3(3) Whole implant 
submerged) 
100±0 Dog mandible 6 months Paragon ScrewVent (Non- 3(3) Best 3 threads 
submerged) 
63.4 ± 15.9 Dog mandible 6 months Paragon ScrewVent 3 (3) Whole implant 
(submerged) 
98.9 ± 1.0 Dog mandible 6 months Paragon ScrewVent 3 (3) Best 3 threads 
(submerged) 
58.7 ± 12.2 Dog mandible 3 months Paragon ScrewVent 6 (3) Whole implant 
(submerged) 
96.2 ± 2.2 Dog mandible 3 months Paragon ScrewVent 6 (3) Best 3 threads 
Brogniez et al. 860 2000 91 ± 2 Dog mandible 6 months 
(submerged) 
SteriOss HA 12 (3) "Zone A" cortical bone 
87 ± 2 Dog mandible 6 months SteriOss HA 12 (3) Whole implant 
Hayashi et al.861 1989 91.2 ± 5.4 Dog femur 1 month HA-coated s.s. screw 8 (9) Whole implant 
96.7 ± 2.7 Dog femur 2 months HA-coated s.s. screw 8 (9) Whole implant 
97.8 ± 1.8 Dog femur 6 months HA-coated s.s. screw 8 (9) Whole implant 
96.8 ± 1.0 Dog femur 12 months HA-coated s.s. screw 8 (9) Whole implant 
97.5 ± 1.4 Dog femur 24 months HA-coated s.s. screw 8 (9) Whole implant 
63.4 ± 14.5 Dog femur 1 month Al2O3-coated s.s.screw 8 (9) Whole implant 
85.9 ± 7.5 Dog femur 2 months Al2O3-coated s.s.screw 8 (9) Whole implant 
94.8 ± 3.8 Dog femur 6 months Al2Orcoated s.s.screw 8 (9) Whole implant 
90.9 ± 5.6 Dog femur 12 months Al2O3-coated s.s.screw 8 (9) Whole implant 
95.0 ± 3.0 Dog femur 24 months Al2O3-coated s.s.screw 8 (9) Whole implant 
Caulier et al.288 1997a 67.4 ± 27 Goat maxilla 10 months (4 months) FA- coated Branemark 14 (16) Best 3 threads 
63.1 ± 24.9 Goat maxilla 10 months (4 months) HART- coated Branemark 15 (16) Best 3 threads 
77.1±13 Goat maxilla 10 months (4 months) HA - coated Branemark 13 (16) Best 3 threads 
Caulier et al. 289 1997b 27 ± 33 (0 - 68) Goat maxilla 3 months FA- coated Branemark 4 (5) Best 3 threads 
16±31(0-63) Goat maxilla 3 months HART - coated Branemark 4 (5) Best 3 threads 
36 ± 20 (12-58) Goat maxilla 3 months HA- coated Branemark 5 (5) Best 3 threads 
26 ± 13 (10 - 44) Goat maxilla 6 months FA-coated Branemark 5 (6) Best 3 threads 
22 ± 16.4 (0 - 40) Goat maxilla 6 months HART - coated Branemark 5 (6) Best 3 threads 
35 ± 24 (2 - 54) Goat maxilla 6 months HA - coated Branemark 5 (6) Best 3 threads 
Vercaigne et al. 291 1998a 29.5 ± 7.4 (14.5 - 37.6) Goat maxilla 3 months HA - coated Ti 10(10) Whole implant 
Hulshoff et al. 300 1997a 68.83 (60.94 - 81.31) Goat femur 3 months HA/FA-coated Biocomp 9 (9) Whole implant mean 
screw 
81.31 ± 16.74 Goat femur 3 months HA/FA-coated Biocomp 9 (9) Coronal-3-threads 
screw 
43.35 (31.12 - 67.28) Goat femur 3 months TPS/CaP-coated Biocomp 9 (9) Whole implant mean 
screw 
67.28 ± 22.87 Goat femur 3 months TPS/CaP-coated Biocomp 9 (9) Coronal-3-threads 
screw 
Hulshoff et al.301 1997b 72.81 ± 17.89 Goat femur 24 days HA/FA-coated Biocomp 5 (5) Whole implant mean 
screw 
90.85 ± 8.72 Goat femur 24 days HA/FA-coated Biocomp 5 (5) Coronal-3-threads 
screw 
46.20 ± 16.31 Goat femur 24 days CaP-coated Biocomp screw 5 (5) Whole implant mean 
68.25 ± 31.56 Goat femur 24 days CaP-coated Biocomp screw 5 (5) Coronal-3-threads 
Giavaresi et al.403 2002 63.4 ± 3.4 Sheep femur 8 weeks Oxidised, CaP-coated 4(4) Best3 threads 
screw 
78.5 ± 5.9 Sheep femur 12 weeks Oxidised, CaP-coated 4(4) Best3 threads 
screw 
Giavaresiet al.315• 316 2003a&b 61.5±6.4 Sheep femur 8 weeks HA plasma-sparayed Ti 4(4) Best 3 threads 
screw 
63.6±7.4 Sheep femur 8 weeks Oxidised HA coated Ti 4(4) Best 3 threads 
screw 
71.6±3.8 Sheep femur 12 weeks HA plasma-sparayed Ti 4(4) Best 3 threads 
screw 
72.5±7.2 Sheep femur 12 weeks Oxidised HA coated Ti 4(4) Best 3 threads 
screw 
Caja and Moroni395 1996 85.7 ± 8.9 (74 - 97) Sheep tibia 6 weeks HA-sprayed s.s. ext 7 (7) Cortical passage only 
fixation screw 
Moroni et aL396 1996 30± 12(17-52) Sheep tibia 6 weeks (6 weeks) 5-6 mm dia HA coated s.s. 6 (6) Transverse sections (t-s), both 
ext fixation screw cortical passage only 
87.85 Sheep tibia 4 months HA sprayed s.s. screw 2 (2) Both cortical passages 
93.8 Sheep tibia 12 months HA sprayed s.s. screw 2 (2) Both cortical passages 
t,j Rocca et al. 398 1998 53.24 ± 26.91 Sheep femur & tibia 2 weeks FA/HA-sprayed threaded 7 (3) T-s, cortical passage only \0 
0 screw 
47.68 ± 24.56 Sheep femur & tibia 1 month FA/HA-sprayed threaded 7 (3) T-s, cortical passage only 
screw 
58.76 ± 22.30 Sheep femur & tibia 3 months FA/HA-sprayed threaded 7 (3) T-s, cortical passage only 
screw 
99.0 ± 2.45 Sheep femur & tibia 9 months FA/HA-sprayed threaded 7 (3) T-s, cortical passage only 
screw 
38.52 ± 25.44 Sheep femur & tibia 2 weeks HA-sprayed threaded screw 7 (3) T-s, cortical passage only 
46.74 ± 22.81 Sheep femur & tibia 1 month HA-sprayed threaded screw 7 (3) T-s, cortical passage only 
70.45 ± 17.43 Sheep femur & tibia 3 months HA-sprayed threaded screw 7 (3) T-s, cortical passage only 
96.83 ± 2.14 Sheep femur & tibia 9 months HA-sprayed threaded screw 7 (3) T-s, cortical passage only 
ivI()roni et al. 399 1999 54 Sheep tibia / femur 1 month HA plasma-sprayed 2 (2) Cortical passage only 
titanium screw 
61 Sheep tibia / femur 3 months HA plasma-sprayed 2 (2) Cortical passage only 
titanium screw 
.Carr eta!. 1997a 68.7 Baboon mandible 3 months HA coated Ti-alloy 4 (4) T-s Whole implant 
51.9 Baboon maxilla 3 months HA coated Ti-alloy 2 (2) T-s Whole implant 
• AkagawaetaL862 1998. 67 ±8.2 Macaque mandible 15 months (12 months) Zirconia ceramic screw 16 (4) Whole implant 
Rohrer et al. 845 





72.6 ±7.0 Macaque mandible 
47 ± 12.7 Human maxilla 
80,97 (70,13 C 91.81) Human mandible 
91. 73 (87 .03 to 96.43) Human mandible 
70.62 (60.23 - 81.01) Human mandible 
95.01 Human mandible 
27 months (24 months) Zirconia ceramic screw 12 (3) Whole implant 
38 months Micro Vent HA 2 (1) All threads 
1 month Custom - half HA-coated 2 (2) All threads 
3 month Custom - half HA-coated 2 (2) All threads 
6 month Custom - half HA-coated 2 (2) All threads 
12 month Custom - half HA-coated 1 (1) All threads 
Appendix Table 11. Percent bone density within implant threads, grouped by animal model. 
Sennerby et al.283 1992 33.4 ± 13.4 Rabbit tibia 6 weeks Branemark modified 6 (6) All threads 
42.6 ± 10.0 Rabbit tibia 3 months Branemark modified 6 (6) All threads 
35.7 ± 9.0 Rabbit tibia 6 months Branemark modified 6 (6) All threads 
Wennerberg et al.380 1995 32.5 (5.5-69.7) Rabbit tibia 12 weeks TiO2-blasted solid screw 10 (10) All threads 
64.3 Rabbit tibia 12 weeks TiO2-blasted solid screw 10 (10) All threads 
50.2 (25.7-80.8) Rabbit tibia 12 weeks Turned titanium solid 10 (10) Best 3 threads 
screw 
80.2 Rabbit tibia 12 weeks Turned titanium solid 10 (10) Best 3 threads 
screw 
Wennerberg et al.462 1996a 39.2 Rabbit tibia 12 weeks 25µm AIP3- blasted 9 (9) All threads 
73.2 Best 3 threads 
35.4 Rabbit tibia 12 weeks 75µm Alz03- blasted 9 (9) All threads 
63.3 Best 3 threads 
Ivanoff et al. 455 1996a •. 54.2±17.7 Rabbit tibia 12 weeks Branemark 7 (7) Whole implant 
Wennerberg et al.463 1996b 42.8 Rabbit tibia 12 weeks 25µm TiO2- blasted 10 (10) All threads 
66.7 Best 3 threads 
37.4 Rabbit tibia 12 weeks 25µm Alz03- blasted 10 (10) All threads 
70.4 Best 3 threads 
50.1 Rabbit tibia 12 weeks 75µm Alz03- blasted 10 (10) All threads 
(.;) 
72.8 Best 3 threads 'Ci 
N Wennerberg et al.464 1996c 46.9 Rabbit tibia 4 weeks 25µm TiO2- blasted 9 (9) All threads 
64.7 Best 3 threads 
40.7 Rabbit tibia 4 weeks 250,um TiO2- blasted 9 (9) All threads 
63.7 Best 3 threads 
Michaels et al. 371 1997 48.37 ± 13.37 Rabbit tibia 6 weeks SteriOss ti alloy 2 (1) 4 best threads 
42.95 ± 9.18 Rabbit tibia 18 weeks (12 weeks) SteriOss ti alloy 16 (8) 4 best threads 
; Wennerberg .et al. 465 1997 58 Rabbit tibia 16 weeks turned titanium 1 (1) All threads 
78 Best 3 threads 
41 Rabbit tibia 16 weeks 25µm Al2O3- blasted 1 (1) All threads 
80 Best 3 threads 
60 ±21 Rabbit tibia 1 year turned titanium 9 (9) All threads 
89±4 Best 3 threads 
42±7 Rabbit tibia 1 year 25µm Alz03- blasted 9 (9) All threads 
69 ± 11 Best 3 threads 
Gottlander et al.388 1997a 38.2 ± 8.3 Rabbit tibia 4 weeks Branemark titanium screw 6 (6) All threads 
28.7 ± 7.4 Rabbit tibia 4 weeks HA plasma-sprayed screw 6 (6) All threads 
58.0 ± 16.0 Rabbit tibia 6 months Branemark titanium screw 9 (9) All threads 
41.1 ± 9.0 Rabbit tibia 6 months HA plasma-sprayed screw 9 (9) All threads 
Gottlander et al.524 1997b · 34.7 ± 9.4 Rabbit tibia 4 weeks Branemark titanium screw 9 (9) All threads 
42.1 ± 8.0 Rabbit tibia 4 weeks Ca-P-coated screw 9 (9) All threads 
60.6 ± 15.6 Rabbit tibia 6 months Branemark titanium screw 8 (8) All threads 
41.8 ± 9.4 Rabbit tibia 6 months Ca-P-coated screw 8(8) All threads 
Han et al.850 1998 35 ±5 Rabbit tibia 3 months 25µm-blasted Ti 9 (9) Whole implant 
74 ± 10 Best 3 threads 
32 ± 6.7 Rabbit tibia 3 months 75µm-blasted Ti 10 (10) Whole implant 
72 ±5.9 Best 3 threads 
35 ± 4.9 Rabbit tibia 3 months 75µm-blasted Ti6AL4V 10 (10) Whole implant 
77 ± 7.9 alloy Best 3 threads 
Johansson et al.829 1998 33 ± 6.8 Rabbit tibia 1 month turned titanium 9 (9) Whole implant 
69 ± 4.8 Best 3 threads 
37 ± 7.2 Rabbit tibia 1 month turned titanium alloy 9 (9) Whole implant 
73 ± 5.7 Best 3 threads 
39 ± 10 Rabbit tibia 6 months turned titanium 11 (11) Whole implant 
77 ± 10.2 Best 3 threads 
38 ± 7.7 Rabbit tibia 6 months turned titanium alloy 11 (11) Whole implant 
81 ± 4.7 Best 3 threads 
46 ± 8.5 Rabbit tibia 1 year turned titanium 10 (10) Whole implant 
81 ± 6.7 Best 3 threads 
43 ± 7.2 Rabbit tibia 1 year turned titanium alloy 10 (10) Whole implant 
w 82 ± 5.2 Best 3 threads I.O 
Wennerberg et.al.389 Whole implant w 1998 48 ± 6 Rabbit tibia 12 weeks Machined Ti 10 (10) 
79±3 Best 3 threads 
52± 10 Rabbit tibia 12 weeks Machined Ti 10 (10) Whole implant 
82± 9 Best 3 threads 
49 ± 8 Rabbit tibia 12 weeks 25 µm Al203 -blasted 10 (10) Whole implant 
78 ± 16 Best 3 threads 
41 ± 15 Rabbit tibia 12 weeks 25µm Al203 -blasted 10 (10) Whole implant 
76 ± 9 Best 3 threads 
36± 14 Rabbit tibia 12 weeks 25 Jtm Al203 -blasted 10 (10) Whole implant 
69 ± 16 Best 3 threads 
36 ± 11 Rabbit tibia 12 weeks 75µm Al203 -blasted 10 (10) Whole implant 
72± 19 Best 3 threads 
49 ± 13 Rabbit tibia 12 weeks 250µmAl203 -blasted 10 (10) Whole implant 
83 ± 2 Best 3 threads 
34± 10 Rabbit tibia 12 weeks 250µm Al203 -blasted 10 (10) Whole implant 
70 ± 16 Best 3 threads 
Kim et al. 851 2003 53.1 ± 16.9 Rabbit tibia 4 weeks Blasted 12 (6) Best 3 threads 
44.9 ± 16.9 Rabbit tibia 4 weeks Blasted & oxidised 12 (6) Best 3 threads 
63.0 ± 12.5 Rabbit tibia 12 weeks Blasted 12 (6) Best 3 threads 
69.9 ± 11.6 Rabbit tibia 12 weeks Blasted & oxidised 12 (6) Best 3 threads 
Gottlaiideret al,388 1997a 50.8 ± 15.5 Rabbit combined 4 weeks Branemark titanium screw 12 (6) All threads 
40.6 ± 16.3 Rabbit combined 4 weeks HA plasma-sprayed screw 12 (6) All threads 
63.5 ± 14.5 Rabbit combined 6 months Branemark titanium screw 17 (9) All threads 
38.9 ± 10.5 Rabbit combined 6 months HA plasma-sprayed screw 17 (9) All threads 
·sul et al.412 2002b 58 ± 10 Rabbit tibia & femur 6 weeks Branemark turned 10(10) Whole implant 
(37-74) 
79 Rabbit tibia & femur 6 weeks Branemark turned 10(10) Best-3-threads 
61 ± 12 Rabbit tibia & femur 6 weeks Branemark oxidised (600- 10(10) Whole implant 
(12-74) 1000nm) 
79 Rabbit tibia & femur 6 weeks Branemark oxidised (600- 10(10) Best-3-threads 
Ivanoff et al.455 1996a• 
1000nm) 
55.5±17.6 Rabbit femur 12 weeks Branemark 7 (7) Whole implant 
Wennerberg et al.463 1996b 51.1 Rabbit femur 12 weeks turned titanium 10 (10) All threads 
77.0 Best 3 threads 
W~nnerberg et al.465 1997 59 Rabbit femur 11 weeks turned titanium 1 (1) All threads 
74 Best 3 threads 
39 Rabbit femur 11 weeks 25 µm Alz03- blasted 1 (1) All threads 
74 Best 3 threads 
Gottlander et al.388 1997a 63.4 ± 8.9 Rabbit femur 4 weeks Branemark titanium screw 6 (6) All threads 
53.1 ± 12.6 Rabbit femur 4 weeks HA plasma-sprayed screw 6 (6) All threads 
70.5 ±9.8 Rabbit femur 6 months Branemark titanium screw 8(8) All threads 
w 36.5 ± 12.0 Rabbit femur 6 months HA plasma-sprayed screw 8(8) All threads \0 
-l's Gottland er et al. 524 1997b 10.0 ± 11.3 Rabbit femur 4 weeks Branemark titanium screw 9(9) All threads 
51.0 ± 11.1 Rabbit femur 4 weeks Ca-P-coated screw 9(9) All threads 
69.6 ± 8.0 Rabbit femur 6 months Branemark titanium screw 8(8) All threads 
44.3 ± 12.0 Rabbit femur 6 months Ca-P-coated screw 8(8) All threads 
Han et al.850 1998 38 ± 8 Rabbit femur 3 months 25µm-blasted Ti6AL4V 9 (9) Whole implant 
76 ± 6 alloy Best 3 threads 
Sennerby et al. 283 1992 51.3 ± 16.6 Rabbit knee joint 6 weeks Branemark modified 6 (6) All threads 
63.0 ± 8.7 Rabbit knee joint 3 months Branemark modified 6 (6) All threads 
75.0 ± 8.0 Rabbit knee joint 6 months Branemark modified 6 (6) All threads 
Abrahamsson et al. 863 1996 85.4 ± 0.54 Dog mandible 9 months (6 months) Astra titanium screw 2 (5) 3 mm from superior border a 
87.4 ± 2.42 Dog mandible 9 months (6 months) Branemark titanium screw 2 (5) 3 mm from superior border 
88.4 ± 4.16 Dog mandible 9 months (6 months) ITI Bonefit titanium screw 2 (5) 3 mm from superior border 
Abrahamss.on et al.342 1999 81.9 ± 4.48 Dog mandible 9 months (6 months) Asta Tech 2-stage 16 (6) Non-threaded (cortical) and 
48.9 ± 7.25 (submerged) threaded (cancellous) part 
84.56 ± 3.72 Dog mandible 9 months (9 months) Asta Tech 1-stage 16 (6) Non-threaded (cortical) and 
45.76 ± 12.29 threaded (cancellous) part 
Abrahamsson et al.390 2001 75.80±4.40 Dog mandible 6 months (3 months) 3i turned implant 10(5) Coronal threads only 
78.69±4.64 Dog mandible 6 months (3 months) 3i Osseotite 10(5 Coronal threads only 
77.35±8.17 Dog mandible 6 months (3 months) 3i turned implant 10(5) Apical threads only 
78.18±6.94 Dog mandible 6 months (3 months) 3i Osseotite 10(5 Apical threads only 
Abrahamsson et al.837 20()4 6 1 week Whole implant 
13 2 weeks Whole implant 
22 
Dog mandible 
4 weeks ITI with bone chamber in 
10(5) 
Whole implant 
49 6 weeks thread - turned surface Whole implant 
56 8 weeks Whole implant 
67 12 weeks Whole implant 
12 1 week Whole implant 
22.5 2 weeks Whole implant 
27.5 
Dog mandible 
4 weeks ITI with bone chamber in 
10(5 
Whole implant 
33 6 weeks thread - SLA surface Whole implant 
34 8 weeks Whole implant 
34.5 12 weeks Whole implant 
Clemens et.al. 183 1.997 1.13 ± 1.63 Goat femur 6 weeks Blasted reel-shaped 8 (8) Whole implant, surface to 
cylinder, 1mm gap 500Jtm 
2.20 ± 2.53 Goat femur 6 weeks Blasted reel-shaped 8 (8) Whole implant, surface to 
cylinder 500µm 
2mmgap 
10.3 ± 7.81 Goat femur 6 weeks Amorphous HA-coated 8 (8) Whole implant, surface to 
reel-shaped cylinder, 1mm 500µm 
gap 
(.;) 2.23 ± 2.89 Goat femur 6 weeks Amorphous HA-coated 8 (8) Whole implant, surface to 
I.O 
reel-shaped cylinder, 2mm 500µm Vl 
gap 
5.13 ± 5.43 Goat femur 6 weeks FA-coated reel-shaped 8 (8) Whole implant, surface to 
cylinder, 1mm gap 500µm 
2.82 ± 3.63 Goat femur 6 weeks FA-coated reel-shaped 8 (8) Whole implant, surface to 
cylinder, 2mm gap 500µm 
14.1 ± 12.41 Goat femur 6 weeks Crystalline HA-coated 8 (8) Whole implant, surface to 
reel-shaped cylinder, 1mm 500µm 
gap 
2.06 ± 3.03 Goat femur 6 weeks Crystalline HA-coated 8 (8) Whole implant, surface to 
reel-shaped cylinder, 2mm 500µm 
Lucchini et al.313 1996 56 ± 5.2 Sheep femur 12 weeks 
gap 
SERF 5(2) 6 threads for all implant h 
63 ± 7.3 Sheep femur 12 weeks Branemark 5(2) 6 threads for all implant h 
Chappard et al.314 1999 37.6 ± 3.3 Sheep femur 3 months Branemark cp-Ti screw n=4 (3) Best 3 threads (bilateral) 
43.5 ± 2.1 Sheep femur 3 months Eurotecknika cp-Ti screw 4 (3) Best 3 threads (bilateral) 
38.2 ± 2.3 Sheep femur 6 months Branemark cp-Ti screw n=4 (3) Best 3 threads (bilateral) 
37.1±2.6 Sheep femur 6 months Eurotecknika cp-Ti screw 4 (3) Best 3 threads (bilateral) 
Giavaresi et al.403 2002 77.9 ± 4.5 Sheep femur 8 weeks Blasted & etched Ti screw 4(4) Best3 threads 
92.6±4.2 Sheep femur 12 weeks Blasted & etched Ti screw 4(4) Best3 threads 
73.5 ± 5.2 Sheep femur 8 weeks Oxidised, CaP-coated 4(4) Best3 threads 
screw 
7 
80.6 ± 17.9 Sheep femur 12 weeks Oxidised, CaP-coated 4(4) Best3 threads 
screw 
Giavaresi et al.315• 316 2003a&b 77.9±8.0 Sheep femur 8 weeks Machined Ti screw 4(4) Best 3 threads 
65.9±10.6 Sheep femur 8 weeks Acid-etched Ti screw 4(4) Best 3 threads 
69.2±3.8 Sheep femur 8 weeks HA plasma-sparayed Ti 4(4) Best 3 threads 
screw 
66.0±2.5 Sheep femur 8 weeks Oxidised HA coated Ti 4(4) Best 3 threads 
screw 
88.3±2.9 Sheep femur 12 weeks Machined Ti screw 4(4) Best 3 threads 
76.7±8.7 Sheep femur 12 weeks Acid-etched Ti screw 4(4) Best 3 threads 
80±0 Sheep femur 12 weeks HA plasma-sparayed Ti 4(4) Best 3 threads 
screw 
81.2±5.3 Sheep femur 12 weeks Oxidised HA coated Ti 4(4) Best 3 threads 
screw 
<::aja and Moroni395 1996 95.6 ± 5.7 Sheep tibia 6 weeks HA-sprayed s.s. ext 7 (7) Cortical passage only 
(84 - 100) fixation screw 
69.9 ± 27.9 Sheep tibia 6 weeks Machined s.s. ext fixation 7 (7) Cortical passage only 
(9 - 89) screw 
Moroni et al.396 1996 89.5 Sheep tibia 4 months HA sprayed s.s. screw 2 (2) Both cortical passages 
28.16 Sheep tibia 4 months Machined s.s. screw 2 (2) Both cortical passages 
100 Sheep tibia 12 months HA sprayed s.s. screw 2 (2) Both cortical passages 
w 63.2 Sheep tibia 12 months Machined s.s. screw 2 (2) Both cortical passages 
~ Fini etal.126 2002 87.24 ± 8.57 Sheep tibia 3 months Ti alloy scew 3 (9) All threads 
Carr.etal.536 1997a. 44.9± 6.2 Baboon mandible 3 months SteriOss cpTi, Ti-6Al-4V, 10 (5) b Fixture+ 3mm c 
HA 
Carr et al.840 1997b. 44.0±2.0 Baboon mandible 3 - 4 months (1 day - 1 Ti alloy 10 (6) Fixture + 3mm 
month) 
2000 52.3 Baboon mandible 6 months SteriOss cp_ti 4 (4) Fixture+ 3mm 
53.3 Baboon mandible 6 months SteriOss Ti alloy 4 (4) Fixture + 3mm 
52.2 Baboon mandible 6 months SteriOss TPS 4 (4) Fixture + 3mm 
Carr et al.53? 1997a: 35.8 ± 3.6 Baboon maxilla 3 months SteriOss cpTi, Ti-6Al-4V, 10 (5) Fixture + 3mm 
HA 
Carr et al. 824 2000 43.3 Baboon maxilla 6 months SteriOss cp_ti 4 (4) Fixture + 3mm 
45.0 Baboon maxilla 6 months SteriOss Ti alloy 4 (4) Fixture + 3mm 
42.5 Baboon maxilla 6 months SteriOss TPS 4 (4) Fixture + 3mm 
Akagawa et al. 862 1998 61.3 ±11.3 Macaque mandible 15 months (12 months) Zirconia ceramic screw 16 (4) Whole implantr 
60.2 ±8.7 Macaque mandible 27 months (24 months) Zirconia ceramic screw 12 (3) Whole implantr 
Romanos et al. 855 2002 65.42 ± 19.88 Macaque mandible 6 months (2 months) Ankylos cp-Ti, blasted 18 (6) Best 3 
76.95 ± 11.35 Macaque mandible 3 months (2 months) Ankylos cp-Ti, blasted 18 (6) Best 3 
Albrektsson efal. 842 1993 75.1 Human maxilla 6 months Branemark 3 (1) Best 3 threads/ All threads d 
(55.3 - 87.6) 
88 Human maxilla 1 year (6 months) Branemark 1 (1) Best 3 threads/ All threads d 
79.7 Human maxilla 9 - 16 years (8.5 - 15.5 Branemark 6 (5) Best 3 threads/ All threads d 
(71 - 95.7) years) 
Jensen et al.~62 1998 20 ± 19 Human maxilla 6 to 14 months Ti Mini-implant 6 (4) All threads (mainly represents 
(allografted sinus) cortical contact) 
50 ± 8 Human maxilla 6 to 12 months Ti Mini-implant 6 (5) All threads ( cortical contact + 
(autografted sinus) graft contact) 
Trisi et al. 2002 56.9 ±22.2 Human maxilla 6 months 2 sided (machined vs 11(11) All threads 
Osseotite) 
Ivanoff et al.472 2003 23 ± 13 Human maxilla 6.6 months Branemark (mini-implant) 9 (9) All threads 
machined 
32 ± 18 Human maxilla 6.6 months Branemark (mini-implant) 8 (8) All threads 
Tiunite oxidised 
Trisi ef aL 846 2003a 38.6 ± 13.6 Human maxilla 2 months 2 sided (machined vs 11(11) All threads 
Osseotite) 
Trisi et al. 847 2003b 45.8 ± 9.8 Human maxilla 6 months 2 sided (machined vs MTX 6 (6) All threads 
Lateral sinus wall blasted, acid washed) 
41.57 ± 5.9 Human maxilla 6 months 2 sided (machined vs MTX 3 (3) All threads 
Alveolar crest blasted, acid washed) 
w Albrektssori et al.329 1993 84.9 Human mandible 2.5 - 8 year (2 - 7.5 Branemark 17 (7) Best 3 threads/ All threads d 
\0 
--.) (41.5 - 94) years) 
78 Human mandible 9 - 16 years (8.5 - 15.5 Branemark 6 (4) Best 3 threads/ All threads d 
(35 - 92.8) years) 
Palmer et al. 843 1994 38 (39) Human mandible 5 months Branemark 6 (6) Linguo-coronal 3 threads 
58 (30) Human mandible 5 months Branemark 6 (6) Linguo-apical 3 threads 
Palmer et al.844 1998 49 (38) Human mandible 17 months (12 months) Branemark 6 (10) Linguo-coronal 3 threads 
77 (15) Human mandible 17 months (12 months) Branemark 6 (10) Linguo-apical 3 threads 
Ivanoff et al.472 2003 31 ± 20 Human mandible 3.5 months Branemark (mini-implant) 11 (11) All threads 
machined 
44 ± 12 Human mandible 3.5 months Branemark (mini-implant) 11 (11) All threads 
Tiunite oxidised 
Sennerby et al. 864 1991· 79.4 - 95.7 Human jaws 1 -16 years Branemark titanium screw 6 (4) All threads 
a measured bone within threads starting from superior border ie: within "cortical passage". 
b results combined for different types of fixture surface 
c bone as % of total area measured up to 3mm distant from fixture surface 
d 3-best-threads on each side, or all threads if <3 threads available 
e control (stable) implants only 
f combined M-D and B-L mean data for all superstructure groups 
Appendix Table 12. Percent bone density measured outside implant threads, grouped by animal model. 
Branemark titanium screw 
Rabbit tibia 6 months HA plasma-sprayed screw 9 (9) All threads 
Gottlander et al.524 1997b 42.2 ± 7.1 Rabbit tibia 4 weeks Branemark titanium screw 9 (9) All threads 
44.8 ± 8.2 Rabbit tibia 4 weeks Ca-P-coated screw 9 (9) All threads 
55.2 ± 6.6 Rabbit tibia 6 months Branemark titanium screw 8 (8) All threads 
53.0 ± 11.5 Rabbit tibia 6 months Ca-P-coated screw 8(8) All threads 
Wenrierberg et al. 389 1998 48 ±7 Rabbit tibia 12 weeks Machined Ti 10 (10) Whole implant 
86 ±5 Best 3 threads 
55 ± 11 Rabbit tibia 12 weeks Machined Ti 10 (10) Whole implant 
89 ± 8 Best 3 threads 
50 ± 10 Rabbit tibia 12 weeks 25 µm Al203 -blasted 10 (10) Whole implant 
86 ±9 Best 3 threads 
40 ± 11 Rabbit tibia 12 weeks 25µm Al203 -blasted 10 (10) Whole implant 
81 ± 14 Best 3 threads 
4± 14 Rabbit tibia 12 weeks 25µm Al203 -blasted 10 (10) Whole implant 
78 ± 18 Best 3 threads 
37 ± 12 Rabbit tibia 12 weeks 75µm Al203 -blasted 10 (10) Whole implant 
VJ 
80 ±25 Best 3 threads I.O 
00 
52 ± 13 Rabbit tibia 12 weeks 250µm Al203 -blasted 10 (10) Whole implant 
90±6 Best 3 threads 
33 ±9 Rabbit tibia 12 weeks 250µm Al203 -blasted 10 (10) Whole implant 
73 ±24 Best 3 threads 
Sul etal.412 2002b 81 ± 10 Rabbit tibia & femur 6 weeks Branemark turned 10(10) Best-3-threads min-or-outfold 
(74-99) 
86 ± 6 Rabbit tibia & femur 6 weeks Branemark oxidised (600- 10(10) Best-3-threads min-or-outfold 
(43-97) 1000nm) 
Gottlander et al.388 1997a 59.9 ± 14.7 Rabbit femur 6 months Branemark titanium screw 8(8) All threads 
35.2±10.1 Rabbit femur 6 months HA plasma-sprayed screw 8(8) All threads 
Gottlancler et.al.524 1997b 63.5 ± 19.2 Rabbit femur 4 weeks Branemark titanium screw 9(9) All threads 
4,3.0 ± 10.5 Rabbit femur 4 weeks Ca-P-coated screw 9(9) All threads 
70.3 ± 8.8 Rabbit femur 6 months Branemark titanium screw 8(8) All threads 
39.6 ± 9.0 Rabbit femur 6 months Ca-P-coated screw 8(8) All threads 
Weinlander et al.534 1992 54.66 ± 11.82 Dog mandible 3 month Branemark machined screw 7 (7) 2mm lateral to implant 
55.18 ± 19.58 Dog mandible 3 month Interpore TPS-coated cylinder 7 (7) 2mm lateral to implant 
62.96±17.6 Dog mandible 3 month Calcitek HA-coated cylinder 7 (7) 2mm lateral to implant 
Kohal eta!. 836 · ·1998 24.6 ± 16.2 Dog mandible' 6 months Implant Innovations cp-Ti 4 (2) 2mm x 2mm coronal 1/3 
17.4±3.6 (immediate, GT AM) 2mm x 2mm apical 2/3 
34.4 ± 13.11 Dog mandible' 6 months Implant Innovations cp-Ti 4 (2) 2mm x 2mm coronal 1/3 
7.9 ± 7.9 (immediate, GTAM +HA) 2mm x 2mm apical 2/3 
34.4 ± 18.5 Dog mandible' 6 months Implant Innovations cp-Ti 4 (2) 2mm x 2mm coronal 1/3 
16.1±1.3 (immed, GTAM+ DFDBA) 2mm x 2mm apical 2/3 
Kohalet al.859 1999 53.1 ± 22.0 Dog mandible 6 months HA-coated Paragon ScrewVent 3(3) 2mm x 2mm coronal 1/3 
33.1 ±2.6 (Non-submerged) 2mm x 2mm apical 2/3 
31.3 ± 8.2 Dog mandible 6 months HA-coated Paragon ScrewVent 3 (3) 2mm x 2mm coronal 1/3 
28.6 ± 12.2 (submerged) 2mm x 2mm apical 2/3 
35.9 ± 8.9 Dog mandible 3 months HA-coated Paragon ScrewVent 6 (3) 2mm x 2mm coronal 1/3 
23.6 ± 4.1 (submerged) 2mm x 2mm apical 2/3 
88.31±3.30 Dog mandible 6 months (3 months) 3i turned implant 10(5) 
Outside coronal threads to 
Abrahamsson et al.390 2001 400µm from implant surface 
88.15±2.76 Dog mandible 6 months (3 months) 3i Osseotite 10(5 
Outside coronal threads to 
400µm from implant surface 
87.63±7.03 Dog mandible 6 months (3 months) 3i turned implant 10(5) 
Outside apical threads to 
400µm from implant surface 
84.02±5.57 Dog mandible 6 months (3 months) 3i Osseotite 10(5 
Outside apical threads to 
400µm from implant surface 
Weng et. al.499 2003 49.9±16.7 Dog mandible 4 months 3i Machined Ti screw 10(5) lmm2 area near implant apex 
52.2±8.4 Dog mandible 4 months 3i Osseotite 10(5) lmm2 area near implant apex 
Clemens et.al. 183 1997 11.84 ± 4.97 Goat femur 6 weeks Blasted reel-shaped cylinder, 8 (8) Whole implant 1mm x 8mm 
w lmmgap '-0 
'-0 4.07 ± 2.22 Goat femur 6 weeks Blasted reel-shaped cylinder 8 (8) Whole implant 2mm x 8mm 
2mmgap 
18.29±7.31 Goat femur 6 weeks Amorphous HA-coated reel- 8 (8) Whole implant 1mm x 8mm 
shaped cylinder, 1mm gap 
4.86 ± 3.04 Goat femur 6 weeks Amorphous HA-coated reel- 8 (8) Whole implant 2mm x 8mm 
shaped cylinder, 2mm gap 
18.13 ± 6.78 Goat femur 6 weeks FA-coated reel-shaped cylinder, 8 (8) Whole implant 1mm x 8mm 
lmmgap 
6.54 ± 4.55 Goat femur 6 weeks FA-coated reel-shaped cylinder, 8 (8) Whole implant 2mm x 8mm 
2mmgap 
21.52 ± 12.12 Goat femur 6 weeks Crystalline HA-coated reel- 8 (8) Whole implant 1mm x 8mm 
shaped cylinder, 1mm gap 
5.33 ± 4.16 Goat femur 6 weeks Crystalline HA-coated reel- 8 (8) Whole implant 2mm x 8mm 
shaped cylinder, 2mm gap 
Hulshoff et al.300 1997a 43.82 ± 8.61 Goat femur 3 months HA/FA-coated Biocomp screw 9 (9) 0.5mm x 2.0mm middle 113 
53.26 ± 12.81 Goat femur 3 months TPS/CaP-coated Biocomp screw 9 (9) 0.5mm x 2.0mm middle 113 
Clemens et al.184 1998 
8.0 ± 5.4 
Goat femur 24 weeks Blasted reel-shaped cylinder 8 (8) Whole implant 2mm x 8mm 
2mm gap 
14.2 ± 9.9 
Goat femur 24 weeks Amorphous HA-coated reel- 8 (8) Whole implant 2mm x 8mm 
shaped cylinder- 2mm gap 
14.9 ± 14.8 
Goat femur 24 weeks FA-coated reel-shaped cylinder - 8 (8) Whole implant 2mm x 8mm 
2mmgap 
15.7 ± 8.3 
Goat femur 24 weeks Crystalline HA-coated reel- 8 (8) Whole implant 2mm x 8mm 
shaped cylinder, 2mm gap 
Giavaresi et al.315• 316 2003a&b 87.5±6.8 Sheep femur 8 weeks Machined Ti screw 4(4) 2000 x 1400µm reference area 
from base of threads 
79.3±8.3 Sheep femur 8 weeks Acid-etched Ti screw 4(4) As above 
80.0±3.4 Sheep femur 8 weeks HA plasma-sprayed Ti screw 4(4) As above 
87.9±5.6 Sheep femur 8 weeks Oxidised HA coated Ti screw 4(4) As above 
80.7±7.4 Sheep femur 12 weeks Machined Ti screw 4(4) As above 
82.9±7.1 Sheep femur 12 weeks Acid-etched Ti screw 4(4) As above 
80.0±8.4 Sheep femur 12 weeks HA plasma-sprayed Ti screw 4(4) As above 
92.0±6.6 Sheep femur 12 weeks Oxidised HA coated Ti screw 4(4) As above 
Wadamoto et al.537 1996 61.3 ± 7.4 Macaque monkey 3 months HA-coated cylinder 3 (3) Whole implant 
(58.1 - 71.1) mandible 
Isidor et al.841 1998 55 Macaque mandible 24 months (18 AstraTech (machined & TiO2 6 (3) Whole implant 
.i:,. 
(45.5 - 66.2) months) combined) 
0 38 Macaque mandible 24 months (18 AstraTech (machined & TiO2 10 (4) Whole implant 0 
(21.5 - 60.9) months) combined) 
Ivanoff etal.472 2003 27 ± 12 Human maxilla 6.6 months Branemark (mini-implant) 9 (9) All threads, mirror outfold 
machined 
27 ± 14 Human maxilla 6.6 months Branemark (mini-implant) 8 (8) All threads, mirror outfold 
Tiunite oxidised 
39 ± 19 Human mandible 3.5 months Branemark (mini-implant) 11 (II) All threads, mirror outfold 
machined 
44 ± 13 Human mandible 3.5 months Branemark (mini-implant) 11 (11) All threads, mirror outfold 
Tiunite oxidised 
a 18 months occlusal overload 
b 18 months ligature-induced plaque accumulation 
Appendix Table 13. Histomorphometric analysis of implants in sheep models 
85.7 ± 8.9 Tibia 6 weeks HA-sprayed s.s. ext fixation screw 7 (7) Cortical passage only 
43.1 ± 26.6 Tibia 6 weeks Machined s.s. ext fixation screw 7 (7) Cortical passage only 
Hureet itl.311 1996 60.42±7.94 Femur 6 months cp Ti (Eurotechnika) 6 (2) All threads 
56.02±5.80 Femur 6 months Branemark cp Ti 4 (2) All threads 
Lucchini et al. 313 1996 68.0 ± 11.6 Femur 12 weeks SERF 5(2) 6 threads for all implant h 
61.0 ± 11.7 Femur 12 weeks Branemark 5(2) 6 threads for all implant h 
16 ±9 Tibia 6 weeks 5-6 mm dia s.s. ext fixation screw 6 (6) Transverse sections (t-s), both 
cortical passage only 
Moroni et al. 396 1996 30 ± 12 Tibia 6 weeks 5-6 mm dia HA coated s.s. ext 6 (6) Transverse sections, both 
fixation screw cortical passage only 
26 ± 15 Tibia 6 weeks 5-6 mm dia Ti coated s.s. ext 6 (6) T-s, both cortical passage 
fixation screw only 
87.85 Tibia 4 months HA sprayed s.s. screw 2 (2) Both cortical passages 
+'- 11.26 Tibia 4 months Machined s.s. screw 2 (2) Both cortical passages 
0 - 93.8 Tibia 12 months HA sprayed s.s. screw 2 (2) Both cortical passages 
16.5 Tibia 12 months Machined s.s. screw 2 (2) Both cortical passages 
Rocca et al. 398 1998 15.51 ± 16.93 Femur & Tibia 2 weeks TPS-coated threaded cylindrical 7 (3) T-s, cortical passage only 
screw 
34.48 ± 17.3 Femur & Tibia 1 month TPS-coated threaded cylindrical 7 (3) T-s, cortical passage only 
screw 
46.31 ± 30.91 Femur & Tibia 3 months TPS-coated threaded cylindrical 7 (3) T-s, cortical passage only 
screw 
76.86 ± 15.87 Femur & Tibia 9 months TPS-coated threaded cylindrical 7 (3) T-s, co1tical passage only 
screw 
Rodrigues Y. Baena et 1998 ND Proximal Tibia & 24 days & 45 days AstraTech TiOblast or Standard 3 (1)7 (1) Grafted with Biooss and 
al.141 Distal Femur Vicryl or not grafted. No 
Chappard.et al:314 1999 
histomorphometics a 
57.9 ± 3.37 Femur 3 months Branemark 24(6) Best 3 threads 
85.5 ± 2.0 Femur 6 months Euroteknika 24(6) Best 3 threads 
57.9 ± 3.37 Femur 3 months Branemark 24(6) Best 3 threads 
85.5 ± 2.0 Femur 6 months Euroteknika 24(6) Best 3 threads 
:t,.1:oroni et al.399 1999 30 Tibia/ Femur 1 month Polished titanium screw 2 (2) Cortical passage only 
34 Tibia / Femur 1 month TPS titanium screw 2 (2) Cortical passage only 
54 Tibia / Femur 1 month HA plasma-sprayed titanium 2 (2) Cortical passage only 
screw 
24 Tibia/ Femur 3 months Polished titanium screw 2 (2) Cortical passage only 
51 Tibia / Femur 3 months TPS titanium screw 2 (2) Cortical passage only 
61 Tibia / Femur 3 months HA plasma-sprayed titanium 2 (2) Cortical passage only 
screw 
Fini et al.126 2002 75.79 ± 12.17 Tibia 3 months Ti alloy 9(3) All threads 
. Giavaresi et al. 403 2002 63.4 ± 3.4 Femur 8 weeks Oxidised, CaP-coated screw 4(4) Best3 threads 
78.5 ± 5.9 Femur 12 weeks Oxidised, CaP-coated screw 4(4) Best3 threads 
59.2±3.1 Femur 8 weeks Blasted & etched Ti screw 4(4) Best3 threads 
87.4 ± 8.1 Femur 12 weeks Blasted & etched Ti screw 4(4) Best3 threads 
Svehla et al. 401 • 402· 2000, 71 ± 19 Tibiae 4 weeks Grit-blasted, 50µm HA-sprayed 8(6) Longitudinal sections (1-s), 
2002 cylinder 6.25 x 18mm long HMAofBSEM 
65 ±20 Tibiae 8 weeks Grit-blasted, 50µm HA-sprayed 8(6) L-s, HMA of BSEM 
cylinder 
64 ± 15 Tibiae 12 weeks Grit-blasted, 50µm HA-sprayed 8(6) L-s, HMA of BSEM 
cylinder 
49 ± 39 Tibiae 4 weeks Grit-blasted, lO0µm HA-sprayed 29(6) L-s, HMA of BSEM 
cylinder 
74 ±23 Tibiae 8 weeks Grit-blasted, lO0µm HA-sprayed 29(6) L-s, HMA of BSEM 
cylinder 
75 ± 18 Tibiae 12 weeks Grit-blasted, lO0µm HA-sprayed 29(6) L-s, HMA of BSEM 
cylinder 
.j::. 80 ± 33 Tibiae 26 weeks Grit-blasted, lO0µm HA-sprayed 29(6) L-s, HMA of BSEM 
0 cylinder N 
29 ± 30 Tibiae 4 weeks TPS, 50µm HA HA-sprayed 43(6) L-s, HMA of BSEM 
cylinder 
67 ±27 Tibiae 8 weeks TPS, 50µm HA HA-sprayed 43(6) L-s, HMA of BSEM 
cylinder 
83 ± 14 Tibiae 12 weeks TPS, 50µm HA HA-sprayed 43(6) L-s, HMA of BSEM 
cylinder 
57 ± 18 Tibiae 26 weeks TPS, 50µm HA HA-sprayed 43(6) L-s, HMA of BSEM 
cylinder 
35 ±31 Tibiae 4 weeks TPS, lO0µm HA HA-sprayed 38(6) L-s, HMA of BSEM 
cylinder 
76 ± 25 Tibiae 8 weeks TPS, lO0µm HA HA-sprayed 38(6) L-s, HMA of BSEM 
cylinder 
79 ± 14 Tibiae 12 weeks TPS, lO0µm HA HA-sprayed 38(6) L-s, HMA of BSEM 
cylinder 
93 ± 12 Tibiae 26 weeks TPS, lO0µm HA HA-sprayed 38(6) L-s, HMA of BSEM 
cylinder 
51 ± 32 Tibiae 4 weeks TPS, l50µm HA HA-sprayed 14(6) L-s, HMA of BSEM 
cylinder 
68 ± 31 Tibiae 8 weeks TPS, l50µm HA HA-sprayed 14(6) L-s, HMA of BSEM 
cylinder 
80 ± 18 Tibiae 12 weeks TPS, 150µm HA HA-sprayed 14(6) L-s, HMA ofBSEM 
cylinder 
99±20 Tibiae 26 weeks TPS, 150µm HA HA-sprayed 14(6) L-s, HMA ofBSEM 
cylinder 
Giavaresf et al.31,. 316 2003a&b 59.8±8.9 Femur 8 weeks Machined Ti screw 4(4) Best 3 threads 
75.3±7.8 Femur 12 weeks Machined Ti screw 4(4) Best 3 threads 
49.1±8.6 Femur 8 weeks Acid-etched Ti screw 4(4) Best 3 threads 
50.9±7.8 Femur 12 weeks Acid-etched Ti screw 4(4) Best 3 threads 
61.5±6.4 Femur 8 weeks HA plasma-sparayed Ti screw 4(4) Best 3 threads 
63.6±7.4 Femur 8 weeks Oxidised HA coated Ti screw 4(4) Best 3 threads 
71.6±3.8 Femur 12 weeks HA plasma-sparayed Ti screw 4(4) Best 3 threads 
72.5±7.2 Femur 12 weeks Oxidised HA coated Ti screw 4(4) Best 3 threads 
Haas et al. 
30
' 1998 20.0 Maxillary sinus 12 weeks TPS Friatec cylinders 6(6) All implant 
25.1 Maxillary sinus 16 weeks TPS Friatec cylinders 6(6) All implant 
20.7 Maxillary sinus 26 weeks TPS Friatec cylinders 6(6) All implant 
Arvieret al. 121 1989 ND Extraction mandible 6,12,13 weeks Dentozyl screwsDentozyl (Ag 4 (5), 7 (6), 7 Descriptive histology only 
& Edentulous alloy), Au alloy, Au, Pt, Ag, Cu, (6) 
diastema Pd - cylinders 
Wie et al.30, 1995 28.8 Inferior border of 60 days 2-3x5mm cpTI cylinders 2 (2) Whole implant 
.i:,.. mandibular ramus 
0 
w 76.2 Inferior border of 60 days 2-3x5mm HIP-HA coated- Ti 3 (2) Whole implant 
mandibular ramus cylinders 
Rodrigues Y Baena et 1998 ND Edentulous mandible 74 days Dentsply ScrewVent 13mm 1 (1) Grafted with bone chips and 
al.141 Paroguide membrane. Not 
discussed further. 
Gagg! et al.116 2000a 70- 80 Mandibular distatema 6 months Laser-etched cp-Ti distraction 4 (2) Screw thread area only 
screw 
Appendix Table 14. Bone-to-implant contact with ceramic coated unthreaded (cylindrical) implants, grouped by animal model. 
25.8 ± 4.1 Rabbit tibia 3 weeks HA plasma-sprayed 6 (6) Whole implant 
24.1 ± 3.8 Rabbit tibia 12 weeks HA plasma-sprayed 6 (6) Whole implant 
Hayakawa et al.526 2000 75.4 ±4.3 Rabbit tibia 12 weeks Smooth CaP-coated Ti 6 (6) 3 cross-sectional sections 
84.5 ± 7.3 Rabbit tibia 12 weeks Rough CaP-coated Ti 6 (6) 3 cross-sectional sections 
Gottlander et aL387 1992 75.9 ± 8.0 (63.9 - 87.6) Rabbit femur 6 months IMZ 6 (6) Whole implant 
80.2±5.1 Rabbit femur 6 months IMZ 6 (6) Cortical passage 
. Hayakawaefal.526 2000 83.6 ± 2.5 Rabbit femur 12 weeks Smooth CaP-coated Ti 6 (6) 3 cross-sectional sections 
84.7 ± 2.4 Rabbit femur 12 weeks Rough CaP-coated Ti 6 (6) 3 cross-sectional sections 
Kohri et al:532 1990 61.0 ± 6.9 (49.6-70.0) Dog mandible 4 months (2 months) Apaceram 6 (3) Whole implant 
57.2 ± 10.8 (45.4 - 66.8) Dog mandible 4 months Apaceram 3 (3) Whole implant 
W einlander et al. 534 1992 71.35 ± 11.79 Dog mandible 3 month Calcitek HA-coated cylinder 7 (7) Whole implant 
Cook & Rust~ 1995 81.90 ± 31.84 Dog mandible 12 weeks (4 weeks) Integral HA-coated cylinder 8 (3) Whole implant 
Dawicki340 
66.69 ± 36.49 Dog mandible 16 weeks (8 weeks) Integral HA-coated cylinder 4 (4) Whole implant 
63.74 ± 28.22 Dog mandible 24 weeks (16 weeks) Integral HA-coated cylinder 5 (3) Whole implant 
85.29 ± 22.75 Dog mandible 34 weeks (26 weeks) Integral HA-coated cylinder 7 (5) Whole implant 
Dhert et al.304 • 1993. 59.4 ± 13.2 Goat femur 12 weeks HA-coated cylinders 7 (8) Whole implant 
69.5 ± 12.6 Goat femur 12 weeks FA-coated cylinder 8 (8) Whole implant 
.i:,. 
0 43.8 ± 16.3 Goat femur 12 weeks MW-coated cylinders 7 (8) Whole implant 
.i:,. 
59.5 ± 14.4 Goat femur 25 weeks HA-coated cylinders 7 (8) Whole implant 
75.6 ± 10.0 Goat femur 25 weeks FA-coated cylinder 8 (8) Whole implant 
76.3 ± 15.4 Goat femur 25 weeks MW-coated cylinders 7 (8) Whole implant 
Caulier et al.298 1995 78.2 ± 9.4 Goat femur 3 months HA-coated cylinders 11 (11) Whole implant 
78.4 ± 8.15 Goat femur 3 months FA-coated cylinder 11 (11) Whole implant 
79.1±8.15 Goat femur 3 months HA coated & heated cylinder 11 (11) Whole implant 
Clemens et al. 183 1997 27.44 ± 20.81 Goat femur 6 weeks Amorphous HA-coated reel-shaped 8 (8) Whole implant 
cylinder, Imm gap 
16.41 ± 24.92 Goat femur 6 weeks Amorphous HA-coated reel-shaped 8 (8) Whole implant 
cylinder, 2mm gap 
20.97 ± 21.03 Goat femur 6 weeks FA-coated reel-shaped cylinder, 1mm gap 8 (8) Whole implant 
6.67 ± 11.03 Goat femur 6 weeks FA-coated reel-shaped cylinder, 2mm gap 8 (8) Whole implant 
33.78 ± 22.61 Goat femur 6 weeks Crystalline HA-coated reel-shaped 8 (8) Whole implant 
cylinder, 1mm gap 
9.88 ± 17.73 Goat femur 6 weeks Crystalline HA-coated reel-shaped 8 (8) Whole implant 
cylinder, 2mm gap 
Clemens et al. 184 1998 
19.7 ± 12.5 
Goat femur 24 weeks Amorphous HA-coated reel-shaped 8 (8) Whole implant 
cylinder, 2mm gap 
18.4 ± 17.8 
Goat femur 24 weeks FA-coated reel-shaped cylinder 8 (8) Whole implant 
2mmgap 
21.4 ± 12.4 
Goat femur 24 weeks Crystalline HA-coated reel-shaped 8 (8) Whole implant 
cylinder, 2mm gap 
Dhert et.a!.304 1993 66.8 ± 17.5 Goat humerus 12 weeks HA-coated cylinders 6 (8) Whole implant 
68.2 ± 13.6 Goat humerus 12 weeks FA-coated cylinder 6 (8) Whole implant 
57.1 ± 12.5 Goat humerus 12 weeks MW-coated cylinders 5 (8) Whole implant 
54.8 ± 20.4 Goat humerus 25 weeks HA-coated cylinders 6 (8) Whole implant 
73.7 ± 5.6 Goat humerus 25 weeks FA-coated cylinder 7 (8) Whole implant 
72.1 ± 13.7 Goat humerus 25 weeks MW-coated cylinders 7 (8) Whole implant 
Caulier .et al.535 1997 55.4 ± 15.6 Goat mandible 3 months Cp-Ti cylinder 2(11) 
55.7 ± 22.6 cortical & Whole implant 
trabecular bone 
64.3 ± 19 Goat mandible 3 months HA coated cylinder 7(11) 
60.9 ± 18.1 cortical & Whole implant 
trabecular bone 
63.6 ± 15.5 Goat mandible 3 months HA coated & heat-treated cylinder 6(11) 
65.5 ± 18.5 cortical & Whole implant 
trabecular bone 
77.9± 14.5 Goat mandible 3 months Fluoroapatite-coated cylinder 6(11) 
.J::,. 71.6 ± 16 cortical & Whole implant 
0 
Ut trabecular bone 
Svehla et al.401 • 402 2000, 71 ± 19 Sheep tibiae 4 weeks Grit-blasted, 50µm HA-sprayed cylinder 8(6) Longitudinal sections, 
2002 65 ±20 8 weeks 6.25 x 18mm long HMAofBSEM 
64 ± 15 12 weeks 
49 ±39 Sheep tibiae 4 weeks Grit-blasted, 100Jtm HA-sprayed cylinder 29(6) Longitudinal sections, 
74 ± 23 8 weeks 6.25 x 18mm long HMAofBSEM 
75 ± 18 12 weeks 
80 ± 33 26 weeks 
29 ± 30 Sheep tibiae 4 weeks TPS, 50µm HA HA-sprayed cylinder 43(6) Longitudinal sections, 
67 ±27 8 weeks 6.25 x 18mm long HMAofBSEM 
83 ± 14 12 weeks 
57 ± 18 26 weeks 
35 ± 31 Sheep tibiae 4 weeks TPS, lO0µm HA HA-sprayed cylinder 38(6) Longitudinal sections, 
76 ± 25 8 weeks 6.25 x 18mm long HMAofBSEM 
79 ± 14 12 weeks 
93 ± 12 26 weeks 
51 ± 32 Sheep tibiae 4 weeks TPS, 150µm HA HA-sprayed cylinder 14(6) Longitudinal sections, 
68 ± 31 8 weeks 6.25 x 18mm long HMAofBSEM 
80 ± 18 12 weeks 
99 ± 20 26 weeks 
Buser et al.410 1991 60.6 ± 11.6 Pig mandible 3 weeks HA-coated hollow cylinder 8 (3) Best 4 sections 
69.5 ± 6.5 6 weeks circumferentially 
Sahin et al.538 
W adamoto et al.537 






66.9 ± 3.4 (64.5 - 69.3) 















Appendix Table 15. Histomorphometric analysis of bone-to-metal contact with hollow cylinder implants by animal species 
72.33±7.16 Dog mandible 
52.15±9.19 Dog mandible 3 months TPS 6 (2) All threads 
68.21 ± 10.44 Dog mandible 6 months (3 months) SLA 6 (2) All threads 
78.18 ± 6.81 Dog mandible 6 months (3 months) TPS 6 (2) All threads 
71.68 ± 6.64 Dog mandible 15 months (12 SLA 6 (2) All threads 
months) 
58.88 ± 4.62 Dog mandible 15 months (12 TPS 6 (2) All threads ' 
months) 
Alliot et al. 865 1999 70.2 ±22.2 Dog mandible 4 months ITI hollow screw 5 (10) All threads 
Brogniez et al. 860 2000 76 ±7 Dog mandible 6 months TPS 12 (3) "Zone A" cortical bone 
69 ± 8 Whole implant 
Buser et al.410 1991 24.9 ± 14 Pig femur & tibiah 3 weeks Electropolished Ti 8 (3) Best 4 sections 
circumferentially 
22.3 ± 10.6 Pig femur & tibia 3 weeks 6 weeks Sandblasted + acid 8 (3) Best 4 sections 
(0.12 -0.25µm, HF/HNO3) circumferentially 
30.4 ± 11.6 Pig femur & tibia 3 weeks Sandblasted 8 (3) Best 4 sections 
(0.25 to 0.50µm) circumferentially 
.j:,. 39.2 ± 12 Pig femur & tibia 3 weeks TPS 8 (3) Best 4 sections 
0 circumferential! y --..J 
52.1 ± 13 Pig femur & tibia 3 weeks Sandblasted + acid 8 (3) Best 4 sections 
(0.25 to 0.50µm; HC1/H2SO4 ) circumferentially 
60.6 ± 11.6 Pig femur & tibia 3 weeks HA 8 (3) Best 4 sections 
circumferentially 
25.1±7.4 Pig femur & tibia 6 weeks Electropolished Ti 8 (3) Best 4 sections 
circumferentially 
21.6 ± 9.3 Pig femur & tibia 6 weeks Sandblasted + acid 8 (3) Best 4 sections 
(0.12 -0.25µm, HF/HNO3) circumferentially 
33.6 ± 11.5 Pig femur & tibia 6 weeks Sandblasted 8 (3) Best 4 sections 
(0.25 to 0.50µm) circumferentially 
37.8 ± 11.6 Pig femur & tibia 6 weeks TPS 8 (3) Best 4 sections 
circumferentially 
57.7 ± 9.5 Pig femur & tibia 6 weeks Sandblasted + acid 8 (3) Best 4 sections 
(0.25 to 0.50µm; HCI/H2SO4 ) circumferentially 
69.5 ± 6.5 Pig femur & tibia 6 weeks HA 8 (3) Best 4 sections 
circumferentially 
. Gotfredsen et al. 287 1991 35.17 Green Vervet 22 weeks TPS 1- & 2-stage combined 12 (3) Whole implant 
monkey mandible 
59.67 Green Vervet 
monkey mandible 
Wilson et al. 857 1998 31.07 ± 38.35 Human mandible & 
(2.75 - 87.31) maxilla 
Piattelli et al.866 1998d 93 ± 4.3 Human mandible & 
maxilla 
a immediate implants placed into extraction sockets (control data); lost implants excluded. 
h miniature pig 
23 
00 
22 weeks TPS 1- stage only 12 (3) Whole implant 
6 months ITI TPS-coated hollow-screw 2 (1) All threads 
1.6 to 4.0 years hollow-screw & - cylinder 4 (4) All threads 
( 
Appendix Table 16. Histomorphometric analysis of bone-to-metal contact with solid cylindrical rough-surfaced implants by animal species 
Al20 3 grit-blasted Ti 
Rabbit femur 12 weeks Al20 3 grit-blasted Ti 6 (6) 3 cross-sectional sections 
Weinlander et al.534 1992 54.96 ± 10.85 Dog mandible 3 month Interpore TPS-coated cylinder 7 (7) Whole implant 
Ettinger et al.867 1993 50.45 ± 14.16 (0-100) Dog mandible b 12 weeks IMZ TPS cylinder 4 (3) All of implant (horizontal 
+ longitudinal sections) 
Cook & Rust- 1995 66.81 ± 18.88 Dog mandible 12 weeks CSTi "porous" beaded cylinder 10 (3) Whole implant 
Dawicki340 (4 weeks) 
62.76 ± 20.57 Dog mandible 16 weeks CSTi "porous" beaded cylinder 4 (4) Whole implant 
(8 weeks) 
58.96 ± 25.80 Dog mandible 24 weeks CSTi "porous" beaded cylinder 10 (3) Whole implant 
(16 weeks) 
63.16 ± 28.00 Dog mandible 34 weeks CSTi "porous" beaded cylinder 5 (5) Whole implant 
(26 weeks) 
Kahal et al.868 1997 10.7 Dog mandible 1 week TPS-coated TI cylinder 3 (1) Whole implant 
2.7 ±0.9 Dog mandible 2 week TPS-coated TI cylinder 6 (2) Whole implant 
26.8 ± 11. Dog mandible 4week TPS-coated TI cylinder 6 (2) Whole implant 
4's-
60.7 ± 13.7 Dog mandible 3 months TPS-coated TI cylinder 6 (2) Whole implant 
0 Novaes et al.86~ 1998 38.7 ± 25.5(3.9 - 91.2) Dog mandible a 12 weeks IMZ TPS cylinder 12 (4) Middle 1/3 of implant \0 
Dhert etal.304 1993 33.6 ± 19.5 Goat femur 12 weeks Blasted Ti6Al4V cylinder 5 (8) Whole implant 
52.3 ± 15.4 Goat femur 25 weeks Blasted Ti6Al4V cylinder 5 (8) Whole implant 
Levy et al. 870 1996 38(9-81) Dog mandible & 6 weeks Two-stage Endopore porous-surface 10 (4) Whole implant 
maxilla cylinder 
28 (7 - 75) Dog mandible & 6 weeks One-stage Endopore porous-surface 10 (4) Whole implant 
maxilla cylinder 
Clemens et al. 183 1997 1.05 ± 2.46 Goat femur 6 weeks Blasted reel-shaped cylinder, 1mm 8 (8) Whole implant 
gap 
0.91 ±2.51 Goat femur 6 weeks Blasted reel-shaped cylinder 8 (8) Whole implant 
Clemens et al. 184 
2mm gap 
1998 
2.5 ± 2.9 
Goat femur 24 weeks Blasted reel-shaped cylinder 8 (8) Whole implant 
2mmgap 
Dhert eta!. 304 1993 51.5 ± 5.9 Goat humerus 12 weeks Blasted Ti6Al4V cylinder 6 (8) Whole implant 
51.0 ± 9.5 Goat humerus 25 weeks Blasted Ti6Al4V cylinder 7 (8) Whole implant 
Keller et al. 871 1987 70.4 ± 12.2 Rhesus monkey 3 - 74 months CSTi "porous" beaded cylinder 21 (12) Whole implant 
mandible 
a immediate implants placed into extraction sockets ( control data) 
b immediate implants placed into extraction sockets 
